bcr_patient_uuid	patient_ID	bcr_drug_barcode	bcr_drug_uuid	form_completion_date	pharmaceutical_therapy_drug_name	clinical_trial_drug_classification	pharmaceutical_therapy_type	days_to_drug_start	pharmaceutical_tx_ongoing_indicator	days_to_drug_end	treatment_best_response	days_to_stem_cell_transplantation	pharm_regimen	pharm_regimen_other	drug_cycles	pharma_type_other	drug_units	drug_tota_dose_units	drug_dose	regimen_number	drug_route	stem_cell_transplantation	stem_cell_transplantation_type	therapy_regimen	therapy_regimen_other	drug_total_dose	therapy_on_clinical_trial
1	30a1fe5e-5b12-472c-aa86-c2db8167ab23	TCGA.02.0001	TCGA-02-0001-D22170	2a1a1dd1-cc4a-4bf3-82b6-731e4ec7fcdd	2009-4-3	CELEBREX	NA	CHEMOTHERAPY	92	FALSE	278	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	400	NA
2	30a1fe5e-5b12-472c-aa86-c2db8167ab23	TCGA.02.0001	TCGA-02-0001-D22171	d3b26cd2-fb66-4ec7-8314-698391885e0e	2009-4-3	CRA	NA	CHEMOTHERAPY	92	FALSE	278	NA	NA	NA	NA	4	NA	MG/M2	MG/M2	NA	NA	NA	NA	NA	ADJUVANT	NA	75	NA
3	30a1fe5e-5b12-472c-aa86-c2db8167ab23	TCGA.02.0001	TCGA-02-0001-D22173	5a058cdd-9bef-421b-a0a9-c8e7f3cd6d7e	2010-1-12	CELEBREX	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	RECURRENCE	NA	NA	NA
4	30a1fe5e-5b12-472c-aa86-c2db8167ab23	TCGA.02.0001	TCGA-02-0001-D22172	a1cf26d0-3ef0-4a24-a5e9-4ff9b547b359	2010-1-12	CIS RETINOIC ACID	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	RECURRENCE	NA	NA	NA
5	df3c1d61-79c1-43e9-971a-8029497ffeab	TCGA.02.0003	TCGA-02-0003-D22177	002b8484-0175-4f88-bef8-302dcc58cbec	2009-4-2	TAMOXIFEN	NA	CHEMOTHERAPY	49	FALSE	94	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	80	NA
6	3ac8f759-2df0-4ef5-913f-ce05b8dd8937	TCGA.02.0004	TCGA-02-0004-D22181	e339b977-4671-400c-b0b3-a782471c671a	2009-4-7	TEMOZOLOMIDE	NA	CHEMOTHERAPY	44	FALSE	153	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
7	3ac8f759-2df0-4ef5-913f-ce05b8dd8937	TCGA.02.0004	TCGA-02-0004-D22182	2e973179-037d-49cc-a384-de00ea937af0	2009-4-7	TEMOZOLOMIDE	NA	CHEMOTHERAPY	44	FALSE	153	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	75	NA
8	98714d95-b62e-4f34-9cd1-91542da463eb	TCGA.02.0006	TCGA-02-0006-D22186	320ce724-3c10-45fb-88c3-371db663e082	2009-3-30	TEMOZOLOMIDE	NA	CHEMOTHERAPY	88	NA	148	NA	NA	NA	NA	7	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
9	98714d95-b62e-4f34-9cd1-91542da463eb	TCGA.02.0006	TCGA-02-0006-D22188	92099a94-6caa-4884-816f-3debbd48ffea	2010-1-12	TEMOZOLOMIDE	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	RECURRENCE	NA	NA	NA
10	98714d95-b62e-4f34-9cd1-91542da463eb	TCGA.02.0006	TCGA-02-0006-D22187	d60942f5-44e9-4ed9-b1b6-c5ddcc322fe2	2010-1-12	CIS RETINOIC ACID	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	RECURRENCE	NA	NA	NA
11	fb75eb9d-05be-4e6b-a515-f39efb15e66c	TCGA.02.0007	TCGA-02-0007-D22193	1381035b-2efb-4798-9d74-df273767cc70	2009-4-2	TEMOZOLOMIDE	NA	CHEMOTHERAPY	33	FALSE	338	NA	NA	NA	NA	5	NA	MG/M2/DAY	MG/M2/DAY	NA	NA	ORAL	NA	NA	ADJUVANT	NA	75	NA
12	fb75eb9d-05be-4e6b-a515-f39efb15e66c	TCGA.02.0007	TCGA-02-0007-D22192	bea568d6-0832-4265-8059-36333799bf64	2009-4-2	TEMOZOLOMIDE	NA	CHEMOTHERAPY	33	FALSE	338	NA	NA	NA	NA	5	NA	MG/M2/DAY	MG/M2/DAY	NA	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
13	45a58ede-e7a4-424d-851e-e6a4062e46e4	TCGA.02.0010	TCGA-02-0010-D22199	905a344f-2c01-4d7e-8827-0e95ee366cc6	2009-3-30	TEMOZOLOMIDE	NA	CHEMOTHERAPY	509	NA	569	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
14	45a58ede-e7a4-424d-851e-e6a4062e46e4	TCGA.02.0010	TCGA-02-0010-D22201	5f34c085-4d08-4a72-965c-0b86567bcad9	2010-1-12	THALIDOMIDE	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
15	45a58ede-e7a4-424d-851e-e6a4062e46e4	TCGA.02.0010	TCGA-02-0010-D22200	2efba21c-1f13-4b86-9f24-048e1a28bb39	2010-1-12	CPT 11	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
16	33ae5566-3c72-4cae-b516-1708db090e32	TCGA.02.0011	TCGA-02-0011-D22205	6b9428b1-a33e-420e-b8de-81a7ada75fbc	2009-4-2	TEMOZOLOMIDE	NA	CHEMOTHERAPY	20	FALSE	145	NA	NA	NA	NA	4	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
17	33ae5566-3c72-4cae-b516-1708db090e32	TCGA.02.0011	TCGA-02-0011-D22206	0335931c-c730-41a7-bd44-6d0e7341b15c	2009-4-2	TEMOZOLOMIDE	NA	CHEMOTHERAPY	20	FALSE	145	NA	NA	NA	NA	4	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	OTHER	CONCURRENT	75	NA
18	33ae5566-3c72-4cae-b516-1708db090e32	TCGA.02.0011	TCGA-02-0011-D22207	10bbdac1-8c83-465e-9627-b7a593e0412f	2010-1-12	CARBOPLATIN	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
19	33ae5566-3c72-4cae-b516-1708db090e32	TCGA.02.0011	TCGA-02-0011-D22208	7096b979-87b4-421f-99e6-805c14dbcf71	2010-1-12	IRESSA	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
20	83264f30-94be-4573-b519-fb0b0fce36c3	TCGA.02.0014	TCGA-02-0014-D22212	77649890-b648-4970-869d-030d256135f8	2009-11-30	ANTI NECPLATENS	NA	CHEMOTHERAPY	2349	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
21	83264f30-94be-4573-b519-fb0b0fce36c3	TCGA.02.0014	TCGA-02-0014-D22213	63cc60e9-7eec-4e8b-af9c-f4af6bb71f9f	2010-1-12	TEMOZOLOMIDE	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	RECURRENCE	NA	NA	NA
22	697afd24-9632-4244-a455-f95b1fa4f0bf	TCGA.02.0015	TCGA-02-0015-D22217	6ae29bf7-1eea-4c1c-8fc4-b119b171d775	2009-4-7	GLIADEL WAFER	NA	CHEMOTHERAPY	0	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	OTHER	NA	NA	ADJUVANT	NA	1	NA
23	697afd24-9632-4244-a455-f95b1fa4f0bf	TCGA.02.0015	TCGA-02-0015-D22218	465b317b-ab2d-46d9-96b0-ad9c128e8c70	2010-1-12	AE 788	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	RECURRENCE	NA	NA	NA
24	adc0c9c3-002a-4fab-b148-e162020ad051	TCGA.02.0016	TCGA-02-0016-D22222	02b3ae53-67db-4d28-9fd3-a8cd06d06924	2009-4-1	TEMOZOLOMIDE	NA	CHEMOTHERAPY	84	FALSE	1041	NA	NA	NA	NA	30	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
25	d85fa9be-f7fb-407b-af46-31f495b210d6	TCGA.02.0021	TCGA-02-0021-D22226	d5499e0c-1439-4d9e-bd58-2d15a4171cd1	2009-4-3	TEMOZOLOMIDE	NA	CHEMOTHERAPY	72	FALSE	191	NA	NA	NA	NA	NA	NA	MG/M2/DAY	MG/M2/DAY	NA	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
26	d85fa9be-f7fb-407b-af46-31f495b210d6	TCGA.02.0021	TCGA-02-0021-D22227	c3982d30-95ec-4ec4-b5f7-891f938fe23f	2010-1-12	6 THIGUANINE	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
27	d85fa9be-f7fb-407b-af46-31f495b210d6	TCGA.02.0021	TCGA-02-0021-D22228	1af1c421-aad6-4864-a78c-e772e4f534c4	2010-1-12	CCNU	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
28	d85fa9be-f7fb-407b-af46-31f495b210d6	TCGA.02.0021	TCGA-02-0021-D22229	e2763140-683c-40fe-997b-1fa4b9a5f771	2010-1-12	XELODA	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
29	d85fa9be-f7fb-407b-af46-31f495b210d6	TCGA.02.0021	TCGA-02-0021-D22230	f1f3243d-83f2-48a5-9c99-5db40834e83c	2010-1-12	CELEBREX	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
30	c45e9e8b-35ab-4477-acdc-b18be0b3497d	TCGA.02.0023	TCGA-02-0023-D22234	381a9de3-54d9-46eb-98f1-e1d7a4b6c703	2009-4-1	TEMOZOLOMIDE	NA	CHEMOTHERAPY	-9	FALSE	34	NA	NA	NA	NA	1	NA	MG/M2/DAY	MG/M2/DAY	NA	NA	ORAL	NA	NA	ADJUVANT	NA	75	NA
31	c45e9e8b-35ab-4477-acdc-b18be0b3497d	TCGA.02.0023	TCGA-02-0023-D22235	8519da40-12d5-436f-a778-c1332d5fa008	2010-1-12	TEMOZOLOMIDE	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	RECURRENCE	NA	NA	NA
32	0553e60e-3510-417d-af8a-75947ebe8ab6	TCGA.02.0024	TCGA-02-0024-D22239	8d287c5f-fd9f-4917-9da8-613ebca66e18	2009-3-27	TEMOZOLOMIDE	NA	CHEMOTHERAPY	152	NA	701	NA	NA	NA	NA	18	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	3600	NA
33	6630e547-2596-4fb7-a657-c19497ff13b2	TCGA.02.0025	TCGA-02-0025-D22243	abf7ad8f-866f-4841-b560-a3d5f55b161d	2009-4-7	TEMOZOLOMIDE	NA	CHEMOTHERAPY	118	FALSE	656	NA	NA	NA	NA	18	NA	MG/M2/DAY	MG/M2/DAY	NA	NA	NA	NA	NA	ADJUVANT	NA	200	NA
34	6630e547-2596-4fb7-a657-c19497ff13b2	TCGA.02.0025	TCGA-02-0025-D22244	7726c40b-c129-406c-9934-3045d33bef13	2010-1-12	SARASAR	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	RECURRENCE	NA	NA	NA
35	6630e547-2596-4fb7-a657-c19497ff13b2	TCGA.02.0025	TCGA-02-0025-D22245	817d99bb-c990-4362-98a0-9c2370b9de66	2010-1-12	TEMOZOLOMIDE	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	RECURRENCE	NA	NA	NA
36	43d89926-2378-4498-bfba-6d6624d951b4	TCGA.02.0026	TCGA-02-0026-D22249	b0a8bcf7-62bc-4c7d-9f66-e5867bfa6d22	2009-4-2	TEMOZOLOMIDE	NA	CHEMOTHERAPY	92	FALSE	418	NA	NA	NA	NA	11	NA	MG/M2/DAY	MG/M2/DAY	NA	NA	ORAL	NA	NA	ADJUVANT	NA	150	NA
37	43d89926-2378-4498-bfba-6d6624d951b4	TCGA.02.0026	TCGA-02-0026-D22250	a681c716-74f4-47db-a8d3-3779eb9efe16	2010-1-12	GLEEVEC	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	RECURRENCE	NA	NA	NA
38	43d89926-2378-4498-bfba-6d6624d951b4	TCGA.02.0026	TCGA-02-0026-D22251	89f039df-00db-4c1b-9783-b44ff5c92b40	2010-1-12	HYDROXYUREA	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	RECURRENCE	NA	NA	NA
39	a1eca6d7-09ba-418a-a787-77be67e672dd	TCGA.02.0027	TCGA-02-0027-D22255	9df04f6d-09fb-40f9-acf0-f32ff126ca0b	2009-3-27	TEMOZOLOMIDE	NA	CHEMOTHERAPY	27	NA	256	NA	NA	NA	NA	6	NA	MG/M2/DAY	MG/M2/DAY	NA	NA	ORAL	NA	NA	ADJUVANT	NA	1200	NA
40	a1eca6d7-09ba-418a-a787-77be67e672dd	TCGA.02.0027	TCGA-02-0027-D22257	d7f5f3f3-8e59-4b35-94c3-02355e51025d	2010-1-12	CCNU	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
41	a1eca6d7-09ba-418a-a787-77be67e672dd	TCGA.02.0027	TCGA-02-0027-D22259	8a2601d6-1b2f-45d7-9bea-16481300dc74	2010-1-12	CELEBREX	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
42	a1eca6d7-09ba-418a-a787-77be67e672dd	TCGA.02.0027	TCGA-02-0027-D22258	030333c0-03b7-4284-900d-ac4ba551a88b	2010-1-12	XELODA	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
43	a1eca6d7-09ba-418a-a787-77be67e672dd	TCGA.02.0027	TCGA-02-0027-D22256	6280c8cf-29b4-4d74-b665-8af6ba6811f1	2010-1-12	6 THIGUANINE	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
44	7ef0564e-d95d-4df5-969b-b204c207daea	TCGA.02.0028	TCGA-02-0028-D22263	1a26b01c-d85a-4b21-b938-11e16569d33b	2009-3-27	TEMOZOLOMIDE	NA	CHEMOTHERAPY	1939	NA	2304	NA	NA	NA	NA	12	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
45	7ef0564e-d95d-4df5-969b-b204c207daea	TCGA.02.0028	TCGA-02-0028-D22266	f7885e62-8263-4af0-9b44-e157a399e22a	2010-1-12	XELODA	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	RECURRENCE	NA	NA	NA
46	7ef0564e-d95d-4df5-969b-b204c207daea	TCGA.02.0028	TCGA-02-0028-D22264	d9dcdba1-75c3-4b39-9ce8-567b0edde452	2010-1-12	CELEBREX	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	RECURRENCE	NA	NA	NA
47	7ef0564e-d95d-4df5-969b-b204c207daea	TCGA.02.0028	TCGA-02-0028-D22265	b56285ab-465d-42e0-83bd-dbbee7c7f914	2010-1-12	TEMOZOLOMIDE	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	RECURRENCE	NA	NA	NA
48	69205453-c504-4684-8d32-57c82efc679d	TCGA.02.0034	TCGA-02-0034-D22272	48589866-d698-42b7-9097-bc9ed8082b64	2009-4-6	TEMOZOLOMIDE	NA	CHEMOTHERAPY	89	FALSE	159	NA	NA	NA	NA	2	NA	MG/M2/DAY	MG/M2/DAY	NA	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
49	fcce7f31-a392-4177-8dca-cfbe6e73fc2e	TCGA.02.0038	TCGA-02-0038-D22278	6ea926e4-df08-42ec-ade3-7652d154e9d7	2009-4-6	TANCEVA	NA	CHEMOTHERAPY	113	FALSE	174	NA	NA	NA	NA	2	NA	MG/DAY	MG/DAY	NA	NA	ORAL	NA	NA	ADJUVANT	NA	150	NA
50	de0cb811-bae0-407e-b8b3-97d1512bfa80	TCGA.02.0043	TCGA-02-0043-D22284	66509a77-13aa-4d5b-ab08-c57b60e5ae89	2009-4-3	CCNU	NA	CHEMOTHERAPY	297	FALSE	359	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	100	NA
51	de0cb811-bae0-407e-b8b3-97d1512bfa80	TCGA.02.0043	TCGA-02-0043-D22285	9c1ea4cd-db68-48d9-ba9a-d9a5b654bffd	2010-1-12	6 THIGUANINE	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
52	de0cb811-bae0-407e-b8b3-97d1512bfa80	TCGA.02.0043	TCGA-02-0043-D22287	f211d513-fa21-4154-916c-f25a36f97278	2010-1-12	XELODA	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
53	de0cb811-bae0-407e-b8b3-97d1512bfa80	TCGA.02.0043	TCGA-02-0043-D22286	7c4b6e2a-da96-45c9-90d1-74b0f4ab910e	2010-1-12	CCNU	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
54	de0cb811-bae0-407e-b8b3-97d1512bfa80	TCGA.02.0043	TCGA-02-0043-D22288	82d24b56-9ac3-43ae-8d2d-df2a7204a925	2010-1-12	CELEBREX	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
55	5a448bf3-8e87-4791-91f2-908307a32ed1	TCGA.02.0052	TCGA-02-0052-D22300	a6ff91bc-199f-4e27-ba88-8de1445c2128	2009-4-6	TEMOZOLOMIDE	NA	CHEMOTHERAPY	34	FALSE	204	NA	NA	NA	NA	5	NA	MG/M2/DAY	MG/M2/DAY	NA	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
56	4df7d5e4-f762-4e80-b9d1-96ec21fb43ca	TCGA.02.0054	TCGA-02-0054-D22304	a0bdd31d-089a-4b13-8305-1569b7547024	2009-4-2	TEMOZOLOMIDE	NA	CHEMOTHERAPY	28	FALSE	73	NA	NA	NA	NA	1	NA	MG/M2/DAY	MG/M2/DAY	NA	NA	ORAL	NA	NA	ADJUVANT	NA	75	NA
57	4df7d5e4-f762-4e80-b9d1-96ec21fb43ca	TCGA.02.0054	TCGA-02-0054-D22307	c0dc35a0-30a4-49a7-a186-77add0e2545d	2010-1-12	XELODA	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
58	4df7d5e4-f762-4e80-b9d1-96ec21fb43ca	TCGA.02.0054	TCGA-02-0054-D22305	a9985add-cc7a-494e-8c11-5dacb11645a4	2010-1-12	6 THIGUANINE	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
59	4df7d5e4-f762-4e80-b9d1-96ec21fb43ca	TCGA.02.0054	TCGA-02-0054-D22306	8a13d934-4131-43f6-be8a-10e5f8f2d02b	2010-1-12	CCNU	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
60	4df7d5e4-f762-4e80-b9d1-96ec21fb43ca	TCGA.02.0054	TCGA-02-0054-D22308	f6d318a3-f616-4a92-ae44-3b884e19697c	2010-1-12	CELEBREX	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
61	da5f6940-e8ee-4fd1-a8da-4cd68e02e59c	TCGA.02.0055	TCGA-02-0055-D22312	5d44f37b-8705-452d-89a6-84e6213d425c	2009-4-2	TEMOZOLOMIDE	NA	CHEMOTHERAPY	-112	FALSE	0	NA	NA	NA	NA	NA	NA	MG/M2/DAY	MG/M2/DAY	NA	NA	ORAL	NA	NA	ADJUVANT	NA	75	NA
62	da5f6940-e8ee-4fd1-a8da-4cd68e02e59c	TCGA.02.0055	TCGA-02-0055-D22313	488d0b21-86b6-468f-bb9e-e982ee2ade6c	2009-4-2	TEMOZOLOMIDE	NA	CHEMOTHERAPY	-112	FALSE	0	NA	NA	NA	NA	NA	NA	MG/M2/DAY	MG/M2/DAY	NA	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
63	7ee03602-bfec-413d-a05b-609cf60c6481	TCGA.02.0057	TCGA-02-0057-D22317	e8923938-fe8f-452f-b16a-3dcb080bd1b2	2009-4-3	GLIADEL WAFER	NA	CHEMOTHERAPY	1	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	OTHER	NA	NA	ADJUVANT	NA	1	NA
64	7ee03602-bfec-413d-a05b-609cf60c6481	TCGA.02.0057	TCGA-02-0057-D22318	6cfc4787-75d0-4636-8070-28f88fd51a84	2010-1-12	TEMOZOLOMIDE	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	RECURRENCE	NA	NA	NA
65	9734478b-05a2-4b5c-b8aa-9e6b0b0db02d	TCGA.02.0058	TCGA-02-0058-D22322	ed10899c-ef8d-46a2-ac37-405109f6d899	2009-4-2	TEMOZOMIDE	NA	CHEMOTHERAPY	21	FALSE	143	NA	NA	NA	NA	2	NA	MG/M2/DAY	MG/M2/DAY	NA	NA	ORAL	NA	NA	ADJUVANT	NA	75	NA
66	686ac6b5-fdb2-417e-9e32-cbad7214e677	TCGA.02.0060	TCGA-02-0060-D22328	123720bd-30bc-45bd-a9d7-2676c2a7d56e	2009-4-2	TEMOZOLOMIDE	NA	CHEMOTHERAPY	15	FALSE	182	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	75	NA
67	686ac6b5-fdb2-417e-9e32-cbad7214e677	TCGA.02.0060	TCGA-02-0060-D22329	ab324f3a-3f83-49d7-a42d-9012e081b67b	2009-4-2	TEMOZOLOMIDE	NA	CHEMOTHERAPY	15	FALSE	182	NA	NA	NA	NA	3	NA	MG/M2/DAY	MG/M2/DAY	NA	NA	ORAL	NA	NA	OTHER	CONCURRENT	600	NA
68	d0fe540c-8e4b-4d97-8966-5899dea8555e	TCGA.02.0064	TCGA-02-0064-D22333	f666732d-a31c-47c5-b37e-e9067348783e	2009-4-6	TEMOZOLOMIDE	NA	CHEMOTHERAPY	23	FALSE	358	NA	NA	NA	NA	12	NA	MG/M2/DAY	MG/M2/DAY	NA	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
69	d0fe540c-8e4b-4d97-8966-5899dea8555e	TCGA.02.0064	TCGA-02-0064-D22335	d255a807-f73a-4875-9bed-acaaccf3b263	2010-1-12	BEVACIZUMAB	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
70	d0fe540c-8e4b-4d97-8966-5899dea8555e	TCGA.02.0064	TCGA-02-0064-D22334	4766dfa3-d9b1-4d6d-92ab-549b524bf532	2010-1-12	CPT 11	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
71	38771a9a-f8b1-4867-b540-56c7d9f5820a	TCGA.02.0068	TCGA-02-0068-D22340	233ae38d-fa55-4001-9c8c-8bfec436f961	2009-4-2	TEMOZOLOMIDE	NA	CHEMOTHERAPY	14	FALSE	179	NA	NA	NA	NA	3	NA	MG/M2/DAY	MG/M2/DAY	NA	NA	ORAL	NA	NA	ADJUVANT	NA	75	NA
72	38771a9a-f8b1-4867-b540-56c7d9f5820a	TCGA.02.0068	TCGA-02-0068-D22339	327833c2-eada-4472-a549-47e0aaf24a89	2009-4-2	TEMOZOLOMIDE	NA	CHEMOTHERAPY	14	FALSE	179	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
73	38771a9a-f8b1-4867-b540-56c7d9f5820a	TCGA.02.0068	TCGA-02-0068-D22342	154c9621-ed23-4ff5-bdfb-a072e5d1d9d2	2010-1-12	BEVACIZUMAB	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
74	38771a9a-f8b1-4867-b540-56c7d9f5820a	TCGA.02.0068	TCGA-02-0068-D22341	9c071a67-d256-4f59-8e18-026d5c078f30	2010-1-12	CPT 11	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
75	73b1136f-c4b6-472a-b21d-2c789bd53d26	TCGA.02.0069	TCGA-02-0069-D22346	6ff13c26-9e16-4a6f-b6d1-6e9a5da977dd	2009-4-3	TEMOZOLOMIDE	NA	CHEMOTHERAPY	15	FALSE	945	NA	NA	NA	NA	24	NA	MG/M2/DAY	MG/M2/DAY	NA	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
76	73b1136f-c4b6-472a-b21d-2c789bd53d26	TCGA.02.0069	TCGA-02-0069-D22347	82e93428-1cad-47ee-aee2-47cf7ae9b9b3	2009-4-3	TEMOZOLOMIDE	NA	CHEMOTHERAPY	15	FALSE	945	NA	NA	NA	NA	24	NA	MG/M2/DAY	MG/M2/DAY	NA	NA	ORAL	NA	NA	OTHER	CONCURRENT	75	NA
77	863c285c-5b87-42b9-b8b3-1ae832a6ded3	TCGA.02.0070	TCGA-02-0070-D22351	e2ca146d-2379-4643-9f88-5d7c37b077e9	2009-4-1	TEMOZOLOMIDE	NA	CHEMOTHERAPY	10	FALSE	57	NA	NA	NA	NA	1	NA	MG/M2/DAY	MG/M2/DAY	NA	NA	ORAL	NA	NA	ADJUVANT	NA	75	NA
78	281e1a57-9a8c-4fa0-ac5e-e5e1df7ef8e2	TCGA.02.0074	TCGA-02-0074-D22358	aeabf7d7-93f9-4e3e-96de-89cbb9d9c0c3	2009-4-2	TEMOZOLOMIDE	NA	CHEMOTHERAPY	13	FALSE	154	NA	NA	NA	NA	3	NA	MG/M2/DAY	MG/M2/DAY	NA	NA	ORAL	NA	NA	OTHER	CONCURRENT	200	NA
79	281e1a57-9a8c-4fa0-ac5e-e5e1df7ef8e2	TCGA.02.0074	TCGA-02-0074-D22357	4a0cb621-9779-4919-94ff-84e3f54f5b60	2009-4-2	TEMOZOLOMIDE	NA	CHEMOTHERAPY	13	FALSE	154	NA	NA	NA	NA	3	NA	MG/M2/DAY	MG/M2/DAY	NA	NA	ORAL	NA	NA	ADJUVANT	NA	75	NA
80	b196f82b-ef3f-4e05-99f7-da5df65e691e	TCGA.02.0075	TCGA-02-0075-D22362	bd6a5572-393e-4f6b-a49d-281ad0a57957	2009-4-1	TEMOZOLOMIDE	NA	CHEMOTHERAPY	16	FALSE	36	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	75	NA
81	5da36fd2-0cea-41b8-90dc-b94c3c28cbd9	TCGA.02.0080	TCGA-02-0080-D22368	5ee34649-1c83-49ef-b922-065a0f155cbd	2009-4-6	TEMOZOLOMIDE	NA	CHEMOTHERAPY	352	FALSE	443	NA	NA	NA	NA	4	NA	MG/M2/DAY	MG/M2/DAY	NA	NA	ORAL	NA	NA	ADJUVANT	NA	100	NA
82	5da36fd2-0cea-41b8-90dc-b94c3c28cbd9	TCGA.02.0080	TCGA-02-0080-D22369	0ef5ac75-6090-4b0d-bb21-2fe3bc5aacbe	2010-1-12	CIS RETINOIC ACID	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	RECURRENCE	NA	NA	NA
83	b72fab50-aed2-48e7-b6ad-2a5bc7157cfd	TCGA.02.0083	TCGA-02-0083-D22373	7d85d8f8-72b4-4df5-a4b2-5c11a91aeb35	2009-3-30	TEMOZOLOMIDE	NA	CHEMOTHERAPY	69	NA	404	NA	NA	NA	NA	11	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
84	2deec528-4550-47b2-9a0d-cac7eeb24f3e	TCGA.02.0085	TCGA-02-0085-D22379	ed242d21-f512-4d71-b84a-d984ab74d85a	2009-4-1	TEMOZOLOMIDE	NA	CHEMOTHERAPY	740	FALSE	786	NA	NA	NA	NA	1	NA	MG/M2/DAY	MG/M2/DAY	NA	NA	ORAL	NA	NA	ADJUVANT	NA	75	NA
85	8e3fbea7-d22e-40fc-8031-58fe6fe091bb	TCGA.02.0086	TCGA-02-0086-D22383	76bee23b-29eb-45a4-97b8-071b3128ed10	2009-3-30	TEMOZOLOMIDE	NA	CHEMOTHERAPY	13	NA	85	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	75	NA
86	8e3fbea7-d22e-40fc-8031-58fe6fe091bb	TCGA.02.0086	TCGA-02-0086-D22386	10da5014-8aa5-4d41-973f-9fe43fe804d3	2010-1-12	XELODA	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
87	8e3fbea7-d22e-40fc-8031-58fe6fe091bb	TCGA.02.0086	TCGA-02-0086-D22385	1d2d1b52-3d71-4c73-9a43-42b721cf8ad3	2010-1-12	CCNU	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
88	8e3fbea7-d22e-40fc-8031-58fe6fe091bb	TCGA.02.0086	TCGA-02-0086-D22384	9aeaaf2c-b830-4af5-ace4-7f7d80dc2b49	2010-1-12	6 THIGUANINE	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
89	8e3fbea7-d22e-40fc-8031-58fe6fe091bb	TCGA.02.0086	TCGA-02-0086-D22387	436a7dc4-a65d-4f49-879f-6aad1651f850	2010-1-12	CELEBREX	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
90	dfaae397-52c3-4d29-b665-971969e23432	TCGA.02.0089	TCGA-02-0089-D22393	3b085f46-3808-4f78-9c76-3ca8b5c429ea	2009-4-3	TEMOZOLOMIDE	NA	CHEMOTHERAPY	68	FALSE	282	NA	NA	NA	NA	7	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	1400	NA
91	883dc176-925a-44f7-9ec8-e0cce33c2a54	TCGA.02.0099	TCGA-02-0099-D22397	e2a47f17-36bc-4cba-a6fa-47c158296e09	2009-4-6	TEMOZOLOMIDE	NA	CHEMOTHERAPY	-260	FALSE	-124	NA	NA	NA	NA	3	NA	MG/M2/DAY	MG/M2/DAY	NA	NA	ORAL	NA	NA	ADJUVANT	NA	150	NA
92	883dc176-925a-44f7-9ec8-e0cce33c2a54	TCGA.02.0099	TCGA-02-0099-D22398	c2d328e7-b288-4776-9bbf-04b11d4f7d59	2010-1-12	TEMOZOLOMIDE	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	RECURRENCE	NA	NA	NA
93	f3e57166-c428-4a44-9396-679e3a2b16a2	TCGA.02.0102	TCGA-02-0102-D22402	f05609fb-b7bf-4808-ab41-c11964b611a2	2009-4-3	PROCARBIZINE	NA	CHEMOTHERAPY	158	FALSE	402	NA	NA	NA	NA	5	NA	MG/M2/DAY	MG/M2/DAY	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	60	NA
94	f3e57166-c428-4a44-9396-679e3a2b16a2	TCGA.02.0102	TCGA-02-0102-D22404	3c73d8fc-2b92-4c36-bf08-24950b1a0b67	2009-4-3	VINCRISTINE	NA	CHEMOTHERAPY	158	FALSE	402	NA	NA	NA	NA	5	NA	MG/M2/DAY	MG/M2/DAY	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1.4	NA
95	f3e57166-c428-4a44-9396-679e3a2b16a2	TCGA.02.0102	TCGA-02-0102-D22403	acf036aa-2cb4-4117-afc5-507b3656dea9	2009-4-3	CCNU	NA	CHEMOTHERAPY	158	FALSE	402	NA	NA	NA	NA	5	NA	MG/M2/DAY	MG/M2/DAY	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	110	NA
96	db38e6b7-102f-4670-875f-b327790c70e4	TCGA.02.0104	TCGA-02-0104-D22409	219dee18-a9b8-4cdc-a463-88879617d73c	2009-4-7	TEMOZOLOMIDE	NA	CHEMOTHERAPY	1536	FALSE	1786	NA	NA	NA	NA	9	NA	MG/M2/DAY	MG/M2/DAY	NA	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
97	db38e6b7-102f-4670-875f-b327790c70e4	TCGA.02.0104	TCGA-02-0104-D22408	34d27c68-08bc-44aa-89c8-4555fb49057f	2009-4-7	TEMOZOLOMIDE	NA	CHEMOTHERAPY	1536	FALSE	1786	NA	NA	NA	NA	9	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	75	NA
98	d0b7d446-5488-41a2-a22a-c1e00a009482	TCGA.02.0106	TCGA-02-0106-D22413	0ec06cf1-d0ed-47c5-8646-3bbe5b3eb030	2009-4-2	TEMOZOLOMIDE	NA	CHEMOTHERAPY	15	FALSE	176	NA	NA	NA	NA	5	NA	MG/M2/DAY	MG/M2/DAY	NA	NA	ORAL	NA	NA	ADJUVANT	NA	75	NA
99	d0b7d446-5488-41a2-a22a-c1e00a009482	TCGA.02.0106	TCGA-02-0106-D22414	f6d0c953-dc0b-4d9f-83ec-4cc1624cbdb8	2009-4-2	TEMOZOLOMIDE	NA	CHEMOTHERAPY	15	FALSE	176	NA	NA	NA	NA	5	NA	MG/M2/DAY	MG/M2/DAY	NA	NA	ORAL	NA	NA	ADJUVANT	NA	500	NA
100	d0b7d446-5488-41a2-a22a-c1e00a009482	TCGA.02.0106	TCGA-02-0106-D22415	4c7d5f84-ebce-4c62-b160-6fbfd6c10432	2010-1-12	IL 13	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	RECURRENCE	NA	NA	NA
101	372a4cc6-8fc9-4157-9cdc-fe020b176249	TCGA.02.0107	TCGA-02-0107-D22419	9332ab3e-d1f2-49cd-9c2e-cb27c9b962ff	2009-3-27	TEMOZOLOMIDE	NA	CHEMOTHERAPY	100	NA	130	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
102	09ddf661-25fd-4baa-a1e8-bf90b2bb1d31	TCGA.02.0111	TCGA-02-0111-D22423	f0537f98-6c41-4965-984e-4f548827b55b	2009-5-21	TEMOZOLOMIDE	NA	CHEMOTHERAPY	28	FALSE	74	NA	NA	NA	NA	1	NA	UG/M2	UG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	75	NA
103	b363b624-a5b0-46e4-b671-8813cc12eaf4	TCGA.02.0113	TCGA-02-0113-D22427	c73c0ef0-22b3-4917-94df-d02087332304	2009-3-27	TEMOZOLOMIDE	NA	CHEMOTHERAPY	1930	NA	2628	NA	NA	NA	NA	24	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	4800	NA
104	658c8e31-2c60-40f0-ab25-d0d0168647db	TCGA.02.0114	TCGA-02-0114-D22433	37a224b5-8bb9-438b-91cf-83174264c136	2009-4-3	VINCRISTINE	NA	CHEMOTHERAPY	84	FALSE	197	NA	NA	NA	NA	4	NA	MG/M2/DAY	MG/M2/DAY	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1.4	NA
105	658c8e31-2c60-40f0-ab25-d0d0168647db	TCGA.02.0114	TCGA-02-0114-D22431	1f2ad536-aa3a-4db1-88f4-3451364bfa13	2009-4-3	PROCARBAZINE	NA	CHEMOTHERAPY	75	FALSE	197	NA	NA	NA	NA	4	NA	MG/M2/DAY	MG/M2/DAY	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	60	NA
106	658c8e31-2c60-40f0-ab25-d0d0168647db	TCGA.02.0114	TCGA-02-0114-D22432	8683efcd-7496-4354-8e28-7f3ec63b2641	2009-4-3	CCNU	NA	CHEMOTHERAPY	75	FALSE	197	NA	NA	NA	NA	4	NA	MG/M2/DAY	MG/M2/DAY	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	110	NA
107	658c8e31-2c60-40f0-ab25-d0d0168647db	TCGA.02.0114	TCGA-02-0114-D22434	67f47f28-a7dd-4942-b2b3-6020d81f8765	2010-1-12	CARBOPLATIN	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
108	658c8e31-2c60-40f0-ab25-d0d0168647db	TCGA.02.0114	TCGA-02-0114-D22435	43da4650-5357-4f9a-91e7-cb34251f506b	2010-1-12	TARCEVA	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
109	c9b25b65-ef41-4ffb-8b1c-a9e3a3c5cd8c	TCGA.02.0115	TCGA-02-0115-D22439	bc1308f0-4580-4cfe-a65d-a1414063fc3e	2009-4-3	TEMOZOLOMIDE	NA	CHEMOTHERAPY	27	FALSE	107	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
110	c9b25b65-ef41-4ffb-8b1c-a9e3a3c5cd8c	TCGA.02.0115	TCGA-02-0115-D22440	e7518de3-9dde-4b08-8737-0ed473c88314	2010-1-12	BEVACIZUMAB	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
111	e117fe84-f003-40a4-96b5-8e26d0513151	TCGA.02.0116	TCGA-02-0116-D22444	ba2e9f4d-4ffb-4af0-b77b-5b95795ecac5	2009-4-2	TEMOZOLOMIDE	NA	CHEMOTHERAPY	53	FALSE	388	NA	NA	NA	NA	12	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	900	NA
112	e117fe84-f003-40a4-96b5-8e26d0513151	TCGA.02.0116	TCGA-02-0116-D22445	c8c94551-3b0f-456f-9e2d-fca13581fdd0	2010-1-12	GLEEVEC	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	RECURRENCE	NA	NA	NA
113	e117fe84-f003-40a4-96b5-8e26d0513151	TCGA.02.0116	TCGA-02-0116-D22446	de987cca-547e-43b8-9480-2ce3805760bc	2010-1-12	HYDOXYUREA	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	RECURRENCE	NA	NA	NA
114	96fa386d-f930-45da-96ba-e7ca3f9de5b2	TCGA.02.0289	TCGA-02-0289-D22464	c4cfa885-fa73-4e9e-b8a8-5ccc78cf2d76	2009-4-1	PROCARBAZINE	NA	CHEMOTHERAPY	93	FALSE	182	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	60	NA
115	96fa386d-f930-45da-96ba-e7ca3f9de5b2	TCGA.02.0289	TCGA-02-0289-D22465	12bef7f0-c881-4493-90d0-cc69ab55f33b	2009-4-1	CCNU	NA	CHEMOTHERAPY	93	FALSE	182	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	110	NA
116	96fa386d-f930-45da-96ba-e7ca3f9de5b2	TCGA.02.0289	TCGA-02-0289-D22466	21ee9961-fca0-4eb2-a3d9-592399d70254	2009-4-1	VINCRISTINE	NA	CHEMOTHERAPY	93	FALSE	182	NA	NA	NA	NA	2	NA	MG/M2/DAY	MG/M2/DAY	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1.4	NA
117	74a70685-d95e-45a5-b8a9-80106c8b1bd7	TCGA.02.0290	TCGA-02-0290-D22471	b3816dc9-5c68-4b1a-9911-3a24e466c1d5	2009-3-27	CCNU	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	5	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	110	NA
118	74a70685-d95e-45a5-b8a9-80106c8b1bd7	TCGA.02.0290	TCGA-02-0290-D22470	02f26633-30d0-49d2-8a21-a68c1ff86140	2009-3-27	PROCARBAZINE	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	5	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	60	NA
119	74a70685-d95e-45a5-b8a9-80106c8b1bd7	TCGA.02.0290	TCGA-02-0290-D22472	46b8272d-8180-4cf2-a019-5c3d2d4ef9f0	2009-3-27	VINCRISTINE	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	5	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1.4	NA
120	6879e9da-dacf-48b3-8e95-760796f96a1b	TCGA.02.0317	TCGA-02-0317-D22476	91d4a74b-253a-403c-a8b0-d11fe903c32b	2009-3-27	ANTI NEOPASTONS	NA	CHEMOTHERAPY	23	NA	176	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
121	f49b3e5a-6d40-4018-86ae-8396455d8878	TCGA.02.0325	TCGA-02-0325-D22484	703967d3-9a15-4d3c-8d94-c5e0fcc3ca72	2009-3-27	PROCARBAZINE	NA	CHEMOTHERAPY	84	NA	115	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	60	NA
122	f49b3e5a-6d40-4018-86ae-8396455d8878	TCGA.02.0325	TCGA-02-0325-D22485	6727dd81-6557-46ae-8e31-88e03580df5b	2009-3-27	CCNU	NA	CHEMOTHERAPY	84	NA	115	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	110	NA
123	f49b3e5a-6d40-4018-86ae-8396455d8878	TCGA.02.0325	TCGA-02-0325-D22486	43404af4-1315-44ad-b278-38539c39ab3a	2009-3-27	VINCRISTINE	NA	CHEMOTHERAPY	84	NA	115	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1.4	NA
124	f49b3e5a-6d40-4018-86ae-8396455d8878	TCGA.02.0325	TCGA-02-0325-D22487	fa3bc8e6-6871-4d45-8216-b08c462cd221	2010-1-12	CIS RETINOIC ACID	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	RECURRENCE	NA	NA	NA
125	799bfae2-b189-43bc-a3bc-d425cd4fe556	TCGA.02.0330	TCGA-02-0330-D22494	f3701df0-3721-45d6-a038-3c24661f7f16	2009-3-27	CCNU	NA	CHEMOTHERAPY	107	NA	137	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	110	NA
126	799bfae2-b189-43bc-a3bc-d425cd4fe556	TCGA.02.0330	TCGA-02-0330-D22493	4e0aebfc-df13-42fc-a793-d5d4dc99cf23	2009-3-27	PROCARBAZINE	NA	CHEMOTHERAPY	107	NA	137	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	60	NA
127	799bfae2-b189-43bc-a3bc-d425cd4fe556	TCGA.02.0330	TCGA-02-0330-D22495	bae1d58e-c5b0-41af-a5f5-49bad9bdc115	2009-3-27	VINCRISTINE	NA	CHEMOTHERAPY	107	NA	137	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1.4	NA
128	799bfae2-b189-43bc-a3bc-d425cd4fe556	TCGA.02.0330	TCGA-02-0330-D22496	9c66da29-90f0-4d32-807d-2e26102af9ab	2010-1-12	VP-16	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
129	799bfae2-b189-43bc-a3bc-d425cd4fe556	TCGA.02.0330	TCGA-02-0330-D22497	27d1c399-192b-4a14-b7bf-92b2c5736d9b	2010-1-12	CARBOPLATIN	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
130	54b4c27e-aaa6-4a79-b289-0ba251a5460e	TCGA.02.0332	TCGA-02-0332-D22503	932cf03a-0537-48ff-b690-b3731334f7ed	2009-3-27	VINCRISTINE	NA	CHEMOTHERAPY	99	NA	230	NA	NA	NA	NA	4	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1.4	NA
131	54b4c27e-aaa6-4a79-b289-0ba251a5460e	TCGA.02.0332	TCGA-02-0332-D22501	12cba36b-aeac-4513-8da8-b6a26ca5dc63	2009-3-27	PROCARBAZINE	NA	CHEMOTHERAPY	99	NA	230	NA	NA	NA	NA	4	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	60	NA
132	54b4c27e-aaa6-4a79-b289-0ba251a5460e	TCGA.02.0332	TCGA-02-0332-D22502	3210e4e5-05bd-439c-bfce-71eb25c4eb6a	2009-3-27	CCNU	NA	CHEMOTHERAPY	99	NA	230	NA	NA	NA	NA	4	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	110	NA
133	19146c75-8f41-44f3-8423-7db4d0d0efe1	TCGA.02.0337	TCGA-02-0337-D22509	e042cb9c-02d7-4209-8668-bdd60e2d46fc	2009-4-2	PROCARBAZINE	NA	CHEMOTHERAPY	185	FALSE	428	NA	NA	NA	NA	5	NA	MG/M2/DAY	MG/M2/DAY	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	60	NA
134	19146c75-8f41-44f3-8423-7db4d0d0efe1	TCGA.02.0337	TCGA-02-0337-D22510	3015f1ab-862e-42e0-a887-01e34aa9e664	2009-4-2	CCNU	NA	CHEMOTHERAPY	185	FALSE	434	NA	NA	NA	NA	5	NA	MG/M2/DAY	MG/M2/DAY	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	110	NA
135	19146c75-8f41-44f3-8423-7db4d0d0efe1	TCGA.02.0337	TCGA-02-0337-D22511	7caf9972-ebaa-4d55-83e5-fd60607c4d9e	2009-4-2	VINCRISTINE	NA	CHEMOTHERAPY	185	FALSE	428	NA	NA	NA	NA	5	NA	MG/M2/DAY	MG/M2/DAY	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1.4	NA
136	1e63e985-fbb7-4e43-93a5-e718d0b4ad09	TCGA.02.0432	TCGA-02-0432-D22523	4b421965-8a83-48c3-821e-6abb9028825b	2009-4-2	CCNU	NA	CHEMOTHERAPY	105	FALSE	329	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	100	NA
137	502f47db-7d3d-4081-ab15-1c38e7e78652	TCGA.02.0440	TCGA-02-0440-D22529	39e50ea9-ae50-44b3-a6ee-6a828ccaace4	2009-5-21	CIS-RETINOIC ACID	NA	CHEMOTHERAPY	269	FALSE	288	NA	NA	NA	NA	1	NA	UG/M2	UG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	75	NA
138	c4171de5-8dac-44bd-a6eb-174f9451dbb7	TCGA.02.2466	TCGA-02-2466-D22539	9e4408c4-80d4-4f61-89b8-aeb1d4019c89	2010-4-9	TEMODAR	NA	CHEMOTHERAPY	28	FALSE	71	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	75	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
139	c4171de5-8dac-44bd-a6eb-174f9451dbb7	TCGA.02.2466	TCGA-02-2466-D22540	e22d9741-01d5-4cb1-85f4-5c799debe439	2010-4-9	TEMODAR	NA	CHEMOTHERAPY	72	FALSE	102	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	150	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
140	e948d951-9299-4dec-9772-60b4ac3569cb	TCGA.02.2470	TCGA-02-2470-D22545	ca19a225-58be-46c6-87bf-451aa203a916	2010-4-9	TEMODAR	NA	CHEMOTHERAPY	100	FALSE	183	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	150	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
141	e948d951-9299-4dec-9772-60b4ac3569cb	TCGA.02.2470	TCGA-02-2470-D22544	0f1a9c38-5268-4002-9ca5-fb58a32560c5	2010-4-9	TEMODAR	NA	CHEMOTHERAPY	57	FALSE	99	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	75	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
142	a2ac9937-f351-4d78-9261-264bf6c21e0c	TCGA.02.2483	TCGA-02-2483-D22549	1dfce847-d041-4c1c-adfd-1334273f24b4	2010-4-9	TEMODAR	NA	CHEMOTHERAPY	53	FALSE	94	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	75	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
143	a2ac9937-f351-4d78-9261-264bf6c21e0c	TCGA.02.2483	TCGA-02-2483-D22550	162e3959-b282-44ef-af11-884de20d51af	2010-4-9	TEMODAR	NA	CHEMOTHERAPY	95	FALSE	466	NA	NA	NA	NA	12	NA	MG/M2	MG/M2	150	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
144	521ea765-1bd1-423d-a75d-091243df37a9	TCGA.02.2485	TCGA-02-2485-D22554	a18761a0-c227-4d0c-b4c7-9270e3d86830	2010-4-9	TEMODAR	NA	CHEMOTHERAPY	51	FALSE	92	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	75	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
145	521ea765-1bd1-423d-a75d-091243df37a9	TCGA.02.2485	TCGA-02-2485-D22555	b8b49c28-df16-4cd8-bf0f-5de4714280c3	2010-4-9	TEMODAR	NA	CHEMOTHERAPY	93	FALSE	186	NA	NA	NA	NA	4	NA	MG/M2	MG/M2	150	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
146	79a68b32-29a3-47bf-9b2b-643ec7323d73	TCGA.02.2486	TCGA-02-2486-D22560	e72519ec-4208-49ba-b7c5-4a57556468e1	2010-4-9	TEMODAR	NA	CHEMOTHERAPY	67	FALSE	440	NA	NA	NA	NA	12	NA	MG/M2	MG/M2	150	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
147	79a68b32-29a3-47bf-9b2b-643ec7323d73	TCGA.02.2486	TCGA-02-2486-D22559	cc49574c-adf2-4c38-850d-82c34a75c392	2010-4-9	TEMODAR	NA	CHEMOTHERAPY	24	FALSE	66	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	75	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
148	79a68b32-29a3-47bf-9b2b-643ec7323d73	TCGA.02.2486	TCGA-02-2486-D22561	14647534-0503-45c7-a4fd-c663698cc041	2010-4-9	ACCUTANE	NA	CHEMOTHERAPY	130	FALSE	230	NA	NA	NA	NA	4	NA	MG	MG	40	NA	ORAL	NA	NA	PROGRESSION	NA	NA	NA
149	2cb9975f-2d1e-4c74-867f-8b151c22b246	TCGA.06.0119	TCGA-06-0119-D40091	692851A9-BEB3-4552-BF4B-84D8D2CDF7AA	2013-2-12	TEMOZOLOMIDE	NA	CHEMOTHERAPY	53	FALSE	58	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
150	c2651206-36c5-4f3c-a0d6-3ffc07b27a93	TCGA.06.0124	TCGA-06-0124-D22567	7e3259cc-0c25-4f11-9cf4-0750346e1bab	2009-5-11	TEMOZOLOMIDE	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
151	8da3103e-3e6c-4176-a583-d5fe5e60601e	TCGA.06.0125	TCGA-06-0125-D22571	38d50ec6-4a60-4851-8a76-a99e2c52457d	2009-5-11	CPT 11	NA	CHEMOTHERAPY	880	FALSE	941	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	566	NA
152	8da3103e-3e6c-4176-a583-d5fe5e60601e	TCGA.06.0125	TCGA-06-0125-D22572	0254badb-e288-40cf-b1c2-451ff481f440	2009-5-11	THALIDOMIDE	NA	CHEMOTHERAPY	1032	FALSE	1352	NA	NA	NA	NA	11	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	200	NA
153	8da3103e-3e6c-4176-a583-d5fe5e60601e	TCGA.06.0125	TCGA-06-0125-D22570	44e0e55b-fa57-44e8-a62f-a2faebf89093	2009-5-11	TEMOZOLOMIDE	NA	CHEMOTHERAPY	28	FALSE	452	NA	NA	NA	NA	14	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	300	NA
154	f66d92ff-85ad-4c83-b127-ce34c8488040	TCGA.06.0127	TCGA-06-0127-D22579	b1c20d80-9871-47e2-b6ee-f09d529ffc0e	2011-12-7	TEMOZOLOMIDE	NA	CHEMOTHERAPY	21	FALSE	64	NA	NA	NA	NA	1	NA	MG	MG	75	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
155	31e6e6c8-9197-4927-bfe4-8f6836f963da	TCGA.06.0128	TCGA-06-0128-D22584	5cfe1775-d0a9-4064-b778-b5d1c9e6bd35	2009-5-11	MGI 114	NA	CHEMOTHERAPY	207	FALSE	391	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	11	NA
156	31e6e6c8-9197-4927-bfe4-8f6836f963da	TCGA.06.0128	TCGA-06-0128-D22583	91e8bca9-8278-42fe-96bb-f15a06621726	2009-5-11	SURAMIN	NA	CHEMOTHERAPY	26	FALSE	176	NA	NA	NA	NA	13	NA	NA	NA	NA	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
157	31e6e6c8-9197-4927-bfe4-8f6836f963da	TCGA.06.0128	TCGA-06-0128-D22585	1d3b6e46-d5b9-4f0c-9622-11856df3ecd5	2009-5-11	TEMOZOLOMIDE	NA	CHEMOTHERAPY	422	FALSE	450	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	285	NA
158	31e6e6c8-9197-4927-bfe4-8f6836f963da	TCGA.06.0128	TCGA-06-0128-D22586	9b3053be-86f1-4f2a-a739-56327e3bb658	2009-5-11	BCNU	NA	CHEMOTHERAPY	481	FALSE	511	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	382	NA
159	31e6e6c8-9197-4927-bfe4-8f6836f963da	TCGA.06.0128	TCGA-06-0128-D22587	6743c37a-57a0-40b7-a349-c6233b4ed7d2	2009-5-11	TAMOXIFEN	NA	HORMONE THERAPY	601	FALSE	649	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	18	NA
160	bde84ea9-55c9-4d6d-be86-58fd9222c1d6	TCGA.06.0129	TCGA-06-0129-D22593	abf937a1-94a5-4183-b184-6c50ca8f3de7	2009-5-26	IL-13PE	NA	IMMUNOTHERAPY	183	FALSE	238	NA	NA	NA	NA	NA	NA	ML	ML	NA	NA	NA	NA	NA	OTHER	ADJUVANT AND PROGRESSION	19.5	NA
161	bde84ea9-55c9-4d6d-be86-58fd9222c1d6	TCGA.06.0129	TCGA-06-0129-D22592	10974b31-2686-4ac4-8a3d-991e76adfe45	2009-5-26	TEMOZOLOMIDE	NA	CHEMOTHERAPY	14	FALSE	120	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	ORAL	NA	NA	OTHER	ADJUVANT AND PROGRESSION	NA	NA
162	7cada85b-00b1-41e5-9924-e09eb077ad56	TCGA.06.0130	TCGA-06-0130-D22597	6c2a4e65-a69c-4d2a-be46-949d100ecee9	2009-5-11	TEMOZOLOMIDE	NA	CHEMOTHERAPY	74	FALSE	280	NA	NA	NA	NA	8	NA	NA	NA	NA	NA	ORAL	NA	NA	RECURRENCE	NA	NA	NA
163	0133e584-111e-450a-b451-77a2799ef529	TCGA.06.0133	TCGA-06-0133-D22605	604a09e9-831d-4186-ad3b-3f22fdf2624c	2009-5-11	CPT 11	NA	CHEMOTHERAPY	79	FALSE	430	NA	NA	NA	NA	10	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	263	NA
164	0133e584-111e-450a-b451-77a2799ef529	TCGA.06.0133	TCGA-06-0133-D22603	60a5d5e3-1991-4dc4-b19d-ac60256ea546	2009-5-11	TEMOZOLOMIDE	NA	CHEMOTHERAPY	14	FALSE	53	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
165	0133e584-111e-450a-b451-77a2799ef529	TCGA.06.0133	TCGA-06-0133-D22606	7e1d547f-f584-40de-ab7a-bf94c47a812d	2009-5-11	AVASTIN	NA	CHEMOTHERAPY	79	FALSE	430	NA	NA	NA	NA	10	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	927	NA
166	0133e584-111e-450a-b451-77a2799ef529	TCGA.06.0133	TCGA-06-0133-D22604	cc3a0dee-a602-4643-af4d-b6acc3e91057	2009-5-11	EMD	NA	CHEMOTHERAPY	14	FALSE	53	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	200	NA
167	d0de6676-6ba1-4d79-a9b0-ec3f1e8a8775	TCGA.06.0137	TCGA-06-0137-D22610	c284553d-f34c-4cfa-acb5-836087b0ffc9	2009-5-11	GLIADEL WAFER	NA	CHEMOTHERAPY	637	FALSE	637	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	ORAL	NA	NA	RECURRENCE	NA	NA	NA
168	5bbeb8a7-3ac2-4ef1-bd48-6f83bc994a75	TCGA.06.0139	TCGA-06-0139-D22616	ff6710e6-b842-40e5-842a-f27dfd162d4a	2009-5-11	AVASTIN	NA	TARGETED MOLECULAR THERAPY	203	FALSE	278	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	910	NA
169	5bbeb8a7-3ac2-4ef1-bd48-6f83bc994a75	TCGA.06.0139	TCGA-06-0139-D22615	50a0fd98-cd01-4d3f-a09b-b7ffbb15e201	2009-5-11	CPT11	NA	CHEMOTHERAPY	203	FALSE	278	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	265	NA
170	4b43da9d-60ee-4269-b44d-d92c034b844c	TCGA.06.0141	TCGA-06-0141-D22621	0103ae04-6325-44a5-a6a8-046799ba81da	2012-1-25	PROCARBAZINE	NA	CHEMOTHERAPY	235	FALSE	270	NA	NA	NA	NA	2	NA	MG/DAY	MG/DAY	170	NA	ORAL	NA	NA	PROGRESSION	NA	170	NA
171	4b43da9d-60ee-4269-b44d-d92c034b844c	TCGA.06.0141	TCGA-06-0141-D22619	886aa7a5-5ed0-4363-8c6f-46cde591cd3e	2012-1-25	CAI NABIT 9712	NA	CHEMOTHERAPY	19	FALSE	144	NA	NA	NA	NA	2	NA	MG	MG	250	NA	ORAL	NA	NA	ADJUVANT	NA	250	NA
172	4b43da9d-60ee-4269-b44d-d92c034b844c	TCGA.06.0141	TCGA-06-0141-D22620	05585355-2853-43cb-9ccb-5eab30b24a1b	2012-1-25	TEMOZOLOMIDE	NA	CHEMOTHERAPY	155	FALSE	217	NA	NA	NA	NA	2	NA	MG	MG	200	NA	ORAL	NA	NA	PROGRESSION	NA	NA	NA
173	3258cb3b-f63b-463c-b2e4-d638149157c5	TCGA.06.0145	TCGA-06-0145-D22627	59c565d1-b731-4e6a-8b0b-d07c51187028	2011-11-28	PYRAZINAMIDE	NA	CHEMOTHERAPY	24	FALSE	50	NA	NA	NA	NA	1	NA	MG	MG	871	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1524	NA
174	3003cbfa-98d5-464d-90a5-b1bef32bcef1	TCGA.06.0146	TCGA-06-0146-D22630	570ef6f6-5f74-4479-95d7-429acbe78eb4	2011-11-29	CARMUSTINE (BCNU)	NA	CHEMOTHERAPY	16	FALSE	315	NA	NA	NA	NA	6	NA	MG	MG	200	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	480	NA
175	3003cbfa-98d5-464d-90a5-b1bef32bcef1	TCGA.06.0146	TCGA-06-0146-D22631	0566690b-972e-4bcd-a141-e770fb8cf03d	2011-11-29	CISPLATIN	NA	CHEMOTHERAPY	16	FALSE	315	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
176	562d2831-ea9e-4ee1-bcee-77138e0a7d9d	TCGA.06.0147	TCGA-06-0147-D22638	7feff97f-2e17-40a0-849a-3e180fd4f6f5	2011-12-7	TEMOZOLOMIDE	NA	CHEMOTHERAPY	156	FALSE	399	NA	NA	NA	NA	9	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	NA	NA
177	562d2831-ea9e-4ee1-bcee-77138e0a7d9d	TCGA.06.0147	TCGA-06-0147-D22636	8c1c6e53-1d86-4d32-8b09-2e52f16be47a	2011-12-7	CARMUSTINE (BCNU)	NA	CHEMOTHERAPY	64	FALSE	64	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
178	562d2831-ea9e-4ee1-bcee-77138e0a7d9d	TCGA.06.0147	TCGA-06-0147-D22637	2f7858e7-ab26-42ea-91c0-a714dfffc125	2011-12-7	TAMOXIFEN	NA	CHEMOTHERAPY	94	FALSE	125	NA	NA	NA	NA	2	NA	MG/DAY	MG/DAY	10	NA	ORAL	NA	NA	PROGRESSION	NA	10	NA
179	562d2831-ea9e-4ee1-bcee-77138e0a7d9d	TCGA.06.0147	TCGA-06-0147-D22635	6496d9ca-5bf0-4bda-9529-1fb107bcb6a1	2011-12-7	GLIADEL WAFER	NA	CHEMOTHERAPY	0	FALSE	0	NA	NA	NA	NA	1	NA	WAFER	WAFER	4	NA	INTRATUMORAL	NA	NA	ADJUVANT	NA	4	NA
180	f2cef0e2-fece-4499-9f99-c5719aff8b5a	TCGA.06.0150	TCGA-06-0150-D40099	D3590881-5B0B-47A0-AFC0-CCB49F8E5E1D	2013-2-12	TAXOL	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
181	f2cef0e2-fece-4499-9f99-c5719aff8b5a	TCGA.06.0150	TCGA-06-0150-D40100	01A5865D-4395-4BDD-9BD2-941879FAB640	2013-2-12	CARMUSTINE	NA	CHEMOTHERAPY	335	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
182	f2cef0e2-fece-4499-9f99-c5719aff8b5a	TCGA.06.0150	TCGA-06-0150-D40102	BC761489-0EA6-4B2F-BBC9-A363E881AC5F	2013-2-12	PROCARBAZINE	NA	CHEMOTHERAPY	495	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
183	c57d6674-08d1-4eda-9ec1-ae439923d7cf	TCGA.06.0151	TCGA-06-0151-D40181	B85E2544-B0C2-4E36-9A9E-67DF3A18B9E5	2013-2-13	CARMUSTINE	NA	CHEMOTHERAPY	NA	FALSE	134	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
184	c57d6674-08d1-4eda-9ec1-ae439923d7cf	TCGA.06.0151	TCGA-06-0151-D40182	CB62D25B-80D8-4115-8D85-AE584278C41C	2013-2-13	GLIADEL WAFERS	NA	CHEMOTHERAPY	179	FALSE	179	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
185	c57d6674-08d1-4eda-9ec1-ae439923d7cf	TCGA.06.0151	TCGA-06-0151-D40183	348FF8BA-F450-4DCC-9FF4-9953CE7275FE	2013-2-13	TEMOZOLOMIDE	NA	CHEMOTHERAPY	1330	FALSE	1381	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
186	f5bc5d97-e054-4e53-992d-71b896bd97d5	TCGA.06.0152	TCGA-06-0152-D22649	afeb0618-1975-4d78-a889-c3bd92b36eb7	2011-11-29	CARMUSTINE	NA	CHEMOTHERAPY	263	FALSE	293	NA	NA	NA	NA	1	NA	MG	MG	80	NA	ORAL	NA	NA	PROGRESSION	NA	NA	NA
187	f5bc5d97-e054-4e53-992d-71b896bd97d5	TCGA.06.0152	TCGA-06-0152-D22648	9a226e9f-9727-4c5f-8b0e-1e61618d6e33	2011-11-29	PACLITAXEL	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
188	f5bc5d97-e054-4e53-992d-71b896bd97d5	TCGA.06.0152	TCGA-06-0152-D22650	3d1353a8-5085-4a0d-88b6-fdd4b5f28569	2011-11-29	PROCARBAZINE	NA	CHEMOTHERAPY	293	FALSE	293	NA	NA	NA	NA	1	NA	MG	MG	110	NA	ORAL	NA	NA	PROGRESSION	NA	200	NA
189	f5bc5d97-e054-4e53-992d-71b896bd97d5	TCGA.06.0152	TCGA-06-0152-D22651	a5649f70-0afd-4ce0-9377-9a2c55dcecfc	2011-11-29	TAMOXIFEN	NA	CHEMOTHERAPY	293	FALSE	293	NA	NA	NA	NA	1	NA	MG	MG	10	NA	ORAL	NA	NA	PROGRESSION	NA	20	NA
190	24ae6f30-eec8-49a7-abde-246b3873679e	TCGA.06.0154	TCGA-06-0154-D22655	7ab3f8d8-87db-49d6-bdf2-8b713609ae93	2011-11-29	CI 980	NA	CHEMOTHERAPY	12	FALSE	89	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
191	24ae6f30-eec8-49a7-abde-246b3873679e	TCGA.06.0154	TCGA-06-0154-D22658	2c557135-cdb8-47d5-91de-a196c8fa77d3	2011-11-29	PROCARBAZINE	NA	CHEMOTHERAPY	373	FALSE	NA	NA	NA	NA	NA	NA	NA	MG	MG	100	NA	ORAL	NA	NA	PROGRESSION	NA	150	NA
192	24ae6f30-eec8-49a7-abde-246b3873679e	TCGA.06.0154	TCGA-06-0154-D22657	dbcdec89-79b1-48e7-83b6-ff51dc7bb3a7	2011-11-29	GLIADEL WAFER	NA	CHEMOTHERAPY	235	FALSE	235	NA	NA	NA	NA	1	NA	WAFER	WAFER	8	NA	INTRATUMORAL	NA	NA	PROGRESSION	NA	8	NA
193	24ae6f30-eec8-49a7-abde-246b3873679e	TCGA.06.0154	TCGA-06-0154-D22656	fd6f69ec-53bd-4df7-b878-ffb8c8357eaa	2011-11-29	CARMUSTINE	NA	CHEMOTHERAPY	160	FALSE	191	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
194	fa1f1cfc-9da0-488b-93fe-60aaff99c171	TCGA.06.0155	TCGA-06-0155-D22666	12a9f37f-e7e1-47e5-84f8-6e25d7f19061	2009-5-11	CI980	NA	TARGETED MOLECULAR THERAPY	9	FALSE	52	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	400	NA
195	fa1f1cfc-9da0-488b-93fe-60aaff99c171	TCGA.06.0155	TCGA-06-0155-D22664	cfb4a806-be88-4509-84a0-1ff9aa164266	2009-5-11	GLIADEL WAFER	NA	CHEMOTHERAPY	257	FALSE	257	NA	NA	NA	NA	1	NA	WAFER	WAFER	NA	NA	OTHER	NA	NA	PALLIATIVE	NA	8	NA
196	fa1f1cfc-9da0-488b-93fe-60aaff99c171	TCGA.06.0155	TCGA-06-0155-D22663	afd3dda1-105f-49dc-938b-ed20c47f7d0e	2009-5-11	BCNU	NA	CHEMOTHERAPY	144	FALSE	236	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	80	NA
197	fa1f1cfc-9da0-488b-93fe-60aaff99c171	TCGA.06.0155	TCGA-06-0155-D22665	b17c22ef-2efa-439d-9236-25db55221c3b	2011-11-29	CARMUSTINE	NA	CHEMOTHERAPY	175	FALSE	205	NA	NA	NA	NA	2	NA	MG	MG	80	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
198	15e058e8-2f33-4fb4-92af-3d9dea1fa906	TCGA.06.0156	TCGA-06-0156-D22670	dbb7ebf3-eee9-45fd-8064-afbbb30c75ab	2011-11-28	TAMOXIFEN	NA	CHEMOTHERAPY	48	FALSE	140	NA	NA	NA	NA	2	NA	MG/DAY	MG/DAY	NA	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
199	bc316a17-9d73-4ef3-97e9-c4ac5516b75a	TCGA.06.0158	TCGA-06-0158-D22677	ddceed7c-1346-497b-87f2-f3c1b72f517a	2011-11-28	CARMUSTIN	NA	CHEMOTHERAPY	99	FALSE	160	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	NA	NA
200	5f8f66a0-4068-4e9d-82fc-4fe1fc3f63aa	TCGA.06.0159	TCGA-06-0159-D40188	E5A986AD-E2E2-4B1B-9CAB-D712EC054E3E	2013-2-13	CARMUSTINE	NA	CHEMOTHERAPY	70	FALSE	162	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
201	a9b5ef55-9987-4842-b4f3-d029265ef17f	TCGA.06.0160	TCGA-06-0160-D40192	EF52F1C9-7619-4826-9EDA-6D6F6EF359C5	2013-2-13	CI-980	NA	CHEMOTHERAPY	33	FALSE	63	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
202	a9b5ef55-9987-4842-b4f3-d029265ef17f	TCGA.06.0160	TCGA-06-0160-D40193	2001B8EF-EF02-4982-BEE7-8C785CBF04B9	2013-2-13	CARMUSTINE	NA	CHEMOTHERAPY	190	FALSE	242	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
203	a9b5ef55-9987-4842-b4f3-d029265ef17f	TCGA.06.0160	TCGA-06-0160-D40194	8AECA090-CCAD-4810-909A-C357E3576567	2013-2-13	TEMOZOLOMIDE	NA	CHEMOTHERAPY	277	FALSE	277	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
204	da89dcc7-7453-44a7-b43d-5b3478c5d9a7	TCGA.06.0162	TCGA-06-0162-D22681	ed06b80b-df64-483d-8228-5e747bccc285	2011-12-7	CAI (NABTT 9712)	NA	CHEMOTHERAPY	13	FALSE	74	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
205	88fcfd59-294a-4166-b703-e698a72b1a53	TCGA.06.0165	TCGA-06-0165-D40197	2E4F263F-280C-4694-A7A3-BFA52E4E8556	2013-2-13	OXALIPLATIN	NA	NA	31	FALSE	31	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
206	88fcfd59-294a-4166-b703-e698a72b1a53	TCGA.06.0165	TCGA-06-0165-D40199	00A80670-919B-4311-A8B0-553DA259B21E	2013-2-13	TEMOZOLOMIDE	NA	CHEMOTHERAPY	122	FALSE	153	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
207	88fcfd59-294a-4166-b703-e698a72b1a53	TCGA.06.0165	TCGA-06-0165-D40200	4BDED05E-0D16-44BA-A8CF-A2A15A51C6CA	2013-2-13	ACCUTANE	NA	TARGETED MOLECULAR THERAPY	122	FALSE	153	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
208	88fcfd59-294a-4166-b703-e698a72b1a53	TCGA.06.0165	TCGA-06-0165-D40203	E313C951-871F-415B-A38A-AB56206EF85B	2013-2-13	GLEEVEC	NA	TARGETED MOLECULAR THERAPY	184	FALSE	214	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
209	4a85a43b-4dbc-4081-b552-df06eef1ad80	TCGA.06.0166	TCGA-06-0166-D22687	e89a761c-660b-4ec9-9299-b13331326520	2011-12-7	OXALIPLATIN	NA	CHEMOTHERAPY	14	FALSE	60	NA	NA	NA	NA	4	NA	MG	MG	85	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
210	afd3a4dc-a2e5-4545-92b8-a18e72fc9e94	TCGA.06.0167	TCGA-06-0167-D40209	B4557645-D764-423F-9501-100BE5CA700D	2013-2-13	TEMOZOLOMIDE	NA	CHEMOTHERAPY	24	FALSE	68	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
211	afd3a4dc-a2e5-4545-92b8-a18e72fc9e94	TCGA.06.0167	TCGA-06-0167-D40210	38A39983-9DA0-4CB0-9CCA-CDEB2E642448	2013-2-13	TEMOZOLOMIDE	NA	CHEMOTHERAPY	77	FALSE	197	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
212	afd3a4dc-a2e5-4545-92b8-a18e72fc9e94	TCGA.06.0167	TCGA-06-0167-D40211	40FAA94B-6B53-453B-B030-091810610494	2013-2-13	PS341	NA	CHEMOTHERAPY	258	FALSE	289	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
213	224235c1-5b6e-48d5-a5d1-777dfede0f1e	TCGA.06.0168	TCGA-06-0168-D22693	6e1bfca6-d9c4-40f5-827a-07f71328c2e3	2011-11-28	CARMUSTINE	NA	CHEMOTHERAPY	488	FALSE	519	NA	NA	NA	NA	2	NA	MG	MG	200	NA	ORAL	NA	NA	PROGRESSION	NA	380	NA
214	224235c1-5b6e-48d5-a5d1-777dfede0f1e	TCGA.06.0168	TCGA-06-0168-D22692	66781d87-c055-4454-b5e9-b93231930e86	2011-11-28	TEMOZOLOMIDE	NA	CHEMOTHERAPY	136	FALSE	458	NA	NA	NA	NA	10	NA	MG	MG	200	NA	ORAL	NA	NA	ADJUVANT	NA	380	NA
215	224235c1-5b6e-48d5-a5d1-777dfede0f1e	TCGA.06.0168	TCGA-06-0168-D22691	1ecdb47e-2c54-41fc-9c22-03a976ed78d1	2011-11-28	TEMOZOLOMIDE	NA	CHEMOTHERAPY	28	FALSE	76	NA	NA	NA	NA	1	NA	MG	MG	75	NA	ORAL	NA	NA	ADJUVANT	NA	150	NA
216	bcc72cf4-90ce-466e-a683-bb0ebfb3cf82	TCGA.06.0169	TCGA-06-0169-D22698	1a31b79f-7069-4481-8240-a057a730a3a0	2011-12-7	TEMOZOLOMIDE	NA	CHEMOTHERAPY	29	FALSE	78	NA	NA	NA	NA	1	NA	MG	MG	75	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
217	01a92062-967a-4900-8dc7-a5ecd3b3f8e2	TCGA.06.0171	TCGA-06-0171-D22703	62871dae-a622-4334-a1af-fc5cded07388	2011-11-28	CARMUSTINE (BCNU)	NA	CHEMOTHERAPY	231	FALSE	273	NA	NA	NA	NA	2	NA	MG	MG	200	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	394	NA
218	01a92062-967a-4900-8dc7-a5ecd3b3f8e2	TCGA.06.0171	TCGA-06-0171-D22702	ee711ede-bac7-4d62-b043-48ac4493ae1a	2011-11-28	TEMOZOLOMIDE	NA	CHEMOTHERAPY	81	FALSE	175	NA	NA	NA	NA	3	NA	MG	MG	200	NA	ORAL	NA	NA	ADJUVANT	NA	400	NA
219	ee3fc631-1e88-4f70-ab31-335851b38640	TCGA.06.0174	TCGA-06-0174-D22709	da38c277-79ad-4477-8608-3bd3073bff05	2011-11-28	TIPFARNIB (R115777)	NA	CHEMOTHERAPY	3	FALSE	33	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
220	22297a8b-4761-4f5c-b080-60a39c3a0670	TCGA.06.0175	TCGA-06-0175-D22713	2bf89b93-f929-4a8c-8d2c-9d43f777993d	2011-12-7	TIPIFARNIB (R115777)	NA	CHEMOTHERAPY	15	FALSE	22	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
221	7391f99d-9528-46a1-9799-c5f0a7bfc63e	TCGA.06.0176	TCGA-06-0176-D19254	929ffde3-8b3c-4530-80d0-4c44b13bec64	2011-11-30	TEMOZOLOMIDE	NA	CHEMOTHERAPY	127	FALSE	584	NA	NA	NA	NA	12	NA	MG/M2	MG	200	1	ORAL	NA	NA	PROGRESSION	NA	400	NA
222	7391f99d-9528-46a1-9799-c5f0a7bfc63e	TCGA.06.0176	TCGA-06-0176-D19253	5de1a00d-bd11-4571-b701-d983abbcf3a4	2011-11-30	TEMOZOLOMIDE	NA	CHEMOTHERAPY	50	FALSE	93	NA	NA	NA	NA	1	NA	MG/M2	MG	75	1	ORAL	NA	NA	PROGRESSION	NA	NA	NA
223	53abce1d-7e33-4ebd-832f-f3789f67377f	TCGA.06.0178	TCGA-06-0178-D20895	c0d4abea-6571-4140-88bd-fbcc893cc934	2011-11-30	BEVCIZUMAB	NA	TARGETED MOLECULAR THERAPY	2572	FALSE	2614	NA	NA	NA	NA	2	NA	MG/KG	MG	10	3	INTRAVENOUS	NA	NA	PROGRESSION	NA	909	NA
224	53abce1d-7e33-4ebd-832f-f3789f67377f	TCGA.06.0178	TCGA-06-0178-D20893	5f9d63d7-62e7-457f-8208-c5db7b743cfb	2011-11-30	TEMOZOLOMIDE	NA	CHEMOTHERAPY	113	FALSE	751	NA	NA	NA	NA	24	NA	MG/M2	MG	200	1	ORAL	NA	NA	ADJUVANT	NA	400	NA
225	53abce1d-7e33-4ebd-832f-f3789f67377f	TCGA.06.0178	TCGA-06-0178-D20894	2a90f5d3-64fb-47b0-9be1-689130598227	2011-11-30	MEDT 575	NA	CHEMOTHERAPY	2530	FALSE	NA	NA	NA	NA	NA	2	NA	MG/KG	MG	25	2	ORAL	NA	NA	PROGRESSION	NA	2340	NA
226	53abce1d-7e33-4ebd-832f-f3789f67377f	TCGA.06.0178	TCGA-06-0178-D20892	7db74531-d99d-4392-a5dc-8510bf6c98b6	2011-11-30	TEMOZOLOMIDE	NA	CHEMOTHERAPY	51	FALSE	95	NA	NA	NA	NA	1	NA	MG/M2	MG	200	1	ORAL	NA	NA	ADJUVANT	NA	400	NA
227	1f48f010-98fe-4b5a-b96a-14fb25eff23f	TCGA.06.0184	TCGA-06-0184-D19259	68848ab7-30f8-4275-85bc-f5512ae68d7e	2011-11-30	TEMOZOLOMIDE	NA	CHEMOTHERAPY	93	FALSE	670	NA	NA	NA	NA	22	NA	MG/M2	MG	200	1	ORAL	NA	NA	ADJUVANT	NA	440	NA
228	1f48f010-98fe-4b5a-b96a-14fb25eff23f	TCGA.06.0184	TCGA-06-0184-D19260	e685e22a-4693-4d7a-b168-f0cd86a7b3b4	2011-11-30	TEMOZOLOMIDE	NA	CHEMOTHERAPY	1311	FALSE	1646	NA	NA	NA	NA	12	NA	MG/M2	MG	75	2	ORAL	NA	NA	PROGRESSION	NA	160	NA
229	1f48f010-98fe-4b5a-b96a-14fb25eff23f	TCGA.06.0184	TCGA-06-0184-D19258	502b5c3b-1207-4781-8f35-ef3d0e1b8190	2011-11-30	TEMOZOLOMIDE	NA	CHEMOTHERAPY	23	FALSE	72	NA	NA	NA	NA	1	NA	MG/M2	MG	75	1	ORAL	NA	NA	ADJUVANT	NA	150	NA
230	8f3acbbd-b2ca-4e66-8fe5-dbb49277f35b	TCGA.06.0185	TCGA-06-0185-D19267	03e128de-a504-43dc-9a99-e9bddbf9643a	2011-11-30	IRINOTECAN	NA	CHEMOTHERAPY	739	FALSE	1397	NA	NA	NA	NA	24	NA	MG/M2	MG	125	2	INTRAVENOUS	NA	NA	PROGRESSION	NA	232	NA
231	8f3acbbd-b2ca-4e66-8fe5-dbb49277f35b	TCGA.06.0185	TCGA-06-0185-D19266	2c95edf6-7f28-425c-b4e9-d61fb72bcb70	2011-11-30	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	739	FALSE	1397	NA	NA	NA	NA	24	NA	MG/KG	MG	10	2	INTRAVENOUS	NA	NA	PROGRESSION	NA	689	NA
232	8f3acbbd-b2ca-4e66-8fe5-dbb49277f35b	TCGA.06.0185	TCGA-06-0185-D19271	0495d810-b7ae-4673-8332-288c71fe6a19	2011-11-30	LOMUSTINE	NA	CHEMOTHERAPY	2259	TRUE	NA	NA	NA	NA	NA	4	NA	MG/M2	MG	110	6	ORAL	NA	NA	PROGRESSION	NA	NA	NA
233	8f3acbbd-b2ca-4e66-8fe5-dbb49277f35b	TCGA.06.0185	TCGA-06-0185-D19265	5f103c93-1e65-42e6-8e7a-2223d99a7c23	2011-11-30	TEMOZOLOMIDE	NA	CHEMOTHERAPY	98	FALSE	249	NA	NA	NA	NA	6	NA	MG/M2	MG	200	1	ORAL	NA	NA	ADJUVANT	NA	370	NA
234	8f3acbbd-b2ca-4e66-8fe5-dbb49277f35b	TCGA.06.0185	TCGA-06-0185-D19269	2245203f-60eb-4fd3-8d0a-69d2be051f3c	2011-11-30	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	1664	TRUE	NA	NA	NA	NA	NA	NA	NA	MG/KG	MG	10	4	INTRAVENOUS	NA	NA	PROGRESSION	NA	791	NA
235	8f3acbbd-b2ca-4e66-8fe5-dbb49277f35b	TCGA.06.0185	TCGA-06-0185-D19264	c0ec5175-f85f-4ea4-89d8-52a4c7e9a541	2011-11-30	ARSENIC TRIOXIDE (ATO)	NA	TARGETED MOLECULAR THERAPY	19	FALSE	56	NA	NA	NA	NA	12	NA	MG/KG	MG	0.25	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	17.25	NA
236	8f3acbbd-b2ca-4e66-8fe5-dbb49277f35b	TCGA.06.0185	TCGA-06-0185-D19268	66424f53-9b9c-426b-9cbe-48fac9ef0dcf	2011-11-30	XL184	NA	CHEMOTHERAPY	1502	FALSE	1636	NA	NA	NA	NA	2	NA	MG/DAY	MG/DAY	75	3	ORAL	NA	NA	PROGRESSION	NA	75	NA
237	8f3acbbd-b2ca-4e66-8fe5-dbb49277f35b	TCGA.06.0185	TCGA-06-0185-D19270	b34b52d0-bf01-41b1-9a1a-4dd2cb94973b	2011-11-30	TEMOZOLOMIDE	NA	CHEMOTHERAPY	1986	FALSE	2228	NA	NA	NA	NA	10	NA	MG/M2	MG	75	5	ORAL	NA	NA	PROGRESSION	NA	145	NA
238	6573378a-ad14-4654-8810-9f3bd3597bc2	TCGA.06.0188	TCGA-06-0188-D20857	bb611c12-0f7b-4af8-a5ac-be45d6ed7b60	2011-11-30	TEMOZOLOMIDE	NA	CHEMOTHERAPY	88	FALSE	300	NA	NA	NA	NA	8	NA	MG/M2	MG	200	1	ORAL	NA	NA	ADJUVANT	NA	380	NA
239	6573378a-ad14-4654-8810-9f3bd3597bc2	TCGA.06.0188	TCGA-06-0188-D20864	ca1f90cc-0dce-4fc7-aacb-4324cb975864	2011-11-30	ETOPOSIDE	NA	CHEMOTHERAPY	1342	FALSE	1342	NA	NA	NA	NA	1	NA	MG/M2	MG	75	5	ORAL	NA	NA	PROGRESSION	NA	50	NA
240	6573378a-ad14-4654-8810-9f3bd3597bc2	TCGA.06.0188	TCGA-06-0188-D20860	9498f200-53bc-40e0-8cc6-908ae2da695a	2011-11-30	IRINOTECAN	NA	CHEMOTHERAPY	965	FALSE	1230	NA	NA	NA	NA	8	NA	MG/M2	MG	125	3	INTRAVENOUS	NA	NA	PROGRESSION	NA	254	NA
241	6573378a-ad14-4654-8810-9f3bd3597bc2	TCGA.06.0188	TCGA-06-0188-D20862	948e163e-c541-4922-8d53-83b2b6982f7e	2011-11-30	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	965	FALSE	1342	NA	NA	NA	NA	12	NA	MG/KG	MG	10	3	INTRAVENOUS	NA	NA	PROGRESSION	NA	864	NA
242	6573378a-ad14-4654-8810-9f3bd3597bc2	TCGA.06.0188	TCGA-06-0188-D20863	914dd177-6123-46c2-9acd-1c00faafc764	2011-11-30	TEMOZOLOMIDE	NA	CHEMOTHERAPY	1244	FALSE	1337	NA	NA	NA	NA	2	NA	MG/M2	MG	75	4	ORAL	NA	NA	PROGRESSION	NA	150	NA
243	6573378a-ad14-4654-8810-9f3bd3597bc2	TCGA.06.0188	TCGA-06-0188-D20858	0a5a53d9-4a3b-4b74-b6b7-21c6c6554309	2011-11-30	ERLOTINIB	NA	CHEMOTHERAPY	334	FALSE	949	NA	NA	NA	NA	22	NA	MG/DAY	MG/DAY	75	2	ORAL	NA	NA	PROGRESSION	NA	75	NA
244	6573378a-ad14-4654-8810-9f3bd3597bc2	TCGA.06.0188	TCGA-06-0188-D20856	d7523c46-c78a-4f93-8935-f11326f9d479	2011-11-30	TEMOZOLOMIDE	NA	CHEMOTHERAPY	27	FALSE	68	NA	NA	NA	NA	1	NA	MG/M2	MG	75	1	ORAL	NA	NA	ADJUVANT	NA	140	NA
245	6573378a-ad14-4654-8810-9f3bd3597bc2	TCGA.06.0188	TCGA-06-0188-D20859	6b95f95b-2cd1-4f8d-81b0-369e9e257ac9	2011-11-30	SORAFENIB	NA	CHEMOTHERAPY	334	FALSE	949	NA	NA	NA	NA	22	NA	MG/DAY	MG/DAY	200	2	ORAL	NA	NA	PROGRESSION	NA	200	NA
246	f08280d6-2c80-4dd7-93d3-a0c55f7da5b3	TCGA.06.0192	TCGA-06-0192-D20873	4af10e02-c74b-4fa0-bed2-3f5fb6e74689	2011-12-7	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	816	FALSE	1153	NA	NA	NA	NA	10	NA	MG/KG	MG	10	3	INTRAVENOUS	NA	NA	PROGRESSION	NA	873	NA
247	f08280d6-2c80-4dd7-93d3-a0c55f7da5b3	TCGA.06.0192	TCGA-06-0192-D20871	fa5e4006-f2a0-4122-b0ed-fba0201e0f1e	2011-12-7	LOMUSTINE	NA	CHEMOTHERAPY	725	FALSE	767	NA	NA	NA	NA	2	NA	MG	MG	160	2	ORAL	NA	NA	PROGRESSION	NA	160	NA
248	f08280d6-2c80-4dd7-93d3-a0c55f7da5b3	TCGA.06.0192	TCGA-06-0192-D20875	1c4ae90b-7bb6-4887-a4c1-4576c1f90f08	2011-12-7	IRINOTECAN	NA	CHEMOTHERAPY	816	FALSE	907	NA	NA	NA	NA	3	NA	MG/M2	NA	125	3	INTRAVENOUS	NA	NA	PROGRESSION	NA	262.5	NA
249	f08280d6-2c80-4dd7-93d3-a0c55f7da5b3	TCGA.06.0192	TCGA-06-0192-D20872	c21531d8-c97c-435f-b306-e577109bed0f	2011-12-7	CEDIRANIB/PLACEBO	NA	TARGETED MOLECULAR THERAPY	725	FALSE	808	NA	NA	NA	NA	2	NA	MG/DAY	MG/DAY	20	2	ORAL	NA	NA	PROGRESSION	NA	20	NA
250	f08280d6-2c80-4dd7-93d3-a0c55f7da5b3	TCGA.06.0192	TCGA-06-0192-D20869	a2291f31-1fec-4d97-acbc-5e24b84ee3a1	2011-12-7	TEMOZOLOMIDE	NA	CHEMOTHERAPY	18	FALSE	60	NA	NA	NA	NA	1	NA	MG/M2	MG	75	1	ORAL	NA	NA	ADJUVANT	NA	150	NA
251	f08280d6-2c80-4dd7-93d3-a0c55f7da5b3	TCGA.06.0192	TCGA-06-0192-D20876	b1f4fa20-7a9f-4d81-91b7-fc1479be2ac4	2011-12-7	TEMOZOLOMIDE	NA	CHEMOTHERAPY	919	FALSE	980	NA	NA	NA	NA	2	NA	MG/M2	MG	75	4	ORAL	NA	NA	PROGRESSION	NA	140	NA
252	f08280d6-2c80-4dd7-93d3-a0c55f7da5b3	TCGA.06.0192	TCGA-06-0192-D20870	fab6fdc5-e184-4d7b-b57a-49600b74beca	2011-12-7	TEMOZOLOMIDE	NA	CHEMOTHERAPY	96	FALSE	462	NA	NA	NA	NA	12	NA	MG/M2	MG	200	1	ORAL	NA	NA	ADJUVANT	NA	420	NA
253	67e2af1c-3478-4652-8759-b9d5c5b6a3e0	TCGA.06.0195	TCGA-06-0195-D22745	f64b3f24-50c3-4c9b-8910-0f5106216c5f	2011-11-29	VINCRISTINE	NA	CHEMOTHERAPY	95	FALSE	169	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
254	67e2af1c-3478-4652-8759-b9d5c5b6a3e0	TCGA.06.0195	TCGA-06-0195-D22746	47d0a8e7-6a06-4a12-bcdb-e19cd63c7f05	2011-11-29	VP 16 (ETOPOSIDE)	NA	CHEMOTHERAPY	169	FALSE	200	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
255	67e2af1c-3478-4652-8759-b9d5c5b6a3e0	TCGA.06.0195	TCGA-06-0195-D22743	a0b911a9-1e26-4745-b73e-be8da4e7995b	2011-11-29	PROCARBAZINE	NA	CHEMOTHERAPY	95	FALSE	169	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
256	67e2af1c-3478-4652-8759-b9d5c5b6a3e0	TCGA.06.0195	TCGA-06-0195-D22744	7f0ea126-94f4-4cdd-ad59-17589585a38d	2011-11-29	LOMUSTINE	NA	CHEMOTHERAPY	95	FALSE	169	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
257	67e2af1c-3478-4652-8759-b9d5c5b6a3e0	TCGA.06.0195	TCGA-06-0195-D22747	b9612743-3757-4309-be97-863b1007bae3	2011-11-29	CARBOPLATIN	NA	CHEMOTHERAPY	169	FALSE	200	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
258	9733968f-262f-4e97-9194-240cda8caf65	TCGA.06.0197	TCGA-06-0197-D22751	a925243f-86c3-43d5-8abc-393e9c1ab638	2011-11-29	TAXOL	NA	CHEMOTHERAPY	26	FALSE	79	NA	NA	NA	NA	3	NA	MG	MG	175	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
259	4d04939f-9509-4e9b-9406-16051afecf82	TCGA.06.0206	TCGA-06-0206-D22756	776098d0-19be-4f7b-a6e0-d7e9dd126a81	2011-11-29	CARMUSTINE (BCNU)	NA	CHEMOTHERAPY	138	FALSE	138	NA	NA	NA	NA	1	NA	MG	MG	200	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
260	e3711a9b-6d4c-44df-bbab-0a675046a5df	TCGA.06.0208	TCGA-06-0208-D22760	abd127de-4081-4844-8715-79add07f6b4e	2011-11-29	CISPLATIN	NA	CHEMOTHERAPY	39	FALSE	98	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
261	e3711a9b-6d4c-44df-bbab-0a675046a5df	TCGA.06.0208	TCGA-06-0208-D22761	743e879c-c5ba-4391-a70d-1efaacbf3ea5	2011-11-29	CARMUSTINE (BCNU)	NA	CHEMOTHERAPY	39	FALSE	98	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
262	5c984433-33cf-42fc-b3ba-511efcdcab19	TCGA.06.0211	TCGA-06-0211-D22772	6bd9bbe4-d9de-41cf-b3fa-810fa0119bac	2011-11-29	CARMUSTINE	NA	CHEMOTHERAPY	149	FALSE	210	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
263	5c984433-33cf-42fc-b3ba-511efcdcab19	TCGA.06.0211	TCGA-06-0211-D22773	759a71e3-46c1-44d2-8f9b-185cb37ff8d9	2011-11-29	GLIADEL WAFER	NA	CHEMOTHERAPY	221	FALSE	221	NA	NA	NA	NA	1	NA	WAFER	WAFER	8	NA	INTRATUMORAL	NA	NA	PROGRESSION	NA	8	NA
264	5c984433-33cf-42fc-b3ba-511efcdcab19	TCGA.06.0211	TCGA-06-0211-D22771	84157643-f71e-48df-a39c-23601933d4c0	2011-11-29	CI-980	NA	CHEMOTHERAPY	25	FALSE	44	NA	NA	NA	NA	2	NA	MG	MG	4	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
265	9853c6bb-a42c-4698-abe5-f3c897ebc8f6	TCGA.06.0214	TCGA-06-0214-D22780	74b04c6e-2125-48db-85fb-f90ba671ed74	2011-11-28	CARMUSTINE (BCNU)	NA	CHEMOTHERAPY	119	FALSE	331	NA	NA	NA	NA	6	NA	MG	MG	200	NA	ORAL	NA	NA	PROGRESSION	NA	NA	NA
266	9853c6bb-a42c-4698-abe5-f3c897ebc8f6	TCGA.06.0214	TCGA-06-0214-D22779	f21edf2f-2d4d-4850-860f-2c822f5a9798	2011-11-28	CI-980	NA	CHEMOTHERAPY	18	FALSE	52	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
267	9853c6bb-a42c-4698-abe5-f3c897ebc8f6	TCGA.06.0214	TCGA-06-0214-D22781	a889796c-27c5-495e-bcfd-47986442b74f	2011-11-28	TAMOXIFEN	NA	CHEMOTHERAPY	331	FALSE	453	NA	NA	NA	NA	4	NA	MG/DAY	MG/DAY	10	NA	ORAL	NA	NA	PROGRESSION	NA	10	NA
268	a8033f85-ac9b-41f3-b775-a1aee3f21b8f	TCGA.06.0216	TCGA-06-0216-D22786	3cc272ec-fba2-4492-8262-a6fc4c7e0e50	2011-12-7	TEMOZOLOMIDE	NA	CHEMOTHERAPY	250	FALSE	463	NA	NA	NA	NA	7	NA	MG	MG	150	NA	ORAL	NA	NA	PROGRESSION	NA	280	NA
269	a8033f85-ac9b-41f3-b775-a1aee3f21b8f	TCGA.06.0216	TCGA-06-0216-D22785	923595d9-11a6-4c85-ac67-9c017449c9fa	2011-12-7	CI 980	NA	CHEMOTHERAPY	36	FALSE	97	NA	NA	NA	NA	4	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
270	a8033f85-ac9b-41f3-b775-a1aee3f21b8f	TCGA.06.0216	TCGA-06-0216-D22787	28fc2476-c207-4a60-a53c-753c090fa845	2011-12-7	CARMUSTINE	NA	CHEMOTHERAPY	586	FALSE	586	NA	NA	NA	NA	1	NA	MEQ	MEQ	NA	NA	ORAL	NA	NA	PROGRESSION	NA	NA	NA
271	054f472f-98cb-4559-b2e2-b5f800fc8eef	TCGA.06.0221	TCGA-06-0221-D22800	4b17d81b-d5c1-4f69-bb5f-1c0bb0098807	2011-12-7	CARMUSTINE (BCNU)	NA	CHEMOTHERAPY	502	FALSE	532	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
272	054f472f-98cb-4559-b2e2-b5f800fc8eef	TCGA.06.0221	TCGA-06-0221-D22795	14d68576-2d46-48e9-91c2-d5156d715433	2011-12-7	GLIADEL WAFER	NA	CHEMOTHERAPY	280	FALSE	280	NA	NA	NA	NA	1	NA	WAFER	WAFER	6	NA	INTRATUMORAL	NA	NA	PROGRESSION	NA	6	NA
273	054f472f-98cb-4559-b2e2-b5f800fc8eef	TCGA.06.0221	TCGA-06-0221-D22794	d08ff5bb-27b0-4f09-ba06-843db1df5155	2011-12-7	CAI (NABTT 97212)	NA	CHEMOTHERAPY	14	FALSE	259	NA	NA	NA	NA	8	NA	MG/DAY	MG/DAY	250	NA	ORAL	NA	NA	ADJUVANT	NA	250	NA
274	054f472f-98cb-4559-b2e2-b5f800fc8eef	TCGA.06.0221	TCGA-06-0221-D22796	0736e5df-6ad1-442e-b54f-95809339145b	2011-12-7	06-BG (NABTT 0803)	NA	CHEMOTHERAPY	280	FALSE	285	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
275	054f472f-98cb-4559-b2e2-b5f800fc8eef	TCGA.06.0221	TCGA-06-0221-D22799	afd86caa-d628-467a-b95b-b971c5f6f8a9	2011-12-7	VATALANIB (PTK787)	NA	CHEMOTHERAPY	471	FALSE	502	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
276	054f472f-98cb-4559-b2e2-b5f800fc8eef	TCGA.06.0221	TCGA-06-0221-D22798	7732fe67-16b8-439c-a842-2d4550ae661b	2011-12-7	REINOID/CIS RETINOIC ACID	NA	CHEMOTHERAPY	379	FALSE	471	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	NA	NA
277	054f472f-98cb-4559-b2e2-b5f800fc8eef	TCGA.06.0221	TCGA-06-0221-D22801	46bc19b2-d79d-480b-b367-156fbb1ce11a	2011-12-7	06-BG	NA	CHEMOTHERAPY	502	FALSE	532	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
278	054f472f-98cb-4559-b2e2-b5f800fc8eef	TCGA.06.0221	TCGA-06-0221-D22797	215a60ad-ece2-4e5a-83bb-75a4bad84253	2011-12-7	TEMOZOLOMIDE	NA	CHEMOTHERAPY	318	FALSE	471	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	NA	NA
279	a0700d6d-df7b-4327-8738-97b8ad08fd4c	TCGA.06.0240	TCGA-06-0240-D40214	B174A8ED-3DC7-48D8-B624-4E20C131FEA6	2013-2-13	TEMOZOLOMIDE	NA	CHEMOTHERAPY	34	FALSE	65	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
280	a0700d6d-df7b-4327-8738-97b8ad08fd4c	TCGA.06.0240	TCGA-06-0240-D40215	AC89545B-B9D6-4C8C-BC96-5F76EE4B2048	2013-2-13	TEMOZOLOMIDE	NA	CHEMOTHERAPY	36	FALSE	320	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
281	a0700d6d-df7b-4327-8738-97b8ad08fd4c	TCGA.06.0240	TCGA-06-0240-D40216	B1B57089-EB7E-400B-91E1-29AC72454190	2013-2-13	CILENGITIDE	NA	CHEMOTHERAPY	36	FALSE	320	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
282	a0700d6d-df7b-4327-8738-97b8ad08fd4c	TCGA.06.0240	TCGA-06-0240-D40217	AE41095E-F10E-4DF7-9FA9-005A4CE2A242	2013-2-13	IRINOTECAN	NA	CHEMOTHERAPY	337	FALSE	407	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
283	a0700d6d-df7b-4327-8738-97b8ad08fd4c	TCGA.06.0240	TCGA-06-0240-D40218	375AB109-E2E0-4188-8276-88E579F795AD	2013-2-13	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	337	FALSE	589	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
284	a0700d6d-df7b-4327-8738-97b8ad08fd4c	TCGA.06.0240	TCGA-06-0240-D40219	C401065A-A4D6-451B-9237-90977C90AD0B	2013-2-13	TEMOZOLOMIDE	NA	CHEMOTHERAPY	435	FALSE	511	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
285	a0700d6d-df7b-4327-8738-97b8ad08fd4c	TCGA.06.0240	TCGA-06-0240-D40220	347AFA57-8215-4FFF-8C8C-D8CC91ED1BDD	2013-2-13	CARBOPLATIN	NA	CHEMOTHERAPY	547	FALSE	589	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
286	6d4ab866-ca0b-4455-898e-df8a6ac3e924	TCGA.06.0241	TCGA-06-0241-D20960	f53cd066-12bf-4342-abe4-91a6377735d3	2011-12-5	TEMOZOLOMIDE	NA	CHEMOTHERAPY	1324	FALSE	1383	NA	NA	NA	NA	3	NA	MG/M2	MG	100	3	ORAL	NA	NA	PROGRESSION	NA	140	NA
287	6d4ab866-ca0b-4455-898e-df8a6ac3e924	TCGA.06.0241	TCGA-06-0241-D20958	3c9b20fd-115d-47d4-aee6-a05e598467f3	2011-12-5	IRINOTECAN	NA	CHEMOTHERAPY	477	FALSE	728	NA	NA	NA	NA	17	NA	MG/M2	MG	125	2	INTRAVENOUS	NA	NA	PROGRESSION	NA	773	NA
288	6d4ab866-ca0b-4455-898e-df8a6ac3e924	TCGA.06.0241	TCGA-06-0241-D20961	5c6e9edb-8726-4309-8822-6b247c957c19	2011-12-5	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	1043	FALSE	1435	NA	NA	NA	NA	10	NA	MG/KG	MG	10	5	INTRAVENOUS	NA	NA	PROGRESSION	NA	822	NA
289	6d4ab866-ca0b-4455-898e-df8a6ac3e924	TCGA.06.0241	TCGA-06-0241-D20955	5bb4a821-26f3-49de-9dc9-a4b4aabbaecf	2011-12-5	CILENGITIDE	NA	TARGETED MOLECULAR THERAPY	84	FALSE	192	NA	NA	NA	NA	4	NA	MG	MG	2000	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1600	NA
290	6d4ab866-ca0b-4455-898e-df8a6ac3e924	TCGA.06.0241	TCGA-06-0241-D20956	2f9f7bf8-9dc1-46ac-a223-3cf31a0f90d4	2011-12-5	TEMOZOLOMIDE	NA	CHEMOTHERAPY	15	FALSE	81	NA	NA	NA	NA	1	NA	MG/DAY	MG/DAY	140	1	ORAL	NA	NA	ADJUVANT	NA	140	NA
291	6d4ab866-ca0b-4455-898e-df8a6ac3e924	TCGA.06.0241	TCGA-06-0241-D20959	ec62c0f3-1bbc-472a-9750-c1abbec94ffe	2011-12-5	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	203	FALSE	799	NA	NA	NA	NA	20	NA	MG/KG	MG	10	2	INTRAVENOUS	NA	NA	PROGRESSION	NA	773	NA
292	6d4ab866-ca0b-4455-898e-df8a6ac3e924	TCGA.06.0241	TCGA-06-0241-D20954	9a9b2dc4-dd57-4100-9d6c-e1fa1e179ab2	2011-12-5	CILENGITIDE	NA	TARGETED MOLECULAR THERAPY	15	FALSE	81	NA	NA	NA	NA	1	NA	MG	MG	2000	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	4000	NA
293	6d4ab866-ca0b-4455-898e-df8a6ac3e924	TCGA.06.0241	TCGA-06-0241-D20957	d101d49d-1005-451b-bcbe-f30ba5f0d7fd	2011-12-5	TEMOZOLOMIDE	NA	CHEMOTHERAPY	84	FALSE	192	NA	NA	NA	NA	4	NA	MG/DAY	MG/DAY	390	1	ORAL	NA	NA	ADJUVANT	NA	390	NA
294	7ffeaa19-61c5-4af1-aafd-36ec65cf4768	TCGA.06.0394	TCGA-06-0394-D22813	ef673f41-6149-4c4e-8c41-b16af9df3b93	2011-11-29	6 THIOGUANINE	NA	CHEMOTHERAPY	97	FALSE	128	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
295	7ffeaa19-61c5-4af1-aafd-36ec65cf4768	TCGA.06.0394	TCGA-06-0394-D22814	7e64cded-ac59-4d66-be91-740e92fe25f0	2011-11-29	CARMUSTINE	NA	CHEMOTHERAPY	158	FALSE	281	NA	NA	NA	NA	4	NA	MG	MG	80	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
296	7ffeaa19-61c5-4af1-aafd-36ec65cf4768	TCGA.06.0394	TCGA-06-0394-D22812	c251269a-92af-4b58-a68a-3d55c4f1f029	2011-11-29	VINCRISTINE	NA	CHEMOTHERAPY	97	FALSE	128	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
297	7ffeaa19-61c5-4af1-aafd-36ec65cf4768	TCGA.06.0394	TCGA-06-0394-D22811	fbfe5a21-f80f-420c-b031-a7ef1bc5e79f	2011-11-29	ESTRAMUSTINE	NA	CHEMOTHERAPY	97	FALSE	128	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
298	28bf7388-f041-4ff6-ba70-4dcfa05805a3	TCGA.06.0397	TCGA-06-0397-D22820	ed0a62e2-6479-47cb-947d-0fafc4a4e897	2011-11-29	VINCRISTINE	NA	CHEMOTHERAPY	126	FALSE	176	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
299	28bf7388-f041-4ff6-ba70-4dcfa05805a3	TCGA.06.0397	TCGA-06-0397-D22818	87eab039-c36b-4aa5-8227-79b62a5fb4ab	2011-11-29	PROCARBAZINE	NA	CHEMOTHERAPY	126	FALSE	176	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
300	28bf7388-f041-4ff6-ba70-4dcfa05805a3	TCGA.06.0397	TCGA-06-0397-D22819	5d2ec807-f295-4411-b216-ec13f2d8d835	2011-11-29	LOMUSTINE	NA	CHEMOTHERAPY	126	FALSE	176	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
301	6db66d6e-b44e-41fa-b904-aa61af0acf1c	TCGA.06.0409	TCGA-06-0409-D22826	77f56acb-5b7b-4db2-9994-e37e0b5a47ab	2011-11-29	HYROXYUREA	NA	CHEMOTHERAPY	75	FALSE	149	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
302	6db66d6e-b44e-41fa-b904-aa61af0acf1c	TCGA.06.0409	TCGA-06-0409-D22829	d5c62680-dae5-4634-ad2c-c3cc59132478	2011-11-29	VINCRISTINE	NA	CHEMOTHERAPY	168	FALSE	348	NA	NA	NA	NA	4	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
303	6db66d6e-b44e-41fa-b904-aa61af0acf1c	TCGA.06.0409	TCGA-06-0409-D22831	71f309f5-09c6-4be0-8508-d57b0d52dfd7	2011-11-29	GLIADEL WAFER	NA	CHEMOTHERAPY	1267	FALSE	1267	NA	NA	NA	NA	1	NA	WAFER	WAFER	NA	NA	INTRATUMORAL	NA	NA	PROGRESSION	NA	NA	NA
304	6db66d6e-b44e-41fa-b904-aa61af0acf1c	TCGA.06.0409	TCGA-06-0409-D22832	22a6969c-40ff-4d12-b813-d08f7f36049d	2011-11-29	TAMOXIFEN	NA	CHEMOTHERAPY	1294	FALSE	1779	NA	NA	NA	NA	19	NA	MG	MG	20	NA	ORAL	NA	NA	PROGRESSION	NA	140	NA
305	6db66d6e-b44e-41fa-b904-aa61af0acf1c	TCGA.06.0409	TCGA-06-0409-D22834	916495e6-cb05-4605-bd45-d22f95620573	2011-11-29	IRINOTECAN	NA	CHEMOTHERAPY	1845	FALSE	2114	NA	NA	NA	NA	4	NA	MG	MG	125	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
306	6db66d6e-b44e-41fa-b904-aa61af0acf1c	TCGA.06.0409	TCGA-06-0409-D22827	7ba5a9b1-760b-4743-b977-af31b8c4d168	2011-11-29	PROCARBAZINE	NA	CHEMOTHERAPY	168	FALSE	348	NA	NA	NA	NA	4	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
307	6db66d6e-b44e-41fa-b904-aa61af0acf1c	TCGA.06.0409	TCGA-06-0409-D22830	b900a154-e45d-41af-a0a4-a1fc145bf019	2011-11-29	9 IMMUNOAMINO CAMPTNETECIN	NA	CHEMOTHERAPY	379	FALSE	471	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
308	6db66d6e-b44e-41fa-b904-aa61af0acf1c	TCGA.06.0409	TCGA-06-0409-D22833	c6ba58a3-c0f3-4f4e-8861-631242d450f1	2011-11-29	PROCARBAZINE	NA	CHEMOTHERAPY	1294	FALSE	1628	NA	NA	NA	NA	12	NA	MG	MG	50	NA	ORAL	NA	NA	PROGRESSION	NA	100	NA
309	6db66d6e-b44e-41fa-b904-aa61af0acf1c	TCGA.06.0409	TCGA-06-0409-D22828	0983038a-bfcb-4a28-89e8-a5f9dccb4a52	2011-11-29	LOMUSTINE	NA	CHEMOTHERAPY	168	FALSE	348	NA	NA	NA	NA	4	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
310	98d3ae4b-1f14-4067-ac60-7eaace5007f2	TCGA.06.0412	TCGA-06-0412-D22841	46748223-93e9-4e26-97c4-649bc8b2f810	2011-11-29	TAXOL	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
311	98d3ae4b-1f14-4067-ac60-7eaace5007f2	TCGA.06.0412	TCGA-06-0412-D22842	645d6a7d-d8c2-4f77-8c0f-5584ee23711d	2011-11-29	9AC 9 AMINOCAMPLOTECIAN	NA	CHEMOTHERAPY	106	FALSE	137	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
312	98d3ae4b-1f14-4067-ac60-7eaace5007f2	TCGA.06.0412	TCGA-06-0412-D22843	65dd4eaf-842f-4dfa-ac44-10671cafe7fd	2011-11-29	CARMUSTINE	NA	CHEMOTHERAPY	137	FALSE	258	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
313	a9601d20-d51d-4db3-9e82-7171f5f7e034	TCGA.06.0414	TCGA-06-0414-D22849	2021c1cb-a12d-4d7f-be7b-958e2ec4e153	2009-4-24	BCNU	NA	CHEMOTHERAPY	5	NA	370	NA	NA	NA	NA	4	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
314	a9601d20-d51d-4db3-9e82-7171f5f7e034	TCGA.06.0414	TCGA-06-0414-D22850	6ecb7887-46f8-48d6-99f9-a7d0103817e0	2009-4-24	CISPLATAIN	NA	CHEMOTHERAPY	5	NA	370	NA	NA	NA	NA	4	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
315	652a39f0-c539-4303-bedc-f0d7f4669d9f	TCGA.06.0644	TCGA-06-0644-D20900	78a90b97-d6ab-417c-b7c7-717626de2443	2011-12-5	IRINOTECAN	NA	CHEMOTHERAPY	106	FALSE	263	NA	NA	NA	NA	5	NA	MG/M2	MG	125	2	INTRAVENOUS	NA	NA	PROGRESSION	NA	270	NA
316	652a39f0-c539-4303-bedc-f0d7f4669d9f	TCGA.06.0644	TCGA-06-0644-D20901	16f06a10-425f-43ac-bbf3-a335e697b5b9	2011-12-5	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	96	FALSE	333	NA	NA	NA	NA	7	NA	MG/KG	MG	10	2	INTRAVENOUS	NA	NA	PROGRESSION	NA	986	NA
317	652a39f0-c539-4303-bedc-f0d7f4669d9f	TCGA.06.0644	TCGA-06-0644-D20902	54567449-052e-4f32-8b76-8db401052ea0	2011-12-5	TEMOZOLOMIDE	NA	CHEMOTHERAPY	288	FALSE	319	NA	NA	NA	NA	2	NA	MG/M2	MG	75	3	ORAL	NA	NA	PROGRESSION	NA	190	NA
318	652a39f0-c539-4303-bedc-f0d7f4669d9f	TCGA.06.0644	TCGA-06-0644-D20899	fba0c9d9-1dd7-467b-b26b-59b031c4e296	2011-12-5	TEMOZOLOMIDE	NA	CHEMOTHERAPY	23	FALSE	65	NA	NA	NA	NA	1	NA	MG/M2	MG	75	1	ORAL	NA	NA	ADJUVANT	NA	165	NA
319	522808a2-f19d-4fab-b67e-0c31ec54b757	TCGA.06.0650	TCGA-06-0650-D23094	bcacea2d-9846-4d57-b3a6-d0f69e0147d1	2011-10-10	IRINOTECAN	NA	CHEMOTHERAPY	516	FALSE	560	NA	NA	NA	NA	2	NA	MG	MG	125	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	200	NA
320	522808a2-f19d-4fab-b67e-0c31ec54b757	TCGA.06.0650	TCGA-06-0650-D23095	4bc0254f-d6c7-4dc5-b0bf-29f041c1434a	2011-10-10	TEMOZOLOMIDE	NA	CHEMOTHERAPY	586	FALSE	678	NA	NA	NA	NA	3	NA	MG	MG	100	NA	ORAL	NA	NA	PROGRESSION	NA	160	NA
321	522808a2-f19d-4fab-b67e-0c31ec54b757	TCGA.06.0650	TCGA-06-0650-D23090	861bfd2d-6cee-4187-9abf-457f63539982	2011-10-10	TEMOZOLOMIDE	NA	CHEMOTHERAPY	96	FALSE	355	NA	NA	NA	NA	4	NA	MG	MG	150	NA	ORAL	NA	NA	ADJUVANT	NA	230	NA
322	522808a2-f19d-4fab-b67e-0c31ec54b757	TCGA.06.0650	TCGA-06-0650-D23093	67185a38-48fc-4c42-9dff-403b7dd80eda	2011-10-10	ERLOTINIB	NA	CHEMOTHERAPY	495	FALSE	513	NA	NA	NA	NA	1	NA	MG/DAY	MG/DAY	150	NA	ORAL	NA	NA	PROGRESSION	NA	150	NA
323	522808a2-f19d-4fab-b67e-0c31ec54b757	TCGA.06.0650	TCGA-06-0650-D23091	04007984-e8ca-44ef-880b-6ec64d6154b9	2011-10-10	LOMUSTINE	NA	CHEMOTHERAPY	389	FALSE	389	NA	NA	NA	NA	1	NA	MG	MG	160	NA	ORAL	NA	NA	PROGRESSION	NA	160	NA
324	522808a2-f19d-4fab-b67e-0c31ec54b757	TCGA.06.0650	TCGA-06-0650-D23096	f2d3b76e-c8f6-46d3-8c25-b918dd86776f	2011-10-10	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	516	FALSE	658	NA	NA	NA	NA	NA	NA	MG	MG	10	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	614	NA
325	522808a2-f19d-4fab-b67e-0c31ec54b757	TCGA.06.0650	TCGA-06-0650-D23089	b4cff9f4-78ec-43df-a7f3-c6a8c79e8b24	2011-10-10	TEMOZOLOMIDE	NA	CHEMOTHERAPY	26	FALSE	67	NA	NA	NA	NA	1	NA	MG	MG	75	NA	ORAL	NA	NA	ADJUVANT	NA	110	NA
326	522808a2-f19d-4fab-b67e-0c31ec54b757	TCGA.06.0650	TCGA-06-0650-D23092	a301e609-2782-4520-9640-095ba9e16eab	2011-10-10	AZD	NA	CHEMOTHERAPY	389	FALSE	431	NA	NA	NA	NA	1	NA	MG/DAY	MG/DAY	20	NA	ORAL	NA	NA	PROGRESSION	NA	20	NA
327	c931f3bd-74c5-4ebd-bc0f-c7c6becd25ab	TCGA.06.0686	TCGA-06-0686-D29193	5fc64962-89a0-4cf1-b052-27a029341a14	2011-11-30	ERLOTINIB (TARCEVA)	NA	CHEMOTHERAPY	309	FALSE	370	NA	NA	NA	NA	2	NA	MG/DAY	MG/DAY	150	3	ORAL	NA	NA	PROGRESSION	NA	150	NA
328	c931f3bd-74c5-4ebd-bc0f-c7c6becd25ab	TCGA.06.0686	TCGA-06-0686-D29584	41250619-20ea-4425-a60b-8686a67cc422	2011-11-30	A4QN	NA	TARGETED MOLECULAR THERAPY	25	FALSE	60	NA	NA	NA	NA	1	NA	MG/M2	MG	750	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1875	NA
329	c931f3bd-74c5-4ebd-bc0f-c7c6becd25ab	TCGA.06.0686	TCGA-06-0686-D29189	0b50b8e4-9453-4696-ab1f-b15a0e823f83	2011-11-30	TEMOZOLOMIDE	NA	CHEMOTHERAPY	29	FALSE	66	NA	NA	NA	NA	1	NA	MG/M2	MG	75	1	ORAL	NA	NA	ADJUVANT	NA	185	NA
330	c931f3bd-74c5-4ebd-bc0f-c7c6becd25ab	TCGA.06.0686	TCGA-06-0686-D29191	4d293449-89f5-4713-849c-02cddd5a638b	2011-11-30	A4QN	NA	TARGETED MOLECULAR THERAPY	25	FALSE	66	NA	NA	NA	NA	1	NA	MG/M2	MG	150	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	1876	NA
331	c931f3bd-74c5-4ebd-bc0f-c7c6becd25ab	TCGA.06.0686	TCGA-06-0686-D29194	8629d509-03a5-4cf4-b835-6c6a189ccb08	2011-11-30	IRINTOTECAN	NA	CHEMOTHERAPY	384	FALSE	412	NA	NA	NA	NA	1.5	NA	MG/M2	MG	125	4	INTRAVENOUS	NA	NA	PROGRESSION	NA	312	NA
332	c931f3bd-74c5-4ebd-bc0f-c7c6becd25ab	TCGA.06.0686	TCGA-06-0686-D29195	1956d556-0c14-441d-a02b-cec7dc3d8e7c	2011-11-30	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	412	FALSE	412	NA	NA	NA	NA	0.5	NA	MG/KG	MG	10	4	INTRAVENOUS	NA	NA	PROGRESSION	NA	1182	NA
333	c931f3bd-74c5-4ebd-bc0f-c7c6becd25ab	TCGA.06.0686	TCGA-06-0686-D29192	414a05fe-a534-4db8-ab51-c5adcb8855bd	2011-11-30	AT 101	NA	TARGETED MOLECULAR THERAPY	175	FALSE	279	NA	NA	NA	NA	4	NA	MG/DAY	MG	20	2	ORAL	NA	NA	PROGRESSION	NA	20	NA
334	c931f3bd-74c5-4ebd-bc0f-c7c6becd25ab	TCGA.06.0686	TCGA-06-0686-D29190	f00748c8-96be-4d2f-9bce-8641b9845e90	2011-11-30	TEMOZOLOMIDE	NA	CHEMOTHERAPY	95	FALSE	127	NA	NA	NA	NA	2	NA	MG/M2	MG	150	1	ORAL	NA	NA	ADJUVANT	NA	380	NA
335	e2e83064-7d1c-4dd5-993f-cc7a5ee228ed	TCGA.06.0743	TCGA-06-0743-D29627	AD88E1C7-333D-49D9-9319-667019B65531	2011-12-1	TEMOZOLOMODE	NA	CHEMOTHERAPY	122	FALSE	178	NA	NA	NA	NA	2	NA	MG/M2	MG	150	1	ORAL	NA	NA	ADJUVANT	NA	280	NA
336	e2e83064-7d1c-4dd5-993f-cc7a5ee228ed	TCGA.06.0743	TCGA-06-0743-D29626	103E8972-39DB-490E-B671-DEC694BF7EAC	2011-12-7	TEMOZOLOMIDE	NA	CHEMOTHERAPY	55	FALSE	94	NA	NA	NA	NA	1	NA	MG/M2	MG	75	1	ORAL	NA	NA	ADJUVANT	NA	140	NA
337	e2e83064-7d1c-4dd5-993f-cc7a5ee228ed	TCGA.06.0743	TCGA-06-0743-D29629	BBCFB707-0CFD-494F-8FD3-613C4BD6F2E3	2011-12-7	IRINOTECAN	NA	CHEMOTHERAPY	203	FALSE	704	NA	NA	NA	NA	16	NA	MG/M2	MG	125	2	INTRAVENOUS	NA	NA	PROGRESSION	NA	224	NA
338	e2e83064-7d1c-4dd5-993f-cc7a5ee228ed	TCGA.06.0743	TCGA-06-0743-D29630	5D6EE55D-C5BF-48B9-8314-F324646CF689	2011-12-7	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	203	FALSE	704	NA	NA	NA	NA	16	NA	MG/KG	MG	10	2	INTRAVENOUS	NA	NA	PROGRESSION	NA	655	NA
339	e2e83064-7d1c-4dd5-993f-cc7a5ee228ed	TCGA.06.0743	TCGA-06-0743-D29628	D7CE9ABA-4249-4F59-89DA-96E2EA24DBA2	2011-12-7	CILENGITIDE	NA	TARGETED MOLECULAR THERAPY	55	FALSE	178	NA	NA	NA	NA	2	NA	NA	MG	500	1	INTRAVENOUS	NA	NA	ADJUVANT	NA	500	NA
340	5613f5f6-086d-470b-8f77-6dcb7f8625b7	TCGA.06.0744	TCGA-06-0744-D20888	6f4317ca-0569-4558-aa12-06b0ed32a633	2011-12-7	TEMOZOLOMIDE	NA	CHEMOTHERAPY	111	FALSE	477	NA	NA	NA	NA	12	NA	MG/M2	MG	150	1	ORAL	NA	NA	ADJUVANT	NA	380	NA
341	5613f5f6-086d-470b-8f77-6dcb7f8625b7	TCGA.06.0744	TCGA-06-0744-D20887	7eaf7f15-de91-43ef-877e-636b8b25abde	2011-12-7	TEMOZOLOMIDE	NA	CHEMOTHERAPY	81	FALSE	111	NA	NA	NA	NA	1	NA	MG/M2	MG	75	1	ORAL	NA	NA	ADJUVANT	NA	190	NA
342	98e0344d-71c6-477c-a990-0bd0277606af	TCGA.06.0875	TCGA-06-0875-D22878	2aeca28a-f982-49f6-ac04-af50dec0df0a	2009-4-24	TEMOZOLOMIDE	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	135	NA
343	98e0344d-71c6-477c-a990-0bd0277606af	TCGA.06.0875	TCGA-06-0875-D31570	38065438-b30a-40a0-a3d6-cd1d84215fee	2012-5-6	TEMOZOLOMIDE	NA	CHEMOTHERAPY	89	FALSE	454	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
344	c5e08764-822b-4214-9ce6-f3ec2756190e	TCGA.06.0876	TCGA-06-0876-D22882	6b48f8bb-e45c-4f0c-b001-d9e38b01d1c0	2009-4-24	TEMOZOLOMIDE	NA	CHEMOTHERAPY	98	NA	271	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	350	NA
345	c5e08764-822b-4214-9ce6-f3ec2756190e	TCGA.06.0876	TCGA-06-0876-D31558	c79f9ef1-9a66-4dc9-b1ad-1a5ae851ef4d	2012-5-6	TEMOZOLOMIDE	NA	CHEMOTHERAPY	17	FALSE	60	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
346	c5e08764-822b-4214-9ce6-f3ec2756190e	TCGA.06.0876	TCGA-06-0876-D31559	9f203417-2412-441c-a903-11e0f24dbee6	2012-5-6	TEMOZOLOMIDE	NA	CHEMOTHERAPY	112	FALSE	416	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
347	c5e08764-822b-4214-9ce6-f3ec2756190e	TCGA.06.0876	TCGA-06-0876-D31560	c35122f1-7318-4861-a4d5-58a1ae3f1f0c	2012-5-6	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	462	FALSE	1146	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
348	c5e08764-822b-4214-9ce6-f3ec2756190e	TCGA.06.0876	TCGA-06-0876-D31561	dd1ab83c-376d-4236-b55a-9d80171200a9	2012-5-6	IRINTOCEAN	NA	CHEMOTHERAPY	462	FALSE	560	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
349	98e2f2ec-bdcd-490a-bf45-600e3b6c7491	TCGA.06.0878	TCGA-06-0878-D22889	4d9eb796-2e8e-4496-ad96-598bd3e582b5	2009-4-24	TEMODAR	NA	CHEMOTHERAPY	6	NA	53	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	145	NA
350	98e2f2ec-bdcd-490a-bf45-600e3b6c7491	TCGA.06.0878	TCGA-06-0878-D22891	0a0e15d5-0189-4f13-83c8-b0297ac6bb24	2009-4-24	AVASTIN	NA	CHEMOTHERAPY	78	TRUE	NA	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	811	NA
351	98e2f2ec-bdcd-490a-bf45-600e3b6c7491	TCGA.06.0878	TCGA-06-0878-D22890	c9366f9a-4f85-4709-a30b-2e0cfe441d2f	2009-4-24	IRINOTECAN	NA	CHEMOTHERAPY	78	TRUE	NA	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	242	NA
352	f9ce2045-2821-4843-b5e9-cf7cc7e783d4	TCGA.06.0879	TCGA-06-0879-D22895	337887e3-a6e3-4603-a8eb-720c4ada73e1	2009-3-26	TEMOZOLOMIDE	NA	CHEMOTHERAPY	67	TRUE	NA	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
353	f9ce2045-2821-4843-b5e9-cf7cc7e783d4	TCGA.06.0879	TCGA-06-0879-D22896	83c0a015-4085-4859-94b0-42a965cf163e	2009-3-26	DCVAX	NA	TARGETED MOLECULAR THERAPY	84	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
354	f9ce2045-2821-4843-b5e9-cf7cc7e783d4	TCGA.06.0879	TCGA-06-0879-D31531	223c816c-79d9-4a8b-bdb1-3e1d0c958e57	2012-5-5	TEMOZOLOMIDE	NA	CHEMOTHERAPY	19	FALSE	60	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
355	f9ce2045-2821-4843-b5e9-cf7cc7e783d4	TCGA.06.0879	TCGA-06-0879-D31532	96335edd-0b15-4b56-ace9-3ee429a34bb0	2012-5-5	TEMOZOLOMIDE	NA	CHEMOTHERAPY	117	FALSE	435	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
356	f9ce2045-2821-4843-b5e9-cf7cc7e783d4	TCGA.06.0879	TCGA-06-0879-D31533	1b3f952f-1e64-4af4-8a76-b8016841bc5d	2012-5-5	DC VAX (DENDRITIC CELL VACCINE)	NA	TARGETED MOLECULAR THERAPY	84	FALSE	580	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
357	f9ce2045-2821-4843-b5e9-cf7cc7e783d4	TCGA.06.0879	TCGA-06-0879-D31534	813a6fb9-f10f-49ab-91b3-c11af1f2062f	2012-5-5	TEMOZOLOMIDE	NA	CHEMOTHERAPY	718	FALSE	960	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
358	f9ce2045-2821-4843-b5e9-cf7cc7e783d4	TCGA.06.0879	TCGA-06-0879-D31535	cb50cbb6-9a3b-4464-9a6b-a711d13a6eec	2012-5-5	DENDRITIC CELL VACCINE (DCVAX)	NA	TARGETED MOLECULAR THERAPY	708	FALSE	942	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
359	f9ce2045-2821-4843-b5e9-cf7cc7e783d4	TCGA.06.0879	TCGA-06-0879-D31536	52920ce0-5439-440b-8c08-05b67545b8a5	2012-5-5	CEDICANIB	NA	TARGETED MOLECULAR THERAPY	998	FALSE	1025	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
360	f9ce2045-2821-4843-b5e9-cf7cc7e783d4	TCGA.06.0879	TCGA-06-0879-D31537	d66830ee-5cd8-430a-bc60-43e0fa060ad4	2012-5-5	CILENGITIDE	NA	TARGETED MOLECULAR THERAPY	998	FALSE	1025	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
361	f9ce2045-2821-4843-b5e9-cf7cc7e783d4	TCGA.06.0879	TCGA-06-0879-D31538	94d4ccf8-667e-46be-b8b5-6d4c0cb271c1	2012-5-5	LOMUSTINE CCNU	NA	CHEMOTHERAPY	1029	FALSE	1029	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
362	f9ce2045-2821-4843-b5e9-cf7cc7e783d4	TCGA.06.0879	TCGA-06-0879-D31539	9a14bb6f-b8e3-4251-bf76-a926634747ef	2012-5-5	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	1029	FALSE	1205	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
363	f9ce2045-2821-4843-b5e9-cf7cc7e783d4	TCGA.06.0879	TCGA-06-0879-D31540	5da27735-6464-4318-aa78-c7ff252882c4	2012-5-5	CARBOPLATIN	NA	CHEMOTHERAPY	1085	FALSE	1085	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
364	1b6c184a-5868-4a51-8a82-aa16a7e65126	TCGA.06.0881	TCGA-06-0881-D22900	9e1571a0-22a5-49b8-9e63-18008c51eeb0	2009-4-24	TEMODAR	NA	CHEMOTHERAPY	72	NA	133	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	140	NA
365	1b6c184a-5868-4a51-8a82-aa16a7e65126	TCGA.06.0881	TCGA-06-0881-D22902	61dcdd55-abda-4ba9-a57e-20757ca7ac5a	2009-4-24	IRINOTECAN	NA	CHEMOTHERAPY	150	TRUE	NA	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	250	NA
366	1b6c184a-5868-4a51-8a82-aa16a7e65126	TCGA.06.0881	TCGA-06-0881-D22901	47d51745-dbcb-4af9-a001-25fc13d1c771	2009-4-24	AVASTIN	NA	CHEMOTHERAPY	150	TRUE	NA	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	747.7	NA
367	2188c194-dfe4-4471-9b8b-050db1a1062c	TCGA.06.0882	TCGA-06-0882-D22906	c148a012-035c-415b-9876-d06f4c2a3e99	2009-4-24	TEMOZOLOMIDE	NA	CHEMOTHERAPY	160	TRUE	NA	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	300	NA
368	2188c194-dfe4-4471-9b8b-050db1a1062c	TCGA.06.0882	TCGA-06-0882-D31544	49f8b1a7-7a00-4bc9-a834-2bba0bf9f46c	2012-5-5	TEMOZOLOMIDE	NA	CHEMOTHERAPY	17	FALSE	60	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
369	2188c194-dfe4-4471-9b8b-050db1a1062c	TCGA.06.0882	TCGA-06-0882-D31545	3eace622-2c0f-45e7-b568-568d417dab47	2012-5-5	TEMOZOLOMIDE	NA	CHEMOTHERAPY	113	FALSE	205	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
370	2188c194-dfe4-4471-9b8b-050db1a1062c	TCGA.06.0882	TCGA-06-0882-D31546	b5b214d2-392d-4eb2-865c-2db25ba7758a	2012-5-5	TEMOZOLOMIDE	NA	CHEMOTHERAPY	236	FALSE	403	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
371	2188c194-dfe4-4471-9b8b-050db1a1062c	TCGA.06.0882	TCGA-06-0882-D31547	90f14d54-76b2-477d-81f2-c1386e5f32c7	2012-5-5	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	236	FALSE	403	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
372	2188c194-dfe4-4471-9b8b-050db1a1062c	TCGA.06.0882	TCGA-06-0882-D31548	647fec73-d982-445b-ad58-467a46f415f4	2012-5-5	IRINOTECAN	NA	CHEMOTHERAPY	447	FALSE	487	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
373	2188c194-dfe4-4471-9b8b-050db1a1062c	TCGA.06.0882	TCGA-06-0882-D31549	ca648d90-6fc7-45c1-8105-4d0ef76a1c78	2012-5-5	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	447	FALSE	502	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
374	2188c194-dfe4-4471-9b8b-050db1a1062c	TCGA.06.0882	TCGA-06-0882-D31550	df428185-e857-4af1-b10a-57a40fe16297	2012-5-5	CARBOPLATIN	NA	CHEMOTHERAPY	502	FALSE	502	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
375	cb9f842c-9bf5-48c3-8d3e-b344b1b6c190	TCGA.06.0939	TCGA-06-0939-D18621	f7e7db9f-6b86-49e7-a19e-a1533b79ee8a	2011-11-16	IRINOTECAN	NA	CHEMOTHERAPY	378	FALSE	609	NA	NA	NA	NA	5	NA	MG/M2	MG	125	2	INTRAVENOUS	NA	NA	PROGRESSION	NA	175	NA
376	cb9f842c-9bf5-48c3-8d3e-b344b1b6c190	TCGA.06.0939	TCGA-06-0939-D18622	5e29015c-ddc0-4a18-8365-b700f81f3bfd	2011-11-16	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	378	FALSE	665	NA	NA	NA	NA	10	NA	MG/KG	MG	10	2	INTRAVENOUS	NA	NA	PROGRESSION	NA	516	NA
377	ac3582a9-46b1-4322-95fa-9e8b149b8044	TCGA.06.1084	TCGA-06-1084-D22912	6173598e-2352-413d-8b05-68d07a3f1e01	2009-5-11	TEMOZOLOMIDE	NA	CHEMOTHERAPY	89	FALSE	209	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	500	NA
378	ac3582a9-46b1-4322-95fa-9e8b149b8044	TCGA.06.1084	TCGA-06-1084-D22913	d443b491-6e6a-4915-aa39-0c4b7218da39	2010-4-19	AVASTIN	NA	TARGETED MOLECULAR THERAPY	242	FALSE	323	NA	NA	NA	NA	NA	NA	MG	MG	10	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	1455	NA
379	ac3582a9-46b1-4322-95fa-9e8b149b8044	TCGA.06.1084	TCGA-06-1084-D18614	7d1979a9-d0f6-400c-bd75-e906f7cf8f60	2011-11-16	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	242	FALSE	323	NA	NA	NA	NA	3	NA	MG	MG	10	2	INTRAVENOUS	NA	NA	PROGRESSION	NA	1455	NA
380	ac3582a9-46b1-4322-95fa-9e8b149b8044	TCGA.06.1084	TCGA-06-1084-D18613	2db55c80-88d5-4bc0-97af-8588f79a051c	2011-11-16	IRINOTECAN	NA	CHEMOTHERAPY	246	FALSE	288	NA	NA	NA	NA	2	NA	MG/M2	MG	125	2	INTRAVENOUS	NA	NA	PROGRESSION	NA	337	NA
381	ac3582a9-46b1-4322-95fa-9e8b149b8044	TCGA.06.1084	TCGA-06-1084-D18618	ce1edf02-8209-44e7-bf07-55b7675c3ac0	2011-11-16	DOXIL	NA	CHEMOTHERAPY	445	FALSE	546	NA	NA	NA	NA	4	NA	MG/M2	MG	30	4	INTRAVENOUS	NA	NA	PROGRESSION	NA	81	NA
382	ac3582a9-46b1-4322-95fa-9e8b149b8044	TCGA.06.1084	TCGA-06-1084-D18617	4e1f489c-f1e3-454e-86de-ed01f81d4ca7	2011-11-16	TEMOZOLOMIDE	NA	CHEMOTHERAPY	301	FALSE	331	NA	NA	NA	NA	1	NA	MG/M2	MG	NA	3	ORAL	NA	NA	PROGRESSION	NA	180	NA
383	97686ab2-3b7e-4b21-9bf3-9a5a01709e04	TCGA.06.1086	TCGA-06-1086-D22918	13d9b153-ea61-4b4b-8e0e-118fb6b43ccb	2009-5-11	TEMOZOLOMIDE	NA	CHEMOTHERAPY	73	FALSE	194	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	400	NA
384	98dd5ea6-8d40-4963-bbae-2d37001d71c8	TCGA.06.1087	TCGA-06-1087-D22922	86e3f83c-d7e2-4844-9f02-0d2ef7eb3efb	2009-5-11	TEMODAR	NA	CHEMOTHERAPY	18	FALSE	75	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	75	NA
385	b1ce95bf-7441-4aac-8131-19a177d2b8ac	TCGA.06.1800	TCGA-06-1800-D22926	68c6d65a-f0b1-4c05-84cb-c3378581a543	2009-8-19	TEMODAR	NA	CHEMOTHERAPY	94	FALSE	275	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	400	NA
386	bdc75722-1076-49f3-8dc7-f2b91e5a15eb	TCGA.06.1801	TCGA-06-1801-D18590	80bf8343-fe68-413a-90ec-ffa9720923da	[Not Available]	TEMODAR	NA	CHEMOTHERAPY	80	FALSE	231	NA	NA	NA	NA	5	NA	MG/M2	MG	150	NA	ORAL	NA	NA	ADJUVANT	NA	280	NA
387	bdc75722-1076-49f3-8dc7-f2b91e5a15eb	TCGA.06.1801	TCGA-06-1801-D18604	b7491d83-51db-4071-9447-1a6c901aab2f	2011-11-16	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	238	FALSE	323	NA	NA	NA	NA	3	NA	MG/KG	MG	10	2	INTRAVENOUS	NA	NA	PROGRESSION	NA	850	NA
388	bdc75722-1076-49f3-8dc7-f2b91e5a15eb	TCGA.06.1801	TCGA-06-1801-D18597	4dd8b979-f41f-428b-989d-c0a3af2bcc92	2011-11-16	IRINOTECAN	NA	CHEMOTHERAPY	238	FALSE	323	NA	NA	NA	NA	3	NA	MG/M2	NA	125	2	INTRAVESICAL	NA	NA	PROGRESSION	NA	227	NA
389	13d12179-3182-4f41-85a2-90fd50e51480	TCGA.06.1802	TCGA-06-1802-D18607	70f12cb8-cbb9-4afe-b0ba-826006b5e630	2011-11-16	IRINOTECAN	NA	CHEMOTHERAPY	97	FALSE	380	NA	NA	NA	NA	10	NA	MG/M2	MG	125	2	INTRAVENOUS	NA	NA	PROGRESSION	NA	646	NA
390	13d12179-3182-4f41-85a2-90fd50e51480	TCGA.06.1802	TCGA-06-1802-D18608	403327ca-3505-4398-96b3-bea1034a856d	2011-11-16	BEVACIZUMAB	NA	CHEMOTHERAPY	97	FALSE	436	NA	NA	NA	NA	11	NA	MG/KG	MG	10	2	INTRAVENOUS	NA	NA	PROGRESSION	NA	845	NA
391	13d12179-3182-4f41-85a2-90fd50e51480	TCGA.06.1802	TCGA-06-1802-D18609	c0e3d606-6893-489b-9ebd-073dcd047936	2011-11-16	TEMOZOLOMIDE	NA	CHEMOTHERAPY	429	FALSE	429	NA	NA	NA	NA	1	NA	MG/M2	MG	75	3	ORAL	NA	NA	PROGRESSION	NA	140	NA
392	9f004b8a-f202-419d-a4d8-01f9430eaca5	TCGA.06.1805	TCGA-06-1805-D22934	bd190086-40a8-4252-9877-e607540544d0	2009-8-19	TEMODAR	NA	CHEMOTHERAPY	44	TRUE	NA	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
393	9f004b8a-f202-419d-a4d8-01f9430eaca5	TCGA.06.1805	TCGA-06-1805-D31553	26d24a1b-c0f8-4fca-b46c-8ce8606d151b	2012-5-6	TEMOZOLOMODE	NA	CHEMOTHERAPY	35	FALSE	76	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
394	9f004b8a-f202-419d-a4d8-01f9430eaca5	TCGA.06.1805	TCGA-06-1805-D31554	6d899e36-462a-4e47-b15c-05aca3bca030	2012-5-6	TEMOZOLOMODE	NA	CHEMOTHERAPY	105	FALSE	433	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
395	a0339182-2fd6-459d-9703-422474222e76	TCGA.06.1806	TCGA-06-1806-D48602	B9697902-8BDC-41A3-B61C-E022F5E990DA	2013-9-18	TEMOZOLOMIDE	NA	CHEMOTHERAPY	26	FALSE	64	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
396	a0339182-2fd6-459d-9703-422474222e76	TCGA.06.1806	TCGA-06-1806-D48603	3BCBB0AA-B506-4706-BA53-D0A0FDFF6653	2013-9-18	TEMOZOLOMIDE	NA	CHEMOTHERAPY	81	FALSE	256	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TRUE
397	a0339182-2fd6-459d-9703-422474222e76	TCGA.06.1806	TCGA-06-1806-D48604	2C19A5A3-9FFC-402C-ABCB-392DFCEA10A3	2013-9-18	ABT-888	NA	CHEMOTHERAPY	81	FALSE	256	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TRUE
398	a0339182-2fd6-459d-9703-422474222e76	TCGA.06.1806	TCGA-06-1806-D48607	3B54E64B-0638-43BC-9C8C-457B090374C8	2013-9-18	CABOZANTINIB	NA	CHEMOTHERAPY	293	FALSE	455	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TRUE
399	ca893d12-3d6c-4e6f-b0e7-7f4eb8bb724b	TCGA.06.2559	TCGA-06-2559-D22943	875b5e0b-0c54-402a-bde2-47a631fbd183	2010-3-22	TEMODAR	NA	CHEMOTHERAPY	28	FALSE	49	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	100	NA
400	d6a48eb1-7c20-4ae3-ae35-b6b641238ef1	TCGA.06.2561	TCGA-06-2561-D22950	4edf1eeb-81cf-4809-a442-7bfb25e878e5	2010-3-22	XL 184	NA	CHEMOTHERAPY	119	FALSE	148	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	125	NA
401	d6a48eb1-7c20-4ae3-ae35-b6b641238ef1	TCGA.06.2561	TCGA-06-2561-D22949	2cb1d8cb-95b3-48cb-bf24-e247bcae5e94	2010-3-22	TEMODAR	NA	CHEMOTHERAPY	21	FALSE	63	NA	NA	NA	NA	1	NA	MG	MG	75	NA	ORAL	NA	NA	ADJUVANT	NA	120	NA
402	d6a48eb1-7c20-4ae3-ae35-b6b641238ef1	TCGA.06.2561	TCGA-06-2561-D22948	b4950ded-4dff-4228-932c-815b0cf3227a	2010-3-22	AVASTIN	NA	CHEMOTHERAPY	171	TRUE	NA	NA	NA	NA	NA	NA	NA	MG	MG	6	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	618	NA
403	d6a48eb1-7c20-4ae3-ae35-b6b641238ef1	TCGA.06.2561	TCGA-06-2561-D22947	c90186ba-0519-4247-a0f3-225615f2c767	2010-3-22	IRINOTECAN	NA	CHEMOTHERAPY	171	TRUE	NA	NA	NA	NA	NA	NA	NA	MG	MG	125	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	201.25	NA
404	d6a48eb1-7c20-4ae3-ae35-b6b641238ef1	TCGA.06.2561	TCGA-06-2561-D29204	a0572472-f1a3-42af-b761-e8801d72d227	2012-2-8	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	171	FALSE	492	NA	NA	NA	NA	9	NA	MG/KG	MG	10	3	INTRAVENOUS	NA	NA	PROGRESSION	NA	618	NA
405	d6a48eb1-7c20-4ae3-ae35-b6b641238ef1	TCGA.06.2561	TCGA-06-2561-D29203	6608dbbd-2941-44f1-9353-f69b7e3424eb	2012-2-8	IRINOTECAN	NA	CHEMOTHERAPY	171	FALSE	325	NA	NA	NA	NA	5	NA	MG/M2	MG	125	3	INTRAVENOUS	NA	NA	PROGRESSION	NA	201.25	NA
406	d6a48eb1-7c20-4ae3-ae35-b6b641238ef1	TCGA.06.2561	TCGA-06-2561-D29206	fe6e2b3e-60bf-4993-b04d-b70e8d33ac52	2012-2-8	CARBOPLATIN	NA	CHEMOTHERAPY	478	FALSE	492	NA	NA	NA	NA	1	NA	AUC	MG	6	5	INTRAVENOUS	NA	NA	PROGRESSION	NA	571	NA
407	d6a48eb1-7c20-4ae3-ae35-b6b641238ef1	TCGA.06.2561	TCGA-06-2561-D29205	3dedc777-8676-47ae-aa69-498054d7e8e6	2012-2-8	TEMOZLOMIDE	NA	CHEMOTHERAPY	348	FALSE	471	NA	NA	NA	NA	3	NA	MG/M2	MG	25	4	ORAL	NA	NA	PROGRESSION	NA	140	NA
408	e3251837-f6f3-4dad-856f-108e20d03dad	TCGA.06.2562	TCGA-06-2562-D22954	c28c63e3-e7c6-4ea9-818d-c0313e21b830	2010-3-22	TEMODAR	NA	CHEMOTHERAPY	26	FALSE	37	NA	NA	NA	NA	1	NA	MG	MG	75	NA	ORAL	NA	NA	ADJUVANT	NA	140	NA
409	ba383ea6-c885-49f0-bddc-e00be0230a6b	TCGA.06.2563	TCGA-06-2563-D22958	7b5ee14d-cec5-4300-9d8d-9354ec8fb1e5	2010-3-22	TEMODAR	NA	CHEMOTHERAPY	27	FALSE	57	NA	NA	NA	NA	1	NA	MG	MG	75	NA	ORAL	NA	NA	ADJUVANT	NA	120	NA
410	ba383ea6-c885-49f0-bddc-e00be0230a6b	TCGA.06.2563	TCGA-06-2563-D29201	79ad5fa0-76fe-4300-ae8f-d1e01d8acd6d	2012-2-8	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	934	TRUE	NA	NA	NA	NA	NA	NA	NA	MG/KG	MG	10	3	INTRAVENOUS	NA	NA	PROGRESSION	NA	549	NA
411	ba383ea6-c885-49f0-bddc-e00be0230a6b	TCGA.06.2563	TCGA-06-2563-D29200	abb35d1b-d581-41b1-8453-6ddb14b1f836	2012-2-8	R04929097	NA	TARGETED MOLECULAR THERAPY	885	FALSE	931	NA	NA	NA	NA	2	NA	MG/DAY	MG/DAY	20	2	ORAL	NA	NA	PROGRESSION	NA	20	NA
412	8ff9f921-f9e9-41c1-a5d4-891fd4cfe979	TCGA.06.2564	TCGA-06-2564-D22962	6df7a740-06de-41da-8266-fccdae5abcae	2010-3-22	TEMODAR	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
413	c7b4fd72-b45d-4524-8424-983120abfec0	TCGA.06.2565	TCGA-06-2565-D22968	10d32403-03ee-4362-8f7c-8626a6a7e6c1	2010-3-22	XL 184	NA	CHEMOTHERAPY	123	FALSE	151	NA	NA	NA	NA	1	NA	MG	MG	75	NA	ORAL	NA	NA	ADJUVANT	NA	75	NA
414	c7b4fd72-b45d-4524-8424-983120abfec0	TCGA.06.2565	TCGA-06-2565-D22967	f58c8193-3ed5-4a87-a541-eb829d54f85a	2010-3-22	TEMODAR	NA	CHEMOTHERAPY	90	FALSE	151	NA	NA	NA	NA	2	NA	MG	MG	200	NA	ORAL	NA	NA	ADJUVANT	NA	320	NA
415	c7b4fd72-b45d-4524-8424-983120abfec0	TCGA.06.2565	TCGA-06-2565-D22969	d5c1ed8f-9567-4e98-88b3-4e9f3a22e5db	2010-3-22	AVASTIN	NA	CHEMOTHERAPY	193	TRUE	NA	NA	NA	NA	NA	NA	NA	MG	MG	10	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	550	NA
416	c7b4fd72-b45d-4524-8424-983120abfec0	TCGA.06.2565	TCGA-06-2565-D22966	e48425a3-a5d5-4019-afee-6c0e744078a8	2010-3-22	TEMODAR	NA	CHEMOTHERAPY	16	FALSE	63	NA	NA	NA	NA	1	NA	MG	MG	75	NA	ORAL	NA	NA	ADJUVANT	NA	75	NA
417	c7b4fd72-b45d-4524-8424-983120abfec0	TCGA.06.2565	TCGA-06-2565-D31563	a4b1ad42-b84c-47c9-99b0-4c56f2df14f6	2012-5-6	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	193	FALSE	406	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
418	c7b4fd72-b45d-4524-8424-983120abfec0	TCGA.06.2565	TCGA-06-2565-D31564	2e01c6b1-63b3-4c84-b894-d4db2781690b	2012-5-6	CARBOPLATIN	NA	CHEMOTHERAPY	319	FALSE	350	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
419	c7b4fd72-b45d-4524-8424-983120abfec0	TCGA.06.2565	TCGA-06-2565-D31565	e5b1838d-a169-4197-8181-0a69dbc761ad	2012-5-6	TEMOZOLOMIDE	NA	CHEMOTHERAPY	363	FALSE	455	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
420	ae5b2e48-d186-4e77-a797-dcc3b3ca4847	TCGA.06.2566	TCGA-06-2566-D22977	ca0b33fc-453c-4bda-8344-f4f08c690d4a	2010-3-22	TEMODAR	NA	CHEMOTHERAPY	95	FALSE	100	NA	NA	NA	NA	1	NA	MG	MG	200	NA	ORAL	NA	NA	ADJUVANT	NA	295	NA
421	ae5b2e48-d186-4e77-a797-dcc3b3ca4847	TCGA.06.2566	TCGA-06-2566-D22976	03aa2a88-16fc-43a6-9480-e80701eb5c0b	2010-3-22	TEMODAR	NA	CHEMOTHERAPY	30	FALSE	69	NA	NA	NA	NA	1	NA	MG	MG	75	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
422	55a063b0-98ad-4700-b3ce-61bfe364fec8	TCGA.06.2567	TCGA-06-2567-D22981	1b774ed0-21bc-4bfa-a573-0722f95fc018	2010-3-22	TEMODAR	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
423	b37d944c-c65c-46d6-bb8b-3eb37cb85b68	TCGA.06.2570	TCGA-06-2570-D22988	fd6c8e61-af72-44cf-92f6-a18c9599ffe2	2010-3-22	TEMODAR	NA	CHEMOTHERAPY	80	FALSE	402	NA	NA	NA	NA	12	NA	MG	MG	200	NA	ORAL	NA	NA	ADJUVANT	NA	350	NA
424	b37d944c-c65c-46d6-bb8b-3eb37cb85b68	TCGA.06.2570	TCGA-06-2570-D22987	f04d7f91-f0a4-4e19-ae6b-64921ba92f4d	2010-3-22	TEMODAR	NA	CHEMOTHERAPY	19	FALSE	61	NA	NA	NA	NA	1	NA	MG	MG	75	NA	ORAL	NA	NA	ADJUVANT	NA	130	NA
425	af055b98-be6a-4012-ac64-f1b6539b23d0	TCGA.06.5408	TCGA-06-5408-D22993	228c59b5-422c-49ff-9c76-e2602ed8c826	2011-1-24	BS1-201	NA	CHEMOTHERAPY	95	FALSE	154	NA	NA	NA	NA	2	NA	MG	MG	9.5	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	652	NA
426	af055b98-be6a-4012-ac64-f1b6539b23d0	TCGA.06.5408	TCGA-06-5408-D22992	57fd409d-ad1e-4663-b014-251d1a846aad	2011-1-24	TEMOZOLOMIDE	NA	CHEMOTHERAPY	95	FALSE	154	NA	NA	NA	NA	2	NA	MG/DL	MG/DL	200	NA	ORAL	NA	NA	ADJUVANT	NA	360	NA
427	af055b98-be6a-4012-ac64-f1b6539b23d0	TCGA.06.5408	TCGA-06-5408-D22994	cbb7ba69-3e48-4785-9dfb-ed5a81a0623a	2011-1-24	AVASTIN	NA	TARGETED MOLECULAR THERAPY	154	FALSE	337	NA	NA	NA	NA	NA	NA	MG	MG	10	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	680	NA
428	3f960d3b-a58c-43d0-a8a4-f3555b399c9d	TCGA.06.5411	TCGA-06-5411-D23000	ddbaa653-98e3-4e61-9bf8-40008626d52a	2011-1-25	TEMOZOLOMIDE	NA	CHEMOTHERAPY	96	FALSE	218	NA	NA	NA	NA	4	NA	MG/M2	MG/M2	200	NA	ORAL	NA	NA	ADJUVANT	NA	300	NA
429	3f960d3b-a58c-43d0-a8a4-f3555b399c9d	TCGA.06.5411	TCGA-06-5411-D23001	61a2676a-391f-4b71-9868-c7e6b128f8df	2011-1-25	AVASTIN	NA	TARGETED MOLECULAR THERAPY	213	FALSE	235	NA	NA	NA	NA	NA	NA	MG	MG	10	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	726	NA
430	e6e2d4c3-d37c-4de3-ac68-b301800770f0	TCGA.06.5412	TCGA-06-5412-D23007	3f2c87d3-aae6-42f7-98e5-19c3fc8a4aa2	2011-1-25	ABTC 0603 HYDROXYCHLOROQUINE	NA	CHEMOTHERAPY	14	FALSE	23	NA	NA	NA	NA	0.5	NA	NA	NA	NA	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
431	e6e2d4c3-d37c-4de3-ac68-b301800770f0	TCGA.06.5412	TCGA-06-5412-D23006	02a5f80e-d605-4bef-8a1e-04d431f20d4f	2011-1-25	TEMOZOLOMIDE	NA	CHEMOTHERAPY	71	FALSE	71	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	200	NA	ORAL	NA	NA	ADJUVANT	NA	300	NA
432	8d2e88d9-d8d0-4c42-8aa2-205a788dea58	TCGA.06.5413	TCGA-06-5413-D23012	3460ec2c-e614-4ead-bb06-e228d250d68f	2011-1-25	AVASTIN	NA	TARGETED MOLECULAR THERAPY	261	TRUE	NA	NA	NA	NA	NA	NA	NA	MG	MG	10	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	1059	NA
433	8d2e88d9-d8d0-4c42-8aa2-205a788dea58	TCGA.06.5413	TCGA-06-5413-D23011	7ba339b8-b9a5-4924-8dd0-493ffa511e05	2011-1-25	TEMOZOLOMIDE	NA	CHEMOTHERAPY	87	FALSE	179	NA	NA	NA	NA	3	NA	MG	MG	200	NA	ORAL	NA	NA	ADJUVANT	NA	340	NA
434	7a650a2c-bc3f-4e0c-820e-4f492977107b	TCGA.06.5414	TCGA-06-5414-D23016	e4ccdd13-07ac-4cb0-abbf-9fdf2e477f70	2011-1-24	TEMOZOLOMIDE	NA	CHEMOTHERAPY	41	FALSE	112	NA	NA	NA	NA	3	NA	MG	MG	160	NA	ORAL	NA	NA	ADJUVANT	NA	160	NA
435	7a650a2c-bc3f-4e0c-820e-4f492977107b	TCGA.06.5414	TCGA-06-5414-D23017	0e1b1ad3-17b4-404e-a1d8-c6b6af4cb2b5	2011-1-24	HYDROCHOROQUINE	NA	CHEMOTHERAPY	41	FALSE	124	NA	NA	NA	NA	3	NA	MG	MG	600	NA	ORAL	NA	NA	ADJUVANT	NA	600	NA
436	713190ed-c6c1-4695-814b-85ca9b95e6a0	TCGA.06.5415	TCGA-06-5415-D23021	6adb6807-6741-4d73-8e74-53895472089b	2011-1-24	TEMOZOLOMIDE	NA	CHEMOTHERAPY	86	TRUE	NA	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	200	NA	ORAL	NA	NA	ADJUVANT	NA	370	NA
437	3a3fc890-1985-4353-861b-dc3abfb364b1	TCGA.06.5416	TCGA-06-5416-D23025	9afa5606-b833-4684-b041-dec26ec7da42	2011-1-24	TEMOZOLOMIDE	NA	CHEMOTHERAPY	99	TRUE	NA	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	150	NA	ORAL	NA	NA	ADJUVANT	NA	250	NA
438	74ce7e7f-e214-4b6e-8551-114a153ab7fb	TCGA.06.5417	TCGA-06-5417-D23029	3affe5b2-9773-4dd5-903b-728c81a3c861	2011-1-24	TEMODAR	NA	CHEMOTHERAPY	71	TRUE	NA	NA	NA	NA	NA	NA	NA	MG	MG	150	NA	ORAL	NA	NA	ADJUVANT	NA	225	NA
439	d1547b99-3c96-4c62-8261-5111bcf860a9	TCGA.06.5858	TCGA-06-5858-D23039	94e29e0f-1c03-4459-bcae-bec3209aad09	2011-8-8	CARBOPLATIN	NA	CHEMOTHERAPY	196	TRUE	NA	NA	NA	NA	NA	NA	NA	MG	MG	3	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	274	NA
440	d1547b99-3c96-4c62-8261-5111bcf860a9	TCGA.06.5858	TCGA-06-5858-D23040	c30fdc4c-e126-4181-8c37-6a74ef489c22	2011-8-8	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	196	TRUE	NA	NA	NA	NA	NA	NA	NA	MG	MG	10	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	1014	NA
441	d1547b99-3c96-4c62-8261-5111bcf860a9	TCGA.06.5858	TCGA-06-5858-D23038	521e04cd-cb47-427d-a684-0924d4569fcd	2011-8-8	ABT-888 PARP INHIBITOR	NA	CHEMOTHERAPY	88	FALSE	88	NA	NA	NA	NA	1	NA	MG	MG	10	NA	ORAL	NA	NA	ADJUVANT	NA	20	NA
442	d1547b99-3c96-4c62-8261-5111bcf860a9	TCGA.06.5858	TCGA-06-5858-D23037	c2af3ffb-5509-46bd-a86d-4132da6bf69a	2011-8-8	TEMOZOLOMIDE	NA	CHEMOTHERAPY	25	FALSE	68	NA	NA	NA	NA	1	NA	MG	MG	75	NA	ORAL	NA	NA	ADJUVANT	NA	150	NA
443	4644a15f-3115-4f27-86b2-b092419431e1	TCGA.06.5859	TCGA-06-5859-D23044	6b3c9af3-fcc0-4323-88a2-072b0c939a6c	2011-8-9	TEMOZOLOMIDE	NA	CHEMOTHERAPY	13	FALSE	42	NA	NA	NA	NA	1	NA	MG	MG	75	NA	ORAL	NA	NA	ADJUVANT	NA	180	NA
444	4644a15f-3115-4f27-86b2-b092419431e1	TCGA.06.5859	TCGA-06-5859-D23045	50eed09d-5f8f-48fc-8287-805636d80042	2011-8-9	TEMOZOLOMIDE	NA	CHEMOTHERAPY	70	TRUE	NA	NA	NA	NA	NA	NA	NA	MG	MG	200	NA	ORAL	NA	NA	ADJUVANT	NA	460	NA
445	7eb1d526-923d-4b31-b8be-27d83b3dd025	TCGA.06.6388	TCGA-06-6388-D23051	ea4254ea-d4f3-4c4d-856a-85bdc90b1b89	2011-8-8	TEMOZOLOMIDE	NA	CHEMOTHERAPY	120	TRUE	NA	NA	NA	NA	NA	1	NA	MG	MG	75	NA	ORAL	NA	NA	PROGRESSION	NA	150	NA
446	7eb1d526-923d-4b31-b8be-27d83b3dd025	TCGA.06.6388	TCGA-06-6388-D23052	4a6a6055-2813-4c5f-bae7-1ab2d39d8109	2011-8-8	BEVACIZUMAB	NA	TARGETED MOLECULAR THERAPY	120	FALSE	120	NA	NA	NA	NA	NA	NA	MG	MG	10	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	886	NA
447	7eb1d526-923d-4b31-b8be-27d83b3dd025	TCGA.06.6388	TCGA-06-6388-D23050	4e557935-d022-4902-98f5-35168f1da2ed	2011-8-8	TEMOZOLOMIDE	NA	CHEMOTHERAPY	21	FALSE	63	NA	NA	NA	NA	1	NA	MG	MG	75	NA	ORAL	NA	NA	ADJUVANT	NA	125	NA
448	7eb1d526-923d-4b31-b8be-27d83b3dd025	TCGA.06.6388	TCGA-06-6388-D23049	1b7d279a-bb50-4948-9b49-ee2945cabdb4	2011-8-8	TEMOZOLOMIDE	NA	CHEMOTHERAPY	79	FALSE	79	NA	NA	NA	NA	1	NA	MG	MG	150	NA	ORAL	NA	NA	ADJUVANT	NA	300	NA
449	d9cae674-1100-44a4-8c61-2f15ea1b6214	TCGA.06.6389	TCGA-06-6389-D23105	6a338cf3-fce2-4538-addd-7ae040d1a2b4	2011-11-7	TEMOZOLOMIDE	NA	CHEMOTHERAPY	70	TRUE	NA	NA	NA	NA	NA	2	NA	MG	MG	150	NA	ORAL	NA	NA	ADJUVANT	NA	240	NA
450	d9cae674-1100-44a4-8c61-2f15ea1b6214	TCGA.06.6389	TCGA-06-6389-D23104	151a43bd-744c-4f4d-863c-f54239df2896	2011-11-7	TEMOZOLOMIDE	NA	CHEMOTHERAPY	32	FALSE	73	NA	NA	NA	NA	1	NA	MG	MG	75	NA	ORAL	NA	NA	ADJUVANT	NA	140	NA
451	3ed101b5-0007-4957-a25d-4cf43bde08b6	TCGA.06.6390	TCGA-06-6390-D23109	5a73c484-726c-40fb-8816-2bbd38c654b6	2011-11-7	TEMOZOLOMIDE	NA	CHEMOTHERAPY	22	FALSE	69	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
452	3ed101b5-0007-4957-a25d-4cf43bde08b6	TCGA.06.6390	TCGA-06-6390-D23110	e6240190-b034-4d4b-b1e5-82645391000c	2011-11-7	TEMOZOLOMIDE	NA	CHEMOTHERAPY	96	FALSE	96	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
453	0628cb4a-c480-4b2f-bd2e-bb33e6994302	TCGA.06.6695	TCGA-06-6695-D23059	5b6352d1-cbe1-4204-8263-21dd3daf7c5e	2011-9-14	TEMOZOLOMIDE	NA	CHEMOTHERAPY	68	FALSE	127	NA	NA	NA	NA	2	NA	MG	MG	150	NA	ORAL	NA	NA	ADJUVANT	NA	280	NA
454	0628cb4a-c480-4b2f-bd2e-bb33e6994302	TCGA.06.6695	TCGA-06-6695-D23058	5b8032e0-2dcb-42bb-a692-e03039c08eac	2011-9-14	TEMOZOLOMIDE	NA	CHEMOTHERAPY	11	FALSE	56	NA	NA	NA	NA	1	NA	MG	MG	75	NA	ORAL	NA	NA	ADJUVANT	NA	140	NA
455	b28b3575-8097-4a97-b32a-5f0eeff64863	TCGA.06.6697	TCGA-06-6697-D23063	4657d327-7a25-4da4-abfd-4896365f412a	2011-9-14	TEMOZOLOMIDE	NA	CHEMOTHERAPY	232	FALSE	275	NA	NA	NA	NA	1	NA	MG	MG	75	NA	ORAL	NA	NA	ADJUVANT	NA	160	NA
456	b28b3575-8097-4a97-b32a-5f0eeff64863	TCGA.06.6697	TCGA-06-6697-D23065	f9b7a5f7-63ee-418a-8ba4-d871a03a8af0	2011-9-14	TEMOZOLOMIDE	NA	CHEMOTHERAPY	308	FALSE	338	NA	NA	NA	NA	1	NA	MG/DAY	MG/DAY	75	NA	ORAL	NA	NA	PROGRESSION	NA	140	NA
457	b28b3575-8097-4a97-b32a-5f0eeff64863	TCGA.06.6697	TCGA-06-6697-D23066	29f1f584-cc88-40b6-8034-9d7df7bb5e24	2011-9-14	BEVACOZIMAB	NA	TARGETED MOLECULAR THERAPY	359	TRUE	NA	NA	NA	NA	NA	NA	NA	MG	MG	10	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	913	NA
458	b28b3575-8097-4a97-b32a-5f0eeff64863	TCGA.06.6697	TCGA-06-6697-D23064	4dec4991-22e4-4502-bb2e-208d239eaf8f	2011-9-14	TEMOZOLOMIDE	NA	CHEMOTHERAPY	277	FALSE	308	NA	NA	NA	NA	1	NA	MG	MG	150	NA	ORAL	NA	NA	ADJUVANT	NA	320	NA
459	c129c34a-8d40-4d98-b9ad-a10d3f7b3ee0	TCGA.06.6698	TCGA-06-6698-D23071	49da3aa1-a7e6-49e1-aa17-459c6956a16b	2011-9-14	TEMOZOLOMIDE	NA	CHEMOTHERAPY	NA	TRUE	NA	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
460	c129c34a-8d40-4d98-b9ad-a10d3f7b3ee0	TCGA.06.6698	TCGA-06-6698-D23070	0ac944dd-94a1-4c0f-ad66-330ce4f57d68	2011-9-14	TEMOZOLOMIDE	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	1	NA	MG	MG	75	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
461	9848f14b-8eab-4ac9-89b0-99a5ebf14696	TCGA.06.6699	TCGA-06-6699-D23075	10a09877-6c24-42f7-b809-ddedbd61755a	2011-9-14	TEMOZOLOMIDE	NA	CHEMOTHERAPY	31	TRUE	NA	NA	NA	NA	NA	1	NA	MG	MG	75	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
462	3dddfc44-7bb1-4974-8a65-a84fd4bac484	TCGA.06.6700	TCGA-06-6700-D23081	c802f949-c7d2-43e3-a1e5-eacad51d7e3e	2011-9-14	VANDETANIB	NA	TARGETED MOLECULAR THERAPY	22	FALSE	77	NA	NA	NA	NA	NA	NA	MG	MG	100	NA	ORAL	NA	NA	ADJUVANT	NA	400	NA
463	3dddfc44-7bb1-4974-8a65-a84fd4bac484	TCGA.06.6700	TCGA-06-6700-D23080	fae3233a-0ec0-44b3-ad6f-985fe2f35e45	2011-9-14	TEMOZOLOMIDE	NA	CHEMOTHERAPY	100	TRUE	NA	NA	NA	NA	NA	NA	NA	MG	MG	150	NA	ORAL	NA	NA	ADJUVANT	NA	300	NA
464	3dddfc44-7bb1-4974-8a65-a84fd4bac484	TCGA.06.6700	TCGA-06-6700-D23079	aa25f328-3a4b-4f69-bd40-4548a3917dd2	2011-9-14	TEMOZOLOMIDE	NA	CHEMOTHERAPY	27	FALSE	60	NA	NA	NA	NA	1	NA	MG	MG	75	NA	ORAL	NA	NA	ADJUVANT	NA	150	NA
465	13429a31-a193-4180-a8b2-cceaa21ecbfd	TCGA.06.6701	TCGA-06-6701-D23085	e2891780-108a-4ab1-855f-3aa19eb76dec	2011-9-14	TEMOZOLOMIDE	NA	CHEMOTHERAPY	20	FALSE	63	NA	NA	NA	NA	1	NA	MG	MG	75	NA	ORAL	NA	NA	ADJUVANT	NA	140	NA
466	603D2B61-B636-4054-AC95-AB66DABB3B48	TCGA.06.A5U0	TCGA-06-A5U0-D43096	839EBD09-9CA4-40FB-8718-6F765D110F5D	2013-5-13	TEMODAR	NA	CHEMOTHERAPY	31	FALSE	74	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
467	603D2B61-B636-4054-AC95-AB66DABB3B48	TCGA.06.A5U0	TCGA-06-A5U0-D43097	5BDABD17-5670-4CF6-8F8E-F8CA0FB022B8	2013-5-13	LOMUSTINE	NA	CHEMOTHERAPY	122	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
468	603D2B61-B636-4054-AC95-AB66DABB3B48	TCGA.06.A5U0	TCGA-06-A5U0-D43098	8D92D013-7BAF-41A1-AE22-CF33F99505EF	2013-5-13	PROCARBAZINE	NA	CHEMOTHERAPY	129	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
469	E3953994-0299-4E04-9423-6153B142FB8E	TCGA.06.A6S1	TCGA-06-A6S1-D49395	6EC523DB-C4EE-4173-897D-8E4E70B19713	2013-10-1	TEMOZOLOMIDE	NA	CHEMOTHERAPY	8	FALSE	45	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
470	41685C5A-A548-483A-8A20-305AD8D61771	TCGA.06.A7TK	TCGA-06-A7TK-D54854	1BD28D05-6AD7-4688-B713-AE1A9928319F	2013-12-23	TEMOZOLOMIDE	NA	CHEMOTHERAPY	34	FALSE	76	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
471	41685C5A-A548-483A-8A20-305AD8D61771	TCGA.06.A7TK	TCGA-06-A7TK-D54856	D4BBC880-5580-4E50-B9B1-097423EBB153	2013-12-23	TEMOZOLOMIDE	NA	CHEMOTHERAPY	113	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
472	41685C5A-A548-483A-8A20-305AD8D61771	TCGA.06.A7TK	TCGA-06-A7TK-D71299	57B3A1D0-627D-4914-B96A-F32E878EA3F5	2015-3-24	LOMUSTINE	NA	CHEMOTHERAPY	342	FALSE	419	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
473	41685C5A-A548-483A-8A20-305AD8D61771	TCGA.06.A7TK	TCGA-06-A7TK-D71300	934A8019-1F58-4BFD-B9EB-78B410074517	2015-3-24	PROCARBAZINE	NA	CHEMOTHERAPY	342	FALSE	420	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
474	0CA72EBD-FF33-45B8-A97C-3F1435603D71	TCGA.06.A7TL	TCGA-06-A7TL-D56408	A8EF3A75-75D1-4CBC-83EE-9C71A567BDF3	2014-2-5	TEMOZOLOMIDE	CHEMOTHERAPY	CHEMOTHERAPY	25	FALSE	71	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TRUE
475	0CA72EBD-FF33-45B8-A97C-3F1435603D71	TCGA.06.A7TL	TCGA-06-A7TL-D56410	C6CE2D4E-6AE6-40C9-A7AC-51D2F86BB862	2014-2-5	PLEXXIKON PLX3397	TARGETED MOLECULAR THERAPY	NA	25	TRUE	NA	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TRUE
476	0CA72EBD-FF33-45B8-A97C-3F1435603D71	TCGA.06.A7TL	TCGA-06-A7TL-D56411	A822C259-3F22-40FB-AF6A-4E717693D06D	2014-2-5	TEMOZOLOMIDE	CHEMOTHERAPY	NA	103	TRUE	NA	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TRUE
477	0CA72EBD-FF33-45B8-A97C-3F1435603D71	TCGA.06.A7TL	TCGA-06-A7TL-D71296	B4B339D1-0D47-4536-938B-F6839B1430DB	2015-3-24	LOMUSTINE	NA	CHEMOTHERAPY	209	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
478	0CA72EBD-FF33-45B8-A97C-3F1435603D71	TCGA.06.A7TL	TCGA-06-A7TL-D71297	37A5DE3D-543B-43E1-9AF8-1A8FEC73BFC8	2015-3-24	PROCARBAZINE	NA	CHEMOTHERAPY	209	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
479	1af5c959-0f36-4a14-8383-ebc0543db3bb	TCGA.08.0244	TCGA-08-0244-D23118	a838da42-a76b-4448-8074-dc3822ac1910	2009-4-24	TEMODOR	NA	CHEMOTHERAPY	34	NA	75	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
480	1af5c959-0f36-4a14-8383-ebc0543db3bb	TCGA.08.0244	TCGA-08-0244-D23119	2d87809d-bdd4-468e-ab38-f97899b88b15	2009-4-24	THALIDOMIDE	NA	TARGETED MOLECULAR THERAPY	34	FALSE	483	NA	NA	NA	NA	NA	NA	MG/DAY	MG/DAY	NA	NA	NA	NA	NA	ADJUVANT	NA	500	NA
481	e6dee2d7-ca05-44e2-bf25-1068a416bd14	TCGA.08.0245	TCGA-08-0245-D23123	4c59294b-be56-4189-af18-c983fa2960a0	2009-4-24	TEMODAR	NA	CHEMOTHERAPY	560	NA	843	NA	NA	NA	NA	12	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	150	NA
482	e6dee2d7-ca05-44e2-bf25-1068a416bd14	TCGA.08.0245	TCGA-08-0245-D23126	4c8885e2-1a02-47ca-866d-142e26af2d6c	2009-4-24	NA	NA	HORMONE THERAPY	878	NA	933	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	200	NA
483	e6dee2d7-ca05-44e2-bf25-1068a416bd14	TCGA.08.0245	TCGA-08-0245-D23124	1f435cf6-7e43-4132-b098-d09017572da7	2009-4-24	BCNU	NA	CHEMOTHERAPY	875	NA	933	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	150	NA
484	e6dee2d7-ca05-44e2-bf25-1068a416bd14	TCGA.08.0245	TCGA-08-0245-D23125	4d79e3dd-d8bc-4eba-a8e1-fbb617a4b813	2009-4-24	BCNU	NA	CHEMOTHERAPY	933	NA	1065	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	150	NA
485	66d2e309-eaa1-4225-a34d-4565b4ef8019	TCGA.08.0246	TCGA-08-0246-D23132	0557d171-a8fd-4b40-961a-185e77661fc9	2009-4-24	TEMODOR	NA	CHEMOTHERAPY	35	NA	103	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
486	bef21d11-f743-4d9d-8cba-fb5cd24b6927	TCGA.08.0344	TCGA-08-0344-D23136	7de0f2a9-af92-45b3-8b0b-7b1ff203bca0	2009-4-24	BCNU	NA	CHEMOTHERAPY	2577	FALSE	2850	NA	NA	NA	NA	7	NA	NA	NA	NA	NA	ORAL	NA	NA	PROGRESSION	NA	NA	NA
487	5536201c-e739-46e6-8200-0bdcc28ae9ef	TCGA.08.0346	TCGA-08-0346-D23145	c517757c-5421-428e-985a-c33b45578079	2009-4-24	HYDROXYUREA	NA	CHEMOTHERAPY	20	NA	68	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	300	NA
488	dbb601ed-e39c-48a6-aa00-645f740fc6e2	TCGA.08.0347	TCGA-08-0347-D23150	f61a9d25-b2a9-47e1-b1c9-f72ca782cc39	2009-4-24	BCNU	NA	CHEMOTHERAPY	69	NA	419	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	400	NA
489	dbb601ed-e39c-48a6-aa00-645f740fc6e2	TCGA.08.0347	TCGA-08-0347-D23152	64e750af-895b-4fcd-a77d-9e1bbe1200b0	2009-4-24	CARBOPLATIN	NA	CHEMOTHERAPY	486	NA	605	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	350	NA
490	dbb601ed-e39c-48a6-aa00-645f740fc6e2	TCGA.08.0347	TCGA-08-0347-D23149	261a4177-1274-4ec4-9c02-a60417fa6954	2009-4-24	HYDROXUREA	NA	CHEMOTHERAPY	10	NA	54	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	300	NA
491	dbb601ed-e39c-48a6-aa00-645f740fc6e2	TCGA.08.0347	TCGA-08-0347-D23151	d4c0f064-30ec-44cd-9bac-17931bdc90ac	2009-4-24	PROCARBAZINE	NA	CHEMOTHERAPY	422	NA	465	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	100	NA
492	e1aabb11-f499-445e-a6fd-59a32b3c3531	TCGA.08.0348	TCGA-08-0348-D23159	1a86c44e-d9f0-4284-b77d-e71f3ddc0bd2	2009-4-24	VP-16	NA	CHEMOTHERAPY	215	FALSE	287	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
493	e1aabb11-f499-445e-a6fd-59a32b3c3531	TCGA.08.0348	TCGA-08-0348-D23158	76dd844a-473c-4fa2-8aac-6ee3a0c4cd6b	2009-4-24	TEMODOR	NA	CHEMOTHERAPY	28	FALSE	204	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
494	e1aabb11-f499-445e-a6fd-59a32b3c3531	TCGA.08.0348	TCGA-08-0348-D23160	fd59d7a3-894a-4d41-a810-25154af87fbf	2009-4-24	THALIDOMIDE	NA	TARGETED MOLECULAR THERAPY	28	NA	136	NA	NA	NA	NA	NA	NA	MG/DAY	MG/DAY	NA	NA	NA	NA	NA	ADJUVANT	NA	1000	NA
495	e1aabb11-f499-445e-a6fd-59a32b3c3531	TCGA.08.0348	TCGA-08-0348-D23161	9015101c-037c-4096-8433-ef542913bc10	2009-4-24	TAMOXIFEN	NA	TARGETED MOLECULAR THERAPY	215	FALSE	287	NA	NA	NA	NA	NA	NA	MG/DAY	MG/DAY	NA	NA	NA	NA	NA	PROGRESSION	NA	180	NA
496	0645038d-8abe-4a79-8695-bf8824d33f67	TCGA.08.0349	TCGA-08-0349-D23166	cdc59f49-d267-4427-b84c-5fd7e707cca4	2009-3-26	TEMODAR	NA	CHEMOTHERAPY	38	FALSE	93	NA	NA	NA	NA	1	NA	MG/M2/DAY	MG/M2/DAY	NA	NA	ORAL	NA	NA	ADJUVANT	NA	150	NA
497	0645038d-8abe-4a79-8695-bf8824d33f67	TCGA.08.0349	TCGA-08-0349-D23169	5f6c4610-c7b3-4810-88e0-989a769bea1c	2009-3-26	THALIDOMIDE	NA	TARGETED MOLECULAR THERAPY	38	FALSE	93	NA	NA	NA	NA	NA	NA	MG/DAY	MG/DAY	NA	NA	NA	NA	NA	ADJUVANT	NA	200	NA
498	0645038d-8abe-4a79-8695-bf8824d33f67	TCGA.08.0349	TCGA-08-0349-D23167	b309f2d3-af1e-45cd-94c2-2e16fe14f1f8	2009-4-24	BCNU	NA	CHEMOTHERAPY	105	NA	183	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	480	NA
499	0645038d-8abe-4a79-8695-bf8824d33f67	TCGA.08.0349	TCGA-08-0349-D23168	dbf995df-b25f-4801-ba7c-d7d7fd278092	2009-4-24	FENRETINIDE	NA	CHEMOTHERAPY	231	NA	259	NA	NA	NA	NA	1	NA	MG/DAY	MG/DAY	NA	NA	ORAL	NA	NA	PROGRESSION	NA	2600	NA
500	dc624b20-2854-4235-ae7e-672156ee30e3	TCGA.08.0350	TCGA-08-0350-D23174	bf9033fd-0c2c-4fac-89e3-6ccd90b1e437	2009-4-24	TARCEVA	NA	TARGETED MOLECULAR THERAPY	678	FALSE	838	NA	NA	NA	NA	NA	NA	MG/DAY	MG/DAY	NA	NA	NA	NA	NA	PROGRESSION	NA	450	NA
501	dc624b20-2854-4235-ae7e-672156ee30e3	TCGA.08.0350	TCGA-08-0350-D23173	3441cfac-cebc-445b-978a-38b0986ed31a	2009-4-24	TEMODOR	NA	CHEMOTHERAPY	446	FALSE	629	NA	NA	NA	NA	5	NA	NA	NA	NA	NA	ORAL	NA	NA	PROGRESSION	NA	NA	NA
502	91063e7e-60db-47a5-aeca-af7c37b1074e	TCGA.08.0351	TCGA-08-0351-D23182	dffca87e-cbeb-42e7-b2e6-278697b9c840	2009-4-24	THALIDOMIDE	NA	TARGETED MOLECULAR THERAPY	1594	FALSE	NA	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	200	NA
503	91063e7e-60db-47a5-aeca-af7c37b1074e	TCGA.08.0351	TCGA-08-0351-D23181	89b84e61-699e-4176-be30-02b2a9617f92	2009-4-24	THALIDOMIDE	NA	TARGETED MOLECULAR THERAPY	72	FALSE	581	NA	NA	NA	NA	NA	NA	MG/DAY	MG/DAY	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
504	91063e7e-60db-47a5-aeca-af7c37b1074e	TCGA.08.0351	TCGA-08-0351-D23179	e9223f0b-2945-4679-b769-ecf78234d514	2009-4-24	TEMODOR	NA	CHEMOTHERAPY	72	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
505	91063e7e-60db-47a5-aeca-af7c37b1074e	TCGA.08.0351	TCGA-08-0351-D23180	10fb7850-932c-4a66-ba6b-b6556d3097ce	2009-4-24	TEMODOR	NA	CHEMOTHERAPY	1594	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	PROGRESSION	NA	NA	NA
506	872cb8e8-cd79-4c0b-9b54-5553b07a6ca6	TCGA.08.0353	TCGA-08-0353-D23188	6d8048ff-4849-46cc-b928-7dd435627f6a	2009-4-24	TEMODAR	NA	CHEMOTHERAPY	6	FALSE	76	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
507	872cb8e8-cd79-4c0b-9b54-5553b07a6ca6	TCGA.08.0353	TCGA-08-0353-D23189	b1a4241e-37fa-438e-b07b-47e726f0594c	2009-4-24	TEMODAR	NA	CHEMOTHERAPY	112	FALSE	174	NA	NA	NA	NA	2	NA	MG/M2/DAY	MG/M2/DAY	NA	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
508	a23511df-ed31-4f3f-9fe5-87a3621c0de9	TCGA.08.0354	TCGA-08-0354-D23194	f1ab2c3a-b108-4f3d-8459-f53a2f3bcdb3	2009-3-26	TEMADOR	NA	CHEMOTHERAPY	261	FALSE	320	NA	NA	NA	NA	2	NA	MG/DAY	MG/DAY	NA	NA	ORAL	NA	NA	PROGRESSION	NA	200	NA
509	a23511df-ed31-4f3f-9fe5-87a3621c0de9	TCGA.08.0354	TCGA-08-0354-D23198	d3c34d3e-bcd5-4fe3-bb75-491ecb8c77fc	2009-3-26	TARCEVA	NA	TARGETED MOLECULAR THERAPY	261	FALSE	320	NA	NA	NA	NA	NA	NA	MG/DAY	MG/DAY	NA	NA	NA	NA	NA	PROGRESSION	NA	450	NA
510	a23511df-ed31-4f3f-9fe5-87a3621c0de9	TCGA.08.0354	TCGA-08-0354-D23195	f68f01cb-4e1b-4d61-a57c-1535e6d19e72	2009-4-24	POLY LCLC	NA	CHEMOTHERAPY	28	FALSE	253	NA	NA	NA	NA	8	NA	ML	ML	NA	NA	OTHER	NA	NA	ADJUVANT	NA	0.8	NA
511	a23511df-ed31-4f3f-9fe5-87a3621c0de9	TCGA.08.0354	TCGA-08-0354-D23197	9671c964-bc72-4fe2-ab18-7baea00cad04	2009-4-24	CIS RETINOIC ACID	NA	CHEMOTHERAPY	345	FALSE	393	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	180	NA
512	a23511df-ed31-4f3f-9fe5-87a3621c0de9	TCGA.08.0354	TCGA-08-0354-D23196	ca539ec6-0e57-4612-8370-6c7fb7950ea7	2009-4-24	BCNU	NA	CHEMOTHERAPY	345	FALSE	390	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	380	NA
513	bb8230b5-f984-4d28-9f10-b3c89bab1c28	TCGA.08.0355	TCGA-08-0355-D23207	10297e0f-d3a7-4e3a-9fa3-22d48fa63966	2009-4-24	TAMOXIFEN	NA	TARGETED MOLECULAR THERAPY	573	NA	607	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	540	NA
514	bb8230b5-f984-4d28-9f10-b3c89bab1c28	TCGA.08.0355	TCGA-08-0355-D23202	f69c5dec-e97f-4a4f-bb5d-6f1e84a4671e	2009-4-24	TEMODOR	NA	CHEMOTHERAPY	25	NA	68	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	75	NA
515	bb8230b5-f984-4d28-9f10-b3c89bab1c28	TCGA.08.0355	TCGA-08-0355-D23206	348793dc-db8b-468b-bec3-dcf963fab0d9	2009-4-24	THALOMID	NA	TARGETED MOLECULAR THERAPY	531	NA	572	NA	NA	NA	NA	NA	NA	MG/DAY	MG/DAY	NA	NA	NA	NA	NA	PROGRESSION	NA	1000	NA
516	bb8230b5-f984-4d28-9f10-b3c89bab1c28	TCGA.08.0355	TCGA-08-0355-D23203	256feb0d-286a-4752-87aa-5d75a4b03387	2009-4-24	TEMODOR	NA	CHEMOTHERAPY	88	FALSE	498	NA	NA	NA	NA	14	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	150	NA
517	bb8230b5-f984-4d28-9f10-b3c89bab1c28	TCGA.08.0355	TCGA-08-0355-D23208	8eb073ca-67c9-4cfa-8c5f-f15e6a5f6eaa	2009-4-24	ENZASTAURIN	NA	TARGETED MOLECULAR THERAPY	638	NA	671	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
518	bb8230b5-f984-4d28-9f10-b3c89bab1c28	TCGA.08.0355	TCGA-08-0355-D23204	ee59349e-3019-40f5-bcde-bdd0fe6ee705	2009-4-24	BCNU	NA	CHEMOTHERAPY	531	NA	531	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	210	NA
519	bb8230b5-f984-4d28-9f10-b3c89bab1c28	TCGA.08.0355	TCGA-08-0355-D23205	bdd996ca-720b-40f1-b1c9-f2b8fe3ebea3	2009-4-24	CARBOPLATIN	NA	CHEMOTHERAPY	582	NA	582	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	590	NA
520	f7532982-524f-4ed5-9e0d-50d3a7d72c3c	TCGA.08.0356	TCGA-08-0356-D23213	fde0eebc-e964-4060-a4e7-e91f0cafbda8	2009-4-24	TEMODAR	NA	CHEMOTHERAPY	101	FALSE	447	NA	NA	NA	NA	12	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
521	f7532982-524f-4ed5-9e0d-50d3a7d72c3c	TCGA.08.0356	TCGA-08-0356-D23212	3c5f687d-1205-4f36-be44-e08b7ced3321	2009-4-24	TEMODAR	NA	CHEMOTHERAPY	42	FALSE	82	NA	NA	NA	NA	1	NA	MG/DAY	MG/DAY	NA	NA	ORAL	NA	NA	ADJUVANT	NA	75	NA
522	548c3d4c-7993-40dc-bd02-5bb304188d28	TCGA.08.0357	TCGA-08-0357-D23226	3d8e0882-1bef-420b-b6fc-3dd7112636d0	2009-3-26	GLEEVAC	NA	TARGETED MOLECULAR THERAPY	689	FALSE	733	NA	NA	NA	NA	NA	NA	MG/DAY	MG/DAY	NA	NA	NA	NA	NA	PROGRESSION	NA	1000	NA
523	548c3d4c-7993-40dc-bd02-5bb304188d28	TCGA.08.0357	TCGA-08-0357-D23222	d7609321-572c-478c-9f19-173dd78fa045	2009-3-26	INTERFERON ALPHA	NA	IMMUNOTHERAPY	736	FALSE	860	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
524	548c3d4c-7993-40dc-bd02-5bb304188d28	TCGA.08.0357	TCGA-08-0357-D23217	b92182ab-60f3-4902-ae8e-d659a83d0dff	2009-3-26	CCNU	NA	CHEMOTHERAPY	736	FALSE	860	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	110	NA
525	548c3d4c-7993-40dc-bd02-5bb304188d28	TCGA.08.0357	TCGA-08-0357-D23225	7ba342c4-0f83-405a-a5a4-08b7a6d81ac0	2009-3-26	THALIDOMIDE	NA	TARGETED MOLECULAR THERAPY	93	FALSE	136	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
526	548c3d4c-7993-40dc-bd02-5bb304188d28	TCGA.08.0357	TCGA-08-0357-D23224	3ccbc13b-bc98-48af-8263-56ebba1c5d4d	2009-3-26	RAPAMYCIN	NA	TARGETED MOLECULAR THERAPY	736	FALSE	860	NA	NA	NA	NA	NA	NA	MG/DAY	MG/DAY	NA	NA	NA	NA	NA	PROGRESSION	NA	5	NA
527	548c3d4c-7993-40dc-bd02-5bb304188d28	TCGA.08.0357	TCGA-08-0357-D23218	99c11925-ce58-4894-aaba-699b1e243d31	2009-3-26	TEMODAR	NA	CHEMOTHERAPY	93	FALSE	136	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	75	NA
528	548c3d4c-7993-40dc-bd02-5bb304188d28	TCGA.08.0357	TCGA-08-0357-D23219	bef1f5c0-7826-41a8-b2e8-d1ac6975a14f	2009-3-26	HYRDROXYUREA	NA	CHEMOTHERAPY	689	FALSE	733	NA	NA	NA	NA	1	NA	MG/DAY	MG/DAY	NA	NA	ORAL	NA	NA	PROGRESSION	NA	1000	NA
529	548c3d4c-7993-40dc-bd02-5bb304188d28	TCGA.08.0357	TCGA-08-0357-D23220	a694da0f-ff13-473a-872c-2c6ee66fa7ef	2009-4-24	TEMODAR	NA	CHEMOTHERAPY	29	FALSE	71	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	75	NA
530	548c3d4c-7993-40dc-bd02-5bb304188d28	TCGA.08.0357	TCGA-08-0357-D23227	375d4c00-07df-453d-a60c-c38265e9271f	2009-4-24	IRINOTECAN	NA	TARGETED MOLECULAR THERAPY	471	TRUE	688	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	775	NA
531	548c3d4c-7993-40dc-bd02-5bb304188d28	TCGA.08.0357	TCGA-08-0357-D23223	a27af51d-409b-42a2-a5bf-5d3e29d7850d	2009-4-24	IL-13 PSEUDOMONAS EXOTOXIN	NA	IMMUNOTHERAPY	184	FALSE	188	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	36	NA
532	548c3d4c-7993-40dc-bd02-5bb304188d28	TCGA.08.0357	TCGA-08-0357-D23229	1a6c1215-31e8-4b4e-8eb0-37cf0acca160	2009-4-24	CYTOXAN	NA	TARGETED MOLECULAR THERAPY	1097	TRUE	1112	NA	NA	NA	NA	NA	NA	MG/DAY	MG/DAY	NA	NA	NA	NA	NA	PROGRESSION	NA	100	NA
533	548c3d4c-7993-40dc-bd02-5bb304188d28	TCGA.08.0357	TCGA-08-0357-D23221	6a8e0c94-eb69-49d8-898c-cfae7559a838	2009-4-24	VP-16	NA	CHEMOTHERAPY	875	FALSE	985	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	100	NA
534	548c3d4c-7993-40dc-bd02-5bb304188d28	TCGA.08.0357	TCGA-08-0357-D23228	0fe3e11e-2877-4b60-b2cd-cdda901a691e	2009-4-24	SORAFENIB	NA	TARGETED MOLECULAR THERAPY	1007	FALSE	1084	NA	NA	NA	NA	NA	NA	MG/DAY	MG/DAY	NA	NA	NA	NA	NA	PROGRESSION	NA	400	NA
535	548c3d4c-7993-40dc-bd02-5bb304188d28	TCGA.08.0357	TCGA-08-0357-D23230	d4fe4761-df61-47fd-b4c3-a4b7a42498a9	2009-5-7	TARVECA	NA	TARGETED MOLECULAR THERAPY	1007	NA	1084	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	100	NA
536	548c3d4c-7993-40dc-bd02-5bb304188d28	TCGA.08.0357	TCGA-08-0357-D23231	b6d05d6f-46ce-45a4-90ba-8186e9011b65	2009-5-22	AVASTIN	NA	TARGETED MOLECULAR THERAPY	471	FALSE	688	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	475	NA
537	ec504558-e96a-44e9-835a-7b12680681ed	TCGA.08.0358	TCGA-08-0358-D23241	27cdbcf7-ace5-400e-a9d4-c60f83f75af8	2009-4-24	TARCEVA	NA	TARGETED MOLECULAR THERAPY	91	NA	264	NA	NA	NA	NA	NA	NA	MG/DAY	MG/DAY	NA	NA	NA	NA	NA	ADJUVANT	NA	200	NA
538	ec504558-e96a-44e9-835a-7b12680681ed	TCGA.08.0358	TCGA-08-0358-D23236	44c9f712-4492-49fa-8a39-a260a6b7c458	2009-4-24	TEMODOR	NA	CHEMOTHERAPY	91	NA	264	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
539	ec504558-e96a-44e9-835a-7b12680681ed	TCGA.08.0358	TCGA-08-0358-D23237	38de7c79-302d-4ca6-b235-81b135b8cfcc	2009-4-24	CCNU	NA	CHEMOTHERAPY	491	NA	548	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	220	NA
540	ec504558-e96a-44e9-835a-7b12680681ed	TCGA.08.0358	TCGA-08-0358-D23238	4d3ea852-38f0-42c4-8bfc-0bb6fe5fe1f9	2009-4-24	IL-13 WITH PSEUDOMONAS EXOTOXIN	NA	IMMUNOTHERAPY	288	NA	293	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	36	NA
541	ec504558-e96a-44e9-835a-7b12680681ed	TCGA.08.0358	TCGA-08-0358-D23239	0a1e7b70-1747-42c8-ad6a-49b615ad2b91	2009-4-24	HSPPC-96 VACCINE	NA	IMMUNOTHERAPY	341	NA	467	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	0.4	NA
542	ec504558-e96a-44e9-835a-7b12680681ed	TCGA.08.0358	TCGA-08-0358-D23235	756123e8-ff61-486c-804a-34a9a92b48e1	2009-4-24	TEMODOR	NA	CHEMOTHERAPY	33	NA	75	NA	NA	NA	NA	1	NA	MG/DAY	MG/DAY	NA	NA	ORAL	NA	NA	ADJUVANT	NA	150	NA
543	ec504558-e96a-44e9-835a-7b12680681ed	TCGA.08.0358	TCGA-08-0358-D23240	a29f4049-b90d-4c2a-8f60-5473162ba8c6	2009-4-24	TARCEVA	NA	TARGETED MOLECULAR THERAPY	33	NA	75	NA	NA	NA	NA	NA	NA	MG/DAY	MG/DAY	NA	NA	NA	NA	NA	ADJUVANT	NA	150	NA
544	6d6dae20-431d-4fbe-ba47-e7ed8d73b4d8	TCGA.08.0360	TCGA-08-0360-D23247	abab65c4-8746-435d-b917-141a8ed0dcaf	2009-4-24	IL-13 WITH PSEUDOMONAS EXOTOXIN	NA	IMMUNOTHERAPY	130	FALSE	134	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	36	NA
545	6fc40b53-5db2-4319-a039-b023e1bb1d64	TCGA.08.0380	TCGA-08-0380-D23259	bd96270d-54f2-453e-bdc1-3a3fc050c931	2009-3-26	NA	NA	TARGETED MOLECULAR THERAPY	275	NA	330	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
546	6fc40b53-5db2-4319-a039-b023e1bb1d64	TCGA.08.0380	TCGA-08-0380-D23256	cf946024-3010-4731-9971-627fa2f71668	2009-3-26	VP16	NA	CHEMOTHERAPY	293	FALSE	330	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	50	NA
547	6fc40b53-5db2-4319-a039-b023e1bb1d64	TCGA.08.0380	TCGA-08-0380-D23258	7207fb18-9e10-4b45-8f5a-01453c10f483	2009-4-24	TEMODAR	NA	CHEMOTHERAPY	216	NA	274	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	345	NA
548	6fc40b53-5db2-4319-a039-b023e1bb1d64	TCGA.08.0380	TCGA-08-0380-D23260	0f52d72f-2ed9-42c6-ad05-09419d37cfd6	2009-4-24	MARIMASTAT	NA	TARGETED MOLECULAR THERAPY	NA	TRUE	NA	NA	NA	NA	NA	NA	NA	MG/DAY	MG/DAY	NA	NA	NA	NA	NA	ADJUVANT	NA	200	NA
549	6fc40b53-5db2-4319-a039-b023e1bb1d64	TCGA.08.0380	TCGA-08-0380-D23257	83a0190a-e7d1-487b-b781-dadfe5087a65	2009-4-24	BCNU	NA	CHEMOTHERAPY	161	NA	193	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	375	NA
550	314d9188-c8fd-43fc-905d-b6889de542c8	TCGA.08.0386	TCGA-08-0386-D23267	9d26e686-131c-42b6-ab3e-4d93cf188229	2009-3-26	TEMODAR	NA	CHEMOTHERAPY	95	FALSE	427	NA	NA	NA	NA	11	NA	NA	NA	NA	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
551	314d9188-c8fd-43fc-905d-b6889de542c8	TCGA.08.0386	TCGA-08-0386-D23269	f620fa22-6a39-4f18-abf0-31b11375c701	2009-3-26	TARCEVA	NA	TARGETED MOLECULAR THERAPY	29	FALSE	76	NA	NA	NA	NA	NA	NA	MG/DAY	MG/DAY	NA	NA	NA	NA	NA	ADJUVANT	NA	200	NA
552	314d9188-c8fd-43fc-905d-b6889de542c8	TCGA.08.0386	TCGA-08-0386-D23266	7f467abb-da6c-40e5-a568-6f431c158c83	2009-3-26	TEMODAR	NA	CHEMOTHERAPY	29	FALSE	76	NA	NA	NA	NA	1	NA	MG/M2/DAY	MG/M2/DAY	NA	NA	ORAL	NA	NA	ADJUVANT	NA	75	NA
553	314d9188-c8fd-43fc-905d-b6889de542c8	TCGA.08.0386	TCGA-08-0386-D23270	d9b30b36-dbe1-4435-9c5a-9dacc057c6dd	2009-3-26	TARCEVA	NA	TARGETED MOLECULAR THERAPY	94	FALSE	106	NA	NA	NA	NA	NA	NA	MG/DAY	MG/DAY	NA	NA	NA	NA	NA	ADJUVANT	NA	200	NA
554	314d9188-c8fd-43fc-905d-b6889de542c8	TCGA.08.0386	TCGA-08-0386-D23268	668dac3e-01d7-4e1a-8822-919990ff0b0f	2009-4-24	HSPPC-96 VACCINE	NA	IMMUNOTHERAPY	113	FALSE	125	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	0.4	NA
555	ea980264-d64d-410a-86dd-c129d7d8d1ee	TCGA.08.0389	TCGA-08-0389-D23275	52b6a44a-3f4b-4740-b333-92f51dff9986	2009-4-24	EMD	NA	TARGETED MOLECULAR THERAPY	39	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
556	ea980264-d64d-410a-86dd-c129d7d8d1ee	TCGA.08.0389	TCGA-08-0389-D23274	dd9af520-6133-43cf-978c-c3bc32eb3eda	2009-4-24	TEMODOR	NA	CHEMOTHERAPY	39	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
557	108a8d8e-1ddb-4c0d-a05b-71573b33b9aa	TCGA.08.0390	TCGA-08-0390-D23279	f887296e-cb81-472a-932a-c4efe25583c0	2009-4-24	TEMODAR	NA	CHEMOTHERAPY	28	NA	69	NA	NA	NA	NA	1	NA	MG/DAY	MG/DAY	NA	NA	ORAL	NA	NA	ADJUVANT	NA	150	NA
558	108a8d8e-1ddb-4c0d-a05b-71573b33b9aa	TCGA.08.0390	TCGA-08-0390-D23280	80c63184-c068-4bef-868f-e1b0dee5e9cf	2009-4-24	TEMODAR	NA	CHEMOTHERAPY	105	NA	132	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	300	NA
559	108a8d8e-1ddb-4c0d-a05b-71573b33b9aa	TCGA.08.0390	TCGA-08-0390-D23281	b3f16806-ffbf-4372-9601-7d606e1f7464	2009-6-10	TARCEVA	NA	IMMUNOTHERAPY	28	NA	69	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	100	NA
560	108a8d8e-1ddb-4c0d-a05b-71573b33b9aa	TCGA.08.0390	TCGA-08-0390-D23282	650f54eb-f3f2-4d5b-a271-8ad74d026947	2009-6-10	TARCEVA	NA	IMMUNOTHERAPY	105	NA	132	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	150	NA
561	06e32525-6043-45a1-9fef-fa24ab219a1f	TCGA.08.0510	TCGA-08-0510-D23289	6ca85588-01e5-4eca-90d4-e91fc02b888a	2009-4-24	TEMODOR	NA	CHEMOTHERAPY	35	FALSE	90	NA	NA	NA	NA	2	NA	MG/DAY	MG/DAY	NA	NA	ORAL	NA	NA	ADJUVANT	NA	330	NA
562	06e32525-6043-45a1-9fef-fa24ab219a1f	TCGA.08.0510	TCGA-08-0510-D23290	b19565f4-5ff0-4aa2-91bf-ed05d4873ecd	2009-4-24	THALIDOMIDE	NA	TARGETED MOLECULAR THERAPY	41	FALSE	64	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
563	13480f06-32ee-48b5-a729-a963a7979b90	TCGA.08.0511	TCGA-08-0511-D23294	f89ba681-e3e2-4dbf-8ff3-dcdccbff547a	2009-4-24	CCNU	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	210	NA
564	9773acd0-e8bf-4991-8913-53f0d2adfc72	TCGA.08.0517	TCGA-08-0517-D23309	125ce2ce-53a3-4877-8229-b67a4335f361	2009-4-24	ACCUTANE	NA	CHEMOTHERAPY	NA	FALSE	1754	NA	NA	NA	NA	NA	NA	MG/DAY	MG/DAY	NA	NA	ORAL	NA	NA	PROGRESSION	NA	160	NA
565	9773acd0-e8bf-4991-8913-53f0d2adfc72	TCGA.08.0517	TCGA-08-0517-D23308	80bb4143-6775-4ad8-9b13-6db2df79c961	2009-4-24	PROCARBAZINE/CCNU/VINCRISTINE	NA	CHEMOTHERAPY	1086	FALSE	1359	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	ORAL	NA	NA	PROGRESSION	NA	NA	NA
566	e924d7c6-c98f-4469-8089-70e4ac3ca306	TCGA.08.0520	TCGA-08-0520-D23316	b57bc141-fc8a-49fc-bd12-ffa57079021e	2009-4-24	TEMODOR	NA	CHEMOTHERAPY	175	NA	NA	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	200	NA
567	b2a01580-d18f-40b5-875b-93e9c000b0e1	TCGA.08.0521	TCGA-08-0521-D23322	3e04ec4a-1e27-49cf-adf2-4401a99cbc9c	2009-4-24	TEMODAR	NA	CHEMOTHERAPY	99	FALSE	126	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	300	NA
568	b2a01580-d18f-40b5-875b-93e9c000b0e1	TCGA.08.0521	TCGA-08-0521-D23321	680f2489-45ef-4bc9-8c53-1b187c4959dc	2009-4-24	TEMODAR	NA	CHEMOTHERAPY	27	FALSE	63	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	140	NA
569	51e5a60f-e7b1-4b8b-b0b1-447c28940fe6	TCGA.08.0522	TCGA-08-0522-D23328	a8621f7d-26ea-40ce-a491-c54063176bcd	2009-4-24	CARBOPLATIN	NA	CHEMOTHERAPY	517	FALSE	555	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
570	51e5a60f-e7b1-4b8b-b0b1-447c28940fe6	TCGA.08.0522	TCGA-08-0522-D23330	af652c34-1a2a-4971-8dd2-849b7dac1b67	2009-4-24	LY317615	NA	TARGETED MOLECULAR THERAPY	423	FALSE	511	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
571	51e5a60f-e7b1-4b8b-b0b1-447c28940fe6	TCGA.08.0522	TCGA-08-0522-D23326	611d6606-63a8-4f55-a972-14849d854e06	2009-4-24	TEMODAR	NA	CHEMOTHERAPY	22	FALSE	65	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	140	NA
572	51e5a60f-e7b1-4b8b-b0b1-447c28940fe6	TCGA.08.0522	TCGA-08-0522-D23329	d64f01af-86de-4fe6-841e-ed1449fe4591	2009-4-24	IL-13-PE38QQR CYTOXIN	NA	IMMUNOTHERAPY	268	FALSE	271	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	1	NA
573	51e5a60f-e7b1-4b8b-b0b1-447c28940fe6	TCGA.08.0522	TCGA-08-0522-D23327	662d7ceb-c89c-447e-a6ad-a36a17aa7d5f	2009-4-24	TEMODAR	NA	CHEMOTHERAPY	72	FALSE	225	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	280	NA
574	ea8b757b-3d33-47e1-8657-503cf69939bb	TCGA.08.0524	TCGA-08-0524-D23334	c2a40350-bf1a-4b73-80c9-0d802a7b3a6e	2009-3-26	CCNU	NA	CHEMOTHERAPY	195	NA	199	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	170	NA
575	ea8b757b-3d33-47e1-8657-503cf69939bb	TCGA.08.0524	TCGA-08-0524-D23336	fd5dd288-a7c6-4327-8ff7-3679383f3460	2009-3-26	THALIDOMIDE	NA	TARGETED MOLECULAR THERAPY	195	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
576	ea8b757b-3d33-47e1-8657-503cf69939bb	TCGA.08.0524	TCGA-08-0524-D23335	b2ead0e8-200b-4a43-825f-85b98da68ecd	2009-4-24	TEMODAR	NA	CHEMOTHERAPY	24	NA	52	NA	NA	NA	NA	1	NA	MG/DAY	MG/DAY	NA	NA	ORAL	NA	NA	ADJUVANT	NA	120	NA
577	ea8b757b-3d33-47e1-8657-503cf69939bb	TCGA.08.0524	TCGA-08-0524-D23338	8c5542ae-94b5-4250-a509-cab4462f31a5	2009-4-24	GLEEVEC	NA	TARGETED MOLECULAR THERAPY	138	NA	189	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	350	NA
578	ea8b757b-3d33-47e1-8657-503cf69939bb	TCGA.08.0524	TCGA-08-0524-D23337	4270b4e0-2b49-4d15-a2d2-a6cdccd03f73	2009-4-24	SCH63666	NA	TARGETED MOLECULAR THERAPY	73	FALSE	123	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	150	NA
579	1b042663-dcb1-4fc9-b813-7b90cc2eb392	TCGA.08.0525	TCGA-08-0525-D23342	3f0583ea-e3dd-407e-bd69-7195cfe1001d	2009-4-24	TEMODAR	NA	CHEMOTHERAPY	6	NA	39	NA	NA	NA	NA	1	NA	MG/M2/DAY	MG/M2/DAY	NA	NA	ORAL	NA	NA	ADJUVANT	NA	75	NA
580	1b042663-dcb1-4fc9-b813-7b90cc2eb392	TCGA.08.0525	TCGA-08-0525-D23343	39882308-2a6a-4db3-aac0-e404b8e35454	2009-4-24	TEMODAR	NA	CHEMOTHERAPY	37	NA	341	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
581	1b042663-dcb1-4fc9-b813-7b90cc2eb392	TCGA.08.0525	TCGA-08-0525-D23344	43f8b1d4-ff5c-4d9d-8fa0-4a2db86a2d07	2009-4-24	OS1-774	NA	TARGETED MOLECULAR THERAPY	370	NA	402	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
582	aaa7d45b-ce3c-4099-ab4a-377e3aee9f96	TCGA.08.0529	TCGA-08-0529-D23348	8edbabf9-11f1-4faa-9331-71bad6425735	2009-4-24	TEMODAR	NA	CHEMOTHERAPY	41	FALSE	84	NA	NA	NA	NA	1	NA	MG/DAY	MG/DAY	NA	NA	ORAL	NA	NA	ADJUVANT	NA	75	NA
583	aaa7d45b-ce3c-4099-ab4a-377e3aee9f96	TCGA.08.0529	TCGA-08-0529-D23349	8011d7f2-a247-4adc-85e1-539f022f7899	2009-4-24	TEMODAR	NA	CHEMOTHERAPY	106	FALSE	328	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
584	aaa7d45b-ce3c-4099-ab4a-377e3aee9f96	TCGA.08.0529	TCGA-08-0529-D23350	71e78233-8b19-463d-87a8-2aeebfe0b9bb	2009-4-24	IL-13 PSEUDOMONAS EXOTOXIN	NA	IMMUNOTHERAPY	349	FALSE	353	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	36	NA
585	c7b317a4-f5ba-4bd5-bbde-fd09418d3dee	TCGA.08.0531	TCGA-08-0531-D23354	e2516eda-e23d-4bff-b103-de7cc4b01524	2009-4-24	TEMODAR	NA	CHEMOTHERAPY	27	FALSE	69	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	135	NA
586	c7b317a4-f5ba-4bd5-bbde-fd09418d3dee	TCGA.08.0531	TCGA-08-0531-D23355	9743cbd0-782e-4e71-a8d4-1d2e38351e36	2009-4-24	TEMODAR	NA	CHEMOTHERAPY	102	FALSE	198	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	300	NA
587	141a1ef1-9be6-46d1-b445-305b222727d2	TCGA.12.0615	TCGA-12-0615-D23454	2058a9df-53e5-41ea-9f92-8fb8c1675605	2009-4-24	TEMODAR	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	75	NA
588	141a1ef1-9be6-46d1-b445-305b222727d2	TCGA.12.0615	TCGA-12-0615-D23458	fa620ada-f061-4a9f-87ac-23119ebf5d01	2009-4-24	AVASTIN	NA	TARGETED MOLECULAR THERAPY	278	FALSE	383	NA	NA	NA	NA	NA	NA	MG/KG	MG/KG	NA	NA	NA	NA	NA	PROGRESSION	NA	10	NA
589	141a1ef1-9be6-46d1-b445-305b222727d2	TCGA.12.0615	TCGA-12-0615-D23457	3bdfb509-fda0-43bd-8086-8ddf44a2a793	2009-4-24	AVASTIN	NA	TARGETED MOLECULAR THERAPY	195	FALSE	278	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	10	NA
590	141a1ef1-9be6-46d1-b445-305b222727d2	TCGA.12.0615	TCGA-12-0615-D23456	e1b25fc1-3ec6-47f6-9fcc-27f17452234b	2009-4-24	CPT-11	NA	CHEMOTHERAPY	195	FALSE	278	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	125	NA
591	141a1ef1-9be6-46d1-b445-305b222727d2	TCGA.12.0615	TCGA-12-0615-D23453	0c9a0b3e-adfb-4ae8-ba6c-9c1fe3d08310	2009-4-24	GLIADEL WAFERS	NA	CHEMOTHERAPY	28	FALSE	28	NA	NA	NA	NA	1	NA	WAFER	WAFER	NA	NA	INTRATUMORAL	NA	NA	ADJUVANT	NA	8	NA
592	141a1ef1-9be6-46d1-b445-305b222727d2	TCGA.12.0615	TCGA-12-0615-D23455	f2b9aca2-dd5b-4256-bcd3-0ada2dfa3c59	2009-4-24	TEMODAR	NA	CHEMOTHERAPY	102	FALSE	172	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	150	NA
593	edcfac32-adb4-4fe7-86a0-309d3c6430e5	TCGA.12.0616	TCGA-12-0616-D23467	1fb698c8-dfdb-4a63-8150-bba466ed72c4	2009-3-26	AVASTIN	NA	TARGETED MOLECULAR THERAPY	260	FALSE	348	NA	NA	NA	NA	NA	NA	MG/KG	MG/KG	NA	NA	NA	NA	NA	ADJUVANT	NA	10	NA
594	edcfac32-adb4-4fe7-86a0-309d3c6430e5	TCGA.12.0616	TCGA-12-0616-D23462	5c7b6bc7-c0fe-45da-aa96-54bbe7e105c2	2009-3-26	CPT-11	NA	CHEMOTHERAPY	260	FALSE	348	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	340	NA
595	edcfac32-adb4-4fe7-86a0-309d3c6430e5	TCGA.12.0616	TCGA-12-0616-D23468	62e266bb-9683-49f3-b4cf-cfae84421be5	2009-3-26	GLEEVAC	NA	TARGETED MOLECULAR THERAPY	407	FALSE	433	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	700	NA
596	edcfac32-adb4-4fe7-86a0-309d3c6430e5	TCGA.12.0616	TCGA-12-0616-D23469	17f27132-83fb-4825-8002-27cb5a843d24	2009-3-26	RAD001	NA	TARGETED MOLECULAR THERAPY	407	FALSE	433	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	2.5	NA
597	edcfac32-adb4-4fe7-86a0-309d3c6430e5	TCGA.12.0616	TCGA-12-0616-D23463	20cdff4b-2072-4629-b3e9-444c7c37f6a8	2009-3-26	HYDROXYUREA	NA	CHEMOTHERAPY	407	FALSE	433	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	1000	NA
598	edcfac32-adb4-4fe7-86a0-309d3c6430e5	TCGA.12.0616	TCGA-12-0616-D23466	2fe8013b-55c0-4817-a832-628f5eb96d5b	2009-4-24	TEMOZOLOMIDE	NA	CHEMOTHERAPY	362	FALSE	407	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
599	edcfac32-adb4-4fe7-86a0-309d3c6430e5	TCGA.12.0616	TCGA-12-0616-D23465	04a3ed4c-d254-4846-8eb5-032b75040d66	2009-4-24	TEMOZOLAMIDE	NA	CHEMOTHERAPY	106	FALSE	259	NA	NA	NA	NA	4	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
600	edcfac32-adb4-4fe7-86a0-309d3c6430e5	TCGA.12.0616	TCGA-12-0616-D23464	e1cbbbf7-ee6a-4d6b-ab2d-625738905bce	2009-4-24	TEMOZOLAMIDE	NA	CHEMOTHERAPY	29	FALSE	75	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	75	NA
601	f7ba48c8-46cf-40a9-8826-7e1f67d57171	TCGA.12.0618	TCGA-12-0618-D23474	444f1329-bd6b-4f79-a3e2-6318c1e54ccf	2009-4-24	TEMODAR	NA	CHEMOTHERAPY	9	NA	65	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	150	NA
602	f7ba48c8-46cf-40a9-8826-7e1f67d57171	TCGA.12.0618	TCGA-12-0618-D23473	ef68904b-ae04-4e6b-a596-941492bbb53d	2009-4-24	GLIADEL WAFERS	NA	CHEMOTHERAPY	0	NA	0	NA	NA	NA	NA	1	NA	WAFER	WAFER	NA	NA	INTRATUMORAL	NA	NA	ADJUVANT	NA	8	NA
603	0389b35b-651b-4776-b12a-d315a100f47c	TCGA.12.0619	TCGA-12-0619-D23478	d4423692-0c30-47f0-8b1c-f2d8dc3d584a	2009-4-24	GLIADEL WAFERS	NA	CHEMOTHERAPY	0	FALSE	0	NA	NA	NA	NA	1	NA	WAFER	WAFER	NA	NA	INTRATUMORAL	NA	NA	ADJUVANT	NA	8	NA
604	0389b35b-651b-4776-b12a-d315a100f47c	TCGA.12.0619	TCGA-12-0619-D23483	055624f8-2a14-4a95-8167-73fa4390da01	2009-4-24	VP-16	NA	CHEMOTHERAPY	291	FALSE	350	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	50	NA
605	0389b35b-651b-4776-b12a-d315a100f47c	TCGA.12.0619	TCGA-12-0619-D23479	2c49dfbf-f75b-4a39-8b09-e66dc403bea7	2009-4-24	TEMOZOLAMIDE	NA	CHEMOTHERAPY	21	FALSE	84	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	150	NA
606	0389b35b-651b-4776-b12a-d315a100f47c	TCGA.12.0619	TCGA-12-0619-D23482	a6a54b5b-168e-48d5-8f2a-94ed730f02c6	2009-4-24	TEMOZOLAMIDE	NA	CHEMOTHERAPY	228	FALSE	291	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	200	NA
607	0389b35b-651b-4776-b12a-d315a100f47c	TCGA.12.0619	TCGA-12-0619-D23484	fa2a4628-c2af-46a0-8386-5d741e3f65fc	2009-4-24	VP-16	NA	CHEMOTHERAPY	443	FALSE	571	NA	NA	NA	NA	4	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	50	NA
608	0389b35b-651b-4776-b12a-d315a100f47c	TCGA.12.0619	TCGA-12-0619-D23480	d9223402-48ef-4310-ba23-85f4242adbac	2009-4-24	CCNU	NA	CHEMOTHERAPY	84	FALSE	129	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	110	NA
609	0389b35b-651b-4776-b12a-d315a100f47c	TCGA.12.0619	TCGA-12-0619-D23481	d2a508f4-9e2d-4e0e-a6ab-baa0ef1cde71	2009-4-24	CCNU	NA	CHEMOTHERAPY	163	FALSE	203	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	82.5	NA
610	1dbfbff7-d048-4770-ae02-e6a287256210	TCGA.12.0620	TCGA-12-0620-D23488	4bbe6ac4-7aa5-4f73-9763-d3673ae1d11c	2009-4-24	TEMODAR	NA	CHEMOTHERAPY	21	FALSE	68	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	75	NA
611	1dbfbff7-d048-4770-ae02-e6a287256210	TCGA.12.0620	TCGA-12-0620-D23489	80b5bea0-8ba7-49c8-ab89-8ca137201237	2009-4-24	CCNU	NA	CHEMOTHERAPY	92	FALSE	191	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	110	NA
612	a7b55dae-c9b8-45c6-986f-fb1055f1c67b	TCGA.12.0653	TCGA-12-0653-D33743	0f41a530-6b84-4bcd-96e7-11fefe6aa31a	2012-7-14	GLIADEL WAFERS	NA	CHEMOTHERAPY	0	FALSE	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
613	a7b55dae-c9b8-45c6-986f-fb1055f1c67b	TCGA.12.0653	TCGA-12-0653-D33744	60045ecf-1594-412e-ba97-11a24191c3e0	2012-7-14	TEMOZOLOMIDE	NA	CHEMOTHERAPY	14	FALSE	110	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
614	a7b55dae-c9b8-45c6-986f-fb1055f1c67b	TCGA.12.0653	TCGA-12-0653-D33745	fa2b8930-902e-42e7-ab2e-0abe87b1c1db	2012-7-14	CCNU	NA	CHEMOTHERAPY	110	FALSE	155	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
615	a7b55dae-c9b8-45c6-986f-fb1055f1c67b	TCGA.12.0653	TCGA-12-0653-D33746	5b6ab215-11fe-4093-9444-529cd1f1fac6	2012-7-14	CCNU	NA	CHEMOTHERAPY	155	FALSE	210	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
616	a7b55dae-c9b8-45c6-986f-fb1055f1c67b	TCGA.12.0653	TCGA-12-0653-D33747	dd44d82e-d68f-4213-910d-c04bb08e7d5e	2012-7-14	TEMOZOLOMIDE	NA	CHEMOTHERAPY	210	FALSE	267	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
617	a7b55dae-c9b8-45c6-986f-fb1055f1c67b	TCGA.12.0653	TCGA-12-0653-D33748	5691d622-6e29-414f-bce3-87fe3d6ee417	2012-7-14	O6B6	NA	TARGETED MOLECULAR THERAPY	281	FALSE	283	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
618	a7b55dae-c9b8-45c6-986f-fb1055f1c67b	TCGA.12.0653	TCGA-12-0653-D33749	96e74b79-4a7c-4983-9c16-f1f9fb2628b7	2012-7-14	O6B6	NA	TARGETED MOLECULAR THERAPY	281	FALSE	283	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
619	e67edc2e-5de7-4d3c-ba47-e8558a0b9f5a	TCGA.12.0654	TCGA-12-0654-D23493	cd22b3a0-f35e-4408-8612-8373461f76d8	2009-4-24	MAB I-131	NA	TARGETED MOLECULAR THERAPY	44	FALSE	216	NA	NA	NA	NA	NA	NA	MCI	MCI	NA	NA	NA	NA	NA	ADJUVANT	NA	120	NA
620	e67edc2e-5de7-4d3c-ba47-e8558a0b9f5a	TCGA.12.0654	TCGA-12-0654-D23494	5ee384a9-304e-45e7-ae9b-5251252e49fd	2009-5-22	MU81C6	NA	TARGETED MOLECULAR THERAPY	44	FALSE	216	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	20	NA
621	c4ff28e5-9de7-43df-89a2-6832b8a0c00b	TCGA.12.0656	TCGA-12-0656-D23505	9b3f9504-1f88-4ffe-953f-770f3c5a8df3	2009-4-24	MAB I-131	NA	TARGETED MOLECULAR THERAPY	22	FALSE	22	NA	NA	NA	NA	NA	NA	MCI	MCI	NA	NA	NA	NA	NA	ADJUVANT	NA	120	NA
622	c4ff28e5-9de7-43df-89a2-6832b8a0c00b	TCGA.12.0656	TCGA-12-0656-D23499	cd81ea56-89d5-4ae7-9029-1ad1fb4657f4	2009-4-24	CCNU	NA	CHEMOTHERAPY	204	FALSE	254	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	55	NA
623	c4ff28e5-9de7-43df-89a2-6832b8a0c00b	TCGA.12.0656	TCGA-12-0656-D23502	68706cce-028f-40a0-9356-4a18685ada5a	2009-4-24	CCNU	NA	CHEMOTHERAPY	1758	FALSE	1817	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	110	NA
624	c4ff28e5-9de7-43df-89a2-6832b8a0c00b	TCGA.12.0656	TCGA-12-0656-D23503	cad383d6-b665-4973-8323-e764718c6dd3	2009-4-24	CCNU	NA	CHEMOTHERAPY	1817	FALSE	1873	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	82.5	NA
625	c4ff28e5-9de7-43df-89a2-6832b8a0c00b	TCGA.12.0656	TCGA-12-0656-D23498	831d594f-6292-4dc1-a2a9-0d371d17e6d1	2009-4-24	CCNU	NA	CHEMOTHERAPY	135	FALSE	204	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	110	NA
626	c4ff28e5-9de7-43df-89a2-6832b8a0c00b	TCGA.12.0656	TCGA-12-0656-D23500	c26bd072-17a2-43e9-a719-2ab1b6b12201	2009-4-24	VP-16	NA	CHEMOTHERAPY	301	FALSE	443	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	37.5	NA
627	c4ff28e5-9de7-43df-89a2-6832b8a0c00b	TCGA.12.0656	TCGA-12-0656-D23501	30489eb9-9c80-4381-b259-88134f92e385	2009-4-24	TEMODAR	NA	CHEMOTHERAPY	1488	FALSE	1758	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	200	NA
628	c4ff28e5-9de7-43df-89a2-6832b8a0c00b	TCGA.12.0656	TCGA-12-0656-D23504	372e4e48-06d3-40be-961b-d5deace2e199	2009-4-24	VP-16	NA	CHEMOTHERAPY	1873	FALSE	1899	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	50	NA
629	c4ff28e5-9de7-43df-89a2-6832b8a0c00b	TCGA.12.0656	TCGA-12-0656-D23506	f87abf1c-5c6a-4a72-9cb9-71649f3cb786	2009-5-22	MU81C6	NA	TARGETED MOLECULAR THERAPY	22	FALSE	22	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	20	NA
630	a3cc2845-8a44-4b50-8a3e-17a3c2c3e077	TCGA.12.0662	TCGA-12-0662-D23512	e3b391ea-dfd9-4147-a7e5-eddea9a5ebb3	2009-4-24	CCNU	NA	CHEMOTHERAPY	120	NA	221	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	110	NA
631	a3cc2845-8a44-4b50-8a3e-17a3c2c3e077	TCGA.12.0662	TCGA-12-0662-D23518	871a9df8-31d3-4748-8798-a1f02b382ef7	2009-4-24	GLIADEL WAFERS	NA	CHEMOTHERAPY	876	NA	876	NA	NA	NA	NA	1	NA	WAFER	WAFER	NA	NA	INTRATUMORAL	NA	NA	PROGRESSION	NA	8	NA
632	a3cc2845-8a44-4b50-8a3e-17a3c2c3e077	TCGA.12.0662	TCGA-12-0662-D23521	f5193ae4-5e1e-4036-874d-cee249a468cc	2009-4-24	CYTOXAN	NA	CHEMOTHERAPY	1041	NA	1070	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	100	NA
633	a3cc2845-8a44-4b50-8a3e-17a3c2c3e077	TCGA.12.0662	TCGA-12-0662-D23516	c1bc7091-bb6a-4181-aee4-27e00e8e53e4	2009-4-24	TEMODAR	NA	CHEMOTHERAPY	600	NA	604	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	150	NA
634	a3cc2845-8a44-4b50-8a3e-17a3c2c3e077	TCGA.12.0662	TCGA-12-0662-D23519	257762ca-7c89-42d1-9e44-b9ba36e91db0	2009-4-24	CPT-11	NA	CHEMOTHERAPY	889	NA	1028	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	75	NA
635	a3cc2845-8a44-4b50-8a3e-17a3c2c3e077	TCGA.12.0662	TCGA-12-0662-D23513	cb38326f-fc0c-45e9-b73a-57de9eb4016f	2009-4-24	VP-16	NA	CHEMOTHERAPY	224	NA	278	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	100	NA
636	a3cc2845-8a44-4b50-8a3e-17a3c2c3e077	TCGA.12.0662	TCGA-12-0662-D23520	68e7e6e7-d891-4704-8a0a-ec8e89189ecf	2009-4-24	VP-16	NA	CHEMOTHERAPY	1041	NA	1070	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	50	NA
637	a3cc2845-8a44-4b50-8a3e-17a3c2c3e077	TCGA.12.0662	TCGA-12-0662-D23517	9f7794d8-104c-4f2b-99fe-6a25bb07bea4	2009-4-24	TEMODAR	NA	CHEMOTHERAPY	627	NA	844	NA	NA	NA	NA	7	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	200	NA
638	a3cc2845-8a44-4b50-8a3e-17a3c2c3e077	TCGA.12.0662	TCGA-12-0662-D23524	14710bfe-83dc-4d5d-9860-06177f6ea14b	2009-4-24	TAMOXIFEN	NA	HORMONE THERAPY	473	NA	600	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	200	NA
639	a3cc2845-8a44-4b50-8a3e-17a3c2c3e077	TCGA.12.0662	TCGA-12-0662-D23515	d03e8d69-2316-40f4-b379-195d32908f4d	2009-4-24	VP-16	NA	CHEMOTHERAPY	417	NA	473	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	100	NA
640	a3cc2845-8a44-4b50-8a3e-17a3c2c3e077	TCGA.12.0662	TCGA-12-0662-D23523	eb7a9fee-6e99-4f75-bd60-66ca3cef6afd	2009-4-24	TAMOXITEN	NA	HORMONE THERAPY	278	NA	334	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	100	NA
641	a3cc2845-8a44-4b50-8a3e-17a3c2c3e077	TCGA.12.0662	TCGA-12-0662-D23514	b1b1b418-dd4f-40fb-aea8-a74f0d5575a9	2009-4-24	CCNU	NA	CHEMOTHERAPY	340	NA	417	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	110	NA
642	a3cc2845-8a44-4b50-8a3e-17a3c2c3e077	TCGA.12.0662	TCGA-12-0662-D23522	fd54d4c9-418d-4fec-827d-70c2ae128d00	2009-5-5	TEMODAR	NA	CHEMOTHERAPY	1133	NA	1137	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	10	NA
643	a3cc2845-8a44-4b50-8a3e-17a3c2c3e077	TCGA.12.0662	TCGA-12-0662-D23527	5271192b-62f2-41ec-9e08-fc86db337767	2009-5-5	06GB	NA	TARGETED MOLECULAR THERAPY	1133	NA	1135	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	NA	NA	NA	PROGRESSION	NA	120	NA
644	a3cc2845-8a44-4b50-8a3e-17a3c2c3e077	TCGA.12.0662	TCGA-12-0662-D23528	0dacad5b-d120-432b-ac72-3c591e4db8cd	2009-5-5	06GB	NA	TARGETED MOLECULAR THERAPY	1133	NA	1135	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	NA	NA	NA	PROGRESSION	NA	30	NA
645	a3cc2845-8a44-4b50-8a3e-17a3c2c3e077	TCGA.12.0662	TCGA-12-0662-D23526	a31610b6-b05a-4332-96e0-e6a5d8cbde9e	2009-5-5	THALIDOMIDE	NA	IMMUNOTHERAPY	1073	NA	1090	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	400	NA
646	a3cc2845-8a44-4b50-8a3e-17a3c2c3e077	TCGA.12.0662	TCGA-12-0662-D23525	52230949-b4f3-4314-878c-6b19aa30ddc6	2009-5-5	CELBREX	NA	IMMUNOTHERAPY	1113	NA	1161	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	400	NA
647	f7dd387f-eca9-4028-b296-2ca6d56d3bde	TCGA.12.0670	TCGA-12-0670-D23542	0b141c45-2c41-4ab3-b4d0-988521ba741b	2009-5-28	TAMOXIFEN	NA	HORMONE THERAPY	578	FALSE	601	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
648	f7dd387f-eca9-4028-b296-2ca6d56d3bde	TCGA.12.0670	TCGA-12-0670-D23535	0be12284-5c9f-4fbc-a4bc-16a33097e010	2009-5-28	CPT-11	NA	CHEMOTHERAPY	329	FALSE	378	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	125	NA
649	f7dd387f-eca9-4028-b296-2ca6d56d3bde	TCGA.12.0670	TCGA-12-0670-D23551	b16b7010-4713-4627-988b-b02feb755a02	2009-5-28	MAB I131	NA	TARGETED MOLECULAR THERAPY	43	FALSE	77	NA	NA	NA	NA	NA	NA	MCI	MCI	NA	NA	NA	NA	NA	ADJUVANT	NA	80	NA
650	f7dd387f-eca9-4028-b296-2ca6d56d3bde	TCGA.12.0670	TCGA-12-0670-D23540	76777e34-20ed-4ffe-a982-21c7ba1c2983	2009-5-28	TAMOXIFEN	NA	HORMONE THERAPY	448	FALSE	516	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
651	f7dd387f-eca9-4028-b296-2ca6d56d3bde	TCGA.12.0670	TCGA-12-0670-D23543	f42edd3a-9f14-446d-b279-e671b2f7497c	2009-5-28	TAMOXIFEN	NA	HORMONE THERAPY	601	FALSE	722	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
652	f7dd387f-eca9-4028-b296-2ca6d56d3bde	TCGA.12.0670	TCGA-12-0670-D23534	17c7b5af-61d2-4836-b4db-24ff1f38887c	2009-5-28	CCNU	NA	CHEMOTHERAPY	211	FALSE	288	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	110	NA
653	f7dd387f-eca9-4028-b296-2ca6d56d3bde	TCGA.12.0670	TCGA-12-0670-D23537	16253cb7-0d72-41ce-b650-b17eb6a9572b	2009-5-28	TEMOZOLOMIDE	NA	CHEMOTHERAPY	448	FALSE	516	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
654	f7dd387f-eca9-4028-b296-2ca6d56d3bde	TCGA.12.0670	TCGA-12-0670-D23550	888dc526-60c7-44ce-9fe9-de5128a8f5a9	2009-5-28	CELEBREX	NA	IMMUNOTHERAPY	722	FALSE	770	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	125	NA
655	f7dd387f-eca9-4028-b296-2ca6d56d3bde	TCGA.12.0670	TCGA-12-0670-D23536	6b93f331-1d67-49d2-afbd-72b4fc799ea7	2009-5-28	CPT-11	NA	CHEMOTHERAPY	407	FALSE	448	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	125	NA
656	f7dd387f-eca9-4028-b296-2ca6d56d3bde	TCGA.12.0670	TCGA-12-0670-D23539	c0b23a46-8a32-4ed5-8084-97cf367fd931	2009-5-28	CCNU	NA	CHEMOTHERAPY	578	FALSE	601	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	110	NA
657	f7dd387f-eca9-4028-b296-2ca6d56d3bde	TCGA.12.0670	TCGA-12-0670-D23549	40c15b1f-c954-42f3-805a-f94d9fe2c89a	2009-5-28	CELEBREX	NA	IMMUNOTHERAPY	601	FALSE	722	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	125	NA
658	f7dd387f-eca9-4028-b296-2ca6d56d3bde	TCGA.12.0670	TCGA-12-0670-D23544	700ca24e-da97-4cff-b798-4d6f127be5e5	2009-5-28	CELEBREX	NA	IMMUNOTHERAPY	327	FALSE	378	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	125	NA
659	f7dd387f-eca9-4028-b296-2ca6d56d3bde	TCGA.12.0670	TCGA-12-0670-D23545	50f3f112-ee32-4917-a368-1f949d4b6e9e	2009-5-28	CELEBREX	NA	IMMUNOTHERAPY	407	FALSE	448	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	125	NA
660	f7dd387f-eca9-4028-b296-2ca6d56d3bde	TCGA.12.0670	TCGA-12-0670-D23533	e763e7d6-fc06-41d6-ad0c-e57ae828e655	2009-5-28	TEMOZOLOMIDE	NA	CHEMOTHERAPY	183	FALSE	203	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
661	f7dd387f-eca9-4028-b296-2ca6d56d3bde	TCGA.12.0670	TCGA-12-0670-D23541	bf50ef37-2a1f-4a63-9739-5972ca4ee607	2009-5-28	TAMOXIFEN	NA	HORMONE THERAPY	516	FALSE	576	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
662	f7dd387f-eca9-4028-b296-2ca6d56d3bde	TCGA.12.0670	TCGA-12-0670-D23547	b047e79b-8534-41db-a020-b40c3853e120	2009-5-28	CELEBREX	NA	IMMUNOTHERAPY	516	FALSE	576	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	125	NA
663	f7dd387f-eca9-4028-b296-2ca6d56d3bde	TCGA.12.0670	TCGA-12-0670-D23538	303fe799-e697-40f7-b703-1f9b585ed0c3	2009-5-28	CCNU	NA	CHEMOTHERAPY	516	FALSE	576	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	110	NA
664	f7dd387f-eca9-4028-b296-2ca6d56d3bde	TCGA.12.0670	TCGA-12-0670-D23548	67a7c6ef-2066-4046-a8de-bb8d1bbac08b	2009-5-28	CELEBREX	NA	IMMUNOTHERAPY	578	FALSE	601	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	125	NA
665	f7dd387f-eca9-4028-b296-2ca6d56d3bde	TCGA.12.0670	TCGA-12-0670-D23532	3ecc40a3-dd80-4ab9-b419-821926283eff	2009-5-28	TEMOZOLOMIDE	NA	CHEMOTHERAPY	148	FALSE	183	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	150	NA
666	f7dd387f-eca9-4028-b296-2ca6d56d3bde	TCGA.12.0670	TCGA-12-0670-D23546	add50244-52a7-4126-93be-f81ed9780855	2009-5-28	CELEBREX	NA	IMMUNOTHERAPY	448	FALSE	516	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	125	NA
667	f7dd387f-eca9-4028-b296-2ca6d56d3bde	TCGA.12.0670	TCGA-12-0670-D23552	c2e20295-9ec6-4eb7-86fa-3946cad99033	2009-5-28	CH81C6	NA	TARGETED MOLECULAR THERAPY	43	FALSE	77	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	10	NA
668	65a48904-9532-4dfb-8e84-4deef1881197	TCGA.12.0688	TCGA-12-0688-D23557	0b8b262d-97d9-48ef-8641-8a8d0fa9f879	2009-4-24	VP-16	NA	CHEMOTHERAPY	215	FALSE	238	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	37.5	NA
669	65a48904-9532-4dfb-8e84-4deef1881197	TCGA.12.0688	TCGA-12-0688-D23561	8f2a81d9-70cd-44b3-a6a3-b3279fe28479	2009-4-24	VP-16	NA	CHEMOTHERAPY	649	FALSE	734	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	25	NA
670	65a48904-9532-4dfb-8e84-4deef1881197	TCGA.12.0688	TCGA-12-0688-D23556	195131f2-6287-4e94-a9d5-15b42098f0c9	2009-4-24	CCNU	NA	CHEMOTHERAPY	96	FALSE	179	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	110	NA
671	65a48904-9532-4dfb-8e84-4deef1881197	TCGA.12.0688	TCGA-12-0688-D23559	df929dfb-37dc-4ebe-8de7-a6c46b193451	2009-4-24	TEMOZOLAMIDE	NA	CHEMOTHERAPY	501	FALSE	597	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	150	NA
672	65a48904-9532-4dfb-8e84-4deef1881197	TCGA.12.0688	TCGA-12-0688-D23560	6610f7fa-41f3-44ff-a542-5bcf8e07cb48	2009-4-24	CPT-11	NA	CHEMOTHERAPY	605	FALSE	649	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	340	NA
673	65a48904-9532-4dfb-8e84-4deef1881197	TCGA.12.0688	TCGA-12-0688-D23562	d5e63f56-a668-4356-a3e5-a903ec9a8991	2009-5-5	TAMOXITEN	NA	HORMONE THERAPY	238	NA	353	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	100	NA
674	65a48904-9532-4dfb-8e84-4deef1881197	TCGA.12.0688	TCGA-12-0688-D23558	4625b679-e4f3-4313-98b2-e27816b0edb2	2009-6-3	VP-16	NA	CHEMOTHERAPY	238	NA	353	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	25	NA
675	bb0aca6b-55ab-4b24-8e64-29e0c96a9862	TCGA.12.0691	TCGA-12-0691-D23567	df2315ba-0e8c-47e9-b7cb-34ac838284f8	2009-4-24	TEMODAR	NA	CHEMOTHERAPY	159	FALSE	186	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	200	NA
676	bb0aca6b-55ab-4b24-8e64-29e0c96a9862	TCGA.12.0691	TCGA-12-0691-D23566	044f3ea1-65ca-4e70-8437-b8c1fae4d6df	2009-4-24	TEMODAR	NA	CHEMOTHERAPY	117	FALSE	159	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	150	NA
677	24164e89-16ae-48c1-a464-9be94141deef	TCGA.12.0692	TCGA-12-0692-D23571	4d98309a-23d9-4329-8cce-8413e6bf2891	2009-4-24	TEMOZOLOMIDE	NA	CHEMOTHERAPY	14	FALSE	45	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
678	0a85c7b4-f07d-4727-b9d2-7b14c52edabb	TCGA.12.0703	TCGA-12-0703-D23577	25b7ffab-ad1d-471e-b1ff-50b595d8193d	2009-4-24	MAB I-131	NA	TARGETED MOLECULAR THERAPY	13	FALSE	125	NA	NA	NA	NA	NA	NA	MCI	MCI	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	120	NA
679	0a85c7b4-f07d-4727-b9d2-7b14c52edabb	TCGA.12.0703	TCGA-12-0703-D23574	7c82d2a2-ac10-4721-ac98-08890d7ea9a3	2009-4-24	CPT-11	NA	CHEMOTHERAPY	215	FALSE	302	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	125	NA
680	0a85c7b4-f07d-4727-b9d2-7b14c52edabb	TCGA.12.0703	TCGA-12-0703-D23575	48784185-2f6b-41c9-ba98-b83f32f514f9	2009-4-24	CARMUSTINE	NA	CHEMOTHERAPY	322	FALSE	530	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	100	NA
681	0a85c7b4-f07d-4727-b9d2-7b14c52edabb	TCGA.12.0703	TCGA-12-0703-D23578	ba795525-88e3-4ec2-9394-bed1bfbc9473	2009-5-22	MU81C6	NA	TARGETED MOLECULAR THERAPY	13	FALSE	125	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	20	NA
682	0a85c7b4-f07d-4727-b9d2-7b14c52edabb	TCGA.12.0703	TCGA-12-0703-D23576	feb32385-2310-4a50-909a-04ccef06b767	2009-5-29	TOPECAN	NA	CHEMOTHERAPY	322	FALSE	530	NA	NA	NA	NA	5	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	0.75	NA
683	29b34909-9cdc-4a52-b0ab-fa99f3ab17bb	TCGA.12.0769	TCGA-12-0769-D23585	41686142-04cb-4865-9d58-530f5f9eff58	2009-4-24	TEMODAR	NA	CHEMOTHERAPY	192	FALSE	250	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
684	29b34909-9cdc-4a52-b0ab-fa99f3ab17bb	TCGA.12.0769	TCGA-12-0769-D23586	109c7892-b2fe-4770-b50f-9e8b4b4cf8f4	2009-4-24	CPT-11	NA	CHEMOTHERAPY	250	FALSE	341	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
685	29b34909-9cdc-4a52-b0ab-fa99f3ab17bb	TCGA.12.0769	TCGA-12-0769-D23584	6679dd84-5607-487f-ae0a-0c665ae07410	2009-4-24	CCNU	NA	CHEMOTHERAPY	91	FALSE	192	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	110	NA
686	29b34909-9cdc-4a52-b0ab-fa99f3ab17bb	TCGA.12.0769	TCGA-12-0769-D23583	dd7b2860-6657-4d84-ae01-f3588a4401b1	2009-4-24	TEMODAR	NA	CHEMOTHERAPY	33	FALSE	78	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
687	3726b315-6cf8-49a3-a581-b7f3f4ca6e16	TCGA.12.0772	TCGA-12-0772-D23591	a03d8a5f-3e27-4178-aa87-07e1a9660b80	2009-4-24	VP-16	NA	CHEMOTHERAPY	120	FALSE	489	NA	NA	NA	NA	12	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	50	NA
688	3726b315-6cf8-49a3-a581-b7f3f4ca6e16	TCGA.12.0772	TCGA-12-0772-D23593	142445a2-9326-4d69-bad3-67ee59798549	2009-4-24	CPT-11	NA	CHEMOTHERAPY	670	FALSE	951	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	125	NA
689	3726b315-6cf8-49a3-a581-b7f3f4ca6e16	TCGA.12.0772	TCGA-12-0772-D23596	3a52a24f-1906-42ef-8eba-92485642f4f1	2009-4-24	CCNU	NA	CHEMOTHERAPY	1224	FALSE	1265	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	82.5	NA
690	3726b315-6cf8-49a3-a581-b7f3f4ca6e16	TCGA.12.0772	TCGA-12-0772-D23599	41a12774-46a3-4102-a590-2eeac0e3901c	2009-4-24	TARCEVA	NA	TARGETED MOLECULAR THERAPY	1468	FALSE	1526	NA	NA	NA	NA	NA	NA	MG/KG	MG/KG	NA	NA	NA	NA	NA	PROGRESSION	NA	150	NA
691	3726b315-6cf8-49a3-a581-b7f3f4ca6e16	TCGA.12.0772	TCGA-12-0772-D23598	90345bcd-6db0-47ff-8a77-3ff9c96848f2	2009-4-24	ARIAD AP23573	NA	TARGETED MOLECULAR THERAPY	621	FALSE	670	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	12.5	NA
692	3726b315-6cf8-49a3-a581-b7f3f4ca6e16	TCGA.12.0772	TCGA-12-0772-D23590	e4af3fcd-bdec-465e-b785-55454cb9802d	2009-4-24	TEMOZOLAMIDE	NA	CHEMOTHERAPY	79	FALSE	120	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	150	NA
693	3726b315-6cf8-49a3-a581-b7f3f4ca6e16	TCGA.12.0772	TCGA-12-0772-D23592	1b595aef-2206-402c-8bef-2d2d832e66c2	2009-4-24	CYTOXAN	NA	CHEMOTHERAPY	1307	NA	1468	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	100	NA
694	3726b315-6cf8-49a3-a581-b7f3f4ca6e16	TCGA.12.0772	TCGA-12-0772-D23594	3cd67800-1fdd-4e14-8776-235166a9aeac	2009-4-24	CCNU	NA	CHEMOTHERAPY	951	FALSE	1112	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	110	NA
695	3726b315-6cf8-49a3-a581-b7f3f4ca6e16	TCGA.12.0772	TCGA-12-0772-D23595	76fc75d9-64ad-407f-96d1-cd54754cf5c8	2009-4-24	TEMOZOLAMIDE	NA	CHEMOTHERAPY	1112	FALSE	1174	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	50	NA
696	3726b315-6cf8-49a3-a581-b7f3f4ca6e16	TCGA.12.0772	TCGA-12-0772-D23602	21d49897-504d-4fe4-9a5e-5c69f62a660e	2009-5-5	AVASTIN	NA	TARGETED MOLECULAR THERAPY	1529	NA	1616	NA	NA	NA	NA	NA	NA	MG/KG	MG/KG	NA	NA	NA	NA	NA	PROGRESSION	NA	10	NA
697	3726b315-6cf8-49a3-a581-b7f3f4ca6e16	TCGA.12.0772	TCGA-12-0772-D23600	8bd1d1f3-5138-4055-9f5a-a7e3b18800d0	2009-5-5	SIROLIMUS	NA	TARGETED MOLECULAR THERAPY	1468	NA	1526	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	10	NA
698	3726b315-6cf8-49a3-a581-b7f3f4ca6e16	TCGA.12.0772	TCGA-12-0772-D23601	4ef970fa-74c5-4d61-9b7e-247819f31bb7	2009-5-5	AVASTIN	NA	TARGETED MOLECULAR THERAPY	1468	NA	1526	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	10	NA
699	3726b315-6cf8-49a3-a581-b7f3f4ca6e16	TCGA.12.0772	TCGA-12-0772-D23603	066136db-6169-4752-9dfd-704854b71831	2009-5-5	AVASTIN	NA	TARGETED MOLECULAR THERAPY	1307	NA	1468	NA	NA	NA	NA	NA	NA	MG/KG	MG/KG	NA	NA	NA	NA	NA	PROGRESSION	NA	10	NA
700	3726b315-6cf8-49a3-a581-b7f3f4ca6e16	TCGA.12.0772	TCGA-12-0772-D23597	151d0ced-5d38-43ca-8460-434bfbc802db	2009-6-3	VP-16	NA	CHEMOTHERAPY	1529	NA	1616	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	50	NA
701	df4168bd-9f94-4323-9c33-a446a9fae999	TCGA.12.0773	TCGA-12-0773-D23609	b6ecaadf-5096-423c-b6be-dfe5b3dc2575	2009-4-24	TEMOZOLAMIDE	NA	CHEMOTHERAPY	150	FALSE	245	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	150	NA
702	df4168bd-9f94-4323-9c33-a446a9fae999	TCGA.12.0773	TCGA-12-0773-D23610	113be0a1-223a-4ec4-97de-0d2f6ac75096	2009-4-24	CCNU	NA	CHEMOTHERAPY	235	FALSE	326	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	82.5	NA
703	df4168bd-9f94-4323-9c33-a446a9fae999	TCGA.12.0773	TCGA-12-0773-D23615	da4b3eff-572c-4631-abfd-f98c5d123191	2009-4-24	CCNU	NA	CHEMOTHERAPY	892	FALSE	1015	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	82.5	NA
704	df4168bd-9f94-4323-9c33-a446a9fae999	TCGA.12.0773	TCGA-12-0773-D23616	aae4428e-ea47-411c-a566-91a65e9a9d0f	2009-4-24	VP-16	NA	CHEMOTHERAPY	1015	FALSE	1036	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	37.5	NA
705	df4168bd-9f94-4323-9c33-a446a9fae999	TCGA.12.0773	TCGA-12-0773-D23619	f0d1c15e-3465-493b-98eb-bc2c0bb7f24a	2009-4-24	TAMOXIFEN	NA	HORMONE THERAPY	607	FALSE	725	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	100	NA
706	df4168bd-9f94-4323-9c33-a446a9fae999	TCGA.12.0773	TCGA-12-0773-D23617	c7546cc0-9899-4870-8162-553da8f6a29c	2009-4-24	TEMOZOLOMIDE	NA	CHEMOTHERAPY	1062	FALSE	1141	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	50	NA
707	df4168bd-9f94-4323-9c33-a446a9fae999	TCGA.12.0773	TCGA-12-0773-D23618	9adb7cd6-6395-4579-9dde-6f07da7a64bc	2009-4-24	TEMOZOLAMIDE	NA	CHEMOTHERAPY	1274	FALSE	1311	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	50	NA
708	df4168bd-9f94-4323-9c33-a446a9fae999	TCGA.12.0773	TCGA-12-0773-D23608	d6d34fd3-faa6-439c-a13c-aa70b69ec164	2009-4-24	TEMOZOLOMIDE	NA	CHEMOTHERAPY	1141	NA	1274	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	50	NA
709	df4168bd-9f94-4323-9c33-a446a9fae999	TCGA.12.0773	TCGA-12-0773-D23614	80b126c4-7359-4f31-967a-f2b401df350b	2009-4-24	TEMOZOLAMIDE	NA	CHEMOTHERAPY	773	FALSE	875	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	150	NA
710	df4168bd-9f94-4323-9c33-a446a9fae999	TCGA.12.0773	TCGA-12-0773-D23612	88e217c3-ac45-4349-85ae-e21b06c1ce8f	2009-4-24	TEMOZOLAMIDE	NA	CHEMOTHERAPY	431	FALSE	516	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	150	NA
711	df4168bd-9f94-4323-9c33-a446a9fae999	TCGA.12.0773	TCGA-12-0773-D23613	e73c6da5-447d-4846-8e27-dfd98cfc04b4	2009-4-24	CCNU	NA	CHEMOTHERAPY	516	FALSE	607	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	82.5	NA
712	df4168bd-9f94-4323-9c33-a446a9fae999	TCGA.12.0773	TCGA-12-0773-D23620	330a4cb7-3260-4524-b4fd-600d0dae7c77	2009-4-24	MAB I-131	NA	TARGETED MOLECULAR THERAPY	55	FALSE	56	NA	NA	NA	NA	NA	NA	MCI	MCI	NA	NA	NA	NA	NA	ADJUVANT	NA	61	NA
713	df4168bd-9f94-4323-9c33-a446a9fae999	TCGA.12.0773	TCGA-12-0773-D23611	1756b142-0b65-4176-b305-738b4b6f039f	2009-4-24	CPT-11	NA	CHEMOTHERAPY	326	FALSE	431	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	125	NA
714	df4168bd-9f94-4323-9c33-a446a9fae999	TCGA.12.0773	TCGA-12-0773-D23621	4d17ddf6-8f1e-4156-b5c1-0dbbe03db479	2009-5-5	MU81C6	NA	TARGETED MOLECULAR THERAPY	55	NA	56	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	10	NA
715	df4168bd-9f94-4323-9c33-a446a9fae999	TCGA.12.0773	TCGA-12-0773-D23622	a67dbdd4-6a9b-448f-98ff-95fe5784291b	2009-5-5	AVASTIN	NA	TARGETED MOLECULAR THERAPY	1141	NA	1274	NA	NA	NA	NA	NA	NA	MG/KG	MG/KG	NA	NA	NA	NA	NA	PROGRESSION	NA	10	NA
716	df4168bd-9f94-4323-9c33-a446a9fae999	TCGA.12.0773	TCGA-12-0773-D23623	76066f9e-2cbd-433b-8e83-07dd811edc04	2009-5-22	MU81C6	NA	TARGETED MOLECULAR THERAPY	55	FALSE	56	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	10	NA
717	7751fc13-ec33-4057-965d-3b2ac6183344	TCGA.12.0775	TCGA-12-0775-D23627	ea674d8e-6e27-4789-b18f-6210ed736112	2009-4-24	TEMODAR	NA	CHEMOTHERAPY	37	NA	94	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	160	NA
718	7751fc13-ec33-4057-965d-3b2ac6183344	TCGA.12.0775	TCGA-12-0775-D23628	a3803fc0-a831-4930-a510-e8708fd47693	2009-4-24	CCNU	NA	CHEMOTHERAPY	117	NA	158	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	90	NA
719	c1a00516-091c-480b-991e-7db4e0a30aea	TCGA.12.0776	TCGA-12-0776-D23632	0ce8bde3-9f50-4dd3-85d6-d203e872ed72	2009-4-24	TEMODAR	NA	CHEMOTHERAPY	33	FALSE	74	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	75	NA
720	c1a00516-091c-480b-991e-7db4e0a30aea	TCGA.12.0776	TCGA-12-0776-D23633	c94c63f6-a260-4a4f-bd4c-9e873f09edab	2009-4-24	CCNU	NA	CHEMOTHERAPY	82	FALSE	127	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	110	NA
721	c1a00516-091c-480b-991e-7db4e0a30aea	TCGA.12.0776	TCGA-12-0776-D23634	25631faf-847b-4a1b-8796-5a1f4c466aff	2009-5-6	CPT-11	NA	CHEMOTHERAPY	140	NA	275	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	340	NA
722	c1a00516-091c-480b-991e-7db4e0a30aea	TCGA.12.0776	TCGA-12-0776-D23635	d62458b0-db6b-4d41-9e96-9635f8778795	2009-5-6	AVASTIN	NA	TARGETED MOLECULAR THERAPY	140	FALSE	275	NA	NA	NA	NA	NA	NA	MG/KG	MG/KG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	10	NA
723	db5ea0e6-4cac-4f18-8643-32afb1e0287d	TCGA.12.0778	TCGA-12-0778-D23640	b59567e1-635e-44e5-a5ce-1c2cc389129d	2009-4-24	TEMOZOLAMIDE	NA	CHEMOTHERAPY	89	FALSE	147	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
724	db5ea0e6-4cac-4f18-8643-32afb1e0287d	TCGA.12.0778	TCGA-12-0778-D23639	8909339d-9203-4057-b833-56e2463f29b2	2009-4-24	TEMOZOLAMIDE	NA	CHEMOTHERAPY	22	FALSE	68	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	75	NA
725	db5ea0e6-4cac-4f18-8643-32afb1e0287d	TCGA.12.0778	TCGA-12-0778-D23641	cac6d807-76ec-4b36-a18b-87b73d783a9f	2009-4-24	CCNU	NA	CHEMOTHERAPY	147	FALSE	232	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	110	NA
726	db5ea0e6-4cac-4f18-8643-32afb1e0287d	TCGA.12.0778	TCGA-12-0778-D23645	997e0460-09cb-4eec-98aa-ae4e89c2e57f	2009-4-24	AVASTIN	NA	TARGETED MOLECULAR THERAPY	250	FALSE	329	NA	NA	NA	NA	NA	NA	MG/KG	MG/KG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	10	NA
727	db5ea0e6-4cac-4f18-8643-32afb1e0287d	TCGA.12.0778	TCGA-12-0778-D23643	359761a4-c0af-4ae6-b499-4b938fb79524	2009-5-6	VP-16	NA	CHEMOTHERAPY	329	NA	352	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	50	NA
728	db5ea0e6-4cac-4f18-8643-32afb1e0287d	TCGA.12.0778	TCGA-12-0778-D23647	2c2bb568-9204-41c7-b8c0-e5c31aabf372	2009-5-6	RAPAMYCIN	NA	TARGETED MOLECULAR THERAPY	355	FALSE	385	NA	NA	NA	NA	NA	NA	MG/DAY	MG/DAY	NA	NA	ORAL	NA	NA	PROGRESSION	NA	15	NA
729	db5ea0e6-4cac-4f18-8643-32afb1e0287d	TCGA.12.0778	TCGA-12-0778-D23644	10c06be0-16ad-4c12-b8da-71413fbfd57f	2009-5-6	VP-16	NA	CHEMOTHERAPY	250	FALSE	329	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	50	NA
730	db5ea0e6-4cac-4f18-8643-32afb1e0287d	TCGA.12.0778	TCGA-12-0778-D23648	0009ef9d-35eb-47eb-9a30-859b6b5087c7	2009-5-6	RAPAMCYIN	NA	TARGETED MOLECULAR THERAPY	355	FALSE	385	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	150	NA
731	db5ea0e6-4cac-4f18-8643-32afb1e0287d	TCGA.12.0778	TCGA-12-0778-D23646	bdff6ebe-49de-4842-b983-8beacc2d77da	2009-5-6	TARCEVA	NA	TARGETED MOLECULAR THERAPY	355	NA	385	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	200	NA
732	db5ea0e6-4cac-4f18-8643-32afb1e0287d	TCGA.12.0778	TCGA-12-0778-D23642	02edb427-90d0-4845-b101-1f59c526e166	2009-5-6	TEMOZOLOMIDE	NA	CHEMOTHERAPY	329	FALSE	352	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	50	NA
733	120e257d-1cf1-421f-9a6b-6a5681eaea2e	TCGA.12.0780	TCGA-12-0780-D23657	b7217e75-dff4-41ce-9388-aca0d8746370	2009-4-24	VP-16	NA	CHEMOTHERAPY	360	FALSE	388	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	37.5	NA
734	120e257d-1cf1-421f-9a6b-6a5681eaea2e	TCGA.12.0780	TCGA-12-0780-D23655	76a461e4-83a9-4e2d-a36c-827495312e88	2009-4-24	TEMODAR	NA	CHEMOTHERAPY	21	FALSE	77	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	75	NA
735	120e257d-1cf1-421f-9a6b-6a5681eaea2e	TCGA.12.0780	TCGA-12-0780-D23658	2c4203c3-7505-459e-a4a8-bf4380227b26	2009-4-24	AVASTIN	NA	TARGETED MOLECULAR THERAPY	111	FALSE	350	NA	NA	NA	NA	NA	NA	MG/KG	MG/KG	NA	NA	NA	NA	NA	ADJUVANT	NA	10	NA
736	120e257d-1cf1-421f-9a6b-6a5681eaea2e	TCGA.12.0780	TCGA-12-0780-D23656	1957888f-00e4-4264-a01a-d940735f9eac	2009-4-24	CPT-11	NA	CHEMOTHERAPY	101	FALSE	350	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	125	NA
737	120e257d-1cf1-421f-9a6b-6a5681eaea2e	TCGA.12.0780	TCGA-12-0780-D23659	34293ddf-4475-4fa6-ba77-24263cd27469	2009-4-24	AVASTIN	NA	TARGETED MOLECULAR THERAPY	360	FALSE	388	NA	NA	NA	NA	NA	NA	MG/KG	MG/KG	NA	NA	NA	NA	NA	PROGRESSION	NA	10	NA
738	120e257d-1cf1-421f-9a6b-6a5681eaea2e	TCGA.12.0780	TCGA-12-0780-D23660	a9b346ef-bf06-441d-ae30-24bdd0cff6a2	2009-4-24	TARCEVA	NA	TARGETED MOLECULAR THERAPY	393	FALSE	434	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	5	NA
739	120e257d-1cf1-421f-9a6b-6a5681eaea2e	TCGA.12.0780	TCGA-12-0780-D23661	6190c533-8e4d-42e7-809d-d1c5b80609ff	2009-5-7	RAPAMYCIN	NA	TARGETED MOLECULAR THERAPY	393	NA	434	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	150	NA
740	e57b296a-80e9-4446-a3d1-3dbfeaf04f5e	TCGA.12.0818	TCGA-12-0818-D23668	34ce8de9-761e-4f10-b875-14d8e99974a9	2009-5-27	CCNU	NA	CHEMOTHERAPY	255	FALSE	296	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	110	NA
741	e57b296a-80e9-4446-a3d1-3dbfeaf04f5e	TCGA.12.0818	TCGA-12-0818-D23670	cab47c3a-f5b7-4da5-8ad3-95930211ed8c	2009-5-27	81C6	NA	TARGETED MOLECULAR THERAPY	26	FALSE	47	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	OTHER	NA	NA	ADJUVANT	NA	10	NA
742	e57b296a-80e9-4446-a3d1-3dbfeaf04f5e	TCGA.12.0818	TCGA-12-0818-D23669	8b17871f-303d-475d-aa31-ef735bcea01f	2009-5-27	MAB I-131	NA	TARGETED MOLECULAR THERAPY	26	FALSE	47	NA	NA	NA	NA	NA	NA	MCI	MCI	NA	NA	OTHER	NA	NA	ADJUVANT	NA	80	NA
743	e57b296a-80e9-4446-a3d1-3dbfeaf04f5e	TCGA.12.0818	TCGA-12-0818-D23666	3d9008a7-a174-4c12-b4dd-537b5454fb34	2009-5-27	CCNU	NA	CHEMOTHERAPY	136	FALSE	1643	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	110	NA
744	e57b296a-80e9-4446-a3d1-3dbfeaf04f5e	TCGA.12.0818	TCGA-12-0818-D23667	543cdb8a-55c5-4f56-8986-bc768644e0d2	2009-5-27	VP-16	NA	CHEMOTHERAPY	213	FALSE	255	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	50	NA
745	e57b296a-80e9-4446-a3d1-3dbfeaf04f5e	TCGA.12.0818	TCGA-12-0818-D23665	9443964e-7e47-4c82-8cc2-59ce383808f5	2009-5-27	VP-16	NA	CHEMOTHERAPY	75	FALSE	136	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	50	NA
746	025a7401-a65d-4ea0-8b4e-0ba775b0322a	TCGA.12.0819	TCGA-12-0819-D23674	bdd652c9-bc76-4ad7-8a7e-244a71d074e8	2009-5-27	BCNU	NA	CHEMOTHERAPY	258	FALSE	376	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
747	025a7401-a65d-4ea0-8b4e-0ba775b0322a	TCGA.12.0819	TCGA-12-0819-D23675	29885380-c8eb-4a19-86d4-fcff0f0b21f1	2009-5-27	BCNU	NA	CHEMOTHERAPY	376	FALSE	442	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	150	NA
748	025a7401-a65d-4ea0-8b4e-0ba775b0322a	TCGA.12.0819	TCGA-12-0819-D23678	e4d5c46c-3dac-42ba-b168-286ff5fac37d	2009-5-27	CARBOPLATIN	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	600	NA
749	025a7401-a65d-4ea0-8b4e-0ba775b0322a	TCGA.12.0819	TCGA-12-0819-D23676	54e4593b-c1a9-4a70-ba5c-adfb5386b634	2009-5-27	TOPOTECAN	NA	CHEMOTHERAPY	442	FALSE	495	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	2.6	NA
750	025a7401-a65d-4ea0-8b4e-0ba775b0322a	TCGA.12.0819	TCGA-12-0819-D23680	45d04e69-c27a-4ce5-9f13-7b70ecc03e77	2009-5-27	MU81C6	NA	TARGETED MOLECULAR THERAPY	6	FALSE	180	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	OTHER	NA	NA	ADJUVANT	NA	9.9	NA
751	025a7401-a65d-4ea0-8b4e-0ba775b0322a	TCGA.12.0819	TCGA-12-0819-D23679	c6a1bb0d-2b82-4628-824f-cfd12c7cd147	2009-5-27	MAB I 131	NA	TARGETED MOLECULAR THERAPY	6	FALSE	180	NA	NA	NA	NA	NA	NA	MCI	MCI	NA	NA	OTHER	NA	NA	ADJUVANT	NA	60	NA
752	025a7401-a65d-4ea0-8b4e-0ba775b0322a	TCGA.12.0819	TCGA-12-0819-D23677	704cbe44-37c7-47a4-bd63-7c668c223115	2009-5-27	PROCARBAZINE	NA	CHEMOTHERAPY	505	FALSE	624	NA	NA	NA	NA	4	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	150	NA
753	ca261ec9-888b-47c8-8e71-5a22545d7161	TCGA.12.0820	TCGA-12-0820-D23686	fd4e096c-b26f-4f4e-94a9-6bf4b5979475	2009-5-27	CPT-11	NA	CHEMOTHERAPY	342	FALSE	363	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	300	NA
754	ca261ec9-888b-47c8-8e71-5a22545d7161	TCGA.12.0820	TCGA-12-0820-D23687	558f8409-9d46-401f-824b-e698e4f6bc32	2009-5-27	CPT-11	NA	CHEMOTHERAPY	363	FALSE	433	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	350	NA
755	ca261ec9-888b-47c8-8e71-5a22545d7161	TCGA.12.0820	TCGA-12-0820-D23684	0fc6b3e2-e7e7-42a5-ad49-0d4a6f55f7dd	2009-5-27	TEMOZOLOMIDE	NA	CHEMOTHERAPY	216	FALSE	272	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	150	NA
756	ca261ec9-888b-47c8-8e71-5a22545d7161	TCGA.12.0820	TCGA-12-0820-D23688	19c83926-bc09-4deb-911f-298d25ee5d54	2009-5-27	CPT-11	NA	CHEMOTHERAPY	433	FALSE	502	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	400	NA
757	ca261ec9-888b-47c8-8e71-5a22545d7161	TCGA.12.0820	TCGA-12-0820-D23691	66cb366f-3b2a-41dd-9831-7f730ca79ab2	2009-5-27	06-BG	NA	TARGETED MOLECULAR THERAPY	-1	FALSE	0	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	100	NA
758	ca261ec9-888b-47c8-8e71-5a22545d7161	TCGA.12.0820	TCGA-12-0820-D23685	1e9464fa-2d93-4c9c-a8df-2a086a85abe1	2009-5-27	BCNU	NA	CHEMOTHERAPY	300	FALSE	341	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	13.5	NA
759	ca261ec9-888b-47c8-8e71-5a22545d7161	TCGA.12.0820	TCGA-12-0820-D23689	367647ec-d0e6-43b8-ae89-bc95036a6d98	2009-5-27	VP-16	NA	CHEMOTHERAPY	502	FALSE	543	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	62.5	NA
760	ca261ec9-888b-47c8-8e71-5a22545d7161	TCGA.12.0820	TCGA-12-0820-D23690	eb3a5380-889c-40e7-aa95-b19baef831d3	2009-5-27	TAMOXIFEN	NA	HORMONE THERAPY	502	FALSE	543	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	200	NA
761	ca261ec9-888b-47c8-8e71-5a22545d7161	TCGA.12.0820	TCGA-12-0820-D23692	d4c3b301-b7b2-43ff-8d3a-17ab21661215	2009-5-27	06-BG	NA	TARGETED MOLECULAR THERAPY	300	FALSE	341	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	NA	NA	NA	PROGRESSION	NA	100	NA
762	eae44c1c-1628-4b58-8b90-d3372e3577d5	TCGA.12.0821	TCGA-12-0821-D23697	8b81f1e8-172c-45b7-a13a-8ebc5dd5f81b	2009-5-27	VP-16	NA	CHEMOTHERAPY	203	FALSE	259	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	50	NA
763	eae44c1c-1628-4b58-8b90-d3372e3577d5	TCGA.12.0821	TCGA-12-0821-D23696	d320a047-c4b2-458c-b237-a6d4a7a340ef	2009-5-27	CCNU	NA	CHEMOTHERAPY	123	FALSE	165	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	110	NA
764	eae44c1c-1628-4b58-8b90-d3372e3577d5	TCGA.12.0821	TCGA-12-0821-D23698	507be99d-ad0d-4409-af76-eaf477856d45	2009-5-27	CPT-11	NA	CHEMOTHERAPY	271	FALSE	296	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	190	NA
765	151ca826-a4d7-42eb-8684-f9fe7b93543f	TCGA.12.0822	TCGA-12-0822-D23707	a919cddf-9cd4-4d04-9250-d98a16226e85	2009-5-27	O6BG	NA	TARGETED MOLECULAR THERAPY	190	FALSE	281	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	40	NA
766	151ca826-a4d7-42eb-8684-f9fe7b93543f	TCGA.12.0822	TCGA-12-0822-D23704	5dc0efa8-953b-49c8-b102-8e85a74404d7	2009-5-27	BCNU	NA	CHEMOTHERAPY	190	FALSE	281	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	100	NA
767	151ca826-a4d7-42eb-8684-f9fe7b93543f	TCGA.12.0822	TCGA-12-0822-D23705	abbcda60-5abc-4783-a6e9-0ae0647e9926	2009-5-27	TEMOZOLOMIDE	NA	CHEMOTHERAPY	281	FALSE	583	NA	NA	NA	NA	10	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	200	NA
768	151ca826-a4d7-42eb-8684-f9fe7b93543f	TCGA.12.0822	TCGA-12-0822-D23702	ad25ce92-ecd9-4edf-9a98-2d831b79a7be	2009-5-27	CPT-11	NA	CHEMOTHERAPY	126	FALSE	175	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	150	NA
769	151ca826-a4d7-42eb-8684-f9fe7b93543f	TCGA.12.0822	TCGA-12-0822-D23709	2c3fb682-b1ff-4ced-b01e-556d2ec3ed40	2009-5-27	SCH6636	NA	TARGETED MOLECULAR THERAPY	625	FALSE	652	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	300	NA
770	151ca826-a4d7-42eb-8684-f9fe7b93543f	TCGA.12.0822	TCGA-12-0822-D23703	1b0c3999-4a59-4fd3-b348-58c233239c8f	2009-5-27	BCNU	NA	CHEMOTHERAPY	126	FALSE	175	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	40	NA
771	151ca826-a4d7-42eb-8684-f9fe7b93543f	TCGA.12.0822	TCGA-12-0822-D23708	e24f8fbb-51cf-40cc-aa44-adf6b3f9a70f	2009-5-27	SCH66336	NA	TARGETED MOLECULAR THERAPY	625	FALSE	625	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	150	NA
772	151ca826-a4d7-42eb-8684-f9fe7b93543f	TCGA.12.0822	TCGA-12-0822-D23706	fa7e1b79-40be-40dd-b87c-587fef6b80b3	2009-5-27	VP-16	NA	CHEMOTHERAPY	588	FALSE	624	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	50	NA
773	b75845ed-a19a-4caa-b362-e62b1e538152	TCGA.12.0827	TCGA-12-0827-D23715	11b7e332-e568-4ec4-b0e5-a13a16dafd6d	2009-5-27	CCNU	NA	CHEMOTHERAPY	137	FALSE	181	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	110	NA
774	b75845ed-a19a-4caa-b362-e62b1e538152	TCGA.12.0827	TCGA-12-0827-D23716	c80a6406-d9c3-403d-baac-8611c098f830	2009-5-27	CCNU	NA	CHEMOTHERAPY	181	FALSE	258	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	82.5	NA
775	b75845ed-a19a-4caa-b362-e62b1e538152	TCGA.12.0827	TCGA-12-0827-D23719	2bf02d6c-6b80-4a79-891d-a9a77a6e75f0	2009-5-27	CPT-11	NA	CHEMOTHERAPY	390	FALSE	434	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	410	NA
776	b75845ed-a19a-4caa-b362-e62b1e538152	TCGA.12.0827	TCGA-12-0827-D23721	d5057fae-9fdd-4f4e-91a5-33c225666d64	2009-5-27	TAMOXIFEN	NA	HORMONE THERAPY	615	FALSE	746	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	160	NA
777	b75845ed-a19a-4caa-b362-e62b1e538152	TCGA.12.0827	TCGA-12-0827-D23717	de863c10-3632-407e-8b88-8cce9a41b3d1	2009-5-27	TEMOZOLOMIDE	NA	CHEMOTHERAPY	258	FALSE	350	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	150	NA
778	b75845ed-a19a-4caa-b362-e62b1e538152	TCGA.12.0827	TCGA-12-0827-D23718	08005bb6-0486-4067-89da-81958cad3071	2009-5-27	TEMOZOLOMIDE	NA	CHEMOTHERAPY	350	FALSE	390	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
779	b75845ed-a19a-4caa-b362-e62b1e538152	TCGA.12.0827	TCGA-12-0827-D23722	eb968fc1-4f4f-4429-8c4f-cac388b1b48e	2009-5-27	MABI131	NA	TARGETED MOLECULAR THERAPY	34	FALSE	76	NA	NA	NA	NA	NA	NA	MCI	MCI	NA	NA	NA	NA	NA	ADJUVANT	NA	120	NA
780	b75845ed-a19a-4caa-b362-e62b1e538152	TCGA.12.0827	TCGA-12-0827-D23723	926845c9-026a-497a-a4d4-2a0111b6575d	2009-5-27	81C6	NA	TARGETED MOLECULAR THERAPY	34	FALSE	76	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	20	NA
781	b75845ed-a19a-4caa-b362-e62b1e538152	TCGA.12.0827	TCGA-12-0827-D23720	bdba77a2-bcee-4ce0-b6e3-b4610745bee2	2009-5-27	TEMOZOLOMIDE	NA	CHEMOTHERAPY	466	FALSE	615	NA	NA	NA	NA	4	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
782	dae7e5c3-0b17-419c-a5fc-3bb271222bce	TCGA.12.0828	TCGA-12-0828-D23727	34fad037-d0dd-48bf-b3ca-88f0fc65ad31	2009-5-27	TEMOZOLOMIDE	NA	CHEMOTHERAPY	28	FALSE	152	NA	NA	NA	NA	4	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
783	97094aed-69f7-4f4e-a87e-533979e11514	TCGA.12.0829	TCGA-12-0829-D23734	e0293e31-728f-44e8-9e90-d9fce0a48b5c	2009-5-27	CPT-11	NA	CHEMOTHERAPY	572	FALSE	599	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	125	NA
784	97094aed-69f7-4f4e-a87e-533979e11514	TCGA.12.0829	TCGA-12-0829-D23735	8ceafbdf-414e-4371-bfec-0e5a76465c86	2009-5-27	ATTAC	NA	IMMUNOTHERAPY	115	FALSE	473	NA	NA	NA	NA	NA	NA	ML	ML	NA	NA	NA	NA	NA	ADJUVANT	NA	1	NA
785	97094aed-69f7-4f4e-a87e-533979e11514	TCGA.12.0829	TCGA-12-0829-D23733	6e1438c2-c63c-49f1-ae32-e8894834e8ae	2009-5-27	TEMADOR	NA	CHEMOTHERAPY	474	FALSE	571	NA	NA	NA	NA	4	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	50	NA
786	97094aed-69f7-4f4e-a87e-533979e11514	TCGA.12.0829	TCGA-12-0829-D23736	2e065829-7994-4567-bae2-cbb475683f43	2009-5-27	AVASTIN	NA	TARGETED MOLECULAR THERAPY	474	FALSE	571	NA	NA	NA	NA	NA	NA	MG/KG	MG/KG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	10	NA
787	97094aed-69f7-4f4e-a87e-533979e11514	TCGA.12.0829	TCGA-12-0829-D23732	54c39217-8670-4616-b98a-1424b27379fd	2009-5-27	TEMADOR	NA	CHEMOTHERAPY	95	FALSE	473	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
788	97094aed-69f7-4f4e-a87e-533979e11514	TCGA.12.0829	TCGA-12-0829-D23737	bf59108d-03ca-46e3-b3a2-8b1abdbe5cac	2009-5-27	AVASTIN	NA	TARGETED MOLECULAR THERAPY	572	FALSE	599	NA	NA	NA	NA	NA	NA	MG/KG	MG/KG	NA	NA	NA	NA	NA	PROGRESSION	NA	10	NA
789	97094aed-69f7-4f4e-a87e-533979e11514	TCGA.12.0829	TCGA-12-0829-D23731	64195d91-1112-4ac0-80e0-1d271fb00408	2009-5-27	TEMADOR	NA	CHEMOTHERAPY	16	FALSE	64	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	75	NA
790	ac72738c-8b33-4f03-917c-86b114a2b9bd	TCGA.12.1088	TCGA-12-1088-D23359	36795c4e-ec0a-4ca9-bbf8-ae00614d788c	2009-7-6	CCNU	NA	CHEMOTHERAPY	3779	FALSE	3821	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	82.5	NA
791	ac72738c-8b33-4f03-917c-86b114a2b9bd	TCGA.12.1088	TCGA-12-1088-D23360	029857ca-5177-49ad-90a4-83c14d8c40b8	2009-7-6	CCNU	NA	CHEMOTHERAPY	3735	FALSE	3779	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	110	NA
792	4f50397e-c4bd-4408-b6e9-776b8a14c8a9	TCGA.12.1089	TCGA-12-1089-D23364	4f487e7e-6258-42d7-ae80-afa9ee0c0faa	2009-7-2	CCNU	NA	CHEMOTHERAPY	105	FALSE	147	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	110	NA
793	aef8439b-2797-4c3a-b822-fcf640d200f6	TCGA.12.1090	TCGA-12-1090-D23368	3947e17f-e6f4-465d-9c1a-7974f42740bb	2009-3-17	GLIADEL WATERS	NA	CHEMOTHERAPY	46	NA	46	NA	NA	NA	NA	1	NA	WAFER	WAFER	NA	NA	INTRATUMORAL	NA	NA	ADJUVANT	NA	8	NA
794	aef8439b-2797-4c3a-b822-fcf640d200f6	TCGA.12.1090	TCGA-12-1090-D23370	d21ccf58-f63c-4d00-9f29-1f59bfba146a	2009-3-17	CYCLOPHOSPHAMIDE	NA	CHEMOTHERAPY	126	NA	191	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	100	NA
795	aef8439b-2797-4c3a-b822-fcf640d200f6	TCGA.12.1090	TCGA-12-1090-D23369	035f7a27-682b-4d08-8515-99906bd52613	2009-3-17	THALIDOMIDE	NA	CHEMOTHERAPY	126	NA	191	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	800	NA
796	f8a5b835-b00b-421e-bdf5-9adb4ee84730	TCGA.12.1091	TCGA-12-1091-D23381	be2edadc-356c-46e3-b333-7d026586b8d7	2009-3-17	TEMODOR	NA	CHEMOTHERAPY	484	NA	521	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	125	NA
797	f8a5b835-b00b-421e-bdf5-9adb4ee84730	TCGA.12.1091	TCGA-12-1091-D23387	cdd65a8a-02f9-42e9-b4bb-8a049b143d19	2009-3-17	TAMOXITEN	NA	HORMONE THERAPY	521	NA	691	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	120	NA
798	f8a5b835-b00b-421e-bdf5-9adb4ee84730	TCGA.12.1091	TCGA-12-1091-D23378	79673b73-4bc0-4b93-bc04-329081111a8d	2009-3-17	TEMODOR	NA	CHEMOTHERAPY	331	NA	358	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	200	NA
799	f8a5b835-b00b-421e-bdf5-9adb4ee84730	TCGA.12.1091	TCGA-12-1091-D23384	fa382069-ca6a-4ad1-937b-337899863271	2009-3-17	TAMOXIFEN	NA	HORMONE THERAPY	358	NA	453	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	160	NA
800	f8a5b835-b00b-421e-bdf5-9adb4ee84730	TCGA.12.1091	TCGA-12-1091-D23380	29a49a4d-032a-490f-9c7c-3806e571df6e	2009-3-17	TEMODOR	NA	CHEMOTHERAPY	453	NA	484	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	150	NA
801	f8a5b835-b00b-421e-bdf5-9adb4ee84730	TCGA.12.1091	TCGA-12-1091-D23382	d963963e-b3f9-420a-a5de-ba86781369b8	2009-3-17	TEMODOR	NA	CHEMOTHERAPY	521	NA	691	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	300	NA
802	f8a5b835-b00b-421e-bdf5-9adb4ee84730	TCGA.12.1091	TCGA-12-1091-D23383	1c92d56a-1304-4147-aeef-f52c50e42f57	2009-3-17	VP-16	NA	CHEMOTHERAPY	819	NA	926	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	100	NA
803	f8a5b835-b00b-421e-bdf5-9adb4ee84730	TCGA.12.1091	TCGA-12-1091-D23374	e59d232d-a49e-48fb-9046-ee901d951cba	2009-3-17	TEMODOR	NA	CHEMOTHERAPY	143	NA	169	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	200	NA
804	f8a5b835-b00b-421e-bdf5-9adb4ee84730	TCGA.12.1091	TCGA-12-1091-D23386	750a7d18-e6ca-4701-bbf6-44718e9736a4	2009-3-17	TAMOXIFEN	NA	HORMONE THERAPY	484	NA	521	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	160	NA
805	f8a5b835-b00b-421e-bdf5-9adb4ee84730	TCGA.12.1091	TCGA-12-1091-D23376	ffc5e3c2-c05c-4c78-b5dd-c628e2b869eb	2009-3-17	CCNG	NA	CHEMOTHERAPY	229	NA	287	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	90	NA
806	f8a5b835-b00b-421e-bdf5-9adb4ee84730	TCGA.12.1091	TCGA-12-1091-D23379	743b1437-d61a-4ce1-950c-444be336c041	2009-3-17	VP-16	NA	CHEMOTHERAPY	358	NA	453	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	100	NA
807	f8a5b835-b00b-421e-bdf5-9adb4ee84730	TCGA.12.1091	TCGA-12-1091-D23385	300c0f0e-44d4-4e03-9507-fd64106f8fd8	2009-3-17	TAMOXIFEN	NA	HORMONE THERAPY	453	NA	484	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	160	NA
808	f8a5b835-b00b-421e-bdf5-9adb4ee84730	TCGA.12.1091	TCGA-12-1091-D23375	26953512-7580-495c-8e56-846ab72e4d25	2009-3-17	TEMODOR	NA	CHEMOTHERAPY	179	NA	206	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	150	NA
809	f8a5b835-b00b-421e-bdf5-9adb4ee84730	TCGA.12.1091	TCGA-12-1091-D23377	d1b8410a-b50d-419d-aa57-62e91e442d03	2009-3-17	CCNG	NA	CHEMOTHERAPY	288	NA	330	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	80	NA
810	4c070166-025e-49b7-b4d0-fe25c8a355b1	TCGA.12.1092	TCGA-12-1092-D23396	3e0ce8f5-4a22-4937-9a1a-f517d6cfd8eb	2009-7-2	TEMODAR	NA	CHEMOTHERAPY	551	FALSE	637	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	50	NA
811	4c070166-025e-49b7-b4d0-fe25c8a355b1	TCGA.12.1092	TCGA-12-1092-D23391	6a287679-7316-4389-9bec-9c1df97774ec	2009-7-2	TEMODAR	NA	CHEMOTHERAPY	46	FALSE	96	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	75	NA
812	4c070166-025e-49b7-b4d0-fe25c8a355b1	TCGA.12.1092	TCGA-12-1092-D23397	62ba4c8b-7b1e-4c37-9261-50535180d9b9	2009-7-2	AVASTIN	NA	TARGETED MOLECULAR THERAPY	119	FALSE	204	NA	NA	NA	NA	NA	NA	MG/KG	MG/KG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	10	NA
813	4c070166-025e-49b7-b4d0-fe25c8a355b1	TCGA.12.1092	TCGA-12-1092-D23395	e8ef994b-f752-4b83-b9c7-9f14c9d44523	2009-7-2	CPT 11	NA	CHEMOTHERAPY	368	FALSE	460	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	125	NA
814	4c070166-025e-49b7-b4d0-fe25c8a355b1	TCGA.12.1092	TCGA-12-1092-D23398	d3ad0089-7068-4d8a-b73b-7eac3cbead82	2009-7-2	TARCEVA	NA	TARGETED MOLECULAR THERAPY	460	FALSE	551	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	150	NA
815	4c070166-025e-49b7-b4d0-fe25c8a355b1	TCGA.12.1092	TCGA-12-1092-D23394	12d97238-a55e-4dd2-9ed7-4d29cb0acd36	2009-7-2	TEMODAR	NA	CHEMOTHERAPY	232	FALSE	367	NA	NA	NA	NA	4	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	50	NA
816	4c070166-025e-49b7-b4d0-fe25c8a355b1	TCGA.12.1092	TCGA-12-1092-D23393	36a50f31-578b-4370-bbd9-53429f377461	2009-7-2	TEMODAR	NA	CHEMOTHERAPY	205	FALSE	232	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
817	4c070166-025e-49b7-b4d0-fe25c8a355b1	TCGA.12.1092	TCGA-12-1092-D23399	5a09a18b-51c3-431b-8771-b958549257c6	2009-7-2	RAPAMYCIN	NA	TARGETED MOLECULAR THERAPY	460	FALSE	551	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	5	NA
818	4c070166-025e-49b7-b4d0-fe25c8a355b1	TCGA.12.1092	TCGA-12-1092-D23392	0462a7ee-967b-41ee-96bf-717aa9ee2851	2009-7-2	TEMODAR	NA	CHEMOTHERAPY	119	FALSE	204	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
819	77d4d3ef-3fe0-4f93-a863-b5840926576c	TCGA.12.1093	TCGA-12-1093-D23407	034f41e0-7722-42dc-92c9-9382fe9ab69d	2009-3-17	ATTAC	NA	IMMUNOTHERAPY	126	NA	317	NA	NA	NA	NA	NA	NA	ML	ML	NA	NA	ORAL	NA	NA	ADJUVANT	NA	1	NA
820	77d4d3ef-3fe0-4f93-a863-b5840926576c	TCGA.12.1093	TCGA-12-1093-D23403	74e20754-348f-4d18-96bf-518729e932ac	2009-3-17	TEMODOR	NA	CHEMOTHERAPY	38	NA	79	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	75	NA
821	77d4d3ef-3fe0-4f93-a863-b5840926576c	TCGA.12.1093	TCGA-12-1093-D23406	98ef2454-90a4-4553-86d0-3dde38f1d246	2009-3-17	PANZEM	NA	CHEMOTHERAPY	339	NA	364	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	6000	NA
822	77d4d3ef-3fe0-4f93-a863-b5840926576c	TCGA.12.1093	TCGA-12-1093-D23404	5c758f09-1c42-4b89-917a-cf0672708bcc	2009-3-17	TEMODOR	NA	CHEMOTHERAPY	105	NA	317	NA	NA	NA	NA	5	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	1000	NA
823	77d4d3ef-3fe0-4f93-a863-b5840926576c	TCGA.12.1093	TCGA-12-1093-D23405	ff36d925-1ea9-4968-a97c-dc45ab1a5892	2009-3-17	TEMOZOLAMIDE	NA	CHEMOTHERAPY	339	NA	364	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	50	NA
824	dca3a016-5e89-4850-80bf-e78dc19a2453	TCGA.12.1094	TCGA-12-1094-D23415	99298c91-9f00-459f-a5dc-8507ef3e8021	2009-3-17	ACT PEP3 KLH	NA	IMMUNOTHERAPY	104	FALSE	215	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	ADJUVANT	NA	1	NA
825	dca3a016-5e89-4850-80bf-e78dc19a2453	TCGA.12.1094	TCGA-12-1094-D23416	30138724-8cf3-456d-97a5-afaae76b2e98	2009-3-17	AVASTIN	NA	TARGETED MOLECULAR THERAPY	286	FALSE	336	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	10	NA
826	dca3a016-5e89-4850-80bf-e78dc19a2453	TCGA.12.1094	TCGA-12-1094-D23412	dc899a96-b6aa-4728-aea9-adba0a5a72ac	2009-3-17	TEMODOR	NA	CHEMOTHERAPY	141	FALSE	213	NA	NA	NA	NA	3	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	600	NA
827	dca3a016-5e89-4850-80bf-e78dc19a2453	TCGA.12.1094	TCGA-12-1094-D23414	eb6d6165-3b48-42a6-8c40-9d66ef153c99	2009-3-17	TEMODOR	NA	CHEMOTHERAPY	286	FALSE	336	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	100	NA
828	dca3a016-5e89-4850-80bf-e78dc19a2453	TCGA.12.1094	TCGA-12-1094-D23411	36b7dc9c-ea2b-47c6-aece-4dfa8d948295	2009-3-17	TEMODOR	NA	CHEMOTHERAPY	18	NA	67	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	75	NA
829	dca3a016-5e89-4850-80bf-e78dc19a2453	TCGA.12.1094	TCGA-12-1094-D23413	707316c4-0c76-4128-b7b0-d366ae0e98d2	2009-3-17	CCNG	NA	CHEMOTHERAPY	231	FALSE	269	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	125	NA
830	82a3f532-ae59-4d06-9bfc-e5e7519c0a33	TCGA.12.1095	TCGA-12-1095-D23423	dc6534c8-5ee9-49e2-a551-2a8c1d27376b	2009-7-6	AVASTIN	NA	TARGETED MOLECULAR THERAPY	291	FALSE	370	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	10	NA
831	82a3f532-ae59-4d06-9bfc-e5e7519c0a33	TCGA.12.1095	TCGA-12-1095-D23424	0ded9037-7830-4d8e-9d2d-7f2fcc3d2aec	2009-7-6	AVASTIN	NA	TARGETED MOLECULAR THERAPY	404	FALSE	412	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	10	NA
832	82a3f532-ae59-4d06-9bfc-e5e7519c0a33	TCGA.12.1095	TCGA-12-1095-D23422	0c1db420-ef58-467e-b9c5-246b329ae2d9	2009-7-6	VP 16	NA	CHEMOTHERAPY	404	FALSE	412	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	37.5	NA
833	82a3f532-ae59-4d06-9bfc-e5e7519c0a33	TCGA.12.1095	TCGA-12-1095-D23421	8983c0af-1050-4464-a120-5c56eed1271b	2009-7-6	CPT 11	NA	CHEMOTHERAPY	112	FALSE	286	NA	NA	NA	NA	4	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	340	NA
834	82a3f532-ae59-4d06-9bfc-e5e7519c0a33	TCGA.12.1095	TCGA-12-1095-D23420	3f2e5e09-acf6-4e46-a279-7d1d56fa98f8	2009-7-6	TEMODAR	NA	CHEMOTHERAPY	34	FALSE	82	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	75	NA
835	82a3f532-ae59-4d06-9bfc-e5e7519c0a33	TCGA.12.1095	TCGA-12-1095-D23425	ac30373c-bcc8-40a6-8398-c0ae61139dc3	2009-7-6	AVASTIN	NA	TARGETED MOLECULAR THERAPY	95	FALSE	286	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	NA	NA	NA	PROGRESSION	NA	10	NA
836	b02aa13e-7fd9-40ba-9083-cbf7d4bfc948	TCGA.12.1096	TCGA-12-1096-D23432	9d624d7e-bff5-4f49-ad11-0f1871e28409	2009-3-17	AVASTIN	NA	TARGETED MOLECULAR THERAPY	202	FALSE	277	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
837	b02aa13e-7fd9-40ba-9083-cbf7d4bfc948	TCGA.12.1096	TCGA-12-1096-D23429	14cff663-5ab8-4bc4-b16c-21052223c1cb	2009-3-17	TEMODOR	NA	CHEMOTHERAPY	63	NA	101	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	75	NA
838	b02aa13e-7fd9-40ba-9083-cbf7d4bfc948	TCGA.12.1096	TCGA-12-1096-D23430	8d6ba9db-494e-4cfe-b28a-7ea825e7b1f0	2009-3-17	TEMODOR	NA	CHEMOTHERAPY	130	TRUE	201	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	300	NA
839	b02aa13e-7fd9-40ba-9083-cbf7d4bfc948	TCGA.12.1096	TCGA-12-1096-D23431	761120bb-11a8-4985-9940-58f8b7dcf0a5	2009-3-17	CPT-11	NA	CHEMOTHERAPY	202	FALSE	277	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	250	NA
840	f7106bb6-332a-4542-bc08-59bba48f4b04	TCGA.12.1097	TCGA-12-1097-D23436	7a577acc-b4d5-4a07-a5a5-8ccbbe470afb	2009-7-6	TEMODAR	NA	CHEMOTHERAPY	49	FALSE	96	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	75	NA
841	f7106bb6-332a-4542-bc08-59bba48f4b04	TCGA.12.1097	TCGA-12-1097-D23438	f03461e7-a23d-4c59-b7ec-48b5cb13174b	2009-7-6	TEMODAR	NA	CHEMOTHERAPY	351	FALSE	385	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	50	NA
842	f7106bb6-332a-4542-bc08-59bba48f4b04	TCGA.12.1097	TCGA-12-1097-D23437	6cd4c536-12a7-4ab2-ab76-e2bc5a4bcd69	2009-7-6	TEMODAR	NA	CHEMOTHERAPY	110	FALSE	166	NA	NA	NA	NA	2	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	200	NA
843	f7106bb6-332a-4542-bc08-59bba48f4b04	TCGA.12.1097	TCGA-12-1097-D23439	a0dc8f92-4f4c-4066-b52b-6ef969444753	2009-7-6	VP 16	NA	CHEMOTHERAPY	351	FALSE	385	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	50	NA
844	f7106bb6-332a-4542-bc08-59bba48f4b04	TCGA.12.1097	TCGA-12-1097-D23440	b218bd58-fdb5-4791-a92a-5a6abf8c3a87	2009-7-6	AMG 102	NA	TARGETED MOLECULAR THERAPY	177	FALSE	343	NA	NA	NA	NA	NA	NA	MG/KG	MG/KG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	10	NA
845	a05c4aca-5b7c-452a-a92c-f252539f9e9a	TCGA.12.1098	TCGA-12-1098-D23444	6da9105c-378e-417c-be27-e660c0975501	2009-7-6	TEMODAR	NA	CHEMOTHERAPY	35	FALSE	74	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	75	NA
846	0d04d215-b709-40dd-9d18-d470cfb5bafd	TCGA.12.1099	TCGA-12-1099-D23449	24e45c1e-4983-4550-b9c0-3bcb0e4000e3	2009-3-17	AVASTIN	NA	TARGETED MOLECULAR THERAPY	62	FALSE	104	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	10	NA
847	0d04d215-b709-40dd-9d18-d470cfb5bafd	TCGA.12.1099	TCGA-12-1099-D23448	b01e53b3-23d6-4480-8dc7-ab73a17341d0	2009-3-17	TEMODOR	NA	CHEMOTHERAPY	61	FALSE	101	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	PROGRESSION	NA	75	NA
848	2b82e941-1b16-444e-af41-24dbc0a7e8b5	TCGA.12.1597	TCGA-12-1597-D23741	ac76841f-2cfd-4780-8a33-5901b19b9239	2011-3-9	GLIADEL WAFER	NA	CHEMOTHERAPY	0	FALSE	0	NA	NA	NA	NA	1	NA	WAFER	WAFER	8	NA	INTRATUMORAL	NA	NA	ADJUVANT	NA	8	NA
849	2b82e941-1b16-444e-af41-24dbc0a7e8b5	TCGA.12.1597	TCGA-12-1597-D23744	88d4fab7-bbab-43bb-8416-0219cebd5d8a	2011-3-9	CPT 11	NA	CHEMOTHERAPY	181	FALSE	308	NA	NA	NA	NA	3	NA	MG	MG	125	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	2880	NA
850	2b82e941-1b16-444e-af41-24dbc0a7e8b5	TCGA.12.1597	TCGA-12-1597-D23745	79d23712-2fa4-4973-90d1-7c5b60a300d9	2011-3-9	TEMOZOLOMIDE	NA	CHEMOTHERAPY	313	FALSE	348	NA	NA	NA	NA	5	NA	MG	MG	200	NA	ORAL	NA	NA	PROGRESSION	NA	1950	NA
851	2b82e941-1b16-444e-af41-24dbc0a7e8b5	TCGA.12.1597	TCGA-12-1597-D23743	7c56a89a-427f-4a4e-92ca-28717a4bd5d6	2011-3-9	CCNU	NA	CHEMOTHERAPY	123	FALSE	545	NA	NA	NA	NA	1	NA	MG	MG	110	NA	ORAL	NA	NA	ADJUVANT	NA	220	NA
852	2b82e941-1b16-444e-af41-24dbc0a7e8b5	TCGA.12.1597	TCGA-12-1597-D23742	8d4bb5f6-d811-4917-aa2f-e3e94cb90e6f	2011-3-9	TEMOZOLOMIDE	NA	CHEMOTHERAPY	64	FALSE	88	NA	NA	NA	NA	1	NA	MG	MG	150	NA	ORAL	NA	NA	ADJUVANT	NA	1550	NA
853	2b82e941-1b16-444e-af41-24dbc0a7e8b5	TCGA.12.1597	TCGA-12-1597-D23746	77a681b9-66a1-4141-a79f-acf39f99158d	2011-3-9	TEMOZOLOMIDE	NA	CHEMOTHERAPY	355	FALSE	427	NA	NA	NA	NA	2	NA	MG	MG	150	NA	ORAL	NA	NA	PROGRESSION	NA	1500	NA
854	2b90648c-c99e-4d4d-8d9b-67ff2c4e6115	TCGA.12.1598	TCGA-12-1598-D23750	609092bf-2689-4d1d-8602-34ba487625a7	2009-11-16	TEMODAR	NA	CHEMOTHERAPY	33	FALSE	82	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	5000	NA
855	2b90648c-c99e-4d4d-8d9b-67ff2c4e6115	TCGA.12.1598	TCGA-12-1598-D23751	b176ed23-5d80-414b-816c-83e4b0b10d7a	2009-11-16	TEMODAR	NA	CHEMOTHERAPY	160	FALSE	287	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	4500	NA
856	165b8f99-f7ba-4553-96ed-235e3f77e19c	TCGA.12.1599	TCGA-12-1599-D23760	11897f22-4fbd-4255-9616-39557ab7ac9d	2009-11-16	GLEEVAC	NA	TARGETED MOLECULAR THERAPY	96	FALSE	127	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	30000	NA
857	165b8f99-f7ba-4553-96ed-235e3f77e19c	TCGA.12.1599	TCGA-12-1599-D23764	1753f19a-a50e-4883-9919-230e4603ac5f	2009-11-16	AVASTIN	NA	TARGETED MOLECULAR THERAPY	438	FALSE	602	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	5520	NA
858	165b8f99-f7ba-4553-96ed-235e3f77e19c	TCGA.12.1599	TCGA-12-1599-D23758	0c4016d7-a9d9-4199-982a-9a7879549898	2009-11-16	CPT 11	NA	CHEMOTHERAPY	621	FALSE	671	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	1600	NA
859	165b8f99-f7ba-4553-96ed-235e3f77e19c	TCGA.12.1599	TCGA-12-1599-D23759	af324b51-c4db-46fe-ab60-a5543e596c2b	2009-11-16	CYTOXAN	NA	CHEMOTHERAPY	675	FALSE	727	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	5300	NA
860	165b8f99-f7ba-4553-96ed-235e3f77e19c	TCGA.12.1599	TCGA-12-1599-D23762	9bbd54eb-d11c-4954-8176-470b383d76d8	2009-11-16	ERLOTINIB	NA	TARGETED MOLECULAR THERAPY	406	FALSE	433	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	14000	NA
861	165b8f99-f7ba-4553-96ed-235e3f77e19c	TCGA.12.1599	TCGA-12-1599-D23763	e051490a-56e8-4c86-9ea4-911209bec66a	2009-11-16	SIROLIMUS	NA	TARGETED MOLECULAR THERAPY	406	FALSE	433	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	280	NA
862	165b8f99-f7ba-4553-96ed-235e3f77e19c	TCGA.12.1599	TCGA-12-1599-D23765	eb710218-b81e-4cdd-8117-e3833feaf2d1	2009-11-16	AVASTIN	NA	TARGETED MOLECULAR THERAPY	621	FALSE	671	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	1840	NA
863	165b8f99-f7ba-4553-96ed-235e3f77e19c	TCGA.12.1599	TCGA-12-1599-D23757	02f5bbc5-a33c-4f26-8b77-b6e33482c6ce	2009-11-16	HYDROXYUREA	NA	CHEMOTHERAPY	160	FALSE	391	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	66750	NA
864	165b8f99-f7ba-4553-96ed-235e3f77e19c	TCGA.12.1599	TCGA-12-1599-D23761	d85369f2-478e-453c-8a92-b9028c881f22	2009-11-16	GLEEVAC	NA	TARGETED MOLECULAR THERAPY	160	FALSE	391	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	90400	NA
865	165b8f99-f7ba-4553-96ed-235e3f77e19c	TCGA.12.1599	TCGA-12-1599-D23755	5cb67fef-3646-404f-b988-ccfca2d4ffd3	2009-11-16	TEMODAR	NA	CHEMOTHERAPY	24	FALSE	59	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	5880	NA
866	165b8f99-f7ba-4553-96ed-235e3f77e19c	TCGA.12.1599	TCGA-12-1599-D23766	3fd69306-7fd3-4d59-92ed-d7d71e716145	2009-11-16	AVASTIN	NA	TARGETED MOLECULAR THERAPY	675	FALSE	727	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	1760	NA
867	165b8f99-f7ba-4553-96ed-235e3f77e19c	TCGA.12.1599	TCGA-12-1599-D23756	0a0da274-6f46-4820-9c0d-490e1610f0da	2009-11-16	HYDROXYUREA	NA	CHEMOTHERAPY	461	FALSE	492	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	30000	NA
868	165b8f99-f7ba-4553-96ed-235e3f77e19c	TCGA.12.1599	TCGA-12-1599-D23767	177069f9-7bd5-4c46-87d3-71657dfed220	2010-1-15	AVASTIN	NA	TARGETED MOLECULAR THERAPY	438	FALSE	602	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	5520	NA
869	12b67dc2-5e4c-48eb-92ba-8d91d2eadfe2	TCGA.12.1600	TCGA-12-1600-D23772	06cc5be1-4bd2-4bcc-aa10-f2e8e69b1a4d	2009-11-16	TEMODAR	NA	CHEMOTHERAPY	106	FALSE	218	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	12000	NA
870	12b67dc2-5e4c-48eb-92ba-8d91d2eadfe2	TCGA.12.1600	TCGA-12-1600-D23771	64b25e1d-f06a-472b-999b-a8bf81400ce6	2009-11-16	TEMODAR	NA	CHEMOTHERAPY	43	FALSE	84	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	5880	NA
871	8ac5b22f-3925-47a9-8d09-d819c2e191e5	TCGA.12.1602	TCGA-12-1602-D23777	0d3bd815-a071-407c-8dc0-c5914e9e714c	2009-11-16	TEMODOR	NA	CHEMOTHERAPY	86	FALSE	140	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	8400	NA
872	8ac5b22f-3925-47a9-8d09-d819c2e191e5	TCGA.12.1602	TCGA-12-1602-D23776	b446dca7-55f1-42a5-a694-cc5201208ae8	2009-11-16	TEMODOR	NA	CHEMOTHERAPY	17	FALSE	57	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	6000	NA
873	f6c6e2c9-a3d6-4b81-a421-04ffef6b8744	TCGA.12.3644	TCGA-12-3644-D23786	f608e57b-5a19-4c7b-a0ca-2374cc403f4c	2010-6-18	TEMODAR	NA	CHEMOTHERAPY	1030	FALSE	1142	NA	NA	NA	NA	7	NA	MG	MG	50	NA	ORAL	NA	NA	RECURRENCE	NA	10080	NA
874	f6c6e2c9-a3d6-4b81-a421-04ffef6b8744	TCGA.12.3644	TCGA-12-3644-D23797	cacb1786-abd9-4536-a242-45540f791df9	2010-6-18	AVASTIN	NA	TARGETED MOLECULAR THERAPY	1194	FALSE	1583	NA	NA	NA	NA	NA	NA	MG	MG	10	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	18900	NA
875	f6c6e2c9-a3d6-4b81-a421-04ffef6b8744	TCGA.12.3644	TCGA-12-3644-D23785	ccb25cca-36d9-4ff0-81fb-0f7fed05fce7	2010-6-18	TEMODAR	NA	CHEMOTHERAPY	861	FALSE	891	NA	NA	NA	NA	1	NA	MG	MG	200	NA	ORAL	NA	NA	RECURRENCE	NA	1700	NA
876	f6c6e2c9-a3d6-4b81-a421-04ffef6b8744	TCGA.12.3644	TCGA-12-3644-D23791	1e817328-0469-4ae7-b77c-939fc0027749	2010-6-18	CPT 11	NA	CHEMOTHERAPY	1639	FALSE	1722	NA	NA	NA	NA	3	NA	MG	MG	125	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1200	NA
877	f6c6e2c9-a3d6-4b81-a421-04ffef6b8744	TCGA.12.3644	TCGA-12-3644-D23783	0e157e59-e867-420c-9dd5-3a6b49c3a65a	2010-6-18	CCNU	NA	CHEMOTHERAPY	134	FALSE	179	NA	NA	NA	NA	1	NA	MG	MG	110	NA	ORAL	NA	NA	ADJUVANT	NA	190	NA
878	f6c6e2c9-a3d6-4b81-a421-04ffef6b8744	TCGA.12.3644	TCGA-12-3644-D23788	419ba5be-e8c0-4fe8-9462-3576f6a42791	2010-6-18	CPT 11	NA	CHEMOTHERAPY	1194	FALSE	1583	NA	NA	NA	NA	9	NA	MG	MG	125	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	5400	NA
879	f6c6e2c9-a3d6-4b81-a421-04ffef6b8744	TCGA.12.3644	TCGA-12-3644-D23792	a8aa8cd6-160d-4545-b66d-5191e9153681	2010-6-18	TEMODAR	NA	CHEMOTHERAPY	1639	FALSE	1722	NA	NA	NA	NA	3	NA	MG	MG	150	NA	ORAL	NA	NA	RECURRENCE	NA	1825	NA
880	f6c6e2c9-a3d6-4b81-a421-04ffef6b8744	TCGA.12.3644	TCGA-12-3644-D23806	122e2df6-bcb0-4e33-b374-23e17d9de4ae	2010-6-18	ACCTUANE	NA	TARGETED MOLECULAR THERAPY	1639	FALSE	1722	NA	NA	NA	NA	NA	NA	MG	MG	80	NA	ORAL	NA	NA	RECURRENCE	NA	1680	NA
881	f6c6e2c9-a3d6-4b81-a421-04ffef6b8744	TCGA.12.3644	TCGA-12-3644-D23803	ea5ab866-6fd4-4f56-8810-469ec7f7e86d	2010-6-18	AVASTIN	NA	TARGETED MOLECULAR THERAPY	1611	FALSE	1639	NA	NA	NA	NA	NA	NA	MG	MG	10	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1400	NA
882	f6c6e2c9-a3d6-4b81-a421-04ffef6b8744	TCGA.12.3644	TCGA-12-3644-D23784	5c66bde0-39fb-444d-b4c3-4c1628a36fcf	2010-6-18	TEMODAR	NA	CHEMOTHERAPY	179	FALSE	486	NA	NA	NA	NA	10	NA	MG	MG	200	NA	ORAL	NA	NA	ADJUVANT	NA	17000	NA
883	f6c6e2c9-a3d6-4b81-a421-04ffef6b8744	TCGA.12.3644	TCGA-12-3644-D23789	cc42c290-fa86-4ad5-b0a0-c6db17608271	2010-6-18	HYDROXYUEREA	NA	CHEMOTHERAPY	1583	FALSE	1611	NA	NA	NA	NA	1	NA	MG	MG	500	NA	ORAL	NA	NA	RECURRENCE	NA	14000	NA
884	f6c6e2c9-a3d6-4b81-a421-04ffef6b8744	TCGA.12.3644	TCGA-12-3644-D23798	3d4e6f17-20f9-48b3-9cd4-45e0fc5fc0c5	2010-6-18	RAPAMYCIN	NA	TARGETED MOLECULAR THERAPY	1583	FALSE	1611	NA	NA	NA	NA	NA	NA	MG	MG	5	NA	ORAL	NA	NA	RECURRENCE	NA	140	NA
885	f6c6e2c9-a3d6-4b81-a421-04ffef6b8744	TCGA.12.3644	TCGA-12-3644-D23804	22cebc8f-829f-4a60-9b3f-98acd4f00ec2	2010-6-18	ACCUTANE	NA	TARGETED MOLECULAR THERAPY	1611	FALSE	1639	NA	NA	NA	NA	NA	NA	MG	MG	80	NA	ORAL	NA	NA	RECURRENCE	NA	1680	NA
886	f6c6e2c9-a3d6-4b81-a421-04ffef6b8744	TCGA.12.3644	TCGA-12-3644-D23807	559a610d-a662-4448-99cf-757acf75388b	2010-6-18	CHLOROQUINE	NA	TARGETED MOLECULAR THERAPY	1639	FALSE	1722	NA	NA	NA	NA	NA	NA	MG	MG	500	NA	ORAL	NA	NA	RECURRENCE	NA	21000	NA
887	f6c6e2c9-a3d6-4b81-a421-04ffef6b8744	TCGA.12.3644	TCGA-12-3644-D23805	63b3fd1c-3e08-4f33-ad48-c6da51c84fe9	2010-6-18	AVASTIN	NA	TARGETED MOLECULAR THERAPY	1639	FALSE	1722	NA	NA	NA	NA	NA	NA	MG	MG	10	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	4200	NA
888	f6c6e2c9-a3d6-4b81-a421-04ffef6b8744	TCGA.12.3644	TCGA-12-3644-D23782	6920cecb-924c-4d33-968f-be24c1f32dd6	2010-6-18	TEMODAR	NA	CHEMOTHERAPY	72	FALSE	119	NA	NA	NA	NA	2	NA	MG	MG	200	NA	ORAL	NA	NA	ADJUVANT	NA	3200	NA
889	f6c6e2c9-a3d6-4b81-a421-04ffef6b8744	TCGA.12.3644	TCGA-12-3644-D23801	701b8631-b4d3-46b1-9472-1fd8f5d000e2	2010-6-18	RAPAMYCIN	NA	TARGETED MOLECULAR THERAPY	1611	FALSE	1639	NA	NA	NA	NA	NA	NA	MG	MG	5	NA	ORAL	NA	NA	RECURRENCE	NA	140	NA
890	f6c6e2c9-a3d6-4b81-a421-04ffef6b8744	TCGA.12.3644	TCGA-12-3644-D23795	9565f844-587f-4989-bb40-4a3abd3a2921	2010-6-18	06BG	NA	TARGETED MOLECULAR THERAPY	1150	FALSE	1154	NA	NA	NA	NA	NA	NA	MG	MG	120	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	600	NA
891	f6c6e2c9-a3d6-4b81-a421-04ffef6b8744	TCGA.12.3644	TCGA-12-3644-D23802	37cd6430-be4c-4272-86c6-8e4aa67835ee	2010-6-18	TARCEVA	NA	TARGETED MOLECULAR THERAPY	1611	FALSE	1639	NA	NA	NA	NA	NA	NA	MG	MG	150	NA	ORAL	NA	NA	RECURRENCE	NA	4200	NA
892	f6c6e2c9-a3d6-4b81-a421-04ffef6b8744	TCGA.12.3644	TCGA-12-3644-D23808	cc751e95-16ac-4d6f-8b71-2d1ab76b03fa	2010-6-18	AVASTIN	NA	TARGETED MOLECULAR THERAPY	1765	FALSE	1806	NA	NA	NA	NA	NA	NA	MG	MG	10	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	2100	NA
893	f6c6e2c9-a3d6-4b81-a421-04ffef6b8744	TCGA.12.3644	TCGA-12-3644-D23790	9257d812-89d6-4b0b-b773-f791a03ad624	2010-6-18	HYDROXYUREA	NA	CHEMOTHERAPY	1611	FALSE	1639	NA	NA	NA	NA	1	NA	MG	MG	500	NA	ORAL	NA	NA	RECURRENCE	NA	14000	NA
894	f6c6e2c9-a3d6-4b81-a421-04ffef6b8744	TCGA.12.3644	TCGA-12-3644-D23793	53b7a091-db05-4e47-b98d-c687232fc378	2010-6-18	TARCEVA	NA	TARGETED MOLECULAR THERAPY	891	FALSE	1030	NA	NA	NA	NA	NA	NA	MG	MG	150	NA	ORAL	NA	NA	RECURRENCE	NA	21000	NA
895	f6c6e2c9-a3d6-4b81-a421-04ffef6b8744	TCGA.12.3644	TCGA-12-3644-D23799	e0d1e921-4821-49a7-8864-38309c4cccaa	2010-6-18	TARCEVA	NA	TARGETED MOLECULAR THERAPY	1583	FALSE	1611	NA	NA	NA	NA	NA	NA	MG	MG	150	NA	ORAL	NA	NA	RECURRENCE	NA	4200	NA
896	f6c6e2c9-a3d6-4b81-a421-04ffef6b8744	TCGA.12.3644	TCGA-12-3644-D23796	84c5536c-0539-4ec1-9a5b-697bbce6c905	2010-6-18	06BG	NA	TARGETED MOLECULAR THERAPY	1150	FALSE	1154	NA	NA	NA	NA	NA	NA	MG	MG	30	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	250	NA
897	f6c6e2c9-a3d6-4b81-a421-04ffef6b8744	TCGA.12.3644	TCGA-12-3644-D23781	4b2e262d-a2cd-46a8-bee5-8fa0d81dc92d	2010-6-18	GLIADEL WAFER	NA	CHEMOTHERAPY	37	FALSE	37	NA	NA	NA	NA	1	NA	WAFER	WAFER	8	NA	INTRATUMORAL	NA	NA	ADJUVANT	NA	61.6	NA
898	f6c6e2c9-a3d6-4b81-a421-04ffef6b8744	TCGA.12.3644	TCGA-12-3644-D23794	0bd9e4a8-c736-41ca-891b-f61a57232a1e	2010-6-18	RAPAMYCIN	NA	TARGETED MOLECULAR THERAPY	891	FALSE	1030	NA	NA	NA	NA	NA	NA	MG	MG	5	NA	ORAL	NA	NA	RECURRENCE	NA	700	NA
899	f6c6e2c9-a3d6-4b81-a421-04ffef6b8744	TCGA.12.3644	TCGA-12-3644-D23800	f6d74136-fd65-4e91-ae32-dc3364c3c7c2	2010-6-18	AVASTIN	NA	TARGETED MOLECULAR THERAPY	1583	FALSE	1611	NA	NA	NA	NA	NA	NA	MG	MG	10	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1400	NA
900	f6c6e2c9-a3d6-4b81-a421-04ffef6b8744	TCGA.12.3644	TCGA-12-3644-D23787	0b9da5b6-4d79-4e48-99f4-e6923f3d2b2d	2010-6-18	TEMODAR	NA	CHEMOTHERAPY	1142	FALSE	1180	NA	NA	NA	NA	1	NA	MG	MG	75	NA	ORAL	NA	NA	RECURRENCE	NA	3500	NA
901	e8e43a65-4ec8-4e07-a884-a6989eec28cc	TCGA.12.3646	TCGA-12-3646-D23815	0d8318ed-1889-48f9-a00b-11aa745ba257	2010-6-17	CCNU	NA	CHEMOTHERAPY	151	FALSE	234	NA	NA	NA	NA	2	NA	MG	MG	110	NA	ORAL	NA	NA	ADJUVANT	NA	400	NA
902	e8e43a65-4ec8-4e07-a884-a6989eec28cc	TCGA.12.3646	TCGA-12-3646-D23813	ded65791-82d4-45b4-b114-5eaaf91ca529	2010-6-17	TEMODAR	NA	CHEMOTHERAPY	24	FALSE	66	NA	NA	NA	NA	1	NA	MG	MG	75	NA	ORAL	NA	NA	ADJUVANT	NA	5670	NA
903	e8e43a65-4ec8-4e07-a884-a6989eec28cc	TCGA.12.3646	TCGA-12-3646-D23816	65478c20-e59f-4263-96f7-1dc136e7a421	2010-6-17	CPT 11	NA	CHEMOTHERAPY	248	FALSE	334	NA	NA	NA	NA	2	NA	MG	MG	340	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3610.8	NA
904	e8e43a65-4ec8-4e07-a884-a6989eec28cc	TCGA.12.3646	TCGA-12-3646-D23820	d7cd23dc-b9e6-4675-9d9c-7409aa681386	2010-6-17	AVASTIN	NA	TARGETED MOLECULAR THERAPY	248	FALSE	334	NA	NA	NA	NA	NA	NA	MG	MG	10	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	4182	NA
905	e8e43a65-4ec8-4e07-a884-a6989eec28cc	TCGA.12.3646	TCGA-12-3646-D23814	4f326a90-754a-450e-81ba-ce814080283c	2010-6-17	TEMODAR	NA	CHEMOTHERAPY	90	FALSE	151	NA	NA	NA	NA	2	NA	MG	MG	200	NA	ORAL	NA	NA	ADJUVANT	NA	3600	NA
906	e8e43a65-4ec8-4e07-a884-a6989eec28cc	TCGA.12.3646	TCGA-12-3646-D23817	a7b59ab0-c0a5-4bc5-87fd-cbd2230f19ba	2010-6-17	TEMODAR	NA	CHEMOTHERAPY	334	FALSE	403	NA	NA	NA	NA	2	NA	MG	MG	200	NA	ORAL	NA	NA	ADJUVANT	NA	3500	NA
907	e8e43a65-4ec8-4e07-a884-a6989eec28cc	TCGA.12.3646	TCGA-12-3646-D23819	c2f3eeb0-7493-4d7a-adc5-5379e43d33c4	2010-6-17	TEMODAR	NA	CHEMOTHERAPY	1063	FALSE	1315	NA	NA	NA	NA	8	NA	MG	MG	50	NA	ORAL	NA	NA	RECURRENCE	NA	17920	NA
908	e8e43a65-4ec8-4e07-a884-a6989eec28cc	TCGA.12.3646	TCGA-12-3646-D23818	3be3cd8a-b4ee-404b-ad31-7a7470df79c1	2010-6-17	CCNU	NA	CHEMOTHERAPY	405	FALSE	488	NA	NA	NA	NA	2	NA	MG	MG	110	NA	ORAL	NA	NA	ADJUVANT	NA	380	NA
909	407849a8-8447-4ede-a9d1-c1dfb535222e	TCGA.12.3648	TCGA-12-3648-D23831	ae24f877-7bd9-41f6-95db-f5ad2d2abad5	2010-6-17	AVASTIN	NA	TARGETED MOLECULAR THERAPY	738	FALSE	784	NA	NA	NA	NA	NA	NA	MG	MG	10	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1400	NA
910	407849a8-8447-4ede-a9d1-c1dfb535222e	TCGA.12.3648	TCGA-12-3648-D23829	4afa0a4f-a76b-4992-9412-f03a9f5f6daa	2010-6-17	PEP3 KLH	NA	IMMUNOTHERAPY	83	FALSE	452	NA	NA	NA	NA	NA	NA	UG	UG	500	NA	ORAL	NA	NA	ADJUVANT	NA	6500	NA
911	407849a8-8447-4ede-a9d1-c1dfb535222e	TCGA.12.3648	TCGA-12-3648-D23825	f5c9814e-c6f3-4d1b-981e-5a5dcca91f5f	2010-6-17	TEMODAR	NA	CHEMOTHERAPY	126	FALSE	452	NA	NA	NA	NA	11	NA	MG	MG	100	NA	ORAL	NA	NA	ADJUVANT	NA	46200	NA
912	407849a8-8447-4ede-a9d1-c1dfb535222e	TCGA.12.3648	TCGA-12-3648-D23826	d30b5295-ea98-4025-98ca-0f80826c1d0c	2010-6-17	CPT 11	NA	CHEMOTHERAPY	508	FALSE	731	NA	NA	NA	NA	5	NA	MG	MG	125	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	3450	NA
913	407849a8-8447-4ede-a9d1-c1dfb535222e	TCGA.12.3648	TCGA-12-3648-D23828	03c34ab8-e12c-48d7-8450-85da94a350ae	2010-6-17	VP 16	NA	CHEMOTHERAPY	738	FALSE	784	NA	NA	NA	NA	1	NA	MG	MG	50	NA	ORAL	NA	NA	RECURRENCE	NA	1575	NA
914	407849a8-8447-4ede-a9d1-c1dfb535222e	TCGA.12.3648	TCGA-12-3648-D23830	45804fd5-8fc7-40af-be3e-ac3730731eba	2010-6-17	AVASTIN	NA	TARGETED MOLECULAR THERAPY	508	FALSE	731	NA	NA	NA	NA	NA	NA	MG	MG	10	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	10950	NA
915	407849a8-8447-4ede-a9d1-c1dfb535222e	TCGA.12.3648	TCGA-12-3648-D23824	6d2837e0-54c1-46e8-9aaf-9c8cbf77b338	2010-6-17	TEMODAR	NA	CHEMOTHERAPY	14	FALSE	67	NA	NA	NA	NA	1	NA	MG	MG	75	NA	ORAL	NA	NA	ADJUVANT	NA	5880	NA
916	407849a8-8447-4ede-a9d1-c1dfb535222e	TCGA.12.3648	TCGA-12-3648-D23827	9de746fc-812e-4d9e-a725-ed252d061992	2010-6-17	TEMODAR	NA	CHEMOTHERAPY	738	FALSE	784	NA	NA	NA	NA	1	NA	MG	MG	50	NA	ORAL	NA	NA	RECURRENCE	NA	2800	NA
917	93737759-b088-4d64-adfe-c2d5ec715341	TCGA.12.3649	TCGA-12-3649-D23835	0895b796-1845-437d-90ae-0547189a770a	2010-6-18	TEMODAR	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	3	NA	MG	MG	200	NA	ORAL	NA	NA	ADJUVANT	NA	6000	NA
918	93737759-b088-4d64-adfe-c2d5ec715341	TCGA.12.3649	TCGA-12-3649-D23837	3b49d641-00d1-47e3-a119-4306b8a37548	2010-6-18	TEMODAR	NA	CHEMOTHERAPY	240	FALSE	350	NA	NA	NA	NA	3	NA	MG	MG	200	NA	ORAL	NA	NA	ADJUVANT	NA	6000	NA
919	93737759-b088-4d64-adfe-c2d5ec715341	TCGA.12.3649	TCGA-12-3649-D23841	e21ea1e6-69a7-4f19-8f60-44e66bc7d1ac	2010-6-18	AVASTIN	NA	TARGETED MOLECULAR THERAPY	186	FALSE	240	NA	NA	NA	NA	NA	NA	MG/KG	MG/KG	10	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
920	93737759-b088-4d64-adfe-c2d5ec715341	TCGA.12.3649	TCGA-12-3649-D23840	243dfa39-70ea-4f28-b227-810e9ceaa71e	2010-6-18	AVASTIN	NA	TARGETED MOLECULAR THERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	MG/KG	MG/KG	10	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
921	93737759-b088-4d64-adfe-c2d5ec715341	TCGA.12.3649	TCGA-12-3649-D23839	e0ec0d9d-3f89-4dc1-9af1-63eb9f685d96	2010-6-18	ATTAC	NA	IMMUNOTHERAPY	240	FALSE	350	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	OTHER	NA	NA	ADJUVANT	NA	NA	NA
922	93737759-b088-4d64-adfe-c2d5ec715341	TCGA.12.3649	TCGA-12-3649-D23842	65563c08-f717-4a43-b999-9263c5b5e1c4	2010-6-18	AVASTIN	NA	TARGETED MOLECULAR THERAPY	240	FALSE	347	NA	NA	NA	NA	NA	NA	MG/KG	MG/KG	10	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
923	93737759-b088-4d64-adfe-c2d5ec715341	TCGA.12.3649	TCGA-12-3649-D23838	bd0496a8-7fd5-4276-9fd8-67c7a0fcc72c	2010-6-18	ATTAC	NA	IMMUNOTHERAPY	186	FALSE	245	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	OTHER	NA	NA	ADJUVANT	NA	NA	NA
924	93737759-b088-4d64-adfe-c2d5ec715341	TCGA.12.3649	TCGA-12-3649-D23836	eabdced4-3f7b-492f-8662-4495e12dff74	2010-6-18	TEMODAR	NA	CHEMOTHERAPY	186	FALSE	240	NA	NA	NA	NA	1	NA	MG	MG	200	NA	ORAL	NA	NA	ADJUVANT	NA	2000	NA
925	5ef9486a-aeff-421d-b620-03ef119d85a5	TCGA.12.3650	TCGA-12-3650-D23849	246693f0-6de9-4ae4-a8c3-f13dbbe107bc	2010-6-17	TEMODAR	NA	CHEMOTHERAPY	152	FALSE	239	NA	NA	NA	NA	3	NA	MG	MG	200	NA	ORAL	NA	NA	PROGRESSION	NA	3000	NA
926	5ef9486a-aeff-421d-b620-03ef119d85a5	TCGA.12.3650	TCGA-12-3650-D23852	e6a53131-3989-40af-8c4a-95471516f0e7	2010-6-17	AVASTIN	NA	TARGETED MOLECULAR THERAPY	91	FALSE	148	NA	NA	NA	NA	NA	NA	MG	MG	10	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3892	NA
927	5ef9486a-aeff-421d-b620-03ef119d85a5	TCGA.12.3650	TCGA-12-3650-D23851	e49074c2-b3eb-4ed4-b4af-89360232674e	2010-6-17	AVASTIN	NA	TARGETED MOLECULAR THERAPY	26	FALSE	72	NA	NA	NA	NA	NA	NA	MG	MG	10	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3003	NA
928	5ef9486a-aeff-421d-b620-03ef119d85a5	TCGA.12.3650	TCGA-12-3650-D23854	706aa7be-dcc6-41f7-a886-199ef9ffa051	2010-6-17	TARCEVA	NA	TARGETED MOLECULAR THERAPY	239	FALSE	307	NA	NA	NA	NA	NA	NA	MG	MG	200	NA	ORAL	NA	NA	RECURRENCE	NA	11200	NA
929	5ef9486a-aeff-421d-b620-03ef119d85a5	TCGA.12.3650	TCGA-12-3650-D23850	01e955be-e0e9-4342-8e59-ac85106a809b	2010-6-17	VP 16	NA	CHEMOTHERAPY	307	FALSE	333	NA	NA	NA	NA	1	NA	MG	MG	50	NA	ORAL	NA	NA	PROGRESSION	NA	2100	NA
930	5ef9486a-aeff-421d-b620-03ef119d85a5	TCGA.12.3650	TCGA-12-3650-D23847	fa813f9b-b40f-4020-a700-bece84e19194	2010-6-17	TEMODAR	NA	CHEMOTHERAPY	91	FALSE	148	NA	NA	NA	NA	2	NA	MG	MG	200	NA	ORAL	NA	NA	ADJUVANT	NA	2000	NA
931	5ef9486a-aeff-421d-b620-03ef119d85a5	TCGA.12.3650	TCGA-12-3650-D23855	08de5190-bfc0-43c9-bfe8-63eda0971a81	2010-6-17	AVASTIN	NA	TARGETED MOLECULAR THERAPY	239	FALSE	307	NA	NA	NA	NA	NA	NA	MG	MG	10	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	3860	NA
932	5ef9486a-aeff-421d-b620-03ef119d85a5	TCGA.12.3650	TCGA-12-3650-D23848	c169ec13-9a6f-493d-8925-183ef375c76e	2010-6-17	CPT 11	NA	CHEMOTHERAPY	152	FALSE	239	NA	NA	NA	NA	3	NA	MG	MG	125	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1620	NA
933	5ef9486a-aeff-421d-b620-03ef119d85a5	TCGA.12.3650	TCGA-12-3650-D23853	037e6f21-a548-4321-befe-3d867d11da36	2010-6-17	AVASTIN	NA	TARGETED MOLECULAR THERAPY	148	FALSE	239	NA	NA	NA	NA	NA	NA	MG	MG	10	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5838	NA
934	5ef9486a-aeff-421d-b620-03ef119d85a5	TCGA.12.3650	TCGA-12-3650-D23856	581c1128-6fdd-4589-a882-237544883f2e	2010-6-17	AVASTIN	NA	TARGETED MOLECULAR THERAPY	307	FALSE	333	NA	NA	NA	NA	NA	NA	MG	MG	10	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	1894	NA
935	5ef9486a-aeff-421d-b620-03ef119d85a5	TCGA.12.3650	TCGA-12-3650-D23846	cdcc6ebe-07f4-4d39-a8df-5606be5558a7	2010-6-17	CPT 11	NA	CHEMOTHERAPY	91	FALSE	148	NA	NA	NA	NA	2	NA	MG	MG	340	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6120	NA
936	5ef9486a-aeff-421d-b620-03ef119d85a5	TCGA.12.3650	TCGA-12-3650-D23845	21adc65e-cd5d-47b6-906d-c03361abd316	2010-6-17	TEMODAR	NA	CHEMOTHERAPY	26	FALSE	72	NA	NA	NA	NA	1	NA	MG	MG	75	NA	ORAL	NA	NA	ADJUVANT	NA	6930	NA
937	d540d6d2-266c-48f9-8e73-304389b2060b	TCGA.12.3651	TCGA-12-3651-D23863	63332f1a-e0c0-48fd-a1b5-67ae2ba725fd	2010-6-17	TEMODAR	NA	CHEMOTHERAPY	221	FALSE	358	NA	NA	NA	NA	4	NA	MG	MG	150	NA	ORAL	NA	NA	ADJUVANT	NA	5600	NA
938	d540d6d2-266c-48f9-8e73-304389b2060b	TCGA.12.3651	TCGA-12-3651-D23865	a2f979ae-4c6d-4518-a0fb-e202e967ee0e	2010-6-17	AVASTIN	NA	TARGETED MOLECULAR THERAPY	221	FALSE	358	NA	NA	NA	NA	NA	NA	MG	MG	5	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2840	NA
939	d540d6d2-266c-48f9-8e73-304389b2060b	TCGA.12.3651	TCGA-12-3651-D23861	583ab4c3-7e47-4a7b-8a8a-2cc08f17f37b	2010-6-17	TEMODAR	NA	CHEMOTHERAPY	186	FALSE	212	NA	NA	NA	NA	1	NA	MG	MG	150	NA	ORAL	NA	NA	ADJUVANT	NA	1400	NA
940	d540d6d2-266c-48f9-8e73-304389b2060b	TCGA.12.3651	TCGA-12-3651-D23864	38bacb01-a0de-45d1-a96d-a3ef96b9187a	2010-6-17	AVASTIN	NA	TARGETED MOLECULAR THERAPY	43	FALSE	85	NA	NA	NA	NA	NA	NA	MG	MG	10	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	2430	NA
941	d540d6d2-266c-48f9-8e73-304389b2060b	TCGA.12.3651	TCGA-12-3651-D23860	17a463d2-46c6-4773-8946-410ff432aaed	2010-6-17	TEMODAR	NA	CHEMOTHERAPY	43	FALSE	85	NA	NA	NA	NA	1	NA	MG	MG	75	NA	ORAL	NA	NA	ADJUVANT	NA	5880	NA
942	d540d6d2-266c-48f9-8e73-304389b2060b	TCGA.12.3651	TCGA-12-3651-D23862	bfc5451f-2faa-4116-bdbc-017852173f4d	2010-6-17	CPT 11	NA	CHEMOTHERAPY	221	FALSE	358	NA	NA	NA	NA	4	NA	MG	MG	40	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	592	NA
943	159e0318-6173-440f-be07-8d956086e99d	TCGA.12.3652	TCGA-12-3652-D23874	5f497f85-81e6-4ee1-ad7e-1203c6a855a6	2010-6-17	VP 16	NA	CHEMOTHERAPY	469	FALSE	571	NA	NA	NA	NA	4	NA	MG	MG	50	NA	ORAL	NA	NA	RECURRENCE	NA	8400	NA
944	159e0318-6173-440f-be07-8d956086e99d	TCGA.12.3652	TCGA-12-3652-D23875	5af365b3-d16b-4e52-9ec3-d4d2365abc34	2010-6-17	HYDROXUREA	NA	TARGETED MOLECULAR THERAPY	585	FALSE	750	NA	NA	NA	NA	NA	NA	MG	MG	500	NA	ORAL	NA	NA	RECURRENCE	NA	14000	NA
945	159e0318-6173-440f-be07-8d956086e99d	TCGA.12.3652	TCGA-12-3652-D23869	a0258123-a051-411a-9438-e22823bc3e7c	2010-6-17	TEMODAR	NA	CHEMOTHERAPY	21	FALSE	67	NA	NA	NA	NA	2	NA	MG	MG	150	NA	ORAL	NA	NA	ADJUVANT	NA	3000	NA
946	159e0318-6173-440f-be07-8d956086e99d	TCGA.12.3652	TCGA-12-3652-D23871	13869b12-a6d5-492f-b447-21377d2a77ab	2010-6-17	CCNU	NA	CHEMOTHERAPY	161	FALSE	203	NA	NA	NA	NA	1	NA	MG	MG	82.5	NA	ORAL	NA	NA	ADJUVANT	NA	160	NA
947	159e0318-6173-440f-be07-8d956086e99d	TCGA.12.3652	TCGA-12-3652-D23870	5971905b-fe49-4eb8-908f-5ef2a8104412	2010-6-17	CCNU	NA	CHEMOTHERAPY	91	FALSE	133	NA	NA	NA	NA	1	NA	MG	MG	110	NA	ORAL	NA	NA	ADJUVANT	NA	220	NA
948	159e0318-6173-440f-be07-8d956086e99d	TCGA.12.3652	TCGA-12-3652-D23878	5a096ae9-d9da-491e-8551-3e96a6e013d5	2010-6-17	GLEEVAC	NA	TARGETED MOLECULAR THERAPY	750	FALSE	792	NA	NA	NA	NA	NA	NA	MG	MG	300	NA	ORAL	NA	NA	RECURRENCE	NA	8400	NA
949	159e0318-6173-440f-be07-8d956086e99d	TCGA.12.3652	TCGA-12-3652-D23877	a1292253-d177-432c-9607-291a1ebdc85f	2010-6-17	GLEEVAC	NA	TARGETED MOLECULAR THERAPY	585	FALSE	750	NA	NA	NA	NA	NA	NA	MG	MG	400	NA	ORAL	NA	NA	RECURRENCE	NA	56000	NA
950	159e0318-6173-440f-be07-8d956086e99d	TCGA.12.3652	TCGA-12-3652-D23872	5669a2bc-462d-4f0a-b841-c2b5c5330a39	2010-6-17	TEMODAR	NA	CHEMOTHERAPY	228	FALSE	288	NA	NA	NA	NA	2	NA	MG	MG	200	NA	ORAL	NA	NA	RECURRENCE	NA	4000	NA
951	159e0318-6173-440f-be07-8d956086e99d	TCGA.12.3652	TCGA-12-3652-D23873	2f54f028-dfa1-4077-8487-5e6fd85eeb8d	2010-6-17	VP 16	NA	CHEMOTHERAPY	291	FALSE	358	NA	NA	NA	NA	1	NA	MG	MG	50	NA	ORAL	NA	NA	RECURRENCE	NA	1575	NA
952	159e0318-6173-440f-be07-8d956086e99d	TCGA.12.3652	TCGA-12-3652-D23876	97957116-80e0-4310-861a-78bb3de75922	2010-6-17	HYDROXUREA	NA	TARGETED MOLECULAR THERAPY	750	FALSE	792	NA	NA	NA	NA	NA	NA	MG	MG	500	NA	ORAL	NA	NA	RECURRENCE	NA	2800	NA
953	2f61ea6b-a3f2-477f-ab98-47ed07b3b2cd	TCGA.12.3653	TCGA-12-3653-D23887	c118be6f-5204-45bd-9046-d6c86537bda3	2010-6-17	AVASTIN	NA	TARGETED MOLECULAR THERAPY	316	FALSE	371	NA	NA	NA	NA	NA	NA	MG	MG	10	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	4000	NA
954	2f61ea6b-a3f2-477f-ab98-47ed07b3b2cd	TCGA.12.3653	TCGA-12-3653-D23885	a434d91c-c3bc-4b6c-b6af-95698a9eac32	2010-6-17	DACLIZUMAB	NA	IMMUNOTHERAPY	128	FALSE	224	NA	NA	NA	NA	NA	NA	MG	MG	1	NA	OTHER	NA	NA	ADJUVANT	NA	406.4	NA
955	2f61ea6b-a3f2-477f-ab98-47ed07b3b2cd	TCGA.12.3653	TCGA-12-3653-D23886	bcd6262c-7485-45bf-b4d1-c677ed0cc02c	2010-6-17	ANGIOCEPT	NA	TARGETED MOLECULAR THERAPY	287	FALSE	315	NA	NA	NA	NA	NA	NA	MG	MG	2	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	199	NA
956	2f61ea6b-a3f2-477f-ab98-47ed07b3b2cd	TCGA.12.3653	TCGA-12-3653-D23884	1e0635de-3c73-4912-a3f3-21b0108b4fa4	2010-6-17	VP 16	NA	CHEMOTHERAPY	316	FALSE	371	NA	NA	NA	NA	2	NA	MG	MG	50	NA	ORAL	NA	NA	PROGRESSION	NA	4200	NA
957	2f61ea6b-a3f2-477f-ab98-47ed07b3b2cd	TCGA.12.3653	TCGA-12-3653-D23883	b2dbf473-11b7-485a-bb08-ec5721fc369d	2010-6-17	TEMODAR	NA	CHEMOTHERAPY	128	FALSE	224	NA	NA	NA	NA	3	NA	MG	MG	150	NA	ORAL	NA	NA	ADJUVANT	NA	4500	NA
958	2f61ea6b-a3f2-477f-ab98-47ed07b3b2cd	TCGA.12.3653	TCGA-12-3653-D23882	5dd248d8-710f-443b-9856-c90d45967747	2010-6-17	TEMODAR	NA	CHEMOTHERAPY	46	FALSE	87	NA	NA	NA	NA	1	NA	MG	MG	75	NA	ORAL	NA	NA	ADJUVANT	NA	6300	NA
959	c970240f-03e2-4395-85be-5eb81a69b710	TCGA.12.5295	TCGA-12-5295-D23894	e6443949-ba10-47c2-8cdf-d01f91874e6f	2011-2-7	AVASTIN	NA	TARGETED MOLECULAR THERAPY	277	FALSE	323	NA	NA	NA	NA	NA	NA	MG	MG	10	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1650	NA
960	c970240f-03e2-4395-85be-5eb81a69b710	TCGA.12.5295	TCGA-12-5295-D23891	86be8937-7538-4a31-8d77-f65511d21df1	2011-2-7	TEMOZOLOMIDE	NA	CHEMOTHERAPY	29	FALSE	71	NA	NA	NA	NA	1	NA	MG	MG	75	NA	ORAL	NA	NA	ADJUVANT	NA	4725	NA
961	c970240f-03e2-4395-85be-5eb81a69b710	TCGA.12.5295	TCGA-12-5295-D23892	42cc5949-c34c-4ef4-81c5-6956fdc7d546	2011-2-7	CPT 11	NA	CHEMOTHERAPY	88	FALSE	277	NA	NA	NA	NA	3	NA	MG	MG	340	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	4590	NA
962	c970240f-03e2-4395-85be-5eb81a69b710	TCGA.12.5295	TCGA-12-5295-D23893	aa28eb4a-d590-485e-8241-304f794b847f	2011-2-7	AVASTIN	NA	TARGETED MOLECULAR THERAPY	88	FALSE	277	NA	NA	NA	NA	NA	NA	MG	MG	10	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	4950	NA
963	5327e899-a20d-4571-8236-98454bad574e	TCGA.12.5299	TCGA-12-5299-D23898	cd10eb41-3cb1-4c25-9b1e-7601dda8b0d2	2011-2-7	TEMOZOLOMIDE	NA	CHEMOTHERAPY	45	FALSE	80	NA	NA	NA	NA	1	NA	MG	MG	75	NA	ORAL	NA	NA	ADJUVANT	NA	5250	NA
964	5327e899-a20d-4571-8236-98454bad574e	TCGA.12.5299	TCGA-12-5299-D23899	af067cc9-96df-4fec-b88b-8910060babc0	2011-2-7	AVASTIN	NA	TARGETED MOLECULAR THERAPY	45	FALSE	73	NA	NA	NA	NA	NA	NA	MG	MG	10	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3000	NA
965	10efeb3c-ef55-4227-91b9-8c2bb4ff43d5	TCGA.12.5301	TCGA-12-5301-D23903	78ffd0cc-e45e-4fa9-93d1-f382e466b6a6	2011-2-7	TEMOZOLOMIDE	NA	CHEMOTHERAPY	24	FALSE	59	NA	NA	NA	NA	1	NA	MG	MG	75	NA	ORAL	NA	NA	ADJUVANT	NA	5400	NA
966	cdfcf14d-ed6c-419f-88f5-e7dee96fcaf6	TCGA.14.0736	TCGA-14-0736-D25027	6109596d-0a70-4434-981b-33f59151bbec	2009-6-4	GLIADEL	NA	CHEMOTHERAPY	207	FALSE	NA	NA	NA	NA	NA	NA	NA	WAFER	WAFER	NA	NA	OTHER	NA	NA	PROGRESSION	NA	8	NA
967	cdfcf14d-ed6c-419f-88f5-e7dee96fcaf6	TCGA.14.0736	TCGA-14-0736-D25029	e5165449-e38a-49d1-935c-f07da09015fc	2009-6-4	DEXAMETHASONE	NA	HORMONE THERAPY	0	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	PROGRESSION	NA	NA	NA
968	cdfcf14d-ed6c-419f-88f5-e7dee96fcaf6	TCGA.14.0736	TCGA-14-0736-D25030	df6d7ef0-9916-40ae-a56a-e2e49992a441	2009-6-4	DEXAMETHASONE	NA	HORMONE THERAPY	128	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
969	cdfcf14d-ed6c-419f-88f5-e7dee96fcaf6	TCGA.14.0736	TCGA-14-0736-D25028	dbcd231a-8b89-4538-af33-de66bf55fdab	2009-6-4	TEMADOR	NA	CHEMOTHERAPY	371	FALSE	376	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	2000	NA
970	70c887ce-43e1-4093-9a2f-a9d3dc62da78	TCGA.14.0740	TCGA-14-0740-D25256	313cebc5-142b-481d-85b5-96fe4cb15834	2010-6-24	DEXAMETHASONE	NA	HORMONE THERAPY	0	FALSE	NA	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
971	9b9654c9-5a64-4a8e-b1f0-987437e6012e	TCGA.14.0781	TCGA-14-0781-D25034	1fa40719-7dd6-4d7d-8df5-fc148697adeb	2010-6-24	DEXAMETHASONE	NA	HORMONE THERAPY	0	FALSE	NA	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
972	27c8c458-eb2f-43e4-a06b-6cd61a9a3a28	TCGA.14.0783	TCGA-14-0783-D25037	a3c2c88a-34fc-459c-98f8-1d67d9639719	2009-8-4	CARBOXY AMIDO TRIAZOLE	NA	CHEMOTHERAPY	32	FALSE	147	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	108450	NA
973	27c8c458-eb2f-43e4-a06b-6cd61a9a3a28	TCGA.14.0783	TCGA-14-0783-D25038	9e758ea9-efd4-4235-aada-5321e9db46ff	2009-8-4	DEXAMETHASONE	NA	HORMONE THERAPY	-1	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
974	12824b2b-9c0a-4dcf-8941-34593a4e93da	TCGA.14.0786	TCGA-14-0786-D25050	461ce200-caf6-4662-9abd-34d1c7ea7134	2009-8-4	THALIDOMIDE	NA	CHEMOTHERAPY	574	FALSE	651	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	300	NA
975	12824b2b-9c0a-4dcf-8941-34593a4e93da	TCGA.14.0786	TCGA-14-0786-D25042	d5427ebb-67f8-4a4c-ad62-43094c6428cb	2009-8-4	CARMUSTINE	NA	CHEMOTHERAPY	140	FALSE	142	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
976	12824b2b-9c0a-4dcf-8941-34593a4e93da	TCGA.14.0786	TCGA-14-0786-D25045	ddec111c-4c05-431d-ae3f-0684c89a2f09	2009-8-4	PROCARBAZINE	NA	CHEMOTHERAPY	308	FALSE	357	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	12600	NA
977	12824b2b-9c0a-4dcf-8941-34593a4e93da	TCGA.14.0786	TCGA-14-0786-D25043	69c29c75-960b-44f5-a5dc-06ed4b78745b	2009-8-4	CISPLATIN	NA	CHEMOTHERAPY	140	FALSE	142	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
978	12824b2b-9c0a-4dcf-8941-34593a4e93da	TCGA.14.0786	TCGA-14-0786-D25053	fd77ad49-1a88-4d43-9b6f-797eaa842f92	2009-8-4	DEXAMETHASONE	NA	HORMONE THERAPY	0	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
979	12824b2b-9c0a-4dcf-8941-34593a4e93da	TCGA.14.0786	TCGA-14-0786-D25049	eb117505-c3f4-446a-9c50-d9ef5c6cbe8b	2009-8-4	CARMUSTINE	NA	CHEMOTHERAPY	567	FALSE	570	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	69	NA
980	12824b2b-9c0a-4dcf-8941-34593a4e93da	TCGA.14.0786	TCGA-14-0786-D25051	8783c1ea-bef3-4cd6-94ae-0b8994ccba65	2009-8-4	ETOPOSIDE	NA	CHEMOTHERAPY	659	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
981	12824b2b-9c0a-4dcf-8941-34593a4e93da	TCGA.14.0786	TCGA-14-0786-D25052	76d83075-6f7f-47df-9843-f203adbb2065	2009-8-4	CARBOPLATIN	NA	CHEMOTHERAPY	659	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
982	12824b2b-9c0a-4dcf-8941-34593a4e93da	TCGA.14.0786	TCGA-14-0786-D25044	2070bef0-46d9-462b-9e22-f7bf51fa970a	2009-8-4	CPT 11	NA	CHEMOTHERAPY	182	FALSE	210	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1124	NA
983	12824b2b-9c0a-4dcf-8941-34593a4e93da	TCGA.14.0786	TCGA-14-0786-D25047	fc37b272-3d0f-4fcb-88aa-62e795301ce1	2009-8-4	STREPTOZOCIN	NA	CHEMOTHERAPY	567	FALSE	570	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	3400	NA
984	12824b2b-9c0a-4dcf-8941-34593a4e93da	TCGA.14.0786	TCGA-14-0786-D25046	888e88cd-c2cc-4c5e-aaeb-5a357b7d8e78	2009-8-4	TEMODAR	NA	CHEMOTHERAPY	526	FALSE	567	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	150	NA
985	12824b2b-9c0a-4dcf-8941-34593a4e93da	TCGA.14.0786	TCGA-14-0786-D25048	86d4e0aa-8f20-4773-ab9a-fbbcc869c7bd	2009-8-4	6-MERCAPTOPURINE	NA	CHEMOTHERAPY	567	FALSE	570	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1200	NA
986	12824b2b-9c0a-4dcf-8941-34593a4e93da	TCGA.14.0786	TCGA-14-0786-D25054	38525ebf-b281-4604-8c74-20eca4c862e7	2009-8-4	DEXAMETHASONE	NA	HORMONE THERAPY	127	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
987	a2338b30-f511-4163-af3b-1e4a40ff00e1	TCGA.14.0787	TCGA-14-0787-D25058	ba759209-2fe1-4518-a456-d84ee0581d91	2009-4-24	DEXMETHASONE	NA	HORMONE THERAPY	15	NA	41	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	720	NA
988	a2338b30-f511-4163-af3b-1e4a40ff00e1	TCGA.14.0787	TCGA-14-0787-D25059	48acd207-c274-4686-bccd-7d749d195594	2009-4-24	NA	NA	TARGETED MOLECULAR THERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
989	7cbabf1d-ec38-4048-ae1c-7d0f3001691b	TCGA.14.0789	TCGA-14-0789-D25062	8691af67-9e42-422a-806b-0613902ed648	2009-5-6	TEMODAR	NA	CHEMOTHERAPY	44	NA	75	NA	NA	NA	NA	1	NA	MG/DAY	MG/DAY	NA	NA	ORAL	NA	NA	ADJUVANT	NA	120	NA
990	7cbabf1d-ec38-4048-ae1c-7d0f3001691b	TCGA.14.0789	TCGA-14-0789-D25063	dff8452d-ee4f-4b51-a7df-8aef2ce0f42e	2009-5-6	GLIADEL WAFER (BCNU)	NA	CHEMOTHERAPY	118	FALSE	NA	NA	NA	NA	NA	1	NA	WAFER	WAFER	NA	NA	OTHER	NA	NA	PROGRESSION	NA	8	NA
991	7cbabf1d-ec38-4048-ae1c-7d0f3001691b	TCGA.14.0789	TCGA-14-0789-D25064	c6d5e1e4-2ef1-49be-8332-9f935e0fd5a3	2009-5-15	DEXAMETHAZONE	NA	HORMONE THERAPY	0	FALSE	118	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	2000	NA
992	7cbabf1d-ec38-4048-ae1c-7d0f3001691b	TCGA.14.0789	TCGA-14-0789-D25065	2ecc9c94-8a6b-4abd-ba50-701d85f627de	2009-5-15	DEXAMETHASONE	NA	HORMONE THERAPY	119	FALSE	224	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	1680	NA
993	7fe37feb-e205-4524-8c98-1f9ac5fe0700	TCGA.14.0790	TCGA-14-0790-D25069	61376632-4435-467e-8225-20f4ffea46ec	2010-2-5	GLIADEL BCNU	NA	CHEMOTHERAPY	0	FALSE	NA	NA	NA	NA	NA	NA	NA	WAFER	WAFER	NA	NA	OTHER	NA	NA	ADJUVANT	NA	8	NA
994	7fe37feb-e205-4524-8c98-1f9ac5fe0700	TCGA.14.0790	TCGA-14-0790-D25070	08088403-9225-4775-8ad6-7d259dedc879	2010-2-5	TEMODAR	NA	CHEMOTHERAPY	15	FALSE	410	NA	NA	NA	NA	9	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	17700	NA
995	7fe37feb-e205-4524-8c98-1f9ac5fe0700	TCGA.14.0790	TCGA-14-0790-D25071	057d0f15-9225-48f5-8103-2807f2c26b19	2010-2-5	DEXAMETHASONE	NA	HORMONE THERAPY	0	FALSE	NA	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
996	eff7f13b-ed32-4e85-a8d0-831b655d773f	TCGA.14.0812	TCGA-14-0812-D25075	daaeadab-1253-4a25-9955-d5d3c2bd9640	2009-8-4	GLIADEL WAFERS	NA	CHEMOTHERAPY	0	FALSE	NA	NA	NA	NA	NA	NA	NA	WAFER	WAFER	NA	NA	OTHER	NA	NA	ADJUVANT	NA	8	NA
997	eff7f13b-ed32-4e85-a8d0-831b655d773f	TCGA.14.0812	TCGA-14-0812-D25076	efcb3681-d3d7-4126-8846-a5425cf96d4e	2009-8-4	DEXAMETHASONE	NA	HORMONE THERAPY	0	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
998	cb58b5fe-ee0d-46f1-8502-1c8bcf729f3b	TCGA.14.0813	TCGA-14-0813-D25079	03f5f468-22bf-43a1-9f77-bd2cc9017a28	2009-4-24	DEXAMETHASONE	NA	HORMONE THERAPY	0	FALSE	41	NA	NA	NA	NA	NA	NA	MG/DAY	MG/DAY	NA	NA	NA	NA	NA	ADJUVANT	NA	16	NA
999	5a86d9f1-d38d-4b78-9a23-c7855a20ca2d	TCGA.14.0817	TCGA-14-0817-D25082	b67f2d3e-c6bd-49e8-b816-5ea9a429e39e	2009-4-24	DEXAMETHASONE	NA	HORMONE THERAPY	0	FALSE	15	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	176	NA
1000	31b21dcf-7e13-4522-8b34-a5eb6c0e5d1d	TCGA.14.0862	TCGA-14-0862-D25260	f837d61b-b4cd-4662-b4a4-8b5a2d044ee6	2010-6-24	DEXAMETHASONE	NA	HORMONE THERAPY	0	FALSE	NA	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1001	7d5c3699-ce28-4129-8391-736f670e8beb	TCGA.14.0865	TCGA-14-0865-D25086	dc1c8dd3-d749-445e-b5b4-5ae0a52eb352	2009-8-4	DEXAMETHASONE	NA	HORMONE THERAPY	0	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	OTHER	ADJUVANT AND PROGRESSION	NA	NA
1002	7d5c3699-ce28-4129-8391-736f670e8beb	TCGA.14.0865	TCGA-14-0865-D25087	57b0247a-48c4-4819-af9a-5db48d9712f4	2009-8-4	DEXAMETHASONE	NA	HORMONE THERAPY	205	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
1003	7d5c3699-ce28-4129-8391-736f670e8beb	TCGA.14.0865	TCGA-14-0865-D25085	72832b4f-838a-4c6f-bafe-0da6f61161f0	2009-8-4	TEMODAR	NA	CHEMOTHERAPY	46	FALSE	167	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	9500	NA
1004	c3432b21-d2e9-4caf-9c8e-c6a8d92b195d	TCGA.14.0866	TCGA-14-0866-D25092	0e1d7b1b-7f15-43ee-b6e0-2072981abe83	2009-9-1	TEMODAR	NA	CHEMOTHERAPY	21	FALSE	325	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	ORAL	NA	NA	OTHER	ADJUVANT AND PROGRESSION	62415	NA
1005	c3432b21-d2e9-4caf-9c8e-c6a8d92b195d	TCGA.14.0866	TCGA-14-0866-D25093	db490c11-6d6f-40f4-ad4f-5cd2f31338fc	2009-9-1	DEXAMETHASONE	NA	HORMONE THERAPY	0	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	OTHER	ADJUVANT AND PROGRESSION	NA	NA
1006	5c890137-e03c-4897-8af4-02aafa2fdb70	TCGA.14.0867	TCGA-14-0867-D25097	407fa4a7-c589-43e9-83e9-fb8d9312c09c	2009-4-24	DEXAMETHASONE	NA	HORMONE THERAPY	0	FALSE	15	NA	NA	NA	NA	NA	NA	MG/DAY	MG/DAY	NA	NA	NA	NA	NA	ADJUVANT	NA	24	NA
1007	72f88d18-03be-4b51-9f4a-1151521b7292	TCGA.14.0871	TCGA-14-0871-D25100	0e5266b1-8bae-4167-bdcd-28e12c0d0637	2009-4-24	DEXAMETHASONE	NA	HORMONE THERAPY	0	FALSE	281	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	288	NA
1008	0078b0c4-68a9-483b-9aab-61156d263213	TCGA.14.1034	TCGA-14-1034-D25104	481599a9-c1ab-4f91-948f-9cb624cfe760	2009-6-18	GLIADEL	NA	CHEMOTHERAPY	448	FALSE	NA	NA	NA	NA	NA	NA	NA	WAFER	WAFER	NA	NA	OTHER	NA	NA	PROGRESSION	NA	8	NA
1009	0078b0c4-68a9-483b-9aab-61156d263213	TCGA.14.1034	TCGA-14-1034-D25105	1b9a44e0-77c7-4b67-b563-3959c50ee3a6	2009-6-18	DEXAMETHASONE	NA	HORMONE THERAPY	8	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1010	0078b0c4-68a9-483b-9aab-61156d263213	TCGA.14.1034	TCGA-14-1034-D25106	0559b81b-1da8-4676-bc81-317d969df0d8	2009-6-18	DEXAMETHASONE	NA	HORMONE THERAPY	282	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
1011	6a9d719d-249a-4756-adc8-e92fa60da229	TCGA.14.1037	TCGA-14-1037-D25110	5959163d-ba39-4460-b729-6e97ec9c9665	2009-9-24	OXALIPLATIN	NA	CHEMOTHERAPY	25	FALSE	95	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1012	6a9d719d-249a-4756-adc8-e92fa60da229	TCGA.14.1037	TCGA-14-1037-D25113	651a26d2-4f94-440f-9b6a-becd3ea3c32b	2009-9-24	DEXAMETHASONE	NA	HORMONE THERAPY	326	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
1013	6a9d719d-249a-4756-adc8-e92fa60da229	TCGA.14.1037	TCGA-14-1037-D25114	3a37ced8-55de-4546-b52b-dcad78ef1292	2009-9-24	PS 341	NA	TARGETED MOLECULAR THERAPY	346	FALSE	433	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	36.8	NA
1014	6a9d719d-249a-4756-adc8-e92fa60da229	TCGA.14.1037	TCGA-14-1037-D25111	8a78bfe4-b33a-4547-b155-2d3f7521511b	2009-9-24	TEMODAR	NA	CHEMOTHERAPY	439	FALSE	538	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	6000	NA
1015	6a9d719d-249a-4756-adc8-e92fa60da229	TCGA.14.1037	TCGA-14-1037-D25112	035a2a61-6b32-4764-8ee4-4b79ce2068fd	2009-9-24	DEXAMETHASOME	NA	HORMONE THERAPY	0	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1016	a6cda2a0-21d9-4b72-a4c5-de1142d7ddb8	TCGA.14.1043	TCGA-14-1043-D25263	4e61d7e2-a930-4d63-95a6-aacbb8207eb3	2010-6-24	DEXAMETHASONE	NA	HORMONE THERAPY	0	FALSE	NA	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1017	74331114-65b1-4697-abc4-4769ff377528	TCGA.14.1395	TCGA-14-1395-D25268	94673533-4398-4cca-9638-8e0e2a586706	2009-8-5	DEXAMETHASONE	NA	HORMONE THERAPY	0	FALSE	41	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1018	74331114-65b1-4697-abc4-4769ff377528	TCGA.14.1395	TCGA-14-1395-D25267	3d56e39a-e1d0-42aa-afd9-a295597d2169	2009-8-5	OXALIPLATIN	NA	CHEMOTHERAPY	14	FALSE	28	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	679	NA
1019	aad2c954-39a4-4ef3-9940-e754619007a4	TCGA.14.1396	TCGA-14-1396-D25118	a4943fc9-ee68-46ea-8b2a-9c00c7500bcd	2009-6-4	DEXAMETHASONE	NA	HORMONE THERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1020	6176621d-8534-4fba-a0e7-74a5a78245a9	TCGA.14.1401	TCGA-14-1401-D25121	be419a3b-f37a-4ab5-b30d-61ea021bf0e6	2009-6-4	DEXAMETHSONE	NA	HORMONE THERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1021	bf339349-062f-4ea9-a0b2-d87d3a21099e	TCGA.14.1402	TCGA-14-1402-D25130	80090a14-1345-4380-8b22-5f4fc05d7a5d	2009-6-18	SOVATENIB	NA	TARGETED MOLECULAR THERAPY	619	FALSE	633	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	14000	NA
1022	bf339349-062f-4ea9-a0b2-d87d3a21099e	TCGA.14.1402	TCGA-14-1402-D25131	0d1c38bf-7c60-4fc2-9149-3c420c156104	2009-6-18	AVASTIN	NA	TARGETED MOLECULAR THERAPY	659	FALSE	832	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	11000	NA
1023	bf339349-062f-4ea9-a0b2-d87d3a21099e	TCGA.14.1402	TCGA-14-1402-D25128	132cdd53-5eb7-455e-a8d5-e2b3cfab2777	2009-6-18	PREDNISONE	NA	HORMONE THERAPY	316	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1024	bf339349-062f-4ea9-a0b2-d87d3a21099e	TCGA.14.1402	TCGA-14-1402-D25129	79ffa9e0-b3bc-4ac0-befa-d05356efa51f	2009-6-18	DEXAMETHASONE	NA	HORMONE THERAPY	333	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
1025	bf339349-062f-4ea9-a0b2-d87d3a21099e	TCGA.14.1402	TCGA-14-1402-D25126	c43bd7d3-1348-4e91-be1f-d66bd46b498e	2009-6-18	CARBOPLATIN	NA	CHEMOTHERAPY	659	FALSE	832	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	4969	NA
1026	bf339349-062f-4ea9-a0b2-d87d3a21099e	TCGA.14.1402	TCGA-14-1402-D25125	b9b0a238-9a8f-4771-8e21-950bc8bbfe7c	2009-6-18	ARSENIC TRIOXIDE	NA	CHEMOTHERAPY	57	FALSE	66	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	63	NA
1027	bf339349-062f-4ea9-a0b2-d87d3a21099e	TCGA.14.1402	TCGA-14-1402-D25124	50d9ad33-4de6-4c2a-bd24-0232c3a88065	2009-6-18	TEMODAR	NA	CHEMOTHERAPY	344	FALSE	529	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	9500	NA
1028	bf339349-062f-4ea9-a0b2-d87d3a21099e	TCGA.14.1402	TCGA-14-1402-D25127	98c55c34-612a-4d84-b7de-4deda9083cad	2009-6-18	DEXAMETHASONE	NA	HORMONE THERAPY	316	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1029	f2ec3b94-cb92-4335-bdf9-02c046130bab	TCGA.14.1450	TCGA-14-1450-D25271	267353ea-784c-4e54-81c8-59ffbf029f67	2010-6-24	TEMODAR	NA	CHEMOTHERAPY	22	FALSE	65	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	5160	NA
1030	f2ec3b94-cb92-4335-bdf9-02c046130bab	TCGA.14.1450	TCGA-14-1450-D25272	aab4da5f-682f-45b4-b2ae-c3b54ff29f11	2010-6-24	TEMODAR	NA	CHEMOTHERAPY	127	FALSE	961	NA	NA	NA	NA	15	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	19450	NA
1031	f2ec3b94-cb92-4335-bdf9-02c046130bab	TCGA.14.1450	TCGA-14-1450-D25274	64f42684-0e2d-4d1b-aee8-02de9b860760	2010-6-24	DEXAMETHASONE	NA	HORMONE THERAPY	826	FALSE	NA	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
1032	f2ec3b94-cb92-4335-bdf9-02c046130bab	TCGA.14.1450	TCGA-14-1450-D25275	5b5d48a7-0ce2-4999-bd68-7c532e641977	2010-6-24	AVASTIN	NA	TARGETED MOLECULAR THERAPY	1024	FALSE	1233	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	7800	NA
1033	f2ec3b94-cb92-4335-bdf9-02c046130bab	TCGA.14.1450	TCGA-14-1450-D25273	b300de81-feae-414d-911a-2a226c532909	2010-6-24	DEXAMETHASONE	NA	HORMONE THERAPY	0	FALSE	NA	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1034	06c427a1-8c2d-4003-b744-139114a04440	TCGA.14.1451	TCGA-14-1451-D25136	8a0dd3aa-91c8-49dd-8d30-99e4013e0a6d	2009-9-1	TEMODAR	NA	CHEMOTHERAPY	59	FALSE	101	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	5880	NA
1035	06c427a1-8c2d-4003-b744-139114a04440	TCGA.14.1451	TCGA-14-1451-D25135	5a723aeb-fd73-4767-893b-81b9cdfe6a20	2009-9-1	OXALIPLATIN	NA	CHEMOTHERAPY	20	FALSE	34	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	641	NA
1036	06c427a1-8c2d-4003-b744-139114a04440	TCGA.14.1451	TCGA-14-1451-D25142	7098c34d-95e8-4888-809e-16106791c34c	2009-9-1	DEXAMETHASONE	NA	HORMONE THERAPY	0	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1037	06c427a1-8c2d-4003-b744-139114a04440	TCGA.14.1451	TCGA-14-1451-D25137	d4f8aaaf-7484-46be-8ef5-551c6bc1d4e5	2009-9-1	GLIADEL	NA	CHEMOTHERAPY	153	FALSE	NA	NA	NA	NA	NA	NA	NA	WAFER	WAFER	NA	NA	OTHER	NA	NA	PROGRESSION	NA	8	NA
1038	06c427a1-8c2d-4003-b744-139114a04440	TCGA.14.1451	TCGA-14-1451-D25144	8455c774-2b7d-48a7-981b-e32355952b07	2009-9-1	ERLOTINIB	NA	TARGETED MOLECULAR THERAPY	382	FALSE	504	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	9000	NA
1039	06c427a1-8c2d-4003-b744-139114a04440	TCGA.14.1451	TCGA-14-1451-D25138	64107214-f1c0-4a37-a317-beffdbb5c893	2009-9-1	CISPLATIN	NA	CHEMOTHERAPY	411	FALSE	480	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	780	NA
1040	06c427a1-8c2d-4003-b744-139114a04440	TCGA.14.1451	TCGA-14-1451-D25141	635bb303-629a-4498-9447-d853d11cbd6a	2009-9-1	BCNU	NA	CHEMOTHERAPY	501	FALSE	566	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	720	NA
1041	06c427a1-8c2d-4003-b744-139114a04440	TCGA.14.1451	TCGA-14-1451-D25143	2ed70821-6738-4ab2-8489-8ec4634af692	2009-9-1	DEXAMETHASONE	NA	HORMONE THERAPY	19	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
1042	06c427a1-8c2d-4003-b744-139114a04440	TCGA.14.1451	TCGA-14-1451-D25139	0ff96534-8ac4-4e82-ad17-5afd2a0a6c43	2009-9-1	VINCRISTIN	NA	CHEMOTHERAPY	411	FALSE	480	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	8	NA
1043	06c427a1-8c2d-4003-b744-139114a04440	TCGA.14.1451	TCGA-14-1451-D25140	717c058e-3cde-4fb3-8de4-d71c1ecfbc20	2009-9-1	ETOPOSIDE	NA	CHEMOTHERAPY	411	FALSE	480	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	780	NA
1044	f82bfa67-4e72-4a09-8022-a2fe0050090f	TCGA.14.1452	TCGA-14-1452-D25151	b8cf7105-d43c-43e0-be07-d80fc3624355	2009-6-4	DEXAMETHASONE	NA	HORMONE THERAPY	172	FALSE	216	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	OTHER	ADJUVANT AND PROGRESSION	NA	NA
1045	f82bfa67-4e72-4a09-8022-a2fe0050090f	TCGA.14.1452	TCGA-14-1452-D25149	056a20e0-882c-4296-b3dd-3fe5f4473c9c	2009-6-4	TEMADOR	NA	CHEMOTHERAPY	26	FALSE	185	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	ORAL	NA	NA	OTHER	ADJUVANT AND PROGRESSION	NA	NA
1046	f82bfa67-4e72-4a09-8022-a2fe0050090f	TCGA.14.1452	TCGA-14-1452-D25150	fc581937-ec09-4b9a-8bbd-fae1140ac772	2009-6-4	DEXAMETHASONE	NA	HORMONE THERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1047	f82bfa67-4e72-4a09-8022-a2fe0050090f	TCGA.14.1452	TCGA-14-1452-D25148	c46ea9ec-9719-4328-83b4-76478e9d987c	2009-6-4	GLIADEL	NA	CHEMOTHERAPY	0	FALSE	NA	NA	NA	NA	NA	NA	NA	WAFER	WAFER	NA	NA	OTHER	NA	NA	ADJUVANT	NA	8	NA
1048	a9597785-a1d3-4788-a431-d25d69025690	TCGA.14.1453	TCGA-14-1453-D25155	f6bcbe10-beb8-4e99-9919-de0a8e481690	2009-6-4	DEXAMETHASONE	NA	HORMONE THERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1049	c2399f5d-dc29-42e9-81f1-1d164d4cc55d	TCGA.14.1454	TCGA-14-1454-D25161	9e7607d0-7f2f-4af3-937c-b544f1fac185	2009-6-4	HYDROXYUREA	NA	CHEMOTHERAPY	309	FALSE	900	NA	NA	NA	NA	18	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	NA	NA
1050	c2399f5d-dc29-42e9-81f1-1d164d4cc55d	TCGA.14.1454	TCGA-14-1454-D25159	5d5b80f4-0959-4c73-b2ea-15710d63c4fd	2009-6-4	TEMODAR	NA	CHEMOTHERAPY	29	FALSE	235	NA	NA	NA	NA	7	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	15370	NA
1051	c2399f5d-dc29-42e9-81f1-1d164d4cc55d	TCGA.14.1454	TCGA-14-1454-D25158	4d123551-7e26-4274-9b1f-4f0a2a52c65b	2009-6-4	GLIADEL	NA	CHEMOTHERAPY	0	FALSE	NA	NA	NA	NA	NA	NA	NA	WAFER	WAFER	NA	NA	OTHER	NA	NA	ADJUVANT	NA	8	NA
1052	c2399f5d-dc29-42e9-81f1-1d164d4cc55d	TCGA.14.1454	TCGA-14-1454-D25163	26b6e536-2974-4765-9de7-866c5d2f919d	2009-6-4	DEXAMETHASONE	NA	HORMONE THERAPY	291	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
1053	c2399f5d-dc29-42e9-81f1-1d164d4cc55d	TCGA.14.1454	TCGA-14-1454-D25160	b1aeba62-ae4a-4e78-98c4-763d7f496455	2009-6-4	GLEEVAC	NA	CHEMOTHERAPY	309	FALSE	900	NA	NA	NA	NA	18	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	NA	NA
1054	c2399f5d-dc29-42e9-81f1-1d164d4cc55d	TCGA.14.1454	TCGA-14-1454-D25162	c9c13316-6fcf-4444-9a2c-11453a167fb2	2009-6-4	DEXAMETHASONE	NA	HORMONE THERAPY	0	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1055	04b4ebb4-6780-42d8-a980-711cd10cfe14	TCGA.14.1455	TCGA-14-1455-D25168	7a1e2a51-d117-48fe-b2a5-e8d911f09812	2009-8-5	DEXAMETHASONE	NA	HORMONE THERAPY	17	FALSE	28	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1056	04b4ebb4-6780-42d8-a980-711cd10cfe14	TCGA.14.1455	TCGA-14-1455-D25167	4b7d9d48-cc66-4756-b880-f9db54273088	2009-8-5	GLIADEL WAFER	NA	CHEMOTHERAPY	17	FALSE	NA	NA	NA	NA	NA	NA	NA	WAFER	WAFER	NA	NA	OTHER	NA	NA	ADJUVANT	NA	8	NA
1057	0fe6684a-5ab2-4999-b69d-d99aa5679c97	TCGA.14.1456	TCGA-14-1456-D25171	e7e06d7b-44bd-401d-8a20-70cff0e9b4fc	2010-5-28	ARSENIC TNOXIDE	NA	CHEMOTHERAPY	25	FALSE	70	NA	NA	NA	NA	13	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	290.94	NA
1058	0fe6684a-5ab2-4999-b69d-d99aa5679c97	TCGA.14.1456	TCGA-14-1456-D25173	ad7bfeb2-d697-4a1e-870a-9b7aff74eacb	2010-5-28	DEXAMTHASONE	NA	HORMONE THERAPY	98	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
1059	0fe6684a-5ab2-4999-b69d-d99aa5679c97	TCGA.14.1456	TCGA-14-1456-D25175	fbd2e658-a19f-42cc-a91f-8ee37d2451f5	2010-5-28	TARCEVA	NA	TARGETED MOLECULAR THERAPY	102	FALSE	549	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	PROGRESSION	NA	NA	NA
1060	0fe6684a-5ab2-4999-b69d-d99aa5679c97	TCGA.14.1456	TCGA-14-1456-D25172	24842149-423e-4afa-8fb2-36c79f9f3041	2010-5-28	DEXAMETHASONE	NA	HORMONE THERAPY	0	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1061	0fe6684a-5ab2-4999-b69d-d99aa5679c97	TCGA.14.1456	TCGA-14-1456-D25176	c5f32374-290a-460d-b172-558dd6b9ccaf	2010-5-28	AVASTIN	NA	TARGETED MOLECULAR THERAPY	1129	TRUE	1246	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	3344	NA
1062	0fe6684a-5ab2-4999-b69d-d99aa5679c97	TCGA.14.1456	TCGA-14-1456-D25174	657bea6d-6fdc-4b59-a9eb-2a9d5fd704bb	2010-5-28	AVASTIN	NA	TARGETED MOLECULAR THERAPY	102	FALSE	1128	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	11704	NA
1063	5d2487b9-e0cd-40fc-a158-7b1803c8dc88	TCGA.14.1458	TCGA-14-1458-D25183	c3b771dc-8898-4007-a4b3-4e0f11139bd8	2009-8-5	DEXAMETHASONE	NA	HORMONE THERAPY	81	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
1064	5d2487b9-e0cd-40fc-a158-7b1803c8dc88	TCGA.14.1458	TCGA-14-1458-D25182	d777e33e-b425-44cf-a8e1-0c10862d2164	2009-8-5	DEXAETHASONE	NA	HORMONE THERAPY	0	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1065	5d2487b9-e0cd-40fc-a158-7b1803c8dc88	TCGA.14.1458	TCGA-14-1458-D25180	0fb75b64-638f-4e15-99f4-f14e872ad34a	2009-8-5	TEMODAR	NA	CHEMOTHERAPY	19	FALSE	61	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	8400	NA
1066	5d2487b9-e0cd-40fc-a158-7b1803c8dc88	TCGA.14.1458	TCGA-14-1458-D25184	c260921d-74dd-4f7f-83b8-855ce5d89b68	2009-8-5	AVASTIN	NA	TARGETED MOLECULAR THERAPY	89	FALSE	162	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	10400	NA
1067	5d2487b9-e0cd-40fc-a158-7b1803c8dc88	TCGA.14.1458	TCGA-14-1458-D25181	45443fa9-2905-401d-ac82-a4e7b0437a53	2009-8-5	TEMODAR	NA	CHEMOTHERAPY	83	FALSE	146	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	6450	NA
1068	0798dbe2-1914-427c-a2fe-2a865d0d6eda	TCGA.14.1459	TCGA-14-1459-D25190	35ae9d89-ffc3-4aef-804f-60befa00a363	2009-6-18	DEXAMETHASONE	NA	HORMONE THERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
1069	0798dbe2-1914-427c-a2fe-2a865d0d6eda	TCGA.14.1459	TCGA-14-1459-D25189	77ded3d0-e5c6-4d1e-b2fc-8ca615849d72	2009-6-18	DEXAMETHASONE	NA	HORMONE THERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1070	0798dbe2-1914-427c-a2fe-2a865d0d6eda	TCGA.14.1459	TCGA-14-1459-D25188	37db2378-7803-4e64-a9f7-5a85ed041075	2009-6-18	TEMODAR	NA	CHEMOTHERAPY	22	FALSE	NA	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	9000	NA
1071	eb9c8e66-6710-4141-ae28-1e5c88eaee47	TCGA.14.1794	TCGA-14-1794-D25194	6225f9b2-5bbc-4687-93e9-fad600edf8ac	2009-8-4	DEXAMETHASONE	NA	HORMONE THERAPY	0	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1072	7db115ea-082b-45bb-97d2-4254270b8bb6	TCGA.14.1795	TCGA-14-1795-D25199	867e343c-b596-4161-9e35-a0e13eb00078	2009-8-4	DEXAMETHASONE	NA	HORMONE THERAPY	0	FALSE	60	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1073	7db115ea-082b-45bb-97d2-4254270b8bb6	TCGA.14.1795	TCGA-14-1795-D25198	20469a2e-398e-4c85-9e9b-0ef302b804df	2009-8-4	GLIADEL WAFER	NA	CHEMOTHERAPY	0	FALSE	NA	NA	NA	NA	NA	NA	NA	WAFER	WAFER	NA	NA	OTHER	NA	NA	ADJUVANT	NA	8	NA
1074	38dd826d-06dc-4a73-b852-c3d78c9c3ff4	TCGA.14.1821	TCGA-14-1821-D25204	f92eda1c-eb5b-4931-a78d-c67ed469b91b	2009-9-1	DEXAMETHASONE	NA	HORMONE THERAPY	331	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
1075	38dd826d-06dc-4a73-b852-c3d78c9c3ff4	TCGA.14.1821	TCGA-14-1821-D25203	c3b96b1d-5927-4053-9d0c-643ec9d447e5	2009-9-1	DEXAMETHASONE	NA	HORMONE THERAPY	0	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1076	38dd826d-06dc-4a73-b852-c3d78c9c3ff4	TCGA.14.1821	TCGA-14-1821-D25202	5ba80971-a029-4f90-b541-362e9c41cdf0	2009-9-1	TEMODAR	NA	CHEMOTHERAPY	40	FALSE	69	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	5400	NA
1077	a515cf2d-e918-4958-9bf6-e611b425a97e	TCGA.14.1823	TCGA-14-1823-D25210	cc7fead6-2362-4d18-8365-789dd481e745	2009-9-1	TEMODAR	NA	CHEMOTHERAPY	20	FALSE	450	NA	NA	NA	NA	12	NA	NA	NA	NA	NA	ORAL	NA	NA	PROGRESSION	NA	NA	NA
1078	a515cf2d-e918-4958-9bf6-e611b425a97e	TCGA.14.1823	TCGA-14-1823-D25212	ddb76e62-002b-4cd0-ba5d-0a23fca25385	2009-9-1	DEXAMETHASONE	NA	HORMONE THERAPY	140	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
1079	a515cf2d-e918-4958-9bf6-e611b425a97e	TCGA.14.1823	TCGA-14-1823-D25211	8aeb5e41-29fe-4927-b642-57a663284ce4	2009-9-1	DEXAMETHASONE	NA	HORMONE THERAPY	0	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1080	a515cf2d-e918-4958-9bf6-e611b425a97e	TCGA.14.1823	TCGA-14-1823-D25213	013524ad-d67f-442b-9e30-786a97a0a844	2009-9-1	AVASTIN	NA	TARGETED MOLECULAR THERAPY	378	FALSE	478	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	6400	NA
1081	a515cf2d-e918-4958-9bf6-e611b425a97e	TCGA.14.1823	TCGA-14-1823-D25209	497f874d-9a15-4bba-a92c-5fb30dc5c8c5	2009-9-1	GLIADEL WAFERS	NA	CHEMOTHERAPY	0	FALSE	NA	NA	NA	NA	NA	NA	NA	WAFER	WAFER	NA	NA	OTHER	NA	NA	ADJUVANT	NA	8	NA
1082	a515cf2d-e918-4958-9bf6-e611b425a97e	TCGA.14.1823	TCGA-14-1823-D25208	ed86c9b7-dd08-4e44-8640-ab68b0cc5aac	2009-9-1	TEMODAR	NA	CHEMOTHERAPY	20	FALSE	450	NA	NA	NA	NA	12	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	11150	NA
1083	e0e1b5b3-6e3c-4b79-aa2a-32b320c3e45a	TCGA.14.1825	TCGA-14-1825-D25218	6cea8846-84fd-4280-9857-ad3448aa5721	2009-9-23	DEXAMETHASONE	NA	HORMONE THERAPY	82	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
1084	e0e1b5b3-6e3c-4b79-aa2a-32b320c3e45a	TCGA.14.1825	TCGA-14-1825-D25217	68d713bb-3122-4dd6-9d84-95ed36649c8b	2009-9-23	DEXAMETHASONE	NA	HORMONE THERAPY	0	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1085	61ed8fbd-b753-451e-9683-edd4b266b0f3	TCGA.14.1827	TCGA-14-1827-D25223	c442e895-f214-41ab-a3c2-9659b3de3cd9	2009-9-23	BCNU	NA	CHEMOTHERAPY	42	FALSE	46	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1086	61ed8fbd-b753-451e-9683-edd4b266b0f3	TCGA.14.1827	TCGA-14-1827-D25224	761df7b6-6aef-46d2-8c2d-128e9cf76cc0	2009-9-23	DEXAMETHASONE	NA	HORMONE THERAPY	0	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1087	61ed8fbd-b753-451e-9683-edd4b266b0f3	TCGA.14.1827	TCGA-14-1827-D25222	7310a57a-0583-448c-bb6f-988c4a54a2b3	2009-9-23	CISPLATIN	NA	CHEMOTHERAPY	42	FALSE	46	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1088	47a4161c-9c61-48f5-b9bc-a6d1acad4e5a	TCGA.14.1829	TCGA-14-1829-D25227	c10a50b8-82ee-4a71-8e50-167ffed274e9	2009-9-24	TEMODAR	NA	CHEMOTHERAPY	8	TRUE	NA	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	10040	NA
1089	47a4161c-9c61-48f5-b9bc-a6d1acad4e5a	TCGA.14.1829	TCGA-14-1829-D25228	f8f4e4dc-4709-4604-8d62-a0dba0b985b6	2009-9-24	DEXAMETHASONE	NA	HORMONE THERAPY	0	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1090	b1c4579c-72fa-4974-830c-b6a81ace45f4	TCGA.14.2554	TCGA-14-2554-D25232	bfc2a2aa-a7c2-4655-bdfa-33fcf7c67d4d	2010-2-5	DEXAMETHASONE	NA	HORMONE THERAPY	0	FALSE	NA	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1091	5aa15b7f-35c7-4022-b1b2-74a4f6d3ea85	TCGA.14.2555	TCGA-14-2555-D25236	d8218c10-efee-45cf-8eea-846db9fa0344	2010-5-11	TEMODAR	NA	CHEMOTHERAPY	34	FALSE	242	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	12600	NA
1092	5aa15b7f-35c7-4022-b1b2-74a4f6d3ea85	TCGA.14.2555	TCGA-14-2555-D25237	d17bb6b6-d2b3-4bca-90a6-bc2800ffe5dc	2010-5-11	DEXAMETHASONE	NA	HORMONE THERAPY	0	FALSE	NA	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1093	872511fb-98cd-4fba-82f6-4c3689c75ae2	TCGA.14.3476	TCGA-14-3476-D25241	25c1218c-52a6-44e7-8615-aaa67959e335	2010-7-12	DEXAMETHASONE	NA	HORMONE THERAPY	0	FALSE	NA	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1094	60e47b7d-c664-46c0-ac13-db688d4b8a58	TCGA.14.3477	TCGA-14-3477-D25245	7bc687c3-8e74-4257-b92f-fbb03f27aac6	2010-5-11	DEXAMETHASONE	NA	HORMONE THERAPY	0	NA	NA	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1095	60e47b7d-c664-46c0-ac13-db688d4b8a58	TCGA.14.3477	TCGA-14-3477-D25246	cfef5cf5-f87f-47d5-9c2b-daedec621936	2010-5-11	AVASTIN	NA	TARGETED MOLECULAR THERAPY	56	FALSE	70	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	1480	NA
1096	60e47b7d-c664-46c0-ac13-db688d4b8a58	TCGA.14.3477	TCGA-14-3477-D25244	e496775a-7f9e-4268-a03a-37fbac6adf30	2010-5-11	TEMODAR	NA	CHEMOTHERAPY	35	FALSE	67	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	4480	NA
1097	38acdfc8-8abc-4d89-a68b-58c493650b48	TCGA.14.4157	TCGA-14-4157-D25252	90cabd44-8b4f-4c75-a5df-20af442aaf3e	2010-7-12	DEXAMETHASONE	NA	HORMONE THERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1098	38acdfc8-8abc-4d89-a68b-58c493650b48	TCGA.14.4157	TCGA-14-4157-D25250	c3e0e6df-f66f-479e-9cd2-1d7e3730919c	2010-7-12	TEMODAR	NA	CHEMOTHERAPY	19	FALSE	67	NA	NA	NA	NA	NA	NA	MG	MG	75	NA	ORAL	NA	NA	ADJUVANT	NA	3600	NA
1099	38acdfc8-8abc-4d89-a68b-58c493650b48	TCGA.14.4157	TCGA-14-4157-D25251	ee3325c2-5318-4dd7-8c21-098249464fdd	2010-7-12	TEMODAR	NA	CHEMOTHERAPY	96	TRUE	NA	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	355	NA
1100	f19850cb-50c4-4f3a-ba80-b1464958ffa8	TCGA.15.0742	TCGA-15-0742-D25280	a8f06a13-5d95-484e-af93-7ca10c8c280d	2009-4-24	SAHA	NA	TARGETED MOLECULAR THERAPY	259	FALSE	300	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	200	NA
1101	f19850cb-50c4-4f3a-ba80-b1464958ffa8	TCGA.15.0742	TCGA-15-0742-D25279	899b41e7-c294-4a04-92a4-9f0ee787a22f	2009-4-24	TEMOZOLOMIDE	NA	CHEMOTHERAPY	28	FALSE	59	NA	NA	NA	NA	NA	NA	MG/M2/DAY	MG/M2/DAY	NA	NA	ORAL	NA	NA	ADJUVANT	NA	75	NA
1102	4c42dc4e-66b7-40bf-9fbe-b92543248198	TCGA.15.1444	TCGA-15-1444-D41928	A7691528-3F1B-43A5-A3CC-994A237A391C	2013-4-4	BCNU	NA	CHEMOTHERAPY	38	FALSE	72	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TRUE
1103	4c42dc4e-66b7-40bf-9fbe-b92543248198	TCGA.15.1444	TCGA-15-1444-D46090	9A137468-4D2D-42E0-AAA8-076A86B46974	2013-7-31	CPT-11	NA	CHEMOTHERAPY	38	FALSE	72	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TRUE
1104	05d5da50-52fe-4342-9c15-9ee4c1d6662e	TCGA.15.1446	TCGA-15-1446-D25284	d98d9b83-5d4c-4629-9afc-bb51df4de4ea	2009-5-11	TEMODAR	NA	CHEMOTHERAPY	68	FALSE	280	NA	NA	NA	NA	6	NA	NA	NA	NA	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1105	03e9a354-7c95-4484-9ead-ed04acce7cb6	TCGA.15.1447	TCGA-15-1447-D25290	e1170fd5-43e8-4a6f-8b20-7e4f7db8106f	2009-5-11	TEMODAR	NA	CHEMOTHERAPY	9	FALSE	130	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1106	03e9a354-7c95-4484-9ead-ed04acce7cb6	TCGA.15.1447	TCGA-15-1447-D25289	ce1dd0d5-8c93-4518-8dcb-1ff16640068b	2009-5-11	BCNU	NA	CHEMOTHERAPY	9	FALSE	130	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1107	03e9a354-7c95-4484-9ead-ed04acce7cb6	TCGA.15.1447	TCGA-15-1447-D25288	d618cb6a-5390-4e65-9d86-fcc7d5be0737	2009-5-11	CPT-11	NA	CHEMOTHERAPY	9	FALSE	130	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1108	2749c671-dee1-4d91-b3fa-4b50accf7a11	TCGA.15.1449	TCGA-15-1449-D25294	3e384279-b84a-4a41-b916-91c6b0233497	2009-5-11	TEMODAR	NA	CHEMOTHERAPY	32	FALSE	74	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1109	f473a0d0-72b6-465e-93f7-122224960e80	TCGA.19.0955	TCGA-19-0955-D25336	26fd8e07-facd-4b36-a5b2-cbd20f8131b2	2009-4-24	TEMOZOLOMIDE	NA	CHEMOTHERAPY	31	FALSE	277	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	360	NA
1110	a589e2dc-7649-492c-9569-592698acaa6f	TCGA.19.0957	TCGA-19-0957-D25342	14ca8af8-9943-4c2d-b0ca-de8f24430edd	2009-9-18	TEMOZOLOMIDE	NA	CHEMOTHERAPY	35	FALSE	81	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	ORAL	NA	NA	OTHER	CONCURRENT	5880	NA
1111	a589e2dc-7649-492c-9569-592698acaa6f	TCGA.19.0957	TCGA-19-0957-D25345	360c973d-54ec-4d7d-8cdb-d3d5668ff31e	2009-9-18	AVASTIN	NA	CHEMOTHERAPY	538	FALSE	552	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	1660	NA
1112	a589e2dc-7649-492c-9569-592698acaa6f	TCGA.19.0957	TCGA-19-0957-D25348	1850ca9d-14e8-42d8-955a-3c27864531e3	2009-9-18	IRINOTECAN	NA	CHEMOTHERAPY	594	FALSE	608	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	470	NA
1113	a589e2dc-7649-492c-9569-592698acaa6f	TCGA.19.0957	TCGA-19-0957-D25341	04d630b3-57ba-470a-8bed-10679de0cf64	2009-9-18	AVASTIN	NA	CHEMOTHERAPY	566	FALSE	580	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	1660	NA
1114	a589e2dc-7649-492c-9569-592698acaa6f	TCGA.19.0957	TCGA-19-0957-D25343	24409f69-b2c5-43ac-88a7-0754faa77c84	2009-9-18	TEMOZOLOMIDE	NA	CHEMOTHERAPY	120	FALSE	273	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	9000	NA
1115	a589e2dc-7649-492c-9569-592698acaa6f	TCGA.19.0957	TCGA-19-0957-D25347	9c93da98-3825-4f5c-bbaa-14f56cc91754	2009-9-18	AVASTIN	NA	CHEMOTHERAPY	594	FALSE	608	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	1660	NA
1116	a589e2dc-7649-492c-9569-592698acaa6f	TCGA.19.0957	TCGA-19-0957-D25344	6d8eb8d5-11fe-4242-a274-5d40ffd7e152	2009-9-18	TEMOZOLOMIDE	NA	CHEMOTHERAPY	368	FALSE	372	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	RECURRENCE	NA	1500	NA
1117	a589e2dc-7649-492c-9569-592698acaa6f	TCGA.19.0957	TCGA-19-0957-D25346	be2852c1-7820-410b-b8ef-905b166e6f62	2009-9-18	IRINOTECAN	NA	CHEMOTHERAPY	538	FALSE	552	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	470	NA
1118	37a47ea2-1daa-44a4-ade5-84d383c2b13c	TCGA.19.0960	TCGA-19-0960-D25352	b938861f-4bdc-4ea0-b0cf-a3fb1945bf28	2009-4-24	TEMODAR	NA	CHEMOTHERAPY	42	NA	NA	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	300	NA
1119	163e93a7-4d8d-4f28-a9f6-4d0ed16630cd	TCGA.19.0963	TCGA-19-0963-D25358	96f4d7fa-78d9-4b37-a7db-055104bb6ea1	2011-5-23	TEMODAR	NA	CHEMOTHERAPY	34	FALSE	84	NA	NA	NA	NA	1	NA	MG	MG	120	NA	ORAL	NA	NA	ADJUVANT	NA	5160	NA
1120	163e93a7-4d8d-4f28-a9f6-4d0ed16630cd	TCGA.19.0963	TCGA-19-0963-D25359	aef5b565-0635-4d4a-8b39-17171e573aff	2011-5-23	TEMODAR	NA	CHEMOTHERAPY	129	FALSE	270	NA	NA	NA	NA	5	NA	MG	MG	260	NA	ORAL	NA	NA	ADJUVANT	NA	6500	NA
1121	746aa9fb-0af2-4719-9d48-56e9bf21260c	TCGA.19.0964	TCGA-19-0964-D25363	3d52a89f-8403-4463-965f-0141778e4c4b	2009-4-24	TEMODAR	NA	CHEMOTHERAPY	39	FALSE	82	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	140	NA
1122	a79b97df-d7f7-4df4-861b-936f94a1ab30	TCGA.19.1385	TCGA-19-1385-D25367	9e055320-82a9-46d5-8d65-5eaf85562740	2009-9-18	TEMOZOLOMIDE	NA	CHEMOTHERAPY	89	FALSE	93	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	1600	NA
1123	a79b97df-d7f7-4df4-861b-936f94a1ab30	TCGA.19.1385	TCGA-19-1385-D25368	ed13e1a1-fa5d-4c8d-b02f-61d4a7821134	2009-9-18	TEMOZOLOMIDE	NA	CHEMOTHERAPY	16	FALSE	57	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	ORAL	NA	NA	OTHER	CONCURRENT	6300	NA
1124	fb86044c-161e-41d7-a49e-3d5ec18294ef	TCGA.19.1386	TCGA-19-1386-D25374	14955f76-9f30-4b23-afd7-f87bc7d0a5e7	2009-9-18	TEMOZOLOMIDE	NA	CHEMOTHERAPY	89	FALSE	93	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	1500	NA
1125	fb86044c-161e-41d7-a49e-3d5ec18294ef	TCGA.19.1386	TCGA-19-1386-D25372	4022af6a-7755-4d96-9e5f-b344d5535609	2009-9-18	TARCEVA	NA	CHEMOTHERAPY	230	FALSE	236	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	1050	NA
1126	fb86044c-161e-41d7-a49e-3d5ec18294ef	TCGA.19.1386	TCGA-19-1386-D25375	39301c45-4b69-469f-b8d1-283d326f9b87	2009-9-18	TEMOZOLOMIDE	NA	CHEMOTHERAPY	142	FALSE	234	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	6000	NA
1127	fb86044c-161e-41d7-a49e-3d5ec18294ef	TCGA.19.1386	TCGA-19-1386-D25376	43d0e9ed-9b50-4d43-8947-28a56fc44214	2009-9-18	TARCEVA	NA	CHEMOTHERAPY	216	FALSE	229	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	1800	NA
1128	fb86044c-161e-41d7-a49e-3d5ec18294ef	TCGA.19.1386	TCGA-19-1386-D25373	31dcf874-913a-43bb-8f61-89a333c12aa3	2009-9-18	TEMOZOLOMIDE	NA	CHEMOTHERAPY	21	FALSE	62	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	5880	NA
1129	2f8b698a-cbd0-4cab-a814-dc683e0e9305	TCGA.19.1387	TCGA-19-1387-D25380	3877b4a8-5327-42fe-bdde-8b1d4625b419	2009-9-18	TEMOZOLOMIDE	NA	CHEMOTHERAPY	19	FALSE	58	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	OTHER	CONCURRENT	5600	NA
1130	166e76db-ccd8-4760-a517-d2bc8937ea29	TCGA.19.1388	TCGA-19-1388-D25386	cf7374cb-a6a9-42f1-931c-954fc1816e9b	2009-9-18	TEMOZOLOMIDE	NA	CHEMOTHERAPY	97	FALSE	250	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	ORAL	NA	NA	OTHER	MAINTENANCE	9000	NA
1131	166e76db-ccd8-4760-a517-d2bc8937ea29	TCGA.19.1388	TCGA-19-1388-D25387	0fc6b81d-48d8-4452-a177-a2f6e0a00739	2009-9-18	TEMOZOLOMIDE	NA	CHEMOTHERAPY	269	FALSE	328	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	6000	NA
1132	166e76db-ccd8-4760-a517-d2bc8937ea29	TCGA.19.1388	TCGA-19-1388-D25385	0a9211ea-5201-497e-b0e7-2a5ada1265b0	2009-9-18	TEMOZOLOMIDE	NA	CHEMOTHERAPY	21	FALSE	63	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	OTHER	CONCURRENT	6020	NA
1133	166e76db-ccd8-4760-a517-d2bc8937ea29	TCGA.19.1388	TCGA-19-1388-D25384	d543db84-0ece-4c38-88fc-808f302c136c	2009-9-18	AVASTIN	NA	CHEMOTHERAPY	363	FALSE	377	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	1750	NA
1134	309005a2-93a8-4566-b8d3-6b9310144266	TCGA.19.1389	TCGA-19-1389-D25391	7ecb0132-2d24-46f6-bb0c-e7e5c02f164f	2009-9-18	TEMOZOLOMIDE	NA	CHEMOTHERAPY	48	FALSE	67	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	3600	NA
1135	309005a2-93a8-4566-b8d3-6b9310144266	TCGA.19.1389	TCGA-19-1389-D25393	235380ac-cead-4233-b72a-4a3e8ce912ed	2009-9-18	TEMOZOLOMIDE	NA	CHEMOTHERAPY	26	FALSE	41	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	2880	NA
1136	309005a2-93a8-4566-b8d3-6b9310144266	TCGA.19.1389	TCGA-19-1389-D25392	7eacf5b1-a361-4278-b6ff-9f1079b12195	2009-9-18	TEMOZOLOMIDE	NA	CHEMOTHERAPY	10	FALSE	20	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	1980	NA
1137	456bcab3-165d-456f-94e3-f34f81a61d2e	TCGA.19.1787	TCGA-19-1787-D25404	2d3e555d-c826-4d8b-87c9-06c8fcabc165	2010-8-31	TEMODAR	NA	CHEMOTHERAPY	42	FALSE	85	NA	NA	NA	NA	1	NA	MG	MG	140	NA	ORAL	NA	NA	ADJUVANT	NA	5880	NA
1138	456bcab3-165d-456f-94e3-f34f81a61d2e	TCGA.19.1787	TCGA-19-1787-D25406	d4937992-314a-42b9-921a-6d6e28f7fe4d	2010-8-31	AVASTIN	NA	CHEMOTHERAPY	312	FALSE	347	NA	NA	NA	NA	3	NA	MG	MG	10	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	900	NA
1139	456bcab3-165d-456f-94e3-f34f81a61d2e	TCGA.19.1787	TCGA-19-1787-D25407	34552695-2d81-4bde-b1e8-e64618e270de	2010-9-1	TEMODAR	NA	CHEMOTHERAPY	42	FALSE	85	NA	NA	NA	NA	1	NA	MG	MG	140	NA	ORAL	NA	NA	ADJUVANT	NA	5880	NA
1140	456bcab3-165d-456f-94e3-f34f81a61d2e	TCGA.19.1787	TCGA-19-1787-D25405	043b39cc-a8ba-48c0-b8c1-be1f39a79b57	2010-8-31	TEMODAR	NA	CHEMOTHERAPY	112	FALSE	264	NA	NA	NA	NA	6	NA	MG	MG	280	NA	ORAL	NA	NA	ADJUVANT	NA	9200	NA
1141	9a41f05b-19b1-4269-9997-4b59e378280c	TCGA.19.1788	TCGA-19-1788-D25411	6020fe07-bd82-42b4-b5e8-1e0a78bbe3dc	2009-9-21	TEMOZOLOMIDE	NA	CHEMOTHERAPY	50	FALSE	95	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1142	3a56ef5c-9259-4cdc-905e-5fcf21dac09b	TCGA.19.1789	TCGA-19-1789-D25415	5b539549-8052-478a-ab35-55a0b95c5567	2009-9-21	TEMOZOLOMIDE	NA	CHEMOTHERAPY	26	FALSE	32	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	980	NA
1143	aeeaf19a-3b0d-4c79-a029-44642581f4d8	TCGA.19.1790	TCGA-19-1790-D25419	09a73d22-88d6-418e-9a82-bc80773c6f8c	2010-6-7	TEMOZOLOMIDE	NA	CHEMOTHERAPY	25	FALSE	66	NA	NA	NA	NA	1	NA	MG	MG	140	NA	ORAL	NA	NA	ADJUVANT	NA	5880	NA
1144	f2de4316-026c-4c2d-b091-47bc0ec8612a	TCGA.19.2619	TCGA-19-2619-D25426	ba1a26d3-22c9-4f3b-b132-8b049a04c798	2010-5-14	TEMOZOLOMIDE	NA	CHEMOTHERAPY	113	FALSE	117	NA	NA	NA	NA	1	NA	MG	MG	250	NA	ORAL	NA	NA	ADJUVANT	NA	1250	NA
1145	f2de4316-026c-4c2d-b091-47bc0ec8612a	TCGA.19.2619	TCGA-19-2619-D25427	ff015cdc-b5e4-47e7-9a29-c0e3ceb2e408	2010-5-14	AVASTIN	NA	CHEMOTHERAPY	153	FALSE	295	NA	NA	NA	NA	10	NA	MG	MG	630	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	630	NA
1146	f2de4316-026c-4c2d-b091-47bc0ec8612a	TCGA.19.2619	TCGA-19-2619-D25425	7b0ae2f8-51aa-4c3f-a860-5b6b6763e6cd	2010-5-14	TEMOZOLOMIDE	NA	CHEMOTHERAPY	57	FALSE	85	NA	NA	NA	NA	1	NA	MG	MG	125	NA	ORAL	NA	NA	ADJUVANT	NA	3625	NA
1147	352768f9-3ce1-419c-beef-6515c78f5d7a	TCGA.19.2620	TCGA-19-2620-D25432	b13b00a7-5216-4c87-a6dd-3acaf18dca53	2010-5-12	TEMOZOLOMIDE	NA	CHEMOTHERAPY	33	FALSE	51	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1148	c01ae0ee-fa58-45d2-ac33-d7f64d053bbb	TCGA.19.2623	TCGA-19-2623-D25438	2f5f297f-99e8-423f-894b-44055a57b381	2010-5-12	TEMODAR	NA	CHEMOTHERAPY	25	FALSE	53	NA	NA	NA	NA	1	NA	MG	MG	140	NA	ORAL	NA	NA	ADJUVANT	NA	4060	NA
1149	c01ae0ee-fa58-45d2-ac33-d7f64d053bbb	TCGA.19.2623	TCGA-19-2623-D25440	dc93a9f5-ba29-495a-80de-b93944c63ba1	2010-5-12	TEMODAR	NA	CHEMOTHERAPY	105	TRUE	NA	NA	NA	NA	NA	5	NA	MG	MG	240	NA	ORAL	NA	NA	ADJUVANT	NA	1200	NA
1150	c01ae0ee-fa58-45d2-ac33-d7f64d053bbb	TCGA.19.2623	TCGA-19-2623-D25439	6689f023-ff02-4b0c-aeaa-52e2f6356e5c	2010-5-12	TEMODAR	NA	CHEMOTHERAPY	110	FALSE	114	NA	NA	NA	NA	1	NA	MG	MG	280	NA	ORAL	NA	NA	ADJUVANT	NA	1400	NA
1151	e17a6048-7a72-42c0-ad3f-97cbff02bc9f	TCGA.19.2629	TCGA-19-2629-D25450	37f44132-8d6e-4fac-a9f7-6b585818d149	2010-5-12	AVASTIN	NA	CHEMOTHERAPY	148	FALSE	198	NA	NA	NA	NA	4	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1152	e17a6048-7a72-42c0-ad3f-97cbff02bc9f	TCGA.19.2629	TCGA-19-2629-D25448	d04a8256-7480-48b0-9c5f-f9c2518a664b	2010-5-12	TEMODAR	NA	CHEMOTHERAPY	10	FALSE	69	NA	NA	NA	NA	1	NA	MG	MG	180	NA	ORAL	NA	NA	ADJUVANT	NA	7560	NA
1153	e17a6048-7a72-42c0-ad3f-97cbff02bc9f	TCGA.19.2629	TCGA-19-2629-D25449	9984f16f-f51d-4442-b8a0-a062b31a3d7e	2010-5-12	TEMODAR	NA	CHEMOTHERAPY	104	FALSE	135	NA	NA	NA	NA	2	NA	MG	MG	350	NA	ORAL	NA	NA	ADJUVANT	NA	3500	NA
1154	a262928c-e20a-4c02-8114-1227e05c43e1	TCGA.19.4065	TCGA-19-4065-D25515	76440094-05a1-44a1-9521-83116d548629	2010-6-8	TEMOZOLOMIDE	NA	CHEMOTHERAPY	166	FALSE	170	NA	NA	NA	NA	1	NA	MG	MG	480	NA	ORAL	NA	NA	RECURRENCE	NA	2400	NA
1155	a262928c-e20a-4c02-8114-1227e05c43e1	TCGA.19.4065	TCGA-19-4065-D25512	51b3924b-67b9-4de7-bf7d-d4287a358898	2010-6-8	TEMOZOLOMIDE	NA	CHEMOTHERAPY	39	FALSE	70	NA	NA	NA	NA	1	NA	MG	MG	180	NA	ORAL	NA	NA	ADJUVANT	NA	5400	NA
1156	a262928c-e20a-4c02-8114-1227e05c43e1	TCGA.19.4065	TCGA-19-4065-D25514	303c8d9e-20a9-4504-a4b7-54e01b834c49	2010-6-8	TEMOZOLOMIDE	NA	CHEMOTHERAPY	123	FALSE	128	NA	NA	NA	NA	1	NA	MG	MG	360	NA	ORAL	NA	NA	RECURRENCE	NA	1800	NA
1157	a262928c-e20a-4c02-8114-1227e05c43e1	TCGA.19.4065	TCGA-19-4065-D25513	67c05236-39f1-4a0c-8767-f97ded3430df	2010-6-8	TEMOZOLOMIDE	NA	CHEMOTHERAPY	78	FALSE	89	NA	NA	NA	NA	1	NA	MG	MG	180	NA	ORAL	NA	NA	RECURRENCE	NA	2160	NA
1158	ef646014-78a9-43af-b6fa-85fa288cd51b	TCGA.19.4068	TCGA-19-4068-D25457	fd73b404-953e-4f64-af37-6d0e7474032f	2010-6-8	TEMODAR	NA	CHEMOTHERAPY	60	FALSE	75	NA	NA	NA	NA	1	NA	MG	MG	105	NA	ORAL	NA	NA	ADJUVANT	NA	1200	NA
1159	ef646014-78a9-43af-b6fa-85fa288cd51b	TCGA.19.4068	TCGA-19-4068-D25458	edc32b9c-63bc-400a-a291-cacfdb1fcbc9	2010-6-8	TEMODAR	NA	CHEMOTHERAPY	83	FALSE	109	NA	NA	NA	NA	1	NA	MG	MG	105	NA	ORAL	NA	NA	ADJUVANT	NA	2835	NA
1160	ec56b685-022b-44b4-8051-d8bbbcc17ee0	TCGA.19.5950	TCGA-19-5950-D25466	e19dbcd6-12ea-40b2-b94f-2dcd77b09391	2011-6-3	TEMODAR	NA	CHEMOTHERAPY	27	FALSE	70	NA	NA	NA	NA	NA	NA	MG	MG	140	NA	ORAL	NA	NA	ADJUVANT	NA	6020	NA
1161	ec56b685-022b-44b4-8051-d8bbbcc17ee0	TCGA.19.5950	TCGA-19-5950-D25467	1d8af6d1-a953-4f5d-9b0c-9c657bcfa94a	2011-6-3	TEMODAR	NA	CHEMOTHERAPY	106	FALSE	110	NA	NA	NA	NA	1	NA	MG	MG	270	NA	ORAL	NA	NA	ADJUVANT	NA	1350	NA
1162	ec56b685-022b-44b4-8051-d8bbbcc17ee0	TCGA.19.5950	TCGA-19-5950-D25468	6ef81d3d-16e6-4ad7-a863-8700da4d54fe	2011-6-3	TEMODAR	NA	CHEMOTHERAPY	134	FALSE	249	NA	NA	NA	NA	5	NA	MG	MG	350	NA	ORAL	NA	NA	ADJUVANT	NA	8750	NA
1163	ec56b685-022b-44b4-8051-d8bbbcc17ee0	TCGA.19.5950	TCGA-19-5950-D43162	2C539CE1-CC3E-4905-8A17-AD6A9264C101	2013-5-14	GDC-0449	NA	CHEMOTHERAPY	287	FALSE	343	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TRUE
1164	61e00782-b709-43b1-a164-ee7f89c867e4	TCGA.19.5951	TCGA-19-5951-D25472	2a6557e5-ff9c-46b4-877c-2ab3d48c943a	2011-6-3	TEMODAR	NA	CHEMOTHERAPY	50	FALSE	94	NA	NA	NA	NA	NA	NA	MG	MG	165	NA	ORAL	NA	NA	ADJUVANT	NA	6270	NA
1165	18e04edc-04a3-4d1c-b536-3797e1924f48	TCGA.19.5954	TCGA-19-5954-D25479	b9970d7e-6632-4f63-9919-9db3ad537cc8	2011-6-3	TEMODAR	NA	CHEMOTHERAPY	32	FALSE	75	NA	NA	NA	NA	NA	NA	MG	MG	135	NA	ORAL	NA	NA	ADJUVANT	NA	5805	NA
1166	18e04edc-04a3-4d1c-b536-3797e1924f48	TCGA.19.5954	TCGA-19-5954-D25480	ddfbee37-3f23-42bf-8af6-d618d9813169	2011-6-3	TEMODAR	NA	CHEMOTHERAPY	103	FALSE	107	NA	NA	NA	NA	1	NA	MG	MG	270	NA	ORAL	NA	NA	ADJUVANT	NA	1350	NA
1167	7e70a318-3acc-42f3-8287-158a2199f0bc	TCGA.19.5956	TCGA-19-5956-D25486	0c8a9763-627b-4ea0-a1ce-4f8f81b0be43	2011-6-3	TEMODAR	NA	CHEMOTHERAPY	51	FALSE	70	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1168	7e70a318-3acc-42f3-8287-158a2199f0bc	TCGA.19.5956	TCGA-19-5956-D43173	7D9F81E7-0165-42C9-843A-7D958DE2A177	2013-5-14	AVASTIN	NA	CHEMOTHERAPY	51	FALSE	70	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TRUE
1169	7e70a318-3acc-42f3-8287-158a2199f0bc	TCGA.19.5956	TCGA-19-5956-D43174	69C3BFF8-BA08-408D-A17D-5DFEC97FD097	2013-5-14	TEMODAR	NA	CHEMOTHERAPY	202	FALSE	604	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
1170	81622677-9742-40ea-ad60-5f9b2a624ea7	TCGA.19.5958	TCGA-19-5958-D25494	08c91128-f3c9-4081-9c92-f6bdbe7b1306	2011-6-3	AVASTIN	NA	CHEMOTHERAPY	56	TRUE	265	NA	NA	NA	NA	15	NA	MG	NA	NA	3	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1171	81622677-9742-40ea-ad60-5f9b2a624ea7	TCGA.19.5958	TCGA-19-5958-D25491	8082d031-c08e-4b0c-bc63-35c0b9d76cf9	2011-6-3	TEMODAR	NA	CHEMOTHERAPY	34	FALSE	80	NA	NA	NA	NA	NA	DAILY FOR 42 DAYS	MG	MG	145	1	ORAL	NA	NA	ADJUVANT	NA	6090	NA
1172	81622677-9742-40ea-ad60-5f9b2a624ea7	TCGA.19.5958	TCGA-19-5958-D25492	c867cce3-42de-4a00-88f6-f963826b5179	2011-6-3	TEMODAR	NA	CHEMOTHERAPY	111	FALSE	248	NA	NA	NA	NA	6	NA	MG	MG	NA	2	ORAL	NA	NA	ADJUVANT	NA	11500	NA
1173	42e92d73-29eb-4508-a653-9b77f36021c0	TCGA.19.5959	TCGA-19-5959-D25498	ed8a260c-eb91-4795-a7a1-e60be7ac811d	2011-6-3	TEMODAR	NA	CHEMOTHERAPY	73	FALSE	88	NA	NA	NA	NA	NA	NA	MG	MG	125	NA	ORAL	NA	NA	ADJUVANT	NA	2125	NA
1174	42e92d73-29eb-4508-a653-9b77f36021c0	TCGA.19.5959	TCGA-19-5959-D43168	AF6F45E1-FED9-4D8B-A318-53B5C6B5AE09	2013-5-14	TEMODAR	NA	CHEMOTHERAPY	131	FALSE	290	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
1175	42e92d73-29eb-4508-a653-9b77f36021c0	TCGA.19.5959	TCGA-19-5959-D43170	8A86EEA6-9502-49CD-8954-12E4EA3D373D	2013-5-14	AVASTIN	NA	CHEMOTHERAPY	360	FALSE	388	PROGRESSIVE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
1176	93ed7a2b-b0cb-4a84-871f-5c34a0b6a640	TCGA.19.5960	TCGA-19-5960-D25504	85a6db91-61ec-4dd6-a0de-f2942ae7d388	2011-6-3	TEMODAR	NA	CHEMOTHERAPY	30	FALSE	71	NA	NA	NA	NA	NA	NA	MG	MG	135	NA	ORAL	NA	NA	ADJUVANT	NA	5670	NA
1177	93ed7a2b-b0cb-4a84-871f-5c34a0b6a640	TCGA.19.5960	TCGA-19-5960-D43339	CF998836-C6A7-47AB-9E6F-37FB6C4AD0E8	2013-5-17	AVASTIN	NA	CHEMOTHERAPY	55	FALSE	165	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	TRUE
1178	93ed7a2b-b0cb-4a84-871f-5c34a0b6a640	TCGA.19.5960	TCGA-19-5960-D43340	43A79D6C-2827-4F1A-9617-E8914021F046	2013-5-17	TEMODAR	NA	CHEMOTHERAPY	123	FALSE	155	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
1179	D8628D35-C4C6-443F-9DA2-8517A157F137	TCGA.19.A60I	TCGA-19-A60I-D44821	15424BD5-F749-44D9-806C-95E202121030	2013-6-27	TEMODAR	NA	CHEMOTHERAPY	72	FALSE	114	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
1180	D8628D35-C4C6-443F-9DA2-8517A157F137	TCGA.19.A60I	TCGA-19-A60I-D44871	8EB69170-5175-4473-A351-7DC1414CE949	2013-6-28	TEMODAR	NA	CHEMOTHERAPY	154	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
1181	7638E294-2DCF-4C03-B238-24E40491C2AD	TCGA.19.A6J5	TCGA-19-A6J5-D48305	C9D47DBD-E306-48C4-83A6-9492BAE51ED8	2013-9-11	TEMODAR	NA	CHEMOTHERAPY	34	FALSE	76	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
1182	7638E294-2DCF-4C03-B238-24E40491C2AD	TCGA.19.A6J5	TCGA-19-A6J5-D48502	49415F3D-B8E2-4FBB-A06A-5FF03071921B	2013-9-16	TEMODAR	NA	CHEMOTHERAPY	111	FALSE	658	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
1183	7638E294-2DCF-4C03-B238-24E40491C2AD	TCGA.19.A6J5	TCGA-19-A6J5-D64481	00822EDC-0A9A-4288-AB7F-B03AB3F60B28	2014-9-3	AVASTIN	NA	CHEMOTHERAPY	812	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
1184	7638E294-2DCF-4C03-B238-24E40491C2AD	TCGA.19.A6J5	TCGA-19-A6J5-D64482	CD363BD7-A6B2-4B9A-9834-33B2A740DEE6	2014-9-3	LOMUSTINE	NA	CHEMOTHERAPY	847	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
1185	17dffffc-65d6-4209-9075-18a441001f0f	TCGA.26.1438	TCGA-26-1438-D26848	d5375217-87b8-4f00-8918-a2d0ae61d11a	2009-5-18	TEMOZOLOMIDE	NA	CHEMOTHERAPY	104	FALSE	206	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	1440	NA
1186	17dffffc-65d6-4209-9075-18a441001f0f	TCGA.26.1438	TCGA-26-1438-D26847	9468f9ce-e4ca-4912-bd29-62aa4aa7a54a	2009-5-18	TEMOZOLOMIDE	NA	CHEMOTHERAPY	31	FALSE	73	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	5670	NA
1187	17dffffc-65d6-4209-9075-18a441001f0f	TCGA.26.1438	TCGA-26-1438-D26849	253b07f7-62de-48e3-992c-f928fafdeed6	2009-6-23	LOMUSTINE	NA	CHEMOTHERAPY	221	FALSE	221	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	PROGRESSION	NA	210	NA
1188	17dffffc-65d6-4209-9075-18a441001f0f	TCGA.26.1438	TCGA-26-1438-D26850	2e35b72c-97ad-4a1c-a6c0-621811f07537	2009-6-23	RECENTIN PLACEBO AXDX2171	NA	TARGETED MOLECULAR THERAPY	221	FALSE	264	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	PROGRESSION	NA	880	NA
1189	a6312802-12ad-4545-8109-178a7ebd618f	TCGA.26.1439	TCGA-26-1439-D26854	e3bf77a2-3cab-4e49-9e27-4946fb333045	2010-12-27	TEMODAR	NA	CHEMOTHERAPY	31	FALSE	81	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1190	9b775a6a-242a-4bfa-818d-d2d2f5bac5bf	TCGA.26.1440	TCGA-26-1440-D26859	30692c50-0aa5-4a53-a481-a90e8a55041a	2009-6-23	TEMOZOLOMIDE	NA	CHEMOTHERAPY	108	FALSE	NA	NA	NA	NA	NA	8	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	3140	NA
1191	9b775a6a-242a-4bfa-818d-d2d2f5bac5bf	TCGA.26.1440	TCGA-26-1440-D26858	f9969583-7be7-4bfe-a5d8-8259ab6ac89f	2009-6-23	TEMOZOLOMIDE	NA	CHEMOTHERAPY	30	FALSE	78	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	6300	NA
1192	c29d73c0-c885-4105-bf74-38e9178e71c9	TCGA.26.1442	TCGA-26-1442-D26892	39900ada-9a3e-45a4-9018-cf057212934e	2011-7-5	TEMODAR	NA	CHEMOTHERAPY	94	FALSE	872	NA	NA	NA	NA	27	NA	MG/M2	MG/M2	200	NA	ORAL	NA	NA	ADJUVANT	NA	27000	NA
1193	c29d73c0-c885-4105-bf74-38e9178e71c9	TCGA.26.1442	TCGA-26-1442-D26890	31bf12a2-9754-4572-b3de-dae983256b6b	2011-7-5	MOTEXAFIN GADOLINIUM	NA	CHEMOTHERAPY	27	FALSE	66	NA	NA	NA	NA	22	NA	MG	MG	340	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	7480	NA
1194	c29d73c0-c885-4105-bf74-38e9178e71c9	TCGA.26.1442	TCGA-26-1442-D26891	92b35e00-e3e3-494a-90c0-161c572ef50f	2011-7-5	TEMODAR	NA	CHEMOTHERAPY	27	FALSE	66	NA	NA	NA	NA	1	NA	MG	MG	140	NA	ORAL	NA	NA	ADJUVANT	NA	5600	NA
1195	e4aafd82-fd32-4a52-96fe-21a21297849f	TCGA.26.1443	TCGA-26-1443-D26863	abf596c4-01e5-4504-b968-c8e46cccfa22	2009-6-23	TEMOZOLOMIDE	NA	CHEMOTHERAPY	32	FALSE	79	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	5460	NA
1196	e4aafd82-fd32-4a52-96fe-21a21297849f	TCGA.26.1443	TCGA-26-1443-D26864	d626d73e-12b3-4068-9fee-63e593bfa0ef	2009-6-23	TEMOZOLOMIDE	NA	CHEMOTHERAPY	111	FALSE	195	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	915	NA
1197	ff61d536-b505-47e7-9d3c-a7252e9037a1	TCGA.26.1799	TCGA-26-1799-D26868	6dc20c0b-09c1-4ee2-a72d-b544f2e4b7ad	2009-9-22	TEMODAR	NA	CHEMOTHERAPY	101	FALSE	148	NA	NA	NA	NA	2	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	4150	NA
1198	2c5fa2d4-8e35-42e4-8bca-9fb3371a19c8	TCGA.26.5132	TCGA-26-5132-D26873	1aa188e4-092a-44cf-996c-22c274586bc8	2010-12-21	TEMOZOLOMIDE	NA	CHEMOTHERAPY	205	FALSE	205	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	150	NA	ORAL	NA	NA	ADJUVANT	NA	150	NA
1199	2c5fa2d4-8e35-42e4-8bca-9fb3371a19c8	TCGA.26.5132	TCGA-26-5132-D26872	b05ec676-af92-4bc5-948f-26834129de35	2010-12-21	TEMOZOLOMIDE	NA	CHEMOTHERAPY	40	FALSE	83	NA	NA	NA	NA	1	NA	MG	MG	110	NA	ORAL	NA	NA	ADJUVANT	NA	4620	NA
1200	a28b256e-e085-467d-bdba-5c39718012d7	TCGA.26.5133	TCGA-26-5133-D26878	b8390c6f-deba-4a86-81c3-0a7207035d67	2010-12-21	TEMOZOLOMIDE	NA	CHEMOTHERAPY	116	FALSE	120	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	150	NA	ORAL	NA	NA	ADJUVANT	NA	750	NA
1201	a28b256e-e085-467d-bdba-5c39718012d7	TCGA.26.5133	TCGA-26-5133-D26877	77720aaf-5891-415c-951f-7c746b28074e	2010-12-21	TEMOZOLAMIDE	NA	CHEMOTHERAPY	25	FALSE	68	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	75	NA	ORAL	NA	NA	ADJUVANT	NA	3300	NA
1202	a28b256e-e085-467d-bdba-5c39718012d7	TCGA.26.5133	TCGA-26-5133-D26879	54671333-2c7a-4090-8642-777a9ea17783	2010-12-21	TEMOZOLOMIDE	NA	CHEMOTHERAPY	144	FALSE	351	NA	NA	NA	NA	8	NA	MG/M2	MG/M2	200	NA	ORAL	NA	NA	ADJUVANT	NA	8000	NA
1203	60e69f41-571e-4a1b-ae75-9d49eed620ca	TCGA.26.6173	TCGA-26-6173-D26897	91c193e3-82fa-487c-856a-70690b7ab426	2011-5-2	TEMOZOLOMIDE	NA	CHEMOTHERAPY	31	FALSE	70	NA	NA	NA	NA	75	NA	MG/M2	MG/M2	75	NA	ORAL	NA	NA	ADJUVANT	NA	2250	NA
1204	60e69f41-571e-4a1b-ae75-9d49eed620ca	TCGA.26.6173	TCGA-26-6173-D26898	3b71ed9a-67f0-4f73-aa77-8b327be6efd3	2011-5-2	TEMOZOLOMIDE	NA	CHEMOTHERAPY	101	FALSE	105	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	150	NA	ORAL	NA	NA	ADJUVANT	NA	750	NA
1205	60e69f41-571e-4a1b-ae75-9d49eed620ca	TCGA.26.6173	TCGA-26-6173-D26899	f4a3cae0-1e06-41bc-80e7-685fba3d5c2c	2011-5-2	TEMOZOLOMIDE	NA	CHEMOTHERAPY	129	FALSE	245	NA	NA	NA	NA	5	NA	MG/M2	MG/M2	200	NA	ORAL	NA	NA	ADJUVANT	NA	1000	NA
1206	60e69f41-571e-4a1b-ae75-9d49eed620ca	TCGA.26.6173	TCGA-26-6173-D26896	5f5f67b2-0d94-4150-8c99-7b70d5510dda	2011-5-2	CILENGITIDE	NA	CHEMOTHERAPY	24	TRUE	NA	NA	NA	NA	NA	30	NA	MG	MG	4000	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	120000	NA
1207	4b606edf-07fc-4665-a7cd-a794004e5aca	TCGA.26.6174	TCGA-26-6174-D26903	a2dd9e71-1aff-463d-9eea-2c9ff3eeb9ff	2011-5-2	TEMOZOLOMIDE	NA	CHEMOTHERAPY	29	FALSE	66	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	75	NA	ORAL	NA	NA	ADJUVANT	NA	2850	NA
1208	5F9BAF9B-6D2D-495A-83A1-77F7E4CB9CCD	TCGA.26.A7UX	TCGA-26-A7UX-D65038	24F3A9ED-5D77-4562-8F8C-6E50E2ED3B6B	2014-9-18	TEMODAR	NA	CHEMOTHERAPY	35	FALSE	235	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
1209	5F9BAF9B-6D2D-495A-83A1-77F7E4CB9CCD	TCGA.26.A7UX	TCGA-26-A7UX-D68867	409EEF90-A050-4B3A-8ECC-0247DF4E9D26	2014-12-22	LOMUSTINE	NA	CHEMOTHERAPY	511	TRUE	NA	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
1210	5F9BAF9B-6D2D-495A-83A1-77F7E4CB9CCD	TCGA.26.A7UX	TCGA-26-A7UX-D68868	8876CD9B-D87F-4DA0-9B31-50D6F7CEEB4F	2014-12-22	AVASTIN	NA	TARGETED MOLECULAR THERAPY	511	TRUE	NA	STABLE DISEASE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
1211	6e72d2e2-96fe-4fbb-9fe6-39ec28753eb6	TCGA.27.1830	TCGA-27-1830-D26907	d7b406d6-5e84-4b17-8abb-e5e35d5163fe	2009-10-2	CISPLATIN	NA	CHEMOTHERAPY	8	FALSE	86	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	OTHER	NA	NA	ADJUVANT	NA	420	NA
1212	6e72d2e2-96fe-4fbb-9fe6-39ec28753eb6	TCGA.27.1830	TCGA-27-1830-D26909	5b5b9f37-57e0-4e38-a80e-09074f499715	2009-10-2	DEXAMETHASONE	NA	HORMONE THERAPY	-1	FALSE	70	NA	NA	NA	NA	NA	NA	MG/DAY	MG/DAY	NA	NA	NA	NA	NA	ADJUVANT	NA	4	NA
1213	6e72d2e2-96fe-4fbb-9fe6-39ec28753eb6	TCGA.27.1830	TCGA-27-1830-D26908	bb31a0d1-b24d-4427-b42f-5ad87f384959	2009-10-2	TEMOZOLOMIDE	NA	CHEMOTHERAPY	8	FALSE	86	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	OTHER	NA	NA	ADJUVANT	NA	3750	NA
1214	f45f4a30-6b4c-4f15-9140-959d6a25a45f	TCGA.27.1831	TCGA-27-1831-D26914	497fd61d-6918-4ad8-8ed0-cb9b70dc2711	2010-3-12	CISPLATIN	NA	CHEMOTHERAPY	4	FALSE	98	NA	NA	NA	NA	3	NA	MG	MG	140	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	420	NA
1215	f45f4a30-6b4c-4f15-9140-959d6a25a45f	TCGA.27.1831	TCGA-27-1831-D26917	d2f5a955-3a99-4b88-8d08-0e8bc0de67cf	2010-3-12	OXCARBAZEPINE	NA	HORMONE THERAPY	-8	FALSE	505	NA	NA	NA	NA	NA	NA	MG	MG	600	NA	ORAL	NA	NA	ADJUVANT	NA	307800	NA
1216	f45f4a30-6b4c-4f15-9140-959d6a25a45f	TCGA.27.1831	TCGA-27-1831-D26916	c13e764e-0f29-4f9d-ae69-59c18b788d10	2010-3-12	DEXAMETHASONE	NA	HORMONE THERAPY	-8	FALSE	505	NA	NA	NA	NA	NA	NA	MG	MG	8	NA	OTHER	NA	NA	ADJUVANT	NA	4104	NA
1217	f45f4a30-6b4c-4f15-9140-959d6a25a45f	TCGA.27.1831	TCGA-27-1831-D26915	59c66bff-d29b-401e-9638-7f600ac4d629	2010-3-12	TEMOZOLOMIDE	NA	CHEMOTHERAPY	6	FALSE	103	NA	NA	NA	NA	3	NA	MG	MG	200	NA	ORAL	NA	NA	ADJUVANT	NA	3400	NA
1218	dd76930a-1678-4b70-9864-730534174d41	TCGA.27.1832	TCGA-27-1832-D26922	51f6e02f-ae84-4db3-8db6-d541fe241ba2	2009-10-2	TEMOZOLOMIDE	NA	CHEMOTHERAPY	207	FALSE	207	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	1200	NA
1219	dd76930a-1678-4b70-9864-730534174d41	TCGA.27.1832	TCGA-27-1832-D26921	f341ad9e-47e3-4d8b-8ea7-fa1b2172b296	2009-10-2	TEMOZOLOMIDE	NA	CHEMOTHERAPY	23	FALSE	207	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	3600	NA
1220	dd76930a-1678-4b70-9864-730534174d41	TCGA.27.1832	TCGA-27-1832-D26923	a5790756-374e-419e-ba5e-c3bfde4ff05b	2009-10-2	DEXAMETHASONE	NA	HORMONE THERAPY	0	FALSE	300	NA	NA	NA	NA	NA	NA	MG/DAY	MG/DAY	NA	NA	NA	NA	NA	ADJUVANT	NA	8	NA
1221	f40e45c8-2042-4844-99b5-b629f20afd58	TCGA.27.1833	TCGA-27-1833-D26930	ca5f3895-331f-48f0-80bd-468417a80ba9	2009-10-2	PROCARBAZINE	NA	CHEMOTHERAPY	171	FALSE	725	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	OTHER	NA	NA	ADJUVANT	NA	1300	NA
1222	f40e45c8-2042-4844-99b5-b629f20afd58	TCGA.27.1833	TCGA-27-1833-D26928	ce3f62ad-32b5-4bd6-a17e-966e76673f47	2009-10-2	TEMOZOLOMIDE	NA	CHEMOTHERAPY	171	FALSE	596	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	OTHER	NA	NA	ADJUVANT	NA	3500	NA
1223	f40e45c8-2042-4844-99b5-b629f20afd58	TCGA.27.1833	TCGA-27-1833-D26927	1912f605-8108-419c-a157-771459774202	2009-10-2	CISPLATIN	NA	CHEMOTHERAPY	171	FALSE	596	NA	NA	NA	NA	4	NA	MG	MG	NA	NA	OTHER	NA	NA	ADJUVANT	NA	320	NA
1224	f40e45c8-2042-4844-99b5-b629f20afd58	TCGA.27.1833	TCGA-27-1833-D26931	3f8d12fa-7717-4de5-a369-69ad985f311a	2009-10-2	DEXAMETHASONE	NA	HORMONE THERAPY	-6	FALSE	737	NA	NA	NA	NA	NA	NA	MG/DAY	MG/DAY	NA	NA	NA	NA	NA	ADJUVANT	NA	8	NA
1225	f40e45c8-2042-4844-99b5-b629f20afd58	TCGA.27.1833	TCGA-27-1833-D26929	787400d2-0959-4e3d-937b-cf74836feab1	2009-10-2	FOTEMUSTINE	NA	CHEMOTHERAPY	171	FALSE	359	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	OTHER	NA	NA	ADJUVANT	NA	208	NA
1226	7340f325-579f-4b90-96aa-3a7b362129ca	TCGA.27.1834	TCGA-27-1834-D26936	a325e73e-bc7e-45dc-ad3d-1350266bad6b	2009-10-2	TEMOZOLOMIDE	NA	CHEMOTHERAPY	352	TRUE	662	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	35000	NA
1227	7340f325-579f-4b90-96aa-3a7b362129ca	TCGA.27.1834	TCGA-27-1834-D26939	e168251a-0405-4dd9-bf97-2f229c557e15	2009-10-2	CISPLATIN	NA	CHEMOTHERAPY	15	FALSE	168	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	OTHER	NA	NA	ADJUVANT	NA	320	NA
1228	7340f325-579f-4b90-96aa-3a7b362129ca	TCGA.27.1834	TCGA-27-1834-D26935	7747c480-15aa-44c1-88b7-df4598f08265	2009-10-2	PROCARBAZINE	NA	CHEMOTHERAPY	352	FALSE	540	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	OTHER	NA	NA	ADJUVANT	NA	1248	NA
1229	7340f325-579f-4b90-96aa-3a7b362129ca	TCGA.27.1834	TCGA-27-1834-D26937	f5afb153-8271-4de4-9f6b-a125ea422890	2009-10-2	FOTEMUSTINE	NA	CHEMOTHERAPY	352	FALSE	540	NA	NA	NA	NA	6	NA	MG	MG	NA	NA	OTHER	NA	NA	ADJUVANT	NA	1200	NA
1230	7340f325-579f-4b90-96aa-3a7b362129ca	TCGA.27.1834	TCGA-27-1834-D26938	3510fe07-111c-44ce-8413-c36dc1889288	2009-10-2	TEMOZOLOMOIDE	NA	CHEMOTHERAPY	15	FALSE	168	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	OTHER	NA	NA	ADJUVANT	NA	6250	NA
1231	7340f325-579f-4b90-96aa-3a7b362129ca	TCGA.27.1834	TCGA-27-1834-D26940	f14698b7-373a-4b42-b9e1-b5bf4745cab5	2009-10-2	DEXAMETHASONE	NA	HORMONE THERAPY	-5	FALSE	1233	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	NA	NA	NA	ADJUVANT	NA	7302	NA
1232	987cb702-057b-4198-8ef3-9cf6a9c51989	TCGA.27.1835	TCGA-27-1835-D26945	8426a3d9-288d-432e-b448-7eaecfe12626	2010-3-12	TEMOZOLOMIDE	NA	CHEMOTHERAPY	4	FALSE	158	NA	NA	NA	NA	3	NA	MG	MG	300	NA	ORAL	NA	NA	ADJUVANT	NA	4300	NA
1233	987cb702-057b-4198-8ef3-9cf6a9c51989	TCGA.27.1835	TCGA-27-1835-D26944	f1d3d501-cabb-4bea-9c8f-673c26863c84	2010-3-12	CISPLATIN	NA	CHEMOTHERAPY	2	FALSE	3	NA	NA	NA	NA	1	NA	MG	MG	160	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	160	NA
1234	987cb702-057b-4198-8ef3-9cf6a9c51989	TCGA.27.1835	TCGA-27-1835-D26950	9ec3beba-e9f2-4f33-abd9-c2ecb0f1a5f3	2010-3-12	DEXAMETHASONE	NA	HORMONE THERAPY	-7	FALSE	648	NA	NA	NA	NA	NA	NA	MG	MG	4	NA	ORAL	NA	NA	ADJUVANT	NA	1308	NA
1235	987cb702-057b-4198-8ef3-9cf6a9c51989	TCGA.27.1835	TCGA-27-1835-D26946	02ec0fdd-25af-40c8-b76b-6164c9a8bfa9	2010-3-12	PC2	NA	CHEMOTHERAPY	206	FALSE	462	NA	NA	NA	NA	5	NA	MG	MG	300	NA	ORAL	NA	NA	RECURRENCE	NA	8400	NA
1236	987cb702-057b-4198-8ef3-9cf6a9c51989	TCGA.27.1835	TCGA-27-1835-D26949	05abfffd-767d-4c6c-a5b7-2527ba635c94	2010-3-12	LEVETIRACETAM	NA	HORMONE THERAPY	-7	FALSE	648	NA	NA	NA	NA	NA	NA	MG	MG	1000	NA	ORAL	NA	NA	ADJUVANT	NA	654000	NA
1237	987cb702-057b-4198-8ef3-9cf6a9c51989	TCGA.27.1835	TCGA-27-1835-D26948	68c4baf4-8c51-41f4-8689-fd339dc8a717	2010-3-12	BCNU	NA	CHEMOTHERAPY	270	FALSE	270	NA	NA	NA	NA	1	NA	MG	MG	200	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	200	NA
1238	987cb702-057b-4198-8ef3-9cf6a9c51989	TCGA.27.1835	TCGA-27-1835-D26947	90179c52-58fa-4d89-9277-6858c2639759	2010-3-12	FT	NA	CHEMOTHERAPY	208	FALSE	208	NA	NA	NA	NA	1	NA	ML	ML	12	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	12	NA
1239	4d18f820-6396-46ae-b5d6-4ba446279be8	TCGA.27.1836	TCGA-27-1836-D26959	8e00002c-bc99-44df-89f8-249f7f2548b5	2010-3-12	BEVACIZUMAB	NA	CHEMOTHERAPY	655	FALSE	760	NA	NA	NA	NA	8	NA	MG	MG	800	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	6720	NA
1240	4d18f820-6396-46ae-b5d6-4ba446279be8	TCGA.27.1836	TCGA-27-1836-D26958	76fee391-6810-4735-bf11-cfc6fd058a49	2010-3-12	TEMOZOLOMIDE	NA	CHEMOTHERAPY	472	FALSE	562	NA	NA	NA	NA	3	NA	MG	MG	200	NA	ORAL	NA	NA	ADJUVANT	NA	8400	NA
1241	4d18f820-6396-46ae-b5d6-4ba446279be8	TCGA.27.1836	TCGA-27-1836-D26961	3f0cba42-5e54-42fa-9a15-516217c8df96	2010-3-12	DEXAMETHASONE	NA	HORMONE THERAPY	-7	FALSE	914	NA	NA	NA	NA	NA	NA	MG	MG	24	NA	ORAL	NA	NA	ADJUVANT	NA	22080	NA
1242	4d18f820-6396-46ae-b5d6-4ba446279be8	TCGA.27.1836	TCGA-27-1836-D26954	a4b5b960-95ca-4ceb-83f1-d436d1543b25	2010-3-12	TEMOZOLOMIDE	NA	CHEMOTHERAPY	48	FALSE	90	NA	NA	NA	NA	7	NA	MG	MG	140	NA	ORAL	NA	NA	ADJUVANT	NA	5880	NA
1243	4d18f820-6396-46ae-b5d6-4ba446279be8	TCGA.27.1836	TCGA-27-1836-D26955	88851fbc-e6e6-49b5-a55a-e56f61e81820	2010-3-12	TEMOZOLOMIDE	NA	CHEMOTHERAPY	120	FALSE	181	NA	NA	NA	NA	3	NA	MG	MG	200	NA	ORAL	NA	NA	ADJUVANT	NA	8400	NA
1244	4d18f820-6396-46ae-b5d6-4ba446279be8	TCGA.27.1836	TCGA-27-1836-D26956	f54c392a-9c4f-4fc3-838e-ae243a17b8c1	2010-3-12	PCB	NA	CHEMOTHERAPY	245	FALSE	399	NA	NA	NA	NA	5	NA	MG	MG	500	NA	ORAL	NA	NA	ADJUVANT	NA	3550	NA
1245	4d18f820-6396-46ae-b5d6-4ba446279be8	TCGA.27.1836	TCGA-27-1836-D26960	c14434d9-a3e2-4e16-a7e8-0d712f3d18d8	2010-3-12	IRINOTECAN	NA	CHEMOTHERAPY	655	FALSE	760	NA	NA	NA	NA	7	NA	MG	MG	200	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1440	NA
1246	4d18f820-6396-46ae-b5d6-4ba446279be8	TCGA.27.1836	TCGA-27-1836-D26957	14eebe1d-8a00-4f7c-a85e-64435f86956c	2010-3-12	FOTEMUSTINE	NA	CHEMOTHERAPY	247	FALSE	399	NA	NA	NA	NA	5	NA	MG	MG	160	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	896	NA
1247	4d18f820-6396-46ae-b5d6-4ba446279be8	TCGA.27.1836	TCGA-27-1836-D26962	8ae3a100-c2c6-473d-8af8-1df4134389f0	2010-3-12	VALPROIC ACID	NA	HORMONE THERAPY	-7	FALSE	914	NA	NA	NA	NA	NA	NA	MG	MG	900	NA	ORAL	NA	NA	ADJUVANT	NA	828000	NA
1248	bc7a0c8f-c1c1-447c-8019-389e52525081	TCGA.27.1837	TCGA-27-1837-D26969	2d9c4ae5-5cd1-4707-bff9-07975187e626	2010-3-12	DEXAMETHASONE	NA	HORMONE THERAPY	-6	FALSE	427	NA	NA	NA	NA	NA	NA	MG	MG	4	NA	ORAL	NA	NA	ADJUVANT	NA	2592	NA
1249	bc7a0c8f-c1c1-447c-8019-389e52525081	TCGA.27.1837	TCGA-27-1837-D26968	77f882ab-ef9f-4982-97fa-671a37ffa566	2010-3-12	DOXORUBICIN	NA	CHEMOTHERAPY	35	FALSE	106	NA	NA	NA	NA	4	NA	MG	MG	4	NA	OTHER	NA	NA	ADJUVANT	NA	16	NA
1250	bc7a0c8f-c1c1-447c-8019-389e52525081	TCGA.27.1837	TCGA-27-1837-D26966	b07132d2-d261-4b2b-8db1-376ca0949a55	2010-3-12	CDDP	NA	CHEMOTHERAPY	-1	FALSE	148	NA	NA	NA	NA	5	NA	MG	MG	160	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	800	NA
1251	bc7a0c8f-c1c1-447c-8019-389e52525081	TCGA.27.1837	TCGA-27-1837-D26967	770a6955-d9ba-40c6-937d-7e53b52422bc	2010-3-12	TEMOZOLOMIDE	NA	CHEMOTHERAPY	1	FALSE	153	NA	NA	NA	NA	5	NA	MG	MG	350	NA	ORAL	NA	NA	ADJUVANT	NA	8750	NA
1252	6fc6b9ca-84d8-4647-bbc8-c5ab472b1c02	TCGA.27.1838	TCGA-27-1838-D26977	280f1c21-b53a-456a-aef6-0a027d4b6750	2010-3-12	OXCARBAZEPINE	NA	HORMONE THERAPY	-11	FALSE	350	NA	NA	NA	NA	NA	NA	MG	MG	600	NA	ORAL	NA	NA	ADJUVANT	NA	216600	NA
1253	6fc6b9ca-84d8-4647-bbc8-c5ab472b1c02	TCGA.27.1838	TCGA-27-1838-D26974	a9e40363-1a48-4dc3-8d8f-1d9fe3de8503	2010-3-12	CISPLATIN	NA	CHEMOTHERAPY	1	FALSE	2	NA	NA	NA	NA	1	NA	MG	MG	140	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	140	NA
1254	6fc6b9ca-84d8-4647-bbc8-c5ab472b1c02	TCGA.27.1838	TCGA-27-1838-D26976	979ac63c-de71-461c-ae0d-2840cf17a80b	2010-3-12	DEXAMETHASONE	NA	HORMONE THERAPY	-11	FALSE	350	NA	NA	NA	NA	NA	NA	MG	MG	4	NA	OTHER	NA	NA	ADJUVANT	NA	2214	NA
1255	6fc6b9ca-84d8-4647-bbc8-c5ab472b1c02	TCGA.27.1838	TCGA-27-1838-D26975	6f2a70d9-e4f6-4af5-90c2-9702756c501e	2010-3-12	TEMOZOLOMIDE	NA	CHEMOTHERAPY	3	FALSE	7	NA	NA	NA	NA	1	NA	MG	MG	300	NA	ORAL	NA	NA	ADJUVANT	NA	1500	NA
1256	d3d27286-73e1-4cdd-914a-34c210fd6398	TCGA.27.2518	TCGA-27-2518-D26985	90f73be0-f06c-48aa-8899-ac351e98fad5	2010-3-12	DEXAMETHASONE	NA	HORMONE THERAPY	55	FALSE	753	NA	NA	NA	NA	NA	NA	MG	MG	8	NA	OTHER	NA	NA	ADJUVANT	NA	5576	NA
1257	d3d27286-73e1-4cdd-914a-34c210fd6398	TCGA.27.2518	TCGA-27-2518-D26984	53c0cbc2-add7-4f30-a2d8-15030bd04304	2010-3-12	FOTEMUSTINE	NA	CHEMOTHERAPY	627	FALSE	700	NA	NA	NA	NA	3	NA	MG	MG	180	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	580	NA
1258	d3d27286-73e1-4cdd-914a-34c210fd6398	TCGA.27.2518	TCGA-27-2518-D26983	5377ade0-6c25-43fc-a62c-b1622d04e810	2010-3-12	PC2	NA	CHEMOTHERAPY	627	FALSE	700	NA	NA	NA	NA	3	NA	MG	MG	300	NA	ORAL	NA	NA	RECURRENCE	NA	3600	NA
1259	d3d27286-73e1-4cdd-914a-34c210fd6398	TCGA.27.2518	TCGA-27-2518-D26986	2da94d35-f768-49b4-af4f-381f86d5986a	2010-3-12	LEVENRACETAM	NA	HORMONE THERAPY	55	FALSE	753	NA	NA	NA	NA	NA	NA	MG	MG	1500	NA	ORAL	NA	NA	ADJUVANT	NA	1045500	NA
1260	d3d27286-73e1-4cdd-914a-34c210fd6398	TCGA.27.2518	TCGA-27-2518-D26982	cf8651b4-47f0-4f7f-bc25-f8172a89ef96	2010-3-12	CISPLATIN	NA	CHEMOTHERAPY	20	FALSE	107	NA	NA	NA	NA	3	NA	MG	MG	160	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	500	NA
1261	d3d27286-73e1-4cdd-914a-34c210fd6398	TCGA.27.2518	TCGA-27-2518-D26981	bc218003-fa48-4b3d-acc6-04e993d5f4b9	2010-3-12	TEMOZOLOMIDE	NA	CHEMOTHERAPY	22	FALSE	182	NA	NA	NA	NA	5	NA	MG	MG	350	NA	ORAL	NA	NA	ADJUVANT	NA	8750	NA
1262	6ff96a7e-1b96-4530-b8a8-7f2e9e541955	TCGA.27.2519	TCGA-27-2519-D26991	054b0154-c0fc-4a4b-ba87-8f9a4194a4e7	2010-3-12	TEMOZOLOMIDE	NA	CHEMOTHERAPY	133	FALSE	259	NA	NA	NA	NA	5	NA	MG	MG	300	NA	ORAL	NA	NA	ADJUVANT	NA	7500	NA
1263	6ff96a7e-1b96-4530-b8a8-7f2e9e541955	TCGA.27.2519	TCGA-27-2519-D26993	22fe087d-0d98-4c6b-a6d1-fa622e225ba9	2010-3-12	DEXAMETHASONE	NA	HORMONE THERAPY	-10	TRUE	NA	NA	NA	NA	NA	NA	NA	MG	MG	16	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1264	6ff96a7e-1b96-4530-b8a8-7f2e9e541955	TCGA.27.2519	TCGA-27-2519-D26992	38b4dd8f-f469-4d0e-8cc2-da031ed50f0a	2010-3-12	FOTEMUSTINE	NA	CHEMOTHERAPY	302	TRUE	NA	NA	NA	NA	NA	3	NA	MG	MG	130	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	390	NA
1265	6ff96a7e-1b96-4530-b8a8-7f2e9e541955	TCGA.27.2519	TCGA-27-2519-D26994	930be66e-45b7-4e4c-8fcc-c1377e6c9794	2010-3-12	LEVETIRACETAM	NA	HORMONE THERAPY	-10	TRUE	NA	NA	NA	NA	NA	NA	NA	MG	MG	1500	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1266	6ff96a7e-1b96-4530-b8a8-7f2e9e541955	TCGA.27.2519	TCGA-27-2519-D26990	6b516de8-700d-4246-bb7d-26ea6920fad7	2010-3-12	TEMOZOLOMIDE	NA	CHEMOTHERAPY	49	FALSE	95	NA	NA	NA	NA	1	NA	MG	MG	140	NA	ORAL	NA	NA	ADJUVANT	NA	6440	NA
1267	4776b959-d5f5-41ad-ab39-dba6031f6884	TCGA.27.2521	TCGA-27-2521-D26999	febea3d3-c51a-42ec-bb3f-6725cc55eb8e	2010-3-12	DEXAMETHASONE	NA	HORMONE THERAPY	-15	TRUE	NA	NA	NA	NA	NA	NA	NA	MG	MG	2	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1268	4776b959-d5f5-41ad-ab39-dba6031f6884	TCGA.27.2521	TCGA-27-2521-D27000	bd0142c7-c8dd-4341-a0aa-f5b7deef8097	2010-3-12	LEVETIRACETAM	NA	HORMONE THERAPY	-15	TRUE	NA	NA	NA	NA	NA	NA	NA	MG	MG	1000	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1269	4776b959-d5f5-41ad-ab39-dba6031f6884	TCGA.27.2521	TCGA-27-2521-D26998	c5e44945-242a-4443-9b7e-c9363c3e5482	2010-3-12	TEMOZOLOMIDE	NA	CHEMOTHERAPY	104	TRUE	NA	NA	NA	NA	NA	8	NA	MG	MG	350	NA	ORAL	NA	NA	ADJUVANT	NA	14000	NA
1270	737b35e1-d668-4fce-9b6e-76946c7952b6	TCGA.27.2523	TCGA-27-2523-D27005	158df29a-ed83-4985-9274-248c5ac380d6	2010-3-12	LUMUSTINE	NA	CHEMOTHERAPY	11	FALSE	11	NA	NA	NA	NA	1	NA	MG	MG	160	NA	ORAL	NA	NA	ADJUVANT	NA	160	NA
1271	737b35e1-d668-4fce-9b6e-76946c7952b6	TCGA.27.2523	TCGA-27-2523-D27006	3407ded6-d27c-4bbe-b083-811ca6627856	2010-3-12	TEMOZOLOMIDE	NA	CHEMOTHERAPY	60	FALSE	380	NA	NA	NA	NA	10	NA	MG	MG	300	NA	ORAL	NA	NA	ADJUVANT	NA	15000	NA
1272	737b35e1-d668-4fce-9b6e-76946c7952b6	TCGA.27.2523	TCGA-27-2523-D27004	26a7576c-9c9e-4569-b0f2-a2df1697b401	2010-3-12	CISPLATIN	NA	CHEMOTHERAPY	10	FALSE	59	NA	NA	NA	NA	2	NA	MG	MG	90	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	315	NA
1273	737b35e1-d668-4fce-9b6e-76946c7952b6	TCGA.27.2523	TCGA-27-2523-D27009	761ea42a-1ed5-4232-b593-1290feb6162f	2010-3-12	PHENYTOIN SODIUM	NA	HORMONE THERAPY	-6	FALSE	489	NA	NA	NA	NA	NA	NA	MG	MG	300	NA	ORAL	NA	NA	ADJUVANT	NA	148500	NA
1274	737b35e1-d668-4fce-9b6e-76946c7952b6	TCGA.27.2523	TCGA-27-2523-D27007	39ff9267-265f-4281-8a19-f77be3a9d334	2010-3-12	ERLOTINIB	NA	CHEMOTHERAPY	97	FALSE	386	NA	NA	NA	NA	10	NA	MG	MG	150	NA	ORAL	NA	NA	ADJUVANT	NA	1500	NA
1275	737b35e1-d668-4fce-9b6e-76946c7952b6	TCGA.27.2523	TCGA-27-2523-D27008	c572b79f-3627-4145-bd94-fc2d64558e1d	2010-3-12	DEXAMETHASONE	NA	HORMONE THERAPY	-6	FALSE	489	NA	NA	NA	NA	NA	NA	MG	MG	8	NA	ORAL	NA	NA	ADJUVANT	NA	3960	NA
1276	a597bfa8-8c4d-4f8e-9d85-8a9fdc2c56ff	TCGA.27.2524	TCGA-27-2524-D27016	372a5ac3-0f43-4694-8d93-b0b71d80b1e9	2010-3-12	DEXAMETHASONE	NA	HORMONE THERAPY	-6	FALSE	231	NA	NA	NA	NA	NA	NA	MG	MG	4	NA	OTHER	NA	NA	ADJUVANT	NA	948	NA
1277	a597bfa8-8c4d-4f8e-9d85-8a9fdc2c56ff	TCGA.27.2524	TCGA-27-2524-D27015	1e14366d-ff0f-4113-9cc7-5fcfaa73f087	2010-3-12	TEMOZOLOMIDE	NA	CHEMOTHERAPY	58	FALSE	119	NA	NA	NA	NA	3	NA	MG	MG	300	NA	ORAL	NA	NA	ADJUVANT	NA	7500	NA
1278	a597bfa8-8c4d-4f8e-9d85-8a9fdc2c56ff	TCGA.27.2524	TCGA-27-2524-D27014	ded13931-39b4-4aa7-ae44-579d518ab56e	2010-3-12	GLIADEL WAFER	NA	CHEMOTHERAPY	-6	FALSE	-6	NA	NA	NA	NA	NA	NA	WAFER	WAFER	8	NA	OTHER	NA	NA	ADJUVANT	NA	61.6	NA
1279	a597bfa8-8c4d-4f8e-9d85-8a9fdc2c56ff	TCGA.27.2524	TCGA-27-2524-D27017	4f1509d4-fc32-4fd8-8775-cc5ac1f7db2e	2010-3-12	OXCARBAZEPINE	NA	HORMONE THERAPY	-6	FALSE	231	NA	NA	NA	NA	NA	NA	MG	MG	600	NA	ORAL	NA	NA	ADJUVANT	NA	142200	NA
1280	69d0a566-5fbf-45f6-a240-649b06868e27	TCGA.27.2526	TCGA-27-2526-D27022	ad2c9dad-a0d6-482d-b9da-828ecc9f0f02	2010-3-15	DEXAMETHASONE	NA	HORMONE THERAPY	-6	FALSE	87	NA	NA	NA	NA	NA	NA	MG	MG	8	NA	OTHER	NA	NA	ADJUVANT	NA	744	NA
1281	a61e88cd-5121-4e6e-9319-2978071547c3	TCGA.27.2527	TCGA-27-2527-D27026	51423afa-43b6-40f2-a5e4-91557c8b5cb9	2010-3-15	VALPROIC ACID	NA	HORMONE THERAPY	-7	FALSE	438	NA	NA	NA	NA	NA	NA	MG	MG	1000	NA	ORAL	NA	NA	ADJUVANT	NA	444000	NA
1282	a61e88cd-5121-4e6e-9319-2978071547c3	TCGA.27.2527	TCGA-27-2527-D27025	6bd9896b-d80e-41f2-ae06-5a9bc4d364b9	2010-3-15	DEXAMETHASONE	NA	HORMONE THERAPY	-7	FALSE	438	NA	NA	NA	NA	NA	NA	MG	MG	8	NA	ORAL	NA	NA	ADJUVANT	NA	3552	NA
1283	be3a7ef3-34ed-40e1-9d9c-187940596b26	TCGA.27.2528	TCGA-27-2528-D27035	e451f611-8345-4c41-bcba-12e88bdad3e7	2010-3-15	LEVETIRACETAM	NA	HORMONE THERAPY	-12	FALSE	480	NA	NA	NA	NA	NA	NA	MG	MG	1000	NA	ORAL	NA	NA	ADJUVANT	NA	603500	NA
1284	be3a7ef3-34ed-40e1-9d9c-187940596b26	TCGA.27.2528	TCGA-27-2528-D27033	fd948429-f8c4-4c5c-95f1-bf8b9758e5df	2010-3-15	TEMOZOLOMIDE	NA	CHEMOTHERAPY	445	FALSE	465	NA	NA	NA	NA	1	NA	MG	MG	140	NA	ORAL	NA	NA	RECURRENCE	NA	1960	NA
1285	be3a7ef3-34ed-40e1-9d9c-187940596b26	TCGA.27.2528	TCGA-27-2528-D27032	7668113c-c82f-4bce-8a0f-34b36aa3e665	2010-3-15	TEMOZOLOMIDE	NA	CHEMOTHERAPY	0	FALSE	161	NA	NA	NA	NA	4	NA	MG	MG	300	NA	ORAL	NA	NA	ADJUVANT	NA	6000	NA
1286	be3a7ef3-34ed-40e1-9d9c-187940596b26	TCGA.27.2528	TCGA-27-2528-D27031	07529714-e599-44b7-b343-f73097786ec4	2010-3-15	CISPLATIN	NA	CHEMOTHERAPY	-2	FALSE	150	NA	NA	NA	NA	4	NA	MG	MG	60	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	510	NA
1287	be3a7ef3-34ed-40e1-9d9c-187940596b26	TCGA.27.2528	TCGA-27-2528-D27034	49a652e6-acd2-4da0-90c3-e43a27d40340	2010-3-15	DEXAMETHASONE	NA	HORMONE THERAPY	-12	FALSE	480	NA	NA	NA	NA	NA	NA	MG	MG	8	NA	ORAL	NA	NA	ADJUVANT	NA	3928	NA
1288	1e2108e8-b620-4865-a8d8-77f9a0fe28a2	TCGA.28.1745	TCGA-28-1745-D27041	bbf9afd3-e8b7-40d6-a344-53f30e46b441	2009-11-30	TEMOZOLOMIDE	NA	CHEMOTHERAPY	14	FALSE	180	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	2000	NA
1289	1e2108e8-b620-4865-a8d8-77f9a0fe28a2	TCGA.28.1745	TCGA-28-1745-D27040	b5843d8b-64e0-4be7-9af5-a88184de1cbe	2009-11-30	TEMOZOLOMIDE	NA	CHEMOTHERAPY	14	FALSE	180	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	4500	NA
1290	1e2108e8-b620-4865-a8d8-77f9a0fe28a2	TCGA.28.1745	TCGA-28-1745-D27039	c529e7ff-ed78-414f-8cf4-14419b6df1d0	2009-11-30	TEMOZOLOMIDE	NA	CHEMOTHERAPY	14	FALSE	180	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	7000	NA
1291	35a7e49e-747b-45ce-9a07-3a5faba0ca94	TCGA.28.1747	TCGA-28-1747-D27048	806a64cb-04da-4fc3-8f61-0e3421f0e737	2010-3-3	TEMODAR	NA	CHEMOTHERAPY	25	FALSE	36	NA	NA	NA	NA	1	NA	MG	MG	160	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1292	b92047e1-8a76-46dd-baa7-6e629cfaebdb	TCGA.28.1749	TCGA-28-1749-D27053	52628903-6a1f-44e7-b901-60ef095ea2e8	2009-11-30	TEMOZOLOMIDE	NA	CHEMOTHERAPY	19	FALSE	159	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	7560	NA
1293	b92047e1-8a76-46dd-baa7-6e629cfaebdb	TCGA.28.1749	TCGA-28-1749-D27052	cd823ffa-72df-4277-b9da-3d863f877503	2009-11-30	TEMOZOLOMIDE	NA	CHEMOTHERAPY	19	FALSE	159	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	4400	NA
1294	b92047e1-8a76-46dd-baa7-6e629cfaebdb	TCGA.28.1749	TCGA-28-1749-D27054	d7645386-0538-40e1-9a8d-d5c6dbb9f70f	2009-11-30	TEMOZOLOMIDE	NA	CHEMOTHERAPY	19	FALSE	159	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	3800	NA
1295	f077df02-5056-402f-8522-7198c42bcc98	TCGA.28.1750	TCGA-28-1750-D27058	17b02707-6584-4ac8-bbe7-e2c5e80ab9a6	2009-11-30	TEMOZOLOMIDE	NA	CHEMOTHERAPY	10	FALSE	116	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	5040	NA
1296	f077df02-5056-402f-8522-7198c42bcc98	TCGA.28.1750	TCGA-28-1750-D27059	6984ad06-04cc-491a-9f72-96c98e18bcf9	2009-11-30	TEMOZOLOMIDE	NA	CHEMOTHERAPY	10	FALSE	116	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	1250	NA
1297	f077df02-5056-402f-8522-7198c42bcc98	TCGA.28.1750	TCGA-28-1750-D27060	afa173bd-e750-4c6d-81ee-fc443979d5c3	2009-11-30	TEMOZOLOMIDE	NA	CHEMOTHERAPY	10	FALSE	116	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	1700	NA
1298	28df4629-204f-4352-a19f-303a2e067633	TCGA.28.1751	TCGA-28-1751-D27065	6616f149-0f1f-424e-a233-e85d9c89eef2	2009-11-30	TEMOZOLOMIDE	NA	CHEMOTHERAPY	14	FALSE	208	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	6300	NA
1299	28df4629-204f-4352-a19f-303a2e067633	TCGA.28.1751	TCGA-28-1751-D27067	99fc6bac-8a21-46f2-b898-cd2bd3cbfae5	2009-11-30	TEMOZOLOMIDE	NA	CHEMOTHERAPY	14	FALSE	208	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	2100	NA
1300	28df4629-204f-4352-a19f-303a2e067633	TCGA.28.1751	TCGA-28-1751-D27066	9b28579d-7954-4478-add1-83a173f519a0	2009-11-30	TEMOZOLOMIDE	NA	CHEMOTHERAPY	14	FALSE	208	NA	NA	NA	NA	3	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	2600	NA
1301	28df4629-204f-4352-a19f-303a2e067633	TCGA.28.1751	TCGA-28-1751-D27068	67555c1e-94d0-4d77-bbec-3c877cd82953	2009-11-30	DENDRITICCELL VACCINE	NA	IMMUNOTHERAPY	114	FALSE	142	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	OTHER	NA	NA	ADJUVANT	NA	3	NA
1302	68f6976e-d3f2-432d-a121-274e228735b0	TCGA.28.1752	TCGA-28-1752-D27074	74048dab-3f43-4f2c-8a3c-ef7166049a98	2009-11-30	TEMOZOLOMIDE	NA	CHEMOTHERAPY	11	FALSE	272	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	1440	NA
1303	68f6976e-d3f2-432d-a121-274e228735b0	TCGA.28.1752	TCGA-28-1752-D27075	3ebccaa0-bca5-48d7-80f8-931e0536c80e	2009-11-30	TEMOZOLOMIDE	NA	CHEMOTHERAPY	11	FALSE	272	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	3000	NA
1304	68f6976e-d3f2-432d-a121-274e228735b0	TCGA.28.1752	TCGA-28-1752-D27076	820d8a68-e195-4e3d-bcb7-9ffc99819c14	2009-11-30	DENDRITICCELL VACCINE	NA	IMMUNOTHERAPY	105	FALSE	132	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	OTHER	NA	NA	ADJUVANT	NA	3	NA
1305	68f6976e-d3f2-432d-a121-274e228735b0	TCGA.28.1752	TCGA-28-1752-D27072	39720aac-a855-4883-878b-bdbd7e39d450	2009-11-30	TEMOZOLOMIDE	NA	CHEMOTHERAPY	11	FALSE	272	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	5880	NA
1306	68f6976e-d3f2-432d-a121-274e228735b0	TCGA.28.1752	TCGA-28-1752-D27073	7a0e3cd5-2a4d-4930-afaa-9c0cbcfcac13	2009-11-30	TEMOZOLOMIDE	NA	CHEMOTHERAPY	11	FALSE	272	NA	NA	NA	NA	5	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	1800	NA
1307	3c5e7a3f-29b3-4af4-9023-dc7b151f0445	TCGA.28.1755	TCGA-28-1755-D27083	eefae1ae-b1e5-48a2-ad7c-f957d272d02d	2010-1-7	TEMODAR	NA	CHEMOTHERAPY	15	FALSE	NA	NA	NA	NA	NA	1	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	5040	NA
1308	0c0333c9-60dc-4487-baa2-7ec27acced27	TCGA.28.1756	TCGA-28-1756-D27087	75eb9def-c7ef-4d1b-b08d-5c4ae51e968c	2010-3-3	TEMODAR	NA	CHEMOTHERAPY	21	FALSE	69	NA	NA	NA	NA	NA	NA	MG	MG	160	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1309	b7b86c1f-9688-4129-891c-843e3a37b3e5	TCGA.28.1760	TCGA-28-1760-D27093	5a874847-109f-410f-a8a2-41016ee87984	2010-1-7	TEMODAR	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	100	NA
1310	b7b86c1f-9688-4129-891c-843e3a37b3e5	TCGA.28.1760	TCGA-28-1760-D27094	6319bc3a-f044-4e37-b371-fd4aa136963b	2010-1-7	AVASTIN	NA	CHEMOTHERAPY	105	NA	NA	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	1100	NA
1311	b7b86c1f-9688-4129-891c-843e3a37b3e5	TCGA.28.1760	TCGA-28-1760-D27095	61b192e4-d1ca-4691-bfef-8df3b015c88e	2010-1-7	TARCEVA	NA	CHEMOTHERAPY	250	NA	NA	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	150	NA
1312	ec1791b3-0192-45da-89c1-f942a6736704	TCGA.28.2506	TCGA-28-2506-D27103	429562c2-0f8d-46b1-bf6d-48e419003eaf	2010-3-5	TUMOR VACCINE	NA	IMMUNOTHERAPY	107	FALSE	135	NA	NA	NA	NA	NA	NA	ML	ML	1.1	NA	OTHER	NA	NA	ADJUVANT	NA	NA	NA
1313	ec1791b3-0192-45da-89c1-f942a6736704	TCGA.28.2506	TCGA-28-2506-D27102	777e44a6-c875-48eb-9dc9-dd0c4af9edbf	2010-3-5	TEMODAR	NA	CHEMOTHERAPY	27	FALSE	72	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	100	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1314	ec1791b3-0192-45da-89c1-f942a6736704	TCGA.28.2506	TCGA-28-2506-D27104	a4d04704-9263-4fac-87a3-075bb7b1c993	2010-3-5	BIBW 2992	NA	TARGETED MOLECULAR THERAPY	177	TRUE	NA	NA	NA	NA	NA	NA	NA	MG	MG	40	NA	ORAL	NA	NA	PROGRESSION	NA	NA	NA
1315	aa7ad106-eadc-489e-83b2-5698652434ea	TCGA.28.2509	TCGA-28-2509-D27108	dd10383e-bf28-4809-b66e-21c7985f9737	2010-3-5	TEMODAR	NA	CHEMOTHERAPY	33	TRUE	NA	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	75	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1316	aa7ad106-eadc-489e-83b2-5698652434ea	TCGA.28.2509	TCGA-28-2509-D27109	14279a1e-b318-4be0-a943-efdea31c0652	2010-3-5	CILENAITIDE	NA	TARGETED MOLECULAR THERAPY	26	TRUE	NA	NA	NA	NA	NA	NA	NA	MG/DAY	MG/DAY	2000	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1317	4ca9c0f2-1be9-4376-aa27-d9db948d3f68	TCGA.28.2512	TCGA-28-2512-D30234	85952210-1f03-4fd4-9a19-ee2451d72a3f	2012-1-17	ETOPOSIDE	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
1318	4ca9c0f2-1be9-4376-aa27-d9db948d3f68	TCGA.28.2512	TCGA-28-2512-D30233	7bc1772c-6800-4b0d-bde7-bf2e38b2716c	2012-1-17	AVASTIN	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1319	30256f61-7be9-4d47-8afd-afafa7a079c0	TCGA.28.2513	TCGA-28-2513-D27115	0f29aee4-dfd4-4b7f-a9d1-8d21fb5c08ef	2010-3-5	TEMODAR	NA	CHEMOTHERAPY	44	TRUE	NA	NA	NA	NA	NA	NA	NA	MG/DAY	MG/DAY	280	NA	ORAL	NA	NA	RECURRENCE	NA	NA	NA
1320	30256f61-7be9-4d47-8afd-afafa7a079c0	TCGA.28.2513	TCGA-28-2513-D27116	739b689e-cffb-4e28-b9f5-9e3123161578	2010-3-5	AVASTIN	NA	TARGETED MOLECULAR THERAPY	44	TRUE	NA	NA	NA	NA	NA	NA	NA	MG	MG	10	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	460	NA
1321	30256f61-7be9-4d47-8afd-afafa7a079c0	TCGA.28.2513	TCGA-28-2513-D27114	8947a763-53b2-40a0-a9ce-3045abe3762d	2010-3-5	TEMODAR	NA	CHEMOTHERAPY	28	FALSE	57	NA	NA	NA	NA	NA	NA	MG/DAY	MG/DAY	280	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1322	350232cb-b9ba-465b-be9a-81afbc6a92e9	TCGA.28.2514	TCGA-28-2514-D27121	1ffeff3a-bdb6-4243-a5e9-98db4c78b318	2010-3-5	TEMOZOLOMIDE	NA	CHEMOTHERAPY	29	TRUE	NA	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	75	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1323	28da11ec-f46a-4abc-b4c8-bbb784419c71	TCGA.28.5204	TCGA-28-5204-D15042	f15fd67b-7c1d-4a06-83bb-045299cf6d2f	2011-7-14	TEMODAR	NA	CHEMOTHERAPY	9	FALSE	448	NA	NA	NA	NA	NA	NA	MG	MG	140	1	ORAL	NA	NA	ADJUVANT	NA	8160	NA
1324	28da11ec-f46a-4abc-b4c8-bbb784419c71	TCGA.28.5204	TCGA-28-5204-D28859	f826b8bc-7ff9-4eb3-af4e-25a46d7d2a41	2011-7-25	TEMODAR	NA	CHEMOTHERAPY	9	FALSE	448	NA	NA	NA	NA	NA	NA	MG	MG	140	NA	ORAL	NA	NA	ADJUVANT	NA	8160	NA
1325	d9fcf27f-48e3-43fd-a8cf-3db246cf4221	TCGA.28.5207	TCGA-28-5207-D15034	dfedfcb7-239f-4d6d-8e0f-1d5c27c67c61	2011-7-14	TEMODAR	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1326	d9fcf27f-48e3-43fd-a8cf-3db246cf4221	TCGA.28.5207	TCGA-28-5207-D28863	d3e4bb96-77bf-4132-83a2-6e8eb2ff279d	2011-7-22	TEMODAR	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1327	d9fcf27f-48e3-43fd-a8cf-3db246cf4221	TCGA.28.5207	TCGA-28-5207-D28864	994e0573-de17-448c-bcae-921b60cf0143	2011-8-29	NA	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	PROGRESSION	NA	NA	NA
1328	46bfebf4-0ef6-4348-81dc-d7d3cb52c08f	TCGA.28.5208	TCGA-28-5208-D15029	08b63faf-8283-4fd4-8a9d-34e58353221a	2011-7-14	TEMODAR	NA	CHEMOTHERAPY	11	FALSE	49	NA	NA	NA	NA	1	NA	MG	MG	140	1	ORAL	NA	NA	ADJUVANT	NA	5320	NA
1329	46bfebf4-0ef6-4348-81dc-d7d3cb52c08f	TCGA.28.5208	TCGA-28-5208-D28869	c2f92122-7e4d-4bbd-8270-8cb0e357cd11	2011-7-22	TEMODAR	NA	CHEMOTHERAPY	11	FALSE	49	NA	NA	NA	NA	1	NA	MG	MG	140	NA	ORAL	NA	NA	ADJUVANT	NA	5320	NA
1330	46bfebf4-0ef6-4348-81dc-d7d3cb52c08f	TCGA.28.5208	TCGA-28-5208-D15531	1321e800-1342-41f5-ae14-192e2f62ad40	2011-8-23	AVASTIN	NA	CHEMOTHERAPY	287	FALSE	435	NA	NA	NA	NA	5	NA	MG/KG	NA	10	3	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1331	46bfebf4-0ef6-4348-81dc-d7d3cb52c08f	TCGA.28.5208	TCGA-28-5208-D28870	158c3206-0163-441e-811b-fbbc2f29f4a1	2011-8-24	AVASTIN	NA	CHEMOTHERAPY	287	FALSE	435	NA	NA	NA	NA	5	NA	NA	NA	10	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1332	46bfebf4-0ef6-4348-81dc-d7d3cb52c08f	TCGA.28.5208	TCGA-28-5208-D16142	fa0d7a8e-eeda-40fd-9f07-5818987777a4	2011-9-6	TEMODAR	NA	CHEMOTHERAPY	149	FALSE	285	NA	NA	NA	NA	5	NA	MG	MG	390	2	ORAL	NA	NA	RECURRENCE	NA	9750	NA
1333	46bfebf4-0ef6-4348-81dc-d7d3cb52c08f	TCGA.28.5208	TCGA-28-5208-D28871	058a67ec-61c3-47d5-9dac-2de21b2d148a	2011-9-14	CPT11	NA	CHEMOTHERAPY	287	FALSE	435	NA	NA	NA	NA	5	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
1334	46bfebf4-0ef6-4348-81dc-d7d3cb52c08f	TCGA.28.5208	TCGA-28-5208-D28872	cee5e39d-9590-4e49-8d50-f5295a4b4e3e	2011-9-14	TEMODAR	NA	CHEMOTHERAPY	149	FALSE	285	NA	NA	NA	NA	5	NA	MG	MG	390	NA	ORAL	NA	NA	RECURRENCE	NA	9750	NA
1335	46bfebf4-0ef6-4348-81dc-d7d3cb52c08f	TCGA.28.5208	TCGA-28-5208-D16141	633d8ae7-29e0-4f8e-a24c-4f8fffc2fb80	2011-9-16	CPT11	NA	CHEMOTHERAPY	287	FALSE	435	NA	NA	NA	NA	5	NA	NA	NA	NA	3	NA	NA	NA	RECURRENCE	NA	NA	NA
1336	153c2442-ea61-4b5e-8c5c-c71d287c6055	TCGA.28.5209	TCGA-28-5209-D15025	a87875f1-378a-466a-a2e7-2f39634724e9	2011-7-14	TEMODAR	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1337	153c2442-ea61-4b5e-8c5c-c71d287c6055	TCGA.28.5209	TCGA-28-5209-D28877	e8b6763b-1995-4e30-bbea-09c63123dede	2011-7-22	TEMODAR	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1338	cf6689b9-d0fa-4461-a6b7-db477629e258	TCGA.28.5211	TCGA-28-5211-D15038	87940d98-44ec-4352-ba33-c767d0441a46	2011-7-14	TEMODAR	NA	CHEMOTHERAPY	-1	FALSE	57	NA	NA	NA	NA	1	NA	MG	MG	140	1	ORAL	NA	NA	ADJUVANT	NA	8360	NA
1339	cf6689b9-d0fa-4461-a6b7-db477629e258	TCGA.28.5211	TCGA-28-5211-D28881	b5249e40-0eff-4e36-9275-11553d290d59	2011-7-22	TEMODAR	NA	CHEMOTHERAPY	-1	FALSE	57	NA	NA	NA	NA	1	NA	MG	MG	140	NA	ORAL	NA	NA	ADJUVANT	NA	8360	NA
1340	cf6689b9-d0fa-4461-a6b7-db477629e258	TCGA.28.5211	TCGA-28-5211-D15532	26c394c9-c6a5-4f7b-a079-d49da78d9ba2	2011-8-23	AVASTIN	NA	CHEMOTHERAPY	239	FALSE	307	NA	NA	NA	NA	2	NA	NA	NA	NA	2	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1341	cf6689b9-d0fa-4461-a6b7-db477629e258	TCGA.28.5211	TCGA-28-5211-D28882	6d629d3f-a747-4f2c-b286-ba86a4fa3e3d	2011-8-24	AVASTIN	NA	CHEMOTHERAPY	239	FALSE	307	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
1342	cf6689b9-d0fa-4461-a6b7-db477629e258	TCGA.28.5211	TCGA-28-5211-D16144	40061326-41ee-4202-a88c-02cfdc9d3101	2011-9-6	CPT11	NA	CHEMOTHERAPY	239	FALSE	307	NA	NA	NA	NA	2	NA	NA	NA	NA	2	NA	NA	NA	RECURRENCE	NA	NA	NA
1343	cf6689b9-d0fa-4461-a6b7-db477629e258	TCGA.28.5211	TCGA-28-5211-D28883	5ecc75e0-9e8c-4eb0-aa38-e9fd225f00e1	2011-9-14	CPT11	NA	CHEMOTHERAPY	239	FALSE	307	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	NA	NA	NA	RECURRENCE	NA	NA	NA
1344	7338e476-10ff-444a-a16f-429d28355f65	TCGA.28.5213	TCGA-28-5213-D15020	3ac95a2c-03d1-4ccf-a546-7f3f91d3722b	2011-7-14	TEMODAR	NA	CHEMOTHERAPY	11	TRUE	NA	NA	NA	NA	NA	NA	NA	MG/M2/DAY	MG/KG/DAY	1800	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1345	7338e476-10ff-444a-a16f-429d28355f65	TCGA.28.5213	TCGA-28-5213-D28887	f1c6e33c-134a-4f69-94ac-9b6d0b685931	2011-7-22	TEMODAR	NA	CHEMOTHERAPY	11	TRUE	NA	NA	NA	NA	NA	NA	NA	MG/M2/DAY	MG/M2/DAY	140	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1346	7338e476-10ff-444a-a16f-429d28355f65	TCGA.28.5213	TCGA-28-5213-D45679	C33AEB98-A562-4A68-9DE9-07C959EE1F8B	2013-7-24	TEMODAR	NA	CHEMOTHERAPY	9	FALSE	50	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1347	cb4f4617-8260-475d-a650-2f049474b001	TCGA.28.5214	TCGA-28-5214-D14984	cafa9d69-4906-4db6-a3ef-0ec280d5aae8	2011-7-14	TEMODAR	NA	CHEMOTHERAPY	20	TRUE	NA	NA	NA	NA	NA	2	NA	MG/M2/DAY	MG/M2/DAY	1750	1	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1348	cb4f4617-8260-475d-a650-2f049474b001	TCGA.28.5214	TCGA-28-5214-D28891	eb0f0db2-54e3-4e8b-9e18-5ad851ecebe8	2011-7-22	TEMODAR	NA	CHEMOTHERAPY	20	TRUE	NA	NA	NA	NA	NA	2	NA	MG/M2/DAY	MG/M2/DAY	1750	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1349	cb4f4617-8260-475d-a650-2f049474b001	TCGA.28.5214	TCGA-28-5214-D16137	a47ec641-5d90-4ab3-97ea-d3280dfea7bb	2011-8-23	CPT 11	NA	CHEMOTHERAPY	262	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1350	cb4f4617-8260-475d-a650-2f049474b001	TCGA.28.5214	TCGA-28-5214-D15533	8deb61b6-2782-4b98-a72f-9f387b8f1a73	2011-8-23	AVASTIN	NA	CHEMOTHERAPY	262	TRUE	NA	NA	NA	NA	NA	NA	NA	MG/KG	NA	10	2	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1351	cb4f4617-8260-475d-a650-2f049474b001	TCGA.28.5214	TCGA-28-5214-D28892	df4a2641-3134-4707-8a6b-ae20aafe007c	2011-8-24	AVASTIN	NA	CHEMOTHERAPY	262	TRUE	NA	NA	NA	NA	NA	NA	NA	MG/KG	MG/KG	10	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1352	cb4f4617-8260-475d-a650-2f049474b001	TCGA.28.5214	TCGA-28-5214-D28893	93072190-87a7-4b1b-ba78-f8d42a784b19	2011-9-14	CPT 11	NA	CHEMOTHERAPY	262	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1353	cb4f4617-8260-475d-a650-2f049474b001	TCGA.28.5214	TCGA-28-5214-D45678	6A87CF40-AAB3-40BC-9730-C4D442696300	2013-7-24	TEMODAR	NA	CHEMOTHERAPY	20	FALSE	62	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1354	c9e4f0bf-48fc-4600-9e03-314bc575273f	TCGA.28.5215	TCGA-28-5215-D14980	45bf8e0d-0055-4510-9ea7-5731b2042988	2011-7-14	TEMODAR	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1355	c9e4f0bf-48fc-4600-9e03-314bc575273f	TCGA.28.5215	TCGA-28-5215-D28898	46c53037-75c3-47ff-aa55-c53618028097	2011-7-22	TEMODAR	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1356	c9e4f0bf-48fc-4600-9e03-314bc575273f	TCGA.28.5215	TCGA-28-5215-D15535	dca8fe37-54d0-4150-bb28-35abf620db4f	2011-8-23	AVASTIN	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1357	c9e4f0bf-48fc-4600-9e03-314bc575273f	TCGA.28.5215	TCGA-28-5215-D28899	22456782-eacd-445a-8dfa-a5160e482bf9	2011-8-24	NA	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1358	c2f7f72f-13ae-4efc-9cda-69ca037b4498	TCGA.28.5216	TCGA-28-5216-D14978	9586497c-daab-45b2-bdb6-1289fb48e2df	2011-7-14	TEMODAR	NA	CHEMOTHERAPY	29	FALSE	70	NA	NA	NA	NA	10	NA	MG	MG	140	1	ORAL	NA	NA	ADJUVANT	NA	5880	NA
1359	c2f7f72f-13ae-4efc-9cda-69ca037b4498	TCGA.28.5216	TCGA-28-5216-D28903	677fdeab-e273-4253-8ecf-c4033574dbe7	2011-7-22	TEMODAR	NA	CHEMOTHERAPY	29	FALSE	70	NA	NA	NA	NA	10	NA	MG	MG	140	NA	ORAL	NA	NA	ADJUVANT	NA	5880	NA
1360	c2f7f72f-13ae-4efc-9cda-69ca037b4498	TCGA.28.5216	TCGA-28-5216-D45770	F8BE08BA-5F55-40D6-B6F1-0C0F4D20FFD9	2013-7-24	TEMODAR	NA	NA	29	FALSE	70	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1361	d558203d-3f70-42d4-accb-008ace280f48	TCGA.28.5218	TCGA-28-5218-D14973	73ec135b-0979-40c6-a70e-a0cb22a0f163	2011-7-14	TEMODAR	NA	CHEMOTHERAPY	68	FALSE	NA	NA	NA	NA	NA	NA	NA	MG	NA	100	1	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1362	d558203d-3f70-42d4-accb-008ace280f48	TCGA.28.5218	TCGA-28-5218-D28907	3dbbcdd2-8034-488a-94ae-b6061850d23c	2011-7-22	TEMODAR	NA	CHEMOTHERAPY	68	FALSE	NA	NA	NA	NA	NA	NA	NA	MG	MG	100	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1363	567a8bf1-3793-46bc-9943-16302df056ce	TCGA.28.5219	TCGA-28-5219-D14963	2980a09c-4fdf-40f2-9a0d-73e65f80cdb7	2011-7-14	TEMODAR	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1364	567a8bf1-3793-46bc-9943-16302df056ce	TCGA.28.5219	TCGA-28-5219-D28911	be000c06-f2a2-4c17-98e2-89e9a13f222d	2011-7-22	TEMODAR	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1365	8e6b9705-e9d2-4fbc-ac03-35c1a5115eef	TCGA.28.5220	TCGA-28-5220-D14968	754176da-6696-40ea-9c22-c9af774b78c7	2011-7-14	TEMODAR	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1366	8e6b9705-e9d2-4fbc-ac03-35c1a5115eef	TCGA.28.5220	TCGA-28-5220-D28915	b6ac74e6-7590-4cbb-9045-5dfb55c86cca	2011-7-22	TEMODAR	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1367	8e6b9705-e9d2-4fbc-ac03-35c1a5115eef	TCGA.28.5220	TCGA-28-5220-D45778	45D35AC4-6410-4D35-856A-6BD660552781	2013-7-24	TEMODAR	NA	NA	138	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
1368	82ecf2ce-0782-4238-be0a-668a2b22c57c	TCGA.28.6450	TCGA-28-6450-D15046	dee8d206-85e3-46d4-ad9c-a6a909ab3066	2011-7-14	TEMOZOLOMIDE	NA	CHEMOTHERAPY	25	FALSE	41	NA	NA	NA	NA	3	NA	MG	MG	123	1	ORAL	NA	NA	ADJUVANT	NA	2125	NA
1369	82ecf2ce-0782-4238-be0a-668a2b22c57c	TCGA.28.6450	TCGA-28-6450-D28919	70c4d10f-b3c9-44e8-8385-36ad7aaa2392	2011-7-22	TEMOXOLOMIDE	NA	CHEMOTHERAPY	25	FALSE	41	NA	NA	NA	NA	3	NA	MG	MG	125	NA	ORAL	NA	NA	ADJUVANT	NA	2125	NA
1370	6c5154d2-af36-492f-b520-d925528824e4	TCGA.32.1970	TCGA-32-1970-D27720	5a56bde4-e248-481d-949d-2a2081c5e84a	2010-3-15	TEMODAR	NA	CHEMOTHERAPY	28	FALSE	67	NA	NA	NA	NA	NA	NA	MG	MG	170	NA	ORAL	NA	NA	ADJUVANT	NA	6800	NA
1371	6c5154d2-af36-492f-b520-d925528824e4	TCGA.32.1970	TCGA-32-1970-D27721	22a1e898-e102-4e88-a0da-a1e31d13a020	2010-7-6	TEMODAR	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	MG	MG	200	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1372	f6d64459-e639-4557-bf10-a9148263ee26	TCGA.32.1973	TCGA-32-1973-D27727	92c146a5-ed33-460e-a27e-999907f50690	2011-6-15	TEMODAR	NA	CHEMOTHERAPY	22	FALSE	64	NA	NA	NA	NA	NA	NA	NA	NA	300	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1373	f6d64459-e639-4557-bf10-a9148263ee26	TCGA.32.1973	TCGA-32-1973-D27729	1ab2fc02-68f8-4fb9-8194-ac9aa7706fca	2011-6-15	AVASTIN	NA	CHEMOTHERAPY	549	FALSE	631	NA	NA	NA	NA	6	NA	NA	NA	949	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1374	f6d64459-e639-4557-bf10-a9148263ee26	TCGA.32.1973	TCGA-32-1973-D27730	e902c34d-b887-4d7e-a999-5ac5955c0eea	2011-6-15	IRINOTECAN	NA	CHEMOTHERAPY	549	FALSE	631	NA	NA	NA	NA	6	NA	NA	NA	125	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1375	f6d64459-e639-4557-bf10-a9148263ee26	TCGA.32.1973	TCGA-32-1973-D27726	1914aeb1-3d99-4896-b81a-5ed5e5362d9a	2011-6-15	TEMODAR	NA	CHEMOTHERAPY	521	FALSE	542	NA	NA	NA	NA	1	NA	MG	MG	150	NA	ORAL	NA	NA	PROGRESSION	NA	NA	NA
1376	f6d64459-e639-4557-bf10-a9148263ee26	TCGA.32.1973	TCGA-32-1973-D27725	6770b085-082a-4d02-84a3-27e1604c9488	2011-6-15	BIBW2992	NA	CHEMOTHERAPY	521	FALSE	542	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	ORAL	NA	NA	PROGRESSION	NA	NA	NA
1377	f6d64459-e639-4557-bf10-a9148263ee26	TCGA.32.1973	TCGA-32-1973-D27728	23a0a6a7-9fd2-4eec-a9a5-774a34e51303	2011-6-15	TEMODAR	NA	CHEMOTHERAPY	99	FALSE	417	NA	NA	NA	NA	12	NA	NA	NA	390	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1378	f6d64459-e639-4557-bf10-a9148263ee26	TCGA.32.1973	TCGA-32-1973-D27731	a93fe9c1-ad81-4585-88a1-5d8786b4ddc8	2012-1-24	METEXAFIN GADOLINIUM	NA	CHEMOTHERAPY	23	FALSE	32	NA	NA	NA	NA	2	NA	MG/KG	MG/KG	5	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1379	c34760a2-f70e-48c4-a7c2-eb359f8aeb71	TCGA.32.1982	TCGA-32-1982-D27740	4a36d971-b0df-4fd6-9ace-da9a1a671b69	2010-4-7	GLIADEL WAFER	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	WAFER	WAFER	NA	NA	NA	NA	NA	OTHER	PERI-OPERATIVE PLACEMENT	NA	NA
1380	7ac80045-7c05-4e8f-8217-a380544a6125	TCGA.32.1986	TCGA-32-1986-D27743	4d4ed8e9-a057-47ab-a5ee-5c691e916f27	2010-3-8	TEMODAR	NA	CHEMOTHERAPY	126	FALSE	139	NA	NA	NA	NA	1	NA	MG/DAY	MG/DAY	150	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1381	582f0912-20e9-4790-afd9-1e858728223e	TCGA.32.1987	TCGA-32-1987-D27748	59a6a444-f694-4213-9f91-be66bd1dd655	2010-12-20	GLIADLE WAFER	NA	CHEMOTHERAPY	68	FALSE	68	NA	NA	NA	NA	NA	NA	WAFER	WAFER	5	NA	OTHER	NA	NA	PROGRESSION	NA	NA	NA
1382	582f0912-20e9-4790-afd9-1e858728223e	TCGA.32.1987	TCGA-32-1987-D27747	d968cd26-5505-40c6-8704-3557fa0f654c	2010-12-20	TEMODAR	NA	CHEMOTHERAPY	26	FALSE	67	NA	NA	NA	NA	1	NA	MG/DAY	MG/DAY	NA	NA	ORAL	NA	NA	ADJUVANT	NA	120	NA
1383	582f0912-20e9-4790-afd9-1e858728223e	TCGA.32.1987	TCGA-32-1987-D27749	25bd592b-de2d-4135-9b24-45b8b2aca523	2010-12-20	TEMODAR	NA	CHEMOTHERAPY	130	FALSE	134	NA	NA	NA	NA	1	NA	MG/DAY	MG/DAY	250	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1384	582f0912-20e9-4790-afd9-1e858728223e	TCGA.32.1987	TCGA-32-1987-D27750	ea58f330-7359-469a-9eca-224c12f649b2	2011-1-7	AVASTIN	NA	CHEMOTHERAPY	222	FALSE	NA	NA	NA	NA	NA	NA	NA	MG/KG	MG/KG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1385	73655446-bbf3-4cc9-a032-2c95051bc3e7	TCGA.32.1991	TCGA-32-1991-D27755	3e651692-ea42-4c93-8c1a-96bf3304b71e	2010-12-20	TEMODAR	NA	CHEMOTHERAPY	22	FALSE	65	NA	NA	NA	NA	1	NA	MG/DAY	MG/DAY	165	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1386	73655446-bbf3-4cc9-a032-2c95051bc3e7	TCGA.32.1991	TCGA-32-1991-D27757	1085f111-0ec1-4dab-94f0-750fa2b1207b	2010-12-20	TEMODAR	NA	CHEMOTHERAPY	124	FALSE	341	NA	NA	NA	NA	8	NA	MG/DAY	MG/DAY	425	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1387	73655446-bbf3-4cc9-a032-2c95051bc3e7	TCGA.32.1991	TCGA-32-1991-D27754	4d1502ed-6b1a-4c5f-a6b8-36cbb1a14eea	2010-12-20	GLIADEL WAFER	NA	CHEMOTHERAPY	0	FALSE	0	NA	NA	NA	NA	NA	NA	WAFER	WAFER	5	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1388	73655446-bbf3-4cc9-a032-2c95051bc3e7	TCGA.32.1991	TCGA-32-1991-D27756	39c7a0ed-9b64-4257-b0af-e7cc077a23e1	2010-12-20	TEMODAR	NA	CHEMOTHERAPY	94	FALSE	98	NA	NA	NA	NA	1	NA	MG/DAY	MG/DAY	330	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1389	73655446-bbf3-4cc9-a032-2c95051bc3e7	TCGA.32.1991	TCGA-32-1991-D27758	8c0fc1ef-9971-4683-95a6-c0a8ac6c8c97	2010-12-29	TEMODAR	NA	CHEMOTHERAPY	94	FALSE	98	NA	NA	NA	NA	1	NA	MG/DAY	MG/DAY	330	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1390	73655446-bbf3-4cc9-a032-2c95051bc3e7	TCGA.32.1991	TCGA-32-1991-D27759	993e3736-742e-497f-8708-e52433246b2c	2012-1-24	MOTEXAFIN GADOLINIUM	NA	CHEMOTHERAPY	23	FALSE	65	NA	NA	NA	NA	6	NA	MG/KG	MG/KG	5	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1391	ace727ec-036b-4ddc-9af8-eecf70ec6b46	TCGA.32.2491	TCGA-32-2491-D27763	a1a09f4b-70ab-4b99-b68b-241a27ee282b	2010-12-20	TEMODAR	NA	CHEMOTHERAPY	18	FALSE	59	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	160	NA	ORAL	NA	NA	ADJUVANT	NA	6720	NA
1392	ace727ec-036b-4ddc-9af8-eecf70ec6b46	TCGA.32.2491	TCGA-32-2491-D27764	98c6f9e3-f0c7-4982-a591-0f6e38cfd900	2010-12-20	TEMODAR	NA	CHEMOTHERAPY	117	FALSE	122	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	200	NA	ORAL	NA	NA	PROGRESSION	NA	NA	NA
1393	c50998f6-369c-48fe-a8e7-a4c5a4cef0e6	TCGA.32.2494	TCGA-32-2494-D27772	2a332a3a-ca7f-4da6-ac47-152c0d7d6758	2010-12-20	TEMODAR	NA	CHEMOTHERAPY	620	FALSE	632	NA	NA	NA	NA	1	NA	MG/DAY	MG/DAY	140	NA	ORAL	NA	NA	PROGRESSION	NA	NA	NA
1394	c50998f6-369c-48fe-a8e7-a4c5a4cef0e6	TCGA.32.2494	TCGA-32-2494-D27770	e219e486-472b-48ab-850c-fec4200c4587	2010-12-20	TEMODAR	NA	CHEMOTHERAPY	120	FALSE	403	NA	NA	NA	NA	11	NA	MG/M2	MG/M2	360	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
1395	c50998f6-369c-48fe-a8e7-a4c5a4cef0e6	TCGA.32.2494	TCGA-32-2494-D27768	1e3c0434-c474-4a96-9144-9c9432099042	2010-12-20	TEMODAR	NA	CHEMOTHERAPY	20	FALSE	62	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	140	NA	ORAL	NA	NA	ADJUVANT	NA	75	NA
1396	c50998f6-369c-48fe-a8e7-a4c5a4cef0e6	TCGA.32.2494	TCGA-32-2494-D27769	1eeb1090-c56d-446f-8625-60a84daeb2b9	2010-12-20	TEMODAR	NA	CHEMOTHERAPY	90	FALSE	94	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	270	NA	ORAL	NA	NA	ADJUVANT	NA	150	NA
1397	c50998f6-369c-48fe-a8e7-a4c5a4cef0e6	TCGA.32.2494	TCGA-32-2494-D27771	c24fcaeb-2e4c-41fc-8992-b796383b575a	2010-12-20	TEMODAR	NA	CHEMOTHERAPY	488	FALSE	550	NA	NA	NA	NA	4	NA	MG/DAY	MG/DAY	160	NA	ORAL	NA	NA	PROGRESSION	NA	NA	NA
1398	c50998f6-369c-48fe-a8e7-a4c5a4cef0e6	TCGA.32.2494	TCGA-32-2494-D27773	96787b91-a0da-495a-a13c-40b622e695d4	2010-12-20	AVASTIN	NA	TARGETED MOLECULAR THERAPY	488	FALSE	550	NA	NA	NA	NA	NA	NA	MG	MG	600	NA	ORAL	NA	NA	PROGRESSION	NA	NA	NA
1399	c50998f6-369c-48fe-a8e7-a4c5a4cef0e6	TCGA.32.2494	TCGA-32-2494-D27774	3516c9ee-ab98-4cd4-a9f6-8eecd977d1e7	2010-12-20	AVASTIN	NA	TARGETED MOLECULAR THERAPY	620	FALSE	620	NA	NA	NA	NA	NA	NA	MG/KG	MG/KG	NA	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	10	NA
1400	e7d728e5-1a9f-4f27-9604-272e1235e08a	TCGA.32.2495	TCGA-32-2495-D27780	482fa70c-54dc-4643-9a6d-474e56b43982	2010-12-20	TEMODAR	NA	CHEMOTHERAPY	34	FALSE	75	NA	NA	NA	NA	1	NA	NA	NA	140	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1401	e7d728e5-1a9f-4f27-9604-272e1235e08a	TCGA.32.2495	TCGA-32-2495-D27783	e596888d-1a05-4bf9-afe6-bd0e175b9be0	2010-12-20	GLIADEL WAFER	NA	CHEMOTHERAPY	252	FALSE	252	NA	NA	NA	NA	NA	NA	WAFER	WAFER	5	NA	OTHER	NA	NA	PROGRESSION	NA	NA	NA
1402	e7d728e5-1a9f-4f27-9604-272e1235e08a	TCGA.32.2495	TCGA-32-2495-D27784	9e7affcd-7903-4f1c-9350-91e217ee5238	2010-12-20	TEMODAR	NA	CHEMOTHERAPY	278	FALSE	429	NA	NA	NA	NA	5	NA	NA	NA	380	NA	ORAL	NA	NA	PROGRESSION	NA	NA	NA
1403	e7d728e5-1a9f-4f27-9604-272e1235e08a	TCGA.32.2495	TCGA-32-2495-D27782	ed1ee8a5-93e1-41b9-8b4f-4bf7f59e7d6f	2010-12-20	TEMODAR	NA	CHEMOTHERAPY	131	FALSE	192	NA	NA	NA	NA	3	NA	NA	NA	380	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1404	e7d728e5-1a9f-4f27-9604-272e1235e08a	TCGA.32.2495	TCGA-32-2495-D27781	36802f7d-4ae4-4ad3-ab0e-cade10373128	2010-12-20	TEMODAR	NA	CHEMOTHERAPY	103	FALSE	107	NA	NA	NA	NA	1	NA	NA	NA	290	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1405	30011f30-2926-47f2-a8f3-4f1b58ffa227	TCGA.32.2615	TCGA-32-2615-D27791	582aa494-34c7-47ca-ba58-f426d71a2953	2010-6-1	TEMODAR	NA	CHEMOTHERAPY	96	FALSE	100	NA	NA	NA	NA	1	NA	MG/DAY	MG/DAY	NA	NA	ORAL	NA	NA	ADJUVANT	NA	300	NA
1406	30011f30-2926-47f2-a8f3-4f1b58ffa227	TCGA.32.2615	TCGA-32-2615-D27789	9d0f512f-7989-4862-b7ba-d4a3408cd70a	2010-6-1	TEMODAR	NA	CHEMOTHERAPY	26	FALSE	65	NA	NA	NA	NA	NA	NA	MG/DAY	MG/DAY	160	NA	ORAL	NA	NA	ADJUVANT	NA	160	NA
1407	30011f30-2926-47f2-a8f3-4f1b58ffa227	TCGA.32.2615	TCGA-32-2615-D27793	b9b1765a-c2af-43cd-beff-0fc69aaec23f	2010-6-1	GLIADEL WAFERS	NA	CHEMOTHERAPY	285	FALSE	285	NA	NA	NA	NA	NA	NA	WAFER	WAFER	NA	NA	OTHER	NA	NA	NA	NA	NA	NA
1408	30011f30-2926-47f2-a8f3-4f1b58ffa227	TCGA.32.2615	TCGA-32-2615-D27796	d9e68353-6b88-4800-8754-296aea6c596e	2010-6-1	BEVACIZUMAB AVASTIN	NA	TARGETED MOLECULAR THERAPY	301	TRUE	NA	NA	NA	NA	NA	NA	NA	MG/KG	MG/KG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	10	NA
1409	30011f30-2926-47f2-a8f3-4f1b58ffa227	TCGA.32.2615	TCGA-32-2615-D27790	007d3e5a-507e-4dfa-81eb-439bc7a6dd02	2010-6-1	GLIADEL WAFER	NA	CHEMOTHERAPY	0	FALSE	0	NA	NA	NA	NA	NA	NA	WAFER	WAFER	NA	NA	OTHER	NA	NA	ADJUVANT	NA	NA	NA
1410	30011f30-2926-47f2-a8f3-4f1b58ffa227	TCGA.32.2615	TCGA-32-2615-D27792	dc873395-2359-4e2c-99fe-9d44278518b5	2010-6-1	METRONOMIC TEMODAR	NA	CHEMOTHERAPY	161	FALSE	273	NA	NA	NA	NA	4	NA	MG/DAY	MG/DAY	NA	NA	OTHER	NA	NA	ADJUVANT	NA	155	NA
1411	30011f30-2926-47f2-a8f3-4f1b58ffa227	TCGA.32.2615	TCGA-32-2615-D27795	ff336389-7288-40cd-8dca-6e3e471eb4d3	2010-6-1	AVASTIN	NA	TARGETED MOLECULAR THERAPY	301	TRUE	NA	NA	NA	NA	NA	NA	NA	MG/KG	MG/KG	NA	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	10	NA
1412	30011f30-2926-47f2-a8f3-4f1b58ffa227	TCGA.32.2615	TCGA-32-2615-D27794	3b19be5f-2bc7-421a-8614-ede3652c5f26	2010-10-14	GLIADEL WAFER	NA	CHEMOTHERAPY	285	FALSE	285	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	OTHER	NA	NA	RECURRENCE	NA	NA	NA
1413	52408d9f-2637-4952-9b90-cb607a860f23	TCGA.32.2616	TCGA-32-2616-D30228	c8b4b9a7-cea5-4d49-98a7-8916039fc5fd	2010-7-6	MOTEXATIN GADOINIUM	NA	TARGETED MOLECULAR THERAPY	30	FALSE	51	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	50167	NA
1414	52408d9f-2637-4952-9b90-cb607a860f23	TCGA.32.2616	TCGA-32-2616-D30225	b36e4390-7f11-45a9-a266-b7e3135a7730	2010-7-6	TEMODAR	NA	CHEMOTHERAPY	29	FALSE	71	NA	NA	NA	NA	NA	NA	MG	MG	75	NA	ORAL	NA	NA	ADJUVANT	NA	5590	NA
1415	52408d9f-2637-4952-9b90-cb607a860f23	TCGA.32.2616	TCGA-32-2616-D30227	94ef4eb7-70aa-4d22-83ab-e192b3504fb8	2010-7-6	TEMODAR	NA	CHEMOTHERAPY	129	FALSE	161	NA	NA	NA	NA	2	NA	MG	MG	200	NA	ORAL	NA	NA	ADJUVANT	NA	360	NA
1416	52408d9f-2637-4952-9b90-cb607a860f23	TCGA.32.2616	TCGA-32-2616-D30226	0d32cb36-431d-4b6d-b6e8-3973fdc53252	2010-7-6	TEMODAR	NA	CHEMOTHERAPY	101	FALSE	105	NA	NA	NA	NA	1	NA	MG	MG	270	NA	ORAL	NA	NA	ADJUVANT	NA	1350	NA
1417	1030a6b9-0df8-4d60-b69f-2a36e630a6ad	TCGA.32.2634	TCGA-32-2634-D27802	1b38b4c7-7cc1-4d36-8d39-ab4e7d546337	2010-7-30	GLIADEL WAFER	NA	CHEMOTHERAPY	0	FALSE	0	NA	NA	NA	NA	NA	NA	WAFER	WAFER	NA	NA	OTHER	NA	NA	NA	NA	NA	NA
1418	1030a6b9-0df8-4d60-b69f-2a36e630a6ad	TCGA.32.2634	TCGA-32-2634-D27801	add3771c-2c0e-4ab7-84bc-df8f62747058	2010-7-30	TEMODAR	NA	CHEMOTHERAPY	17	TRUE	59	NA	NA	NA	NA	NA	NA	MG	MG	200	NA	ORAL	NA	NA	ADJUVANT	NA	160	NA
1419	1030a6b9-0df8-4d60-b69f-2a36e630a6ad	TCGA.32.2634	TCGA-32-2634-D27803	490e02e6-76ed-4669-a268-f1f558371b0d	2010-9-16	TEMODAR	NA	CHEMOTHERAPY	108	TRUE	NA	NA	NA	NA	NA	11	NA	MG	MG	200	NA	ORAL	NA	NA	OTHER	MAINTAINENCE	NA	NA
1420	1b25795e-69ad-47fd-bb2f-94ff0910fae1	TCGA.32.2638	TCGA-32-2638-D27809	90bfcd5e-eea7-40b7-bf20-e78b8b99204f	2010-8-31	BEVACIZUMAB OR PLACEBO RTOG 0825	NA	TARGETED MOLECULAR THERAPY	49	FALSE	133	NA	NA	NA	NA	NA	NA	MG/KG	MG/KG	10	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1421	1b25795e-69ad-47fd-bb2f-94ff0910fae1	TCGA.32.2638	TCGA-32-2638-D27807	ec5d9310-7853-4497-9be0-12860c642cae	2010-8-31	TEMOZOLOMIDE	NA	CHEMOTHERAPY	26	FALSE	68	NA	NA	NA	NA	NA	NA	MG/DAY	MG/DAY	NA	NA	ORAL	NA	NA	ADJUVANT	NA	190	NA
1422	1b25795e-69ad-47fd-bb2f-94ff0910fae1	TCGA.32.2638	TCGA-32-2638-D27808	34681eed-1319-4185-93b7-7ddea7bfdc42	2010-10-6	TEMOZOLOMIDE	NA	CHEMOTHERAPY	110	FALSE	114	NA	NA	NA	NA	NA	NA	MG/DAY	MG/DAY	NA	NA	ORAL	NA	NA	ADJUVANT	NA	380	NA
1423	581e04f9-4d0b-4ed2-97f5-2f97ace24928	TCGA.32.4208	TCGA-32-4208-D27814	261e05ff-2058-4315-92af-a17b7df4acd8	2010-12-20	TEMODAR	NA	CHEMOTHERAPY	146	FALSE	150	NA	NA	NA	NA	NA	NA	MG/DAY	MG/DAY	300	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1424	581e04f9-4d0b-4ed2-97f5-2f97ace24928	TCGA.32.4208	TCGA-32-4208-D27813	2e92825d-18c1-4950-a770-75a54f507122	2010-12-20	TEMODAR	NA	CHEMOTHERAPY	41	FALSE	84	NA	NA	NA	NA	1	NA	MG/DAY	MG/DAY	140	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1425	581e04f9-4d0b-4ed2-97f5-2f97ace24928	TCGA.32.4208	TCGA-32-4208-D27815	14130a24-dc74-4da4-8d76-676c9cbc3c31	2010-12-20	TEMODAR	NA	CHEMOTHERAPY	174	TRUE	NA	NA	NA	NA	NA	NA	NA	MG/DAY	MG/DAY	300	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1426	5438322c-9db0-4974-ba01-801020559f97	TCGA.32.4209	TCGA-32-4209-D27819	071dac56-27f1-4506-93e0-c68bbb93a043	2010-12-20	TEMODAR	NA	CHEMOTHERAPY	41	FALSE	85	NA	NA	NA	NA	1	NA	MG/M2	MG/M2	NA	NA	ORAL	NA	NA	ADJUVANT	NA	75	NA
1427	5438322c-9db0-4974-ba01-801020559f97	TCGA.32.4209	TCGA-32-4209-D15702	48ce23ce-d98b-4075-b3e0-fbda78dd4ac7	2011-8-16	CCNU	NA	CHEMOTHERAPY	503	FALSE	532	NA	NA	NA	NA	2	NA	MG/KG	MG	100	2	ORAL	NA	NA	PROGRESSION	NA	200	NA
1428	5438322c-9db0-4974-ba01-801020559f97	TCGA.32.4209	TCGA-32-4209-D15701	ced759d1-9f51-4d4c-ac47-b32f89ea6d2a	2011-8-16	AVASTIN	NA	TARGETED MOLECULAR THERAPY	503	FALSE	553	NA	NA	NA	NA	4	NA	MG/KG	MG	10	3	INTRAVENOUS	NA	NA	PROGRESSION	NA	400	NA
1429	516194e7-2143-4049-be54-141f515bcee5	TCGA.32.4211	TCGA-32-4211-D27826	3a3e8c58-3ab2-42d6-92b4-56fab58864ec	2010-12-20	TEMODAR	NA	CHEMOTHERAPY	93	FALSE	97	NA	NA	NA	NA	1	NA	MG/DAY	MG/DAY	330	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1430	516194e7-2143-4049-be54-141f515bcee5	TCGA.32.4211	TCGA-32-4211-D27827	6db77e7e-7c16-4870-8a80-9179a3c3d386	2010-12-20	TEMODAR	NA	CHEMOTHERAPY	127	FALSE	131	NA	NA	NA	NA	1	NA	MG/DAY	MG/DAY	440	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1431	516194e7-2143-4049-be54-141f515bcee5	TCGA.32.4211	TCGA-32-4211-D27825	cb98caea-22bb-45f2-9292-ced22975dff8	2010-12-20	TEMODAR	NA	CHEMOTHERAPY	24	FALSE	65	NA	NA	NA	NA	1	NA	MG/DAY	MG/DAY	160	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1432	22e0c3ea-9f6d-4d73-9282-17ee4553f436	TCGA.32.4213	TCGA-32-4213-D27831	865a82af-3fc7-43e0-917d-4d944cfcc0f3	2010-12-14	TEMODAR	NA	CHEMOTHERAPY	24	FALSE	107	NA	NA	NA	NA	NA	NA	MG/DAY	MG/DAY	NA	NA	ORAL	NA	NA	ADJUVANT	NA	130	NA
1433	22e0c3ea-9f6d-4d73-9282-17ee4553f436	TCGA.32.4213	TCGA-32-4213-D27832	39690c3e-a90a-4837-ad5b-b507484a97d3	2010-12-14	TEMODAR	NA	CHEMOTHERAPY	130	FALSE	135	NA	NA	NA	NA	NA	NA	MG/DAY	MG/DAY	NA	NA	ORAL	NA	NA	ADJUVANT	NA	390	NA
1434	22e0c3ea-9f6d-4d73-9282-17ee4553f436	TCGA.32.4213	TCGA-32-4213-D27833	cde26995-85fe-4eed-8de5-d6bdd50d364b	2010-12-14	TEMODAR	NA	CHEMOTHERAPY	155	FALSE	289	NA	NA	NA	NA	5	NA	MG/DAY	MG/DAY	NA	NA	ORAL	NA	NA	ADJUVANT	NA	400	NA
1435	22e0c3ea-9f6d-4d73-9282-17ee4553f436	TCGA.32.4213	TCGA-32-4213-D15679	20a88f18-2146-46f0-8db1-6211fedf59f2	2011-8-15	AVASTIN	NA	TARGETED MOLECULAR THERAPY	561	TRUE	NA	NA	NA	NA	NA	4	NA	MG	MG	944	4	INTRAVENOUS	NA	NA	PROGRESSION	NA	3776	NA
1436	71bb1ef7-2bda-4478-b5b8-318f2e1bf5ac	TCGA.32.4719	TCGA-32-4719-D27838	177bd4e1-745f-44c9-802e-80d6fc30484e	2010-12-20	TEMODAR	NA	CHEMOTHERAPY	31	FALSE	70	NA	NA	NA	NA	NA	NA	MG/M2	MG/M2	140	NA	ORAL	NA	NA	ADJUVANT	NA	75	NA
1437	71bb1ef7-2bda-4478-b5b8-318f2e1bf5ac	TCGA.32.4719	TCGA-32-4719-D27839	462da949-9f2b-4637-906b-8d44bcda53a0	2010-12-20	TEMODAR	NA	CHEMOTHERAPY	88	FALSE	245	NA	NA	NA	NA	6	NA	MG/M2	MG/M2	380	NA	ORAL	NA	NA	ADJUVANT	NA	200	NA
1438	e876dd29-68b0-4bf1-83d1-488c40068a35	TCGA.32.5222	TCGA-32-5222-D27843	c6cbe0c0-a19b-45c9-bd7e-87d3fe7c6780	2011-1-4	TEMODAR	NA	CHEMOTHERAPY	33	FALSE	77	NA	NA	NA	NA	4	NA	MG	MG	140	NA	ORAL	NA	NA	ADJUVANT	NA	5880	NA
1439	722f462d-f939-4bc1-aae4-8f78b1335a87	TCGA.41.2571	TCGA-41-2571-D27981	859dbe3d-138e-4209-b273-439380cfcf98	2010-6-3	TEMODAR	NA	CHEMOTHERAPY	22	FALSE	25	NA	NA	NA	NA	1	NA	MG	MG	160	NA	ORAL	NA	NA	PALLIATIVE	NA	640	NA
1440	1e80ccf6-ef81-4662-bf5e-392f092c1e67	TCGA.41.2572	TCGA-41-2572-D27985	bf068f08-f341-47c3-b512-53c5700e4ff5	2010-11-18	TEMODAR	NA	TARGETED MOLECULAR THERAPY	34	FALSE	76	NA	NA	NA	NA	NA	NA	MG	MG	180	NA	ORAL	NA	NA	OTHER	CONCURRENT CHEMORADIATION	7740	NA
1441	1e80ccf6-ef81-4662-bf5e-392f092c1e67	TCGA.41.2572	TCGA-41-2572-D27984	007ce491-6d9c-4f0e-9caa-cd5995906d1e	2010-11-18	BEVACIZUMAB	NA	CHEMOTHERAPY	133	FALSE	351	NA	NA	NA	NA	13	NA	MG	MG	1200	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	15600	NA
1442	12084e89-dbc2-43b3-a6d0-0e71e53d0eac	TCGA.41.2573	TCGA-41-2573-D27991	a3d18c13-e136-4a2b-87bf-5044a815f002	2010-6-3	TEMODAR	NA	CHEMOTHERAPY	100	FALSE	142	NA	NA	NA	NA	1	NA	MG	MG	160	NA	ORAL	NA	NA	ADJUVANT	NA	6880	NA
1443	12084e89-dbc2-43b3-a6d0-0e71e53d0eac	TCGA.41.2573	TCGA-41-2573-D27992	dca3ad96-1573-4f51-b941-8658a79b4585	2010-6-3	BSI-201	NA	TARGETED MOLECULAR THERAPY	127	FALSE	142	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1444	12084e89-dbc2-43b3-a6d0-0e71e53d0eac	TCGA.41.2573	TCGA-41-2573-D27990	f4692860-da70-472d-82c2-6f318eb44ae8	2010-6-3	TEMODAR	NA	CHEMOTHERAPY	29	FALSE	71	NA	NA	NA	NA	1	NA	MG	MG	160	NA	ORAL	NA	NA	ADJUVANT	NA	6720	NA
1445	12084e89-dbc2-43b3-a6d0-0e71e53d0eac	TCGA.41.2573	TCGA-41-2573-D27993	c4068185-3336-49fd-99d6-957b2c325c4d	2010-6-3	AVASTIN	NA	TARGETED MOLECULAR THERAPY	171	TRUE	NA	NA	NA	NA	NA	NA	NA	MG/KG	MG/KG	10	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1446	2c922593-d94d-4e8f-b68b-b4b8cfcbf3e4	TCGA.41.2575	TCGA-41-2575-D27998	73405d0f-18d3-43f3-9647-a7b392e6b4fb	2010-6-3	AVASTIN	NA	TARGETED MOLECULAR THERAPY	166	FALSE	166	NA	NA	NA	NA	NA	NA	MG	MG	800	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	800	NA
1447	2c922593-d94d-4e8f-b68b-b4b8cfcbf3e4	TCGA.41.2575	TCGA-41-2575-D27997	35d81a9a-4706-4bba-a29b-4fbd5ca51e15	2010-6-3	TEMODAR	NA	CHEMOTHERAPY	95	FALSE	145	NA	NA	NA	NA	1	NA	MG	MG	140	NA	ORAL	NA	NA	ADJUVANT	NA	7140	NA
1448	6fac5bce-2bc0-4234-9e3e-11891c2fe00e	TCGA.41.3393	TCGA-41-3393-D28005	5040f925-eee6-4347-af3b-cebf0cec314c	2010-11-18	TEMODAR	NA	CHEMOTHERAPY	51	FALSE	95	NA	NA	NA	NA	1	NA	MG	MG	120	NA	ORAL	NA	NA	OTHER	CONCURRENT CHEMORADIATION	5040	NA
1449	43d98306-8b1f-4840-a1a0-146ba0c36400	TCGA.41.3915	TCGA-41-3915-D28010	0d531287-7767-4564-be4c-99ee0c56afa0	2010-10-26	TEMODAR	NA	CHEMOTHERAPY	115	TRUE	NA	NA	NA	NA	NA	3	NA	MG	MG	320	NA	ORAL	NA	NA	ADJUVANT	NA	5200	NA
1450	43d98306-8b1f-4840-a1a0-146ba0c36400	TCGA.41.3915	TCGA-41-3915-D28009	52655b5c-d821-4647-a51a-45e34ed7383b	2010-10-26	TEMODAR	NA	CHEMOTHERAPY	27	FALSE	71	NA	NA	NA	NA	1	NA	MG	MG	160	NA	ORAL	NA	NA	OTHER	CONCURRENT CHEMORADIATION	6880	NA
1451	43d98306-8b1f-4840-a1a0-146ba0c36400	TCGA.41.3915	TCGA-41-3915-D15059	e5656f8e-19c3-436b-817c-50a2641c993c	2011-5-5	TEMODAR	NA	CHEMOTHERAPY	202	FALSE	289	NA	NA	NA	NA	4	NA	MG	MG	400	2	ORAL	NA	NA	ADJUVANT	NA	8000	NA
1452	c184c3ca-7ad3-4202-b108-cb9fd5f5d947	TCGA.41.5651	TCGA-41-5651-D28019	9c394e26-2496-4a2a-beae-f115e84937d8	2011-7-21	AVASTIN	NA	TARGETED MOLECULAR THERAPY	345	TRUE	NA	NA	NA	NA	NA	NA	NA	MG	MG	800	NA	INTRAVENOUS	NA	NA	RECURRENCE	NA	800	NA
1453	c184c3ca-7ad3-4202-b108-cb9fd5f5d947	TCGA.41.5651	TCGA-41-5651-D28018	4de58769-cb3c-4929-8f4f-7517a228ce43	2011-7-21	GLIADEL WAFER CARMUSTINE	NA	CHEMOTHERAPY	231	FALSE	NA	NA	NA	NA	NA	1	NA	WAFER	WAFER	NA	NA	OTHER	NA	NA	RECURRENCE	NA	NA	NA
1454	c184c3ca-7ad3-4202-b108-cb9fd5f5d947	TCGA.41.5651	TCGA-41-5651-D28017	cc7a3d94-37a3-453a-bd42-14500a5d8f30	2011-7-21	TEMOZOLOMIDE	NA	CHEMOTHERAPY	105	FALSE	195	NA	NA	NA	NA	4	NA	MG	MG	350	NA	ORAL	NA	NA	ADJUVANT	NA	6600	NA
1455	c184c3ca-7ad3-4202-b108-cb9fd5f5d947	TCGA.41.5651	TCGA-41-5651-D28016	60baa3a3-2134-4002-ad3b-3c0204da5b42	2011-7-21	TEMOZOLOMIDE	NA	CHEMOTHERAPY	31	FALSE	77	NA	NA	NA	NA	1	NA	MG	MG	140	NA	ORAL	NA	NA	ADJUVANT	NA	6580	NA
1456	c184c3ca-7ad3-4202-b108-cb9fd5f5d947	TCGA.41.5651	TCGA-41-5651-D19527	f335ba4c-5253-4b79-aafa-a55277c8bda3	2011-12-6	AVASTIN	NA	TARGETED MOLECULAR THERAPY	359	FALSE	387	NA	NA	NA	NA	3	NA	MG	MG	850	4	INTRAVENOUS	NA	NA	RECURRENCE	NA	2550	NA
1457	a8d708ab-6388-4d42-bc6e-05a8a718ecff	TCGA.41.6646	TCGA-41-6646-D28024	e3083c20-1ad0-4e48-af69-06f619ebaf21	2011-10-24	TEMOZOLOMIDE	NA	CHEMOTHERAPY	112	FALSE	196	NA	NA	NA	NA	3	NA	MG	MG	320	NA	ORAL	NA	NA	ADJUVANT	NA	5600	NA
1458	a8d708ab-6388-4d42-bc6e-05a8a718ecff	TCGA.41.6646	TCGA-41-6646-D28023	e380dac2-eab0-4fcf-a1c3-d9aa7f9ac98c	2011-10-24	TEMOZOLOMIDE	NA	CHEMOTHERAPY	40	FALSE	81	NA	NA	NA	NA	1	NA	MG	MG	160	NA	ORAL	NA	NA	ADJUVANT	NA	6720	NA
1459	7A8D2E13-315E-4512-85CE-B018D11C3BD3	TCGA.4W.AA9S	TCGA-4W-AA9S-D57927	C1336EBF-B2BD-46FC-BEA2-30355BFE49F7	2014-3-28	TEMOZOLOMIDE	NA	CHEMOTHERAPY	56	FALSE	105	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
1460	998C8517-89C1-43B2-84E4-B60905787BF6	TCGA.4W.AA9T	TCGA-4W-AA9T-D57622	51F91701-01EF-4C07-B456-A046F5A4CC49	2014-3-18	TEMOZOLOMIDE	NA	CHEMOTHERAPY	36	TRUE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
1461	8d0d7a7e-8fae-437d-9b39-f2f17d0f5e4f	TCGA.74.6573	TCGA-74-6573-D16945	5158357e-c66f-4194-8966-f0fca1fb9522	2011-8-22	TEMOZOLOMIDE	NA	CHEMOTHERAPY	24	FALSE	66	NA	NA	NA	NA	1	NA	MG/DAY	MG	140	1	ORAL	NA	NA	ADJUVANT	NA	6020	NA
1462	66a03e91-77c7-4aef-a825-6deef805640c	TCGA.74.6575	TCGA-74-6575-D16936	a393e4d1-27bc-408b-84d9-5947abec5d4e	2011-8-22	AVASTIN	NA	TARGETED MOLECULAR THERAPY	498	TRUE	NA	NA	NA	NA	NA	1	NA	MG/KG	MG/KG	10	4	INTRAVENOUS	NA	NA	RECURRENCE	NA	NA	NA
1463	66a03e91-77c7-4aef-a825-6deef805640c	TCGA.74.6575	TCGA-74-6575-D16933	a282c037-9736-4ebc-84bb-b65a5f23594f	2011-8-22	TEMOZOLOMIDE	NA	CHEMOTHERAPY	96	FALSE	131	NA	NA	NA	NA	2	NA	MG/DAY	MG	200	2	ORAL	NA	NA	RECURRENCE	NA	2000	NA
1464	66a03e91-77c7-4aef-a825-6deef805640c	TCGA.74.6575	TCGA-74-6575-D16934	bd0e8a02-abc6-48f0-b9bb-1c327a772fde	2011-8-22	AVASTIN	NA	TARGETED MOLECULAR THERAPY	152	FALSE	498	NA	NA	NA	NA	1	NA	MG/KG	MG/KG	5	3	INTRAVENOUS	NA	NA	RECURRENCE	NA	255	NA
1465	66a03e91-77c7-4aef-a825-6deef805640c	TCGA.74.6575	TCGA-74-6575-D16931	5d345e5f-8483-4366-9c33-9d7298fb0a49	2011-8-22	TEMOZOLOMIDE	NA	CHEMOTHERAPY	36	FALSE	73	NA	NA	NA	NA	1	NA	MG/DAY	MG	120	1	ORAL	NA	NA	ADJUVANT	NA	4560	NA
1466	9888bf87-d0d1-474b-960d-d76b13352e7c	TCGA.74.6577	TCGA-74-6577-D16926	0ba76d76-6f18-46a6-a4a9-45943f64f9b7	2011-8-22	AVASTIN	NA	TARGETED MOLECULAR THERAPY	132	TRUE	NA	NA	NA	NA	NA	1	NA	MG/KG	MG/KG	10	2	INTRAVENOUS	NA	NA	PROGRESSION	NA	NA	NA
1467	9888bf87-d0d1-474b-960d-d76b13352e7c	TCGA.74.6577	TCGA-74-6577-D16924	2d901e25-b8e9-4c7d-ba3d-d21b177f807f	2011-8-22	TEMOZOLOMIDE	NA	CHEMOTHERAPY	55	FALSE	99	NA	NA	NA	NA	1	NA	MG/DAY	MG	140	1	ORAL	NA	NA	ADJUVANT	NA	6300	NA
1468	4dee170b-175c-4e08-83f4-af1317b07209	TCGA.74.6578	TCGA-74-6578-D16916	1A5A915F-A227-45D6-8DEE-7B4E90AE1645	2011-8-22	TEMOZOLOMIDE	NA	CHEMOTHERAPY	38	FALSE	80	NA	NA	NA	NA	1	NA	MG/DAY	MG	150	1	ORAL	NA	NA	ADJUVANT	NA	6450	NA
1469	4dee170b-175c-4e08-83f4-af1317b07209	TCGA.74.6578	TCGA-74-6578-D16917	A90B91AC-EF99-41F9-A42C-1BD275DC09D0	2011-8-22	TEMOZOLOMIDE	NA	CHEMOTHERAPY	98	FALSE	103	NA	NA	NA	NA	1	NA	MG/DAY	MG	150	2	ORAL	NA	NA	ADJUVANT	NA	750	NA
1470	4dee170b-175c-4e08-83f4-af1317b07209	TCGA.74.6578	TCGA-74-6578-D16918	E3C9CD99-3327-40B9-A7B3-F0C15AA5826B	2011-8-22	AVASTIN	NA	TARGETED MOLECULAR THERAPY	222	TRUE	NA	NA	NA	NA	NA	1	NA	MG/KG	MG/KG	10	3	INTRAVENOUS	NA	NA	PROGRESSION	NA	200	NA
1471	28629bf9-f447-4650-8fc2-53f1e938ab71	TCGA.74.6581	TCGA-74-6581-D16911	b5258e5a-6ef4-471f-80f5-686fac8268f1	2011-8-29	TEMOZOLOMIDE	NA	CHEMOTHERAPY	94	TRUE	NA	NA	NA	NA	NA	6	NA	MG/M2/DAY	MG/M2	200	2	ORAL	NA	NA	ADJUVANT	NA	6000	NA
1472	28629bf9-f447-4650-8fc2-53f1e938ab71	TCGA.74.6581	TCGA-74-6581-D16910	8c98d7d3-f329-49e9-a3d4-21da9ba48c2c	2011-8-29	TEMOZOLOMIDE	NA	CHEMOTHERAPY	26	FALSE	74	NA	NA	NA	NA	1	NA	MG/DAY	MG	150	1	ORAL	NA	NA	ADJUVANT	NA	7350	NA
1473	22b5cbba-cc78-4377-a08c-a9413294c3bf	TCGA.74.6584	TCGA-74-6584-D16905	3b7a36f8-b01b-459b-9779-a9ea7eea3237	2011-8-29	TEMOZOLOMIDE	NA	CHEMOTHERAPY	99	TRUE	NA	NA	NA	NA	NA	5	NA	MG/DAY	MG	120	2	ORAL	NA	NA	PROGRESSION	NA	12600	NA
1474	22b5cbba-cc78-4377-a08c-a9413294c3bf	TCGA.74.6584	TCGA-74-6584-D16903	45baecb1-3a68-442a-8790-e02b10ec1c05	2011-8-29	TEMOZOLOMIDE	NA	CHEMOTHERAPY	21	FALSE	65	NA	NA	NA	NA	1	NA	MG/DAY	MG	150	1	ORAL	NA	NA	ADJUVANT	NA	6750	NA
1475	22b5cbba-cc78-4377-a08c-a9413294c3bf	TCGA.74.6584	TCGA-74-6584-D16904	e9dddcd8-49f1-4a17-a253-862d933efcad	2011-8-29	AVASTIN	NA	TARGETED MOLECULAR THERAPY	98	TRUE	NA	NA	NA	NA	NA	11	NA	MG/M2	MG/M2	10	1	INTRAVENOUS	NA	NA	PROGRESSION	NA	110	NA
1476	872abc8a-6c1f-4114-b993-7d0327fb38bd	TCGA.76.4925	TCGA-76-4925-D28520	8cef6f46-6be3-416a-bc83-e7749f78ff25	2011-4-6	TEMODAR	NA	CHEMOTHERAPY	NA	FALSE	145	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1477	8df94420-c736-4a36-b001-5dbe3dff17f0	TCGA.76.4926	TCGA-76-4926-D28524	35e4183f-a4ff-47ba-affa-3b4b7adf2edd	2011-4-6	TEMODAR	NA	CHEMOTHERAPY	83	FALSE	115	NA	NA	NA	NA	2	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1478	dfa3ef71-7006-4c6d-81c4-e0c0c7b75c26	TCGA.76.4928	TCGA-76-4928-D28530	dea4b05c-6e7c-46a3-a0f7-fed8446cef13	2011-4-6	TEMODAR	NA	CHEMOTHERAPY	NA	FALSE	70	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1479	752a6e21-9a91-417f-beba-bfdf331d5cac	TCGA.76.4931	TCGA-76-4931-D28536	e85bb422-6797-4491-9a76-ff92f29ccdf2	2011-4-6	TEMODAR	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	RECURRENCE	NA	NA	NA
1480	d6de8d1c-e5ff-45cd-b53e-f943d2578713	TCGA.76.4932	TCGA-76-4932-D28540	c51de629-6d65-44b7-8650-b637d6eaa342	2011-4-6	TEMODAR (ESCALATION)	NA	CHEMOTHERAPY	NA	NA	NA	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	NA	NA	NA	NA
1481	8820ca5f-4f6b-4389-ba86-9015d0bcec1d	TCGA.76.4935	TCGA-76-4935-D28546	43c3b07e-27ce-4106-a5ea-7d70d7705997	2011-4-6	TEMODAR	NA	CHEMOTHERAPY	176	TRUE	NA	NA	NA	NA	NA	NA	NA	MG	MG	250	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1482	8820ca5f-4f6b-4389-ba86-9015d0bcec1d	TCGA.76.4935	TCGA-76-4935-D28547	0b95be72-b90d-462c-ad4e-996802e9c0e8	2011-4-6	AVASTIN	NA	CHEMOTHERAPY	11	TRUE	NA	NA	NA	NA	NA	NA	NA	MG	MG	10	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	590	NA
1483	8c3b2851-fced-473c-9c11-731eb66d8f3e	TCGA.76.6191	TCGA-76-6191-D28551	1ab4e260-08cc-4b28-b828-3960daa2d538	2011-9-22	TEMODAR	NA	CHEMOTHERAPY	24	FALSE	423	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1484	8c3b2851-fced-473c-9c11-731eb66d8f3e	TCGA.76.6191	TCGA-76-6191-D28552	d0b09649-545e-41b3-b841-a65e8c509717	2011-9-22	AVASTIN	NA	CHEMOTHERAPY	269	FALSE	423	NA	NA	NA	NA	NA	NA	MG/KG	MG/KG	10	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	NA	NA
1485	68749001-c4c2-415d-830c-07e39c3a504a	TCGA.76.6192	TCGA-76-6192-D28558	fcbdbb77-3971-4f72-89ee-cd7e287e01f2	2011-9-22	TEMODAR	NA	CHEMOTHERAPY	NA	FALSE	75	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1486	aa15f655-c1e9-4f4a-acee-2fb76ec82858	TCGA.76.6193	TCGA-76-6193-D28562	824b4277-ad11-46d8-aada-57230c2b195e	2011-9-22	TEMODAR	NA	CHEMOTHERAPY	9	FALSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1487	6ccc0eda-96f8-475c-9d8c-016b26fdd81d	TCGA.76.6280	TCGA-76-6280-D30215	037b620a-7bfb-458d-976a-52dfddf89bbf	2011-12-9	TEMODAR	NA	CHEMOTHERAPY	27	FALSE	NA	NA	NA	NA	NA	NA	NA	MG	MG	150	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1488	c472482e-225d-4ab0-8ba5-b659e7ff3e89	TCGA.76.6282	TCGA-76-6282-D28567	eb32e1d0-919c-4062-a67b-bcc714d944c7	2011-10-21	AVASTIN	NA	CHEMOTHERAPY	320	FALSE	374	NA	NA	NA	NA	6	NA	MG	MG	890	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	5340	NA
1489	c472482e-225d-4ab0-8ba5-b659e7ff3e89	TCGA.76.6282	TCGA-76-6282-D28566	20576251-852f-4915-a59b-a0c8f7f110bc	2011-10-21	TEMODAR	NA	CHEMOTHERAPY	24	FALSE	213	NA	NA	NA	NA	NA	NA	MG	MG	210	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1490	9e2efb07-826f-4efc-8c69-8625cbc708a6	TCGA.76.6285	TCGA-76-6285-D28571	dc92ae92-3d93-46f6-a02c-e4e8fd94f1f2	2011-9-22	TEMODAR	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	MG	MG	250	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1491	0a211ae1-a48c-4989-9379-04d59500d94d	TCGA.76.6286	TCGA-76-6286-D28574	2b1a6b22-68b4-4928-bf0a-e64f8ac91a05	2011-11-15	TEMODAR	NA	CHEMOTHERAPY	102	FALSE	NA	NA	NA	NA	NA	NA	NA	MG	MG	100	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1492	0a211ae1-a48c-4989-9379-04d59500d94d	TCGA.76.6286	TCGA-76-6286-D28575	b1233c5f-d90f-4d1b-b464-13d3c445590c	2011-11-15	AVASTIN	NA	CHEMOTHERAPY	510	FALSE	580	NA	NA	NA	NA	6	NA	MG	MG	990	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	5940	NA
1493	770aa1ee-aed9-4219-900e-63523cdf312f	TCGA.76.6656	TCGA-76-6656-D28580	87485212-4c9e-4475-befb-307dd8f1493e	2011-11-15	TEMODAR	NA	CHEMOTHERAPY	11	FALSE	NA	NA	NA	NA	NA	NA	NA	MG	MG	140	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1494	3763b815-308f-4b64-a3a7-56822079765f	TCGA.76.6657	TCGA-76-6657-D28584	c4039667-46cd-433f-8595-ca6b7eff6e42	2011-11-15	TEMODAR	NA	CHEMOTHERAPY	NA	FALSE	NA	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1495	19dd2c8f-05ca-44e8-8c19-bac0327f2ea9	TCGA.76.6661	TCGA-76-6661-D28588	c9f107da-f3f0-409d-8d34-39657b179200	2011-11-15	TEMODAR	NA	CHEMOTHERAPY	48	FALSE	115	NA	NA	NA	NA	NA	NA	MG	MG	NA	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1496	92f323c8-dae4-4fdc-a108-148ddc238d1a	TCGA.76.6662	TCGA-76-6662-D30220	3a8a6c5b-73ea-4951-9e84-021e257b29f7	2011-12-9	TEMODAR	NA	CHEMOTHERAPY	88	FALSE	227	NA	NA	NA	NA	NA	NA	MG	MG	100	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1497	92f323c8-dae4-4fdc-a108-148ddc238d1a	TCGA.76.6662	TCGA-76-6662-D30221	8a8ba6a8-1c52-40b3-97d1-2ae40a89d637	2011-12-9	CARMUSTINE	NA	CHEMOTHERAPY	254	TRUE	NA	NA	NA	NA	NA	4	NA	MG	MG	360	NA	INTRAVENOUS	NA	NA	PROGRESSION	NA	1440	NA
1498	933b9daf-a5bf-46cf-92b6-5ddd8279919c	TCGA.76.6663	TCGA-76-6663-D28593	ea54a5eb-afb3-4898-a7f2-33025286fee7	2011-11-15	ICT-107	NA	IMMUNOTHERAPY	93	FALSE	175	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	ADJUVANT	NA	NA	NA
1499	933b9daf-a5bf-46cf-92b6-5ddd8279919c	TCGA.76.6663	TCGA-76-6663-D28592	0f5789e7-64e1-4c8d-ba2d-37faa6578d2a	2011-11-15	TEMODAR	NA	CHEMOTHERAPY	44	TRUE	NA	NA	NA	NA	NA	NA	NA	MG	MG	320	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1500	97b4eeec-7230-446b-b376-6742fae6f6ab	TCGA.76.6664	TCGA-76-6664-D28597	e3e09b68-6edd-4098-bf83-40d26e23ba28	2011-11-15	TEMODAR	NA	CHEMOTHERAPY	6	TRUE	NA	NA	NA	NA	NA	NA	NA	MG	MG	250	NA	ORAL	NA	NA	ADJUVANT	NA	NA	NA
1501	97b4eeec-7230-446b-b376-6742fae6f6ab	TCGA.76.6664	TCGA-76-6664-D28598	2f92f23e-ab72-4607-95e7-3eb280b3e767	2011-11-15	AVASTIN	NA	CHEMOTHERAPY	43	FALSE	223	NA	NA	NA	NA	14	NA	MG	MG	510	NA	INTRAVENOUS	NA	NA	ADJUVANT	NA	7470	NA
1502	05944575-8473-4ed0-9de8-8091018001c2	TCGA.81.5911	TCGA-81-5911-D28605	5d9fc351-082e-409d-990f-dfa8f828cab5	2011-11-14	TEMODAR	NA	CHEMOTHERAPY	104	FALSE	108	NA	NA	NA	NA	1	NA	MG/DAY	MG/DAY	330	NA	ORAL	NA	NA	ADJUVANT	NA	1650	NA
1503	05944575-8473-4ed0-9de8-8091018001c2	TCGA.81.5911	TCGA-81-5911-D28604	0a1a54e6-04da-4738-9796-e88b99aeeac1	2011-11-14	TEMODAR	NA	CHEMOTHERAPY	130	FALSE	260	NA	NA	NA	NA	5	NA	MG/DAY	MG/DAY	440	NA	ORAL	NA	NA	ADJUVANT	NA	11000	NA
1504	05944575-8473-4ed0-9de8-8091018001c2	TCGA.81.5911	TCGA-81-5911-D28603	461bb260-265d-496e-900a-e2b27972049f	2011-11-14	TEMODAR	NA	CHEMOTHERAPY	21	FALSE	69	NA	NA	NA	NA	1	NA	MG/DAY	MG/DAY	160	NA	ORAL	NA	NA	RECURRENCE	NA	6720	NA
1505	ed879063-e603-4151-bf5e-22a4ee210281	TCGA.87.5896	TCGA-87-5896-D43209	4AD0F058-BB58-469D-9D74-C58994F37A48	2013-5-15	TEMODAR	NA	CHEMOTHERAPY	14	FALSE	642	COMPLETE RESPONSE	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	FALSE
